report on the implementation of national residue ... · 2 regulation (ec) no 396/20055 or the...

1

REPORT ON THE IMPLEMENTATION OF NATIONAL RESIDUE MONITORING

PLANS IN THE MEMBER STATES IN 2013 (Council Directive 96/23/EC)

Part I/III - Introduction

This report contains a summary of the Member States' findings and actions taken as a consequence of

the non-compliant results found in food of animal origin through the implementation of Council

Directive 96/23/EC on measures to monitor certain substances and residues thereof in live animals

and animal products1during 2013.

This report consists of three parts. The first part is a general document introducing the other parts and

situating this report in the European Union's legislative framework.

The second part is a compilation and analysis of data of the results obtained in the Member States in

2013. This compilation and analysis of data is broken down by food commodities (bovines, pigs,

sheep and goats, horses, poultry, rabbit, farmed game, wild game, aquaculture, milk, eggs and honey)

and groups of substances (hormones, corticosteroids, beta-agonists, prohibited substances,

antibacterials, other veterinary medicinal products, “other” substances and contaminants). This

technical part of the report is produced by the European Food Safety Authority (EFSA) at the request

of the European Commission, in the framework of Article 31 of Regulation (EC) No 178/20022.

The third part of the report enumerates the follow-up actions in case of non-compliant findings

performed by the individual Member States.

(1) Introduction

Council Directive 96/23/EC on measures to monitor certain substances and residues thereof

in live animals and animal products requires Member States to adopt and implement a

national residue monitoring plan for specific groups of residues. Member States must assign

the task of co-ordinating the implementation of the controls to a central public department or

body. This department is responsible for drawing up the national plan, co-ordinating the

activities of the central and regional departments responsible for monitoring the various

residues, collecting the data and sending the results of the surveys undertaken to the

Commission each year.

The Directive lays down specific sampling levels and frequencies, as well as the groups of

substances to be monitored for each food commodity. Commission Decision 97/747/EC3

lays down additional rules for milk, eggs, honey, rabbits and game.

National monitoring plans should be targeted: samples should be taken with the aim of

detecting illegal treatment or controlling compliance with the maximum residue limits

(MRLs) for veterinary medicinal products set out in Table I in the Annex to Commission

Regulation (EU) No 37/20104, the maximum residue levels for pesticides set out in

1 OJ L 125, 29.4.1996, p. 10-24. 2 Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying

down the general principles and requirements of food law, establishing the European Food Safety

Authority and laying down procedures in matters of food safety. OJ L 31/1, 1.2.2002, p. 1-24. 3 OJ L 303, 6.11.1997, p. 12-15. 4 Commission Regulation (EU) No 37/2010 on pharmacologically active substances and their classification

regarding maximum residue limits in foodstuffs of animal origin (OJ L 15, 20.1.2010, p. 1)

2

Regulation (EC) No 396/20055 or the maximum levels for contaminants laid down in

Regulation (EC) No 1881/20066. This means that in the national plan the Member States

target the groups of animals/gender/age combinations where the probability of finding

residues is the highest. This approach is different from random sampling, where the objective

is to gather statistically significant data, for instance to evaluate consumer exposure to a

specific substance.

Member States must forward annually to the Commission the national monitoring plans,

together with the results of their residue monitoring for the previous year, by 31 March at the

latest. The Directive lays down a procedure by which the plans are approved on a yearly

basis. This procedure involves the Member States.

As laid down in Article 8 of Directive 96/23/EC, the Commission reports to the Member

States, within the Standing Committee on the Food Chain and Animal Health, the outcome

of the checks carried out, in particular on the implementation of the national plans and on the

development of the situation in the various regions of the Community. To this end, the

Commission has summarised the results of the national residue monitoring plans for the year

2013. Trends within the European Union are also indicated by comparison with previous

reports.

The results of the national monitoring plans for 2013 are summarised into the annual report

in Part II/III.

(2) Actions taken as a consequence of non-compliant results

In accordance with Article 8 of Directive 96/23/EC, the Member States were requested, as a

follow-up, to provide information on actions taken at regional and national level. The

objective is to provide an overview of actions taken as a consequence of non-compliant7

results for residues of non-authorised substances or when the maximum residue limits

(MRLs) established in EU legislation are exceeded.

In order to collect information on actions taken as a consequence of non-compliant results,

the Commission sent a questionnaire to the Member States. These actions could be divided

into the following three groups: sampling as suspect, modifications of the national plans and

other actions.

(a) Sampling as suspect

Suspect samples are defined as:

(1) samples taken as a consequence of non-compliant results on samples taken in

accordance with the monitoring plan (Article 5 of Directive 96/23/EC);

(2) samples taken as a consequence of possession or presence of prohibited

substances at any point during manufacture, storage, distribution or sale

throughout the food and feed production chain (Article 11 of Directive

96/23/EC);

(3) samples taken where the veterinarian suspects or has evidence of illegal

treatment or non-compliance with the withdrawal period for an authorised

veterinary medicinal product (Article 24 of Directive 96/23/EC).

5 Regulation (EC) No 396/2005 of the European Parliament and of the Council on maximum residue levels

of pesticides in or on food and feed of plant and animal origin and amending Council Directive

91/414/EEC (OJ L 70, 16.3.2005, p. 1) 6 Commission Regulation (EC) No 1881/2006 setting maximum levels for certain contaminants in

foodstuffs (OJ L 364, 20.12.2006, p. 5) 7 Non-compliant results correspond to the presence of a prohibited substance or to the presence of an

authorised substance above the maximum level allowed in the legislation.

3

In summary, this means that the term “suspect sample” applies to a sample taken as a

consequence of:

– non-compliant results and/or

– suspicion of an illegal treatment at any stage of the food chain and/or

– suspicion of non-compliance with the withdrawal period for an authorised

veterinary medicinal product.

(b) Modifications of the national plan

The national residue monitoring plan aims at detecting illegal treatment of food-

producing animals, controlling compliance with the maximum residue limits for

veterinary medicinal products, the maximum residue levels for pesticides and the

maximum levels for contaminants. Non-compliant results for a specific

substance/group of substances or a specific food commodity should result in

intensified controls for this substance/group or food commodity in the plan for the

following year.

(c) Other actions taken as a consequence of non-compliant results

Article 16 and Articles 22-28 of Directive 96/23/EC prescribe a series of actions

(other than modifications of the residue monitoring plan) to be taken in the case of

non-compliant results or infringements:

• To carry out investigations in the farm of origin, such as verification of records

and additional sampling

• To hold animals in the farm as a consequence of positive findings

• To slaughter animals in case of confirmation of illegal treatment and to send

them to a high risk processing plant

• To intensify the controls in the farms where non-compliant results were found

• To impound carcasses at the slaughterhouse when non-compliant results have

been found

• To declare the carcasses or products of animal origin unfit for human

consumption.

The changes introduced by some Member States for the 2013 plan together with the

responses of the Member States in relation to this type of actions are summarised in Part

III/III.

4

Part II/III

Report for 2013 on the results from the monitoring of veterinary medicinal

product residues and other substances in live animals and animal products8

European Food Safety Authority (EFSA), Parma, Italy

SUMMARY

The present report summarises the monitoring data from 2013 on the presence of residues of

veterinary medicinal products and certain substances in live animals and animal products in the

European Union (EU).

The presence of unauthorised substances, residues of veterinary medicinal products or chemical

contaminants in food may pose a risk factor for public health. The EU legislative framework defines

maximum limits permitted in food and monitoring programmes for the control of the presence of these

substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of

veterinary medicinal products in food-producing animals and animal products. Maximum residue

levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation

(EC) No 396/2005. Commission Regulation (EC) 1881/2006 lays down the maximum limits for the

presence of certain contaminants in animal products. Council Directive 96/23/EC lays down measures

to monitor certain substances and residues thereof, mainly veterinary medicinal products, in live

animals and animal products. Additionally, Commission Decision 97/747/EC lays down levels and

frequencies of sampling for certain animal products.

In the framework of Article 31 of Regulation EC 178/2002, the European Commission (EC) asked the

European Food Safety Authority (EFSA) to produce an annual compilation of the monitoring results

obtained under the provision of Council Directive 96/23/EC. Animal categories and animal products

covered in the monitoring are: bovines, pigs, sheep and goats, horses, poultry, rabbit, farmed game,

wild game, aquaculture, milk, eggs and honey.

Data were collected in aggregated form in a database managed by the European Commission (EC).

Data collected in this form do not allow for an in-depth analysis. The limitations described in the

previous EFSA reports (EFSA, 2010a, b, 2011, 2012, 2013, 2014) were still applicable in the present

analysis.

Altogether, 1,005,835 samples were reported by the 28 EU Member States in the framework of the

residue monitoring in 2013. They consisted of 419,528 targeted samples and 17,561 suspect samples

reported under Council Directive 96/23/EC, 565,417 samples collected in the framework of other

programmes developed under the national legislation and 3,329 samples checked at import. The data

analysis presented in this report was focused on the targeted samples reported under Council Directive

96/23/EC. Samples collected through other sampling strategies (suspect, import or ‘other’) do not

follow a designed monitoring plan; therefore results on those samples were reported separately from

the results on targeted samples.

The majority of the 28 EU Member States fulfilled the minimum requirements for sampling frequency

laid down in Council Directive 96/23/EC and in Commission Decision 97/747/EC.

Of the total targeted samples, 1,299 samples (0.31 %) out of the 419,528 target samples were

non-compliant in 2013.

8 On request from the European Commission, Question No EFSA-Q-2014-00018, approved on 16 December 2014.

5

Non-compliant samples were reported for stilbenes and derivatives (A1) in bovines and pigs (both

0.01 %). For antithyroid agents (A2), there were 0.77 % non-compliant samples, all for thiouracil,

most likely due to feeding diets rich in cruciferous plants. In the group of steroids (A3), non-compliant

samples (all for anabolic steroids) were found in bovines (0.04 %), pigs (0.18 %), sheep and goats

(0.35 %) and horses (1.73 %).The relatively high percentage of non-compliant results in pigs was most

likely the endogenous production. For corticosteroids, non-compliant results for authorised substances

were reported under “other pharmacologically active substances” (B2f) in 2013. In the group of

resorcyclic acid lactones (A4), 0.14 % of the samples were non-compliant for zearalanone and

derivatives. For beta-agonists (A5), there were 0.05 % non-compliant samples. Prohibited substances

(A6) were found in 0.05 % of samples. Substances identified were chloramphenicol (n = 23),

nitroimidazoles (n = 9), nitrofurans (n = 6) and chloroform (n = 2).

For antibacterials (B1), 0.21 % of the samples analysed under the Directive 96/23/EC monitoring were

non-compliant. The highest frequency of non-compliant samples for antibacterials was found in honey

(0.88 %).

In group B2 (other veterinary drugs), the highest proportion of non-compliant samples was found for

anticoccidials (B2b) and “other pharmacologically active substances” (B2f) (both 0.16 %). For

anticoccidials across the different species, the non-compliant results were reported as follows; bovines

(0.05 %), pigs (0.02 %), sheep and goats (0.11 %), poultry (0.15 %), eggs (0.40 %), rabbits (0.34 %)

and farmed game (1.05 %). An important decrease has been observed in the frequency of

non-compliant samples for anticoccidials in poultry (0.16 % in 2013 and 0.15 % in 2012, compared to

0.22 % in 2011, 0.96 % in 2010 and 2.05 % in 2009). Non-compliant samples were observed for

“other pharmacologically active substances” (B2f), in bovines (0.26 %), pigs (0.03 %) and poultry

(0.14 %).

Instances of non-compliance for anthelmintics (B2a) were reported in bovines (0.04 %), pigs (0.07 %),

sheep and goats (0.13 %) and milk (0.08 %). For pyrethroids (B2c), non-compliant samples were for

reported in pigs (0.04 %), aquaculture (0.29 %) and honey (0.12 %). Non-compliant samples were

reported for sedatives (B2d) in pigs (0.03 %). For non-steroidal anti-inflammatory drugs (B2e),

non-compliant samples were found in bovines (0.16 %), pigs (0.16 %), sheep and goats (0.63 %),

horses (0.11 %), poultry (0.27 %) and milk (0.03 %).

In the group B3 (other substances and environmental contaminants), the chemical elements (B3c) had

the highest overall percentage of non-compliant samples (3.9 %), with cadmium, lead, mercury and

copper being most frequently identified. Non-compliant samples were reported for organochlorine

compounds (B3a) and organophosphorus compounds (B3b); 0.16 % and 0.04 %, respectively. For

mycotoxins (B3d), there were non-compliant samples in bovines (4.0 %), pigs (0.96 %), horses

(2.6 %) and milk (1.33 %). Those identified being, zearalenone and derivatives, ochratoxin A,

aflatoxin B1 and aflatoxin M1. Prevalence of dyes (B3e) in aquaculture samples was lower in 2013

(1.14 %) compared to the previous six years (1.5 % - 2.2 %). Substances found were brilliant green,

malachite green, malachite green-leuco, crystal violet and crystal violet-leuco. No non-compliant

samples were noted for “other substances” (B3f).

The overall frequency of non-compliant samples in 2013 (0.31 %), was comparable to the previous six

years (0.25 % - 0.34 %). The frequency of non-compliant samples in 2013 was higher for stilbenes

(A1), antithyroid agents (A2), beta-agonists (A5), carbamates and pyrethroids (B2c), chemical

elements (B3c; mainly metals) and mycotoxins (B3d), compared to the previous six years. For

resorcyclic acid lactones (A4) the number of non-compliant samples had increased in 2013 compared

to the previous 3 years. Noncompliant samples for anthelmintics (B2a) and dyes (B3e) were lower

compared to previous years. No non-compliant samples were reported in 2013 for “other substances”,

however in the previous six years, non-compliant sample frequencies ranged from 0.03 % to 0.21 %.

In 2012 and 2013, the frequency of non-compliant samples for steroids (A3) and anticoccidials (B2b)

were comparable, however, lower compared previous years. Compared to 2012, lower frequencies of

non-compliant samples were noted for sedatives (B2d) and “other pharmacologically active

6

substances” (B2f). For the other substance groups, there were no notable variations over the seven

years. The decrease in the frequency of non-compliant samples for anticoccidials is most likely the

result of the awareness and the measures that followed the implementation of the Commission

Directive 2009/8/EC setting up maximum levels of unavoidable carry-over of coccidiostats in non-

target feed.

The sampling plans and the pattern of substances analysed are not necessarily the same every year and

the prescribing patterns of veterinary medicines vary between species. Therefore, the outcome of the

data analysis at EU level may not accurately reflect the residue situation in each individual EU

Member State and for each species or product category.

7

TABLE OF CONTENTS

Summary .................................................................................................................................................. 4 Table of contents ...................................................................................................................................... 7 Background as provided by the European Commission ........................................................................... 8 Terms of reference as provided by the European Commission ................................................................ 8 Analysis of residue monitoring data ......................................................................................................... 9 1. Introduction ..................................................................................................................................... 9 2. Objectives ...................................................................................................................................... 11 3. Materials and methods ................................................................................................................... 11

3.1. Materials ............................................................................................................................... 11 3.2. Methods ................................................................................................................................ 12

4. Results ........................................................................................................................................... 12 4.1. EU overall assessment .......................................................................................................... 13

4.1.1. Hormones ......................................................................................................................... 15 4.1.2. Beta-agonists .................................................................................................................... 16 4.1.3. Prohibited substances ....................................................................................................... 16 4.1.4. Antibacterials .................................................................................................................... 17 4.1.5. Other veterinary drugs ...................................................................................................... 18 4.1.6. Other substances and environmental contaminants .......................................................... 20 4.1.7. Multi-year comparison ..................................................................................................... 22

4.2. Bovines ................................................................................................................................. 25 4.3. Pigs ........................................................................................................................................ 27 4.4. Sheep and goats..................................................................................................................... 29 4.5. Horses ................................................................................................................................... 31 4.6. Poultry ................................................................................................................................... 32 4.7. Aquaculture ........................................................................................................................... 35 4.8. Milk ....................................................................................................................................... 36 4.9. Eggs ...................................................................................................................................... 38 4.10. Rabbit meat ........................................................................................................................... 40 4.11. Farmed game ......................................................................................................................... 42 4.12. Wild game ............................................................................................................................. 44 4.13. Honey .................................................................................................................................... 46 4.14. Suspect, import and other samples ........................................................................................ 48

Conclusions ............................................................................................................................................ 50 References .............................................................................................................................................. 52 Appendices ............................................................................................................................................. 53 Abbreviations ......................................................................................................................................... 75

8

BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION

Council Directive 96/23/EC9 requires Member States to adopt and implement a national residue

monitoring plan for specific groups of residues. The Directive lays down sampling levels and

frequency, as well as the group of substances to be monitored for each category of live animals or

animal products. Member States must submit to the Commission, by no later than 31 March of each

year, the national monitoring plans together with the monitoring results for the previous year.

According to Article 8.4 of the aforementioned Directive, each year or whenever it deems it necessary,

the Commission shall report to the Member States on the outcome of the surveys. According to Article

8.5, the Commission sends to the European Parliament and the Council a Communication on the

results and actions taken at regional, national or Community level. The Communication is drafted on

the basis of a summary report which includes the main results reported by the Member States as the

outcome of the implementation of national residue plans. Summary reports have been published since

1998. Since 2001, the Commission has published the annual Communication to the Parliament and the

Council10.

TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION

In the framework of Article 31 of Regulation EC No 178/200211, the European Commission asked

EFSA to prepare an annual compilation (report) of the results of residue monitoring in live animals

and animal products in the Member States. EFSA shall present its report to the Member States in the

Standing Committee of the Food Chain and Animal Health (SCFCAH). Together with the comments

from the Member States and the answers to the questionnaires on actions taken as a consequence of

non-compliant results, the Commission will use EFSA’s report for the drafting of the Annual Report

and the Communication to the European Parliament and the European Council.

Data used in the report were collected from Member States under Directive 96/23/EC and stored in the

Commission’s residue application. Directorate General for Health & Consumers (DG SANCO) is in

charge of the overall coordination of the residue data collection from Member States; it performs a

preliminary format check and examines the data for inconsistencies, omissions or misreporting. It also

requests that, where appropriate, the Member States check and update data that have been uploaded

onto the application. When DG SANCO considers that data provided are in line with the requirements

of Directive 96/23/EC, EFSA starts to produce its contribution.

9 Council Directive 96/23/EC on measures to monitor certain substances and residues thereof in live animals and animal

products and repealing Directives 85/358/EEC and 86/469/EEC and Decisions 89/187/EEC and 91/664/EEC. OJ L 125,

23.5.96, p. 10 – 32. 10 Available online: http://ec.europa.eu/food/food/chemicalsafety/residues/control_en.htm 11 Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general

principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in

matters of food safety. OJ L 31, 1.2.2002, p. 1-24.

http://ec.europa.eu/food/food/chemicalsafety/residues/control_en.htm

9

ANALYSIS OF RESIDUE MONITORING DATA

1. Introduction

The presence of unauthorised substances, residues of veterinary medicinal products or chemical

contaminants in food may pose a risk factor for public health. The EU legislative framework defines

maximum limits permitted in food and monitoring programmes for the control of the presence of these

substances in the food chain.

Council Directive 96/23/EC on measures to monitor certain substances and residues thereof in live

animals and animal products requires Member States to adopt and implement a national residue

monitoring plan for the groups of residues detailed in its Annex I in accordance with the sampling

rules referred to in Annex IV. The Directive lays down sampling levels and frequency for bovines,

pigs, sheep and goats, equine animals, poultry and aquaculture, as well as the groups of substances to

be monitored for each food commodity. Commission Decision 97/747/EC12 lays down rules for levels

and frequencies of sampling for milk, eggs, honey, rabbit meat and game.

Member States should forward to the European Commission (EC) the results of their residue

monitoring by 31 March of each year at the latest. National residue control plans should be targeted to

take the following minimum criteria into account: species, gender, age, fattening system, all available

background information and all evidence of misuse or abuse of substances. Additionally, suspect

samples may also be taken as part of the residue control.

The requirements for the analytical methods to be applied in the testing of official samples and the

common criteria for the interpretation of analytical results are laid down in Commission Decision

2002/657/EC13 of 12 August 2002 implementing Council Directive 96/23/EC.

Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with

the maximum levels laid down in the relevant legislation. This means that, in their national plans

Member States target the groups of animals (species, gender, age) where the probability of finding

residues is the highest. Conversely, the objective of random sampling is to collect significant data to

evaluate, for example, consumer exposure to a specific substance.

Suspect samples are taken as a consequence of i) non-compliant results on samples taken in

accordance with the monitoring plan, ii) possession or presence of prohibited substances at any point

during manufacture, storage, distribution or sale through the food and feed production chain, or

iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an

authorised medicinal veterinary product.

Residues of pharmacologically active substances mean active substances, excipients or degradation

products and their metabolites, which remain in food.

Unauthorised substances or products mean substances or products prohibited under European Union

legislation.

Illegal treatment refers to the use of unauthorised substances or products or the use of substances or

products authorised under EU legislation for purposes or under conditions other than those laid down

in EU legislation or, where appropriate, in the various national legislation.

Withdrawal period represents the period necessary between the last administration of the veterinary

medicinal product to animals under normal conditions of use and the production of foodstuffs from

12 Commission Decision 97/747/EC fixing the levels and frequencies of sampling provided for by Council Directive

96/23/EC for the monitoring of certain substances and residues thereof in certain animal products. OJ L 303, 6.11.1997,

p. 12–15. 13 Commission Decision 2002/657/EC of 12 August 2002 implementing Council Directive 96/23/EC concerning the

performance of analytical methods and the interpretation of results. OJ L 221, 17.8.2002, p. 8-36.

10

such animals, in order to ensure that such foodstuffs do not contain residues in quantities in excess of

the maximum limits laid down in EU legislation.

Non-compliant result: since the entry into force of Decision 2002/657/EC14, the term for analytical

results exceeding the permitted limits (in previous reports termed “positives”) is “non-compliant”. The

result of an analysis shall be considered non-compliant if the decision limit of the confirmatory

method for the analyte is exceeded.

Non-compliant sample: is a sample that has been analysed for the presence of one or more substances

and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-

compliant for one or more substances.

Maximum residue limit (MRL) means the maximum concentration of residue resulting from the use

of a veterinary medicinal product which may be accepted by the Community to be legally permitted or

recognised as acceptable in or on a food. For veterinary medicinal products, MRLs are established

according to the procedures laid down in Regulation (EC) No 470/2009 of the European Parliament

and of the Council of 6 May 200915. Pharmacologically active substances and their classification

regarding maximum residue limits are set out in Commission Regulation (EU) No 37/201016 of

22 December 2009. In addition, Commission Directive No 2009/8/EC17 lays down maximum levels of

unavoidable carry-over of coccidiostats or histomonostats in non-target feed and Commission

Regulation (EC) No 124/200918 lays down maximum levels for the presence of coccidiostats or

histomonostats in food resulting from the unavoidable carry-over of these substances in non-target

feed.

For pesticides, MRLs are laid down in Regulation (EC) No 396/200519. Some substances (e.g.

carbamates, pyrethroids, organophosphorus compounds) are recognised both as veterinary medicinal

products and pesticides and therefore they might have different MRLs in the corresponding legislation.

Maximum levels for contaminants are laid down in Commission Regulation (EC) No 1881/200620. For

contaminants where no EU maximum levels had been fixed at the time when data included in this

report were collected, national tolerance levels were applied.

Minimum Required Performance Limits (MRPLs). According to the Annex to Commission

Decision 2002/657/EC, MRPL means the minimum content of an analyte in a sample which has to be

detected and confirmed. It is intended to harmonise the analytical performance of methods for

substances for which no permitted limit has been established. MRPLs for chloramphenicol, nitrofurans

metabolites and medroxyprogesterone acetate were established by Commission Decision

14 Commission Decision 2002/657/EC of 12 August 2002 implementing Council Directive 96/23/EC concerning the

performance of analytical methods and the interpretation of results. OJ L 221, 17.8.2002, p. 1-29. 15 Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community

procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin,

repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of

the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council. OJ L 152, 16.6.2009,

p. 11-22. 16 Commission Regulation (EC) No 37/2010 of 22 December 2009 on pharmacologically active substances and their

classification regarding maximum residue limits in foodstuffs of animal origin. OJ L 15, 20.1.2010, p. 1-72. 17 Commission Directive 2009/8/EC of 10 February 2009 amending Annex I to Directive 202/32/EC of the European

Parliament and of the Council as regards maximum levels of unavoidable carry-over of coccodiostats or histomonostats in

non-target feed. OJ L 40, 11.2.2009, p. 19-25. 18 Commission Regulation (EC) No 124/2009 of 10 February 2009 setting maximum levels for the presence of coccidiostats

or histomonostats in food resulting from the unavoidable carry-over of these substances in non-target feed. OJ L 40,

11.2.2009, p. 7-11. 19 Regulation (EC) 396/2005 of the European Parliament and of the Council of 23 February 20005 on maximum residue

levels of pesticides in or on food and feed of plant and animal origin and amending Council Directive 91/414/EEC. OJ L

70, 16.3.2005, p. 1-16. 20 Commission Regulation (EC) 1881/2006 setting maximum levels for certain contaminants in foodstuffs. OJ L 364,

20.12.2006, p. 5-24.

11

2003/181/EC21 and for malachite and leuco malachite green were established by Commission Decision

2004/25/EC22.

2. Objectives

The present report summarises the monitoring data from 2013 submitted by the Member States to the

European Commission. Data analysis was mainly focused on data submitted under Directive 96/23/EC

and aimed to provide an overview on:

Production volume and number of samples collected in each Member State. These data were

used to check whether the Member States had fulfilled the minimum requirements on

sampling frequency as stated in Directive 96/23/EC and Commission Decision 97/747/EC.

Number of samples analysed in each animal species or food commodity for substance groups

and subgroups as defined in Annex I to Directive 96/23/EC (see Appendix E).

Summary of non-compliant results per animal species or food commodity and substance

group.

Identification of main substances contributing to non-compliant results within a group.

EU overall distribution of non-compliant samples in the substance groups.

3. Materials and methods

3.1. Materials

Data used in this report have been collected from Member States under Directive 96/23/EC and stored

in the residue database of Directorate General for Health and Consumers (DG SANCO). The samples

included in the monitoring were taken from the production process of animals and primary products of

animal origin (live animals, their excrements, body fluids and tissues, animal products, animal feed

and drinking water).

DG SANCO is in charge of the overall coordination of the residue data collection from Member States

(see “Terms of reference”). Each Member State assigns the coordination of the national monitoring

plan to a central public department or body which is also in charge of the data collection at national

level (Directive 96/23/EC Art. 4). The respective institution is also in charge of the aggregation of the

data received from the various central and regional departments. DG SANCO verifies whether or not

the transmitted results are in line with the established monitoring plan and indicates misreporting. In

case of misreporting, the Member States in question are asked to update their data.

Aggregate data are transmitted to the Commission at the following level of detail:

Animal category and animal products: bovines, pigs, sheep and goats, horses, poultry, rabbit,

farmed game, wild game, aquaculture, milk, eggs and honey.

Production volume expressed in number of animals for bovines, pigs, sheep and goats, and

horses, and in tonnes for poultry, rabbit, farmed game, wild game, aquaculture, milk, eggs and

honey.

Sampling strategy: targeted, suspect, import and ‘others’.

Number of samples analysed for each substance group as defined in Annex I to Directive

96/23/EC.

21 Commission Decision 2003/181/EC of 13 March 2003 amending Decision 2002/657/EC as regards the setting of minimum

required performance limits (MRPLs) for certain residues in food of animal origin. OJ L 71, 15.3.2003, p. 17-18. 22 Commission Decision 2004/25/EC of 22 December 2003 amending Decision 2002/657/EC as regards the setting of

minimum required performance limits (MRPLs) for certain residues in food of animal origin. OJ L 6, 10.1.2004, p. 38-39.

12

Number of non-compliant results within each substance group or subgroup and within each

animal category or animal product. Non-compliant results are listed by the substance

identified. Additional information about the non-compliant samples is given in a separate

document (Questionnaires) provided by the Member States. This information is not included

in the database.

In this context, it is important to note that the number of non-compliant samples is not necessarily the

same as the number of non-compliant results. One sample can be non-compliant for more than one

substance and therefore the sum of non-compliant results might be higher than the sum of non-

compliant samples. The information on sample identification, sample matrix and the corresponding

results was not available in the database and thus it was impossible to perform a more elaborate

statistical analysis at the matrix level (e.g. meat, liver, blood, etc.) and to identify the samples non-

compliant for more substances (multi-residues samples).

Since information on the number of total analyses performed for an individual substance was only

transmitted by the Member States which reported at least one non-compliant result for the respective

substance, it was not possible to extract the full spectrum of substances analysed within one group or

subgroup.

3.2. Methods

For the data analysis, the database and the data extraction tools available in DG SANCO’s residue

application were used. Making use of those tools it was possible to extract the production volume

reported by the Member States and the number of samples analysed for each animal species or animal

product category and for each substance group or subgroup. To verify whether the minimum required

sampling frequencies had been fulfilled, a check between the number of samples collected in 2013 and

the production data used by Member States to prepare the 2013 national residue control plans, was

performed. The number of non-compliant samples could be extracted at the group or subgroup level.

At the substance level, only Member States which found at least one non-compliant result reported the

total number of samples analysed for that substance. The shortcomings mentioned in 3.1 represented

considerable limitations in performing a more elaborate statistical analysis. The data used in the

preparation of this report were extracted from the database between 16 October 2014 and 16

December 2014 and are reflective of the database during this time period.

4. Results

The structure and data analysis performed in the present report follows that of previous reports:

The EU overall assessment includes all animal/animal product categories and is presented for

each main substance group.

Assessment of samples analysed, non-compliant samples and non-compliant results are

presented for each animal/animal product category separately.

Suspect samples are evaluated separately from the targeted samples.

Results which were not reported under the Council Directive 96/23/EC (import and ‘others’)

are not included in the overall assessment but treated separately.

Non-compliant results for the individual substances in each animal/animal product category

are listed in Appendix A (targeted samples), Appendix B (suspect samples), Appendix C

(import samples) and Appendix D (‘other’ samples).

Note: The data submitted by Malta on 30 September 2014 was used in this report, however, this

dataset was only partially complete. As a result it was not possible to verify if minimum required

sampling frequencies were fulfilled by this Member State. Furthermore, this report will not be

13

reflective of the data for Malta in DG SANCO’s residue application once the full dataset from Malta

has been submitted after completion of this report.

4.1. EU overall assessment

The aim of this assessment was to give an overview of the total number of samples analysed for the

individual substance groups and to summarise the non-compliant samples for the major substance

groups at EU level. Further details on the non-compliant samples found in each animal/product

category are presented in Sections 4.2 to 4.13.

In 2013, 1,005,835 samples were reported by the 28 Member States for analysis of substances and

residues covered by Directive 96/23/EC. Out of this, 419,528 were targeted samples collected in

conformity with the specifications of the National Residue Control Plans (NRCPs) for 2013.

Additionally, 17,561 suspect samples were reported as follow-up of non-compliant targeted samples or

suspicion of illegal treatment or non-compliance with the withdrawal period. Apart from the data

submitted in accordance to NRCPs, Member States reported in total 565,417 samples collected in the

framework of other programmes developed under the national legislation. Only a relatively limited

number of data (n = 3,329) was reported for samples checked at import. This is because the control of

samples at import is more linked to the third country monitoring than to the residue monitoring in EU;

thus Member States report those results to the EC (using other tools e.g. the Trade Control and Expert

System (TRACES) and the Rapid Alert System for Food and Feed (RASFF).

Of the total targeted samples, 45 % were analysed for substances having an anabolic effect and

unauthorised substances (group A) and 61 % for veterinary drugs and contaminants (group B)23. Of

the 419,528 targeted samples, 1,299 were non-compliant (0.31 %) (1,443 non-compliant results). The

percentage of non-compliant samples calculated from the total number of samples analysed for

substances in that category was: 0.10 % for substances having an anabolic effect and unauthorised

substances (A), 0.21 % for antibacterials (B1), 0.11 % for the “other veterinary drugs” (B2) and 1.7 %

for “other substances and environmental contaminants” (B3) (Table 1, Figure 1).

23 Some samples were analysed for substances in both groups therefore the sum of percentages is higher than 100.

14

Table 1: Number of targeted samples analysed, non-compliant samples and non-compliant results

in all species and product categories

Substance group(a)

Samples analysed Non-compliant samples Non-compliant results

n(b)

% n(c)

% n(d)

A 188,069 45 192 0.10 205

A1 26,978 6.4 3 0.01 3 A2 9,538 2.3 73 0.77 75 A3 42,846 10 35 0.08 37 A4 22,733 5.4 31 0.14 31

A5 40,692 10 19 0.05 19 A6 74,995 18 39 0.05 40

B 256,474 61 1,107 0.43 1,238 B1 124,262 30 258 0.21 283 B2 95,389 23 107 0.11 109

B2a 26,299 6.3 16 0.06 16

B2b 21,800 5.2 34 0.16 34 B2c 8,535 2.0 3 0.04 4 B2d 9,572 2.3 2 0.02 2 B2e 14,343 3.4 21 0.15 21 B2f 19,920 4.7 32 0.16 32

B3 43,956 10 745 1.7 846

B3a 16,689 4.0 26 0.16 50 B3b 8,065 1.9 3 0.04 3 B3c 14,885 3.5 582 3.9 639 B3d 6,981 1.7 96 1.38 131 B3e 1,930 0.46 22 1.14 23 B3f 2,160 0.51 0 0 0

Total 419,528 100 1,299 0.31 1,443 (a): as detailed in Appendix E;

(b): number of samples analysed for one or more substances of the respective group;

(c): number of non-compliant samples for one or more substances in the respective group;

(d): number of non-compliant results; one sample can be non-compliant for more substances therefore the number of non-

compliant results can be higher than the number of non-compliant samples of the same group.

15

Figure 1: Percentage of non-compliant samples in each substance group

4.1.1. Hormones

Directive 96/22/EC prohibits the use of hormones in food producing animals except for well-defined

therapeutic and zootechnical purposes and under strict veterinary control.

This group includes also synthetic, hormonally active substances such as stilbenes and their

derivatives (A1), antithyroid agents (A2) and steroids (A3). Resorcyclic acid lactones (A4) are

hormonally active as well and potentially used for growth promoting purposes, but their presence in

animals and products of animal origin could also be linked to the ingestion of feed contaminated with

fungi belonging to the genus Fusarium.

Of all the targeted samples analysed for the category “hormones” in all animal/product categories

(102,095 samples) there were 142 non-compliant samples (0.14 %) (146 non-compliant results).

The number of targeted samples analysed for stilbenes and derivatives (A1) in all animal/product

categories together was 26,978, of which three samples were non-compliant (0.01). The non-compliant

samples were found in bovines (n = 2; 0.01 %), and pigs (n = 1; 0.01 %). In previous years

(2007 - 2012), no non-compliant samples have been reported for this group.

Antithyroid agents (A2) were analysed in 9,538 targeted samples of which 73 samples were

non-compliant (0.77 %) (75 non-compliant results). All non-compliant samples in the group A2 were

0,0 0,5 1,0 1,5 2,0 2,5 3,0 3,5 4,0

Total

A

A1

A2

A3

A4

A5

A6

B

B1

B2

B2a

B2b

B2c

B2d

B2e

B2f

B3

B3a

B3b

B3c

B3d

B3e

B3f

0,31

0,10

0.01

0,77

0,08

0,14

0,05

0,05

0,43

0,21

0,11

0,06

0,16

0.04

0,02

0,15

0,16

1,7

0,16

0,04

3,9

1,38

1,14

0

% Non-compliant samples

16

for thiouracil. They were found in bovines (n = 62; 1.2 %), pigs (n = 9; 0.3 %), sheep and goats (n = 1;

0.36 %) and rabbits (n = 1; 4.76 %). Residues of thiouracil resulted most probably from feeding diets

rich in cruciferous plants. Pinel et al. (2006) demonstrated that urinary excretion of thiouracil in adult

bovines fed with cruciferous plants can give erroneous indications of the possible illegal use of

thyrostats in meat production animals.

For steroids (A3), of the 42,846 samples analysed in all animal species and product categories,

35 samples were non-compliant (0.08 %) (37 non-compliant results). All 37 non-compliant results

were for anabolic steroids. The non-compliant samples were found in bovines (n = 9; 0.04 %), pigs

(n = 19; 0.18 %), sheep and goats (n = 4; 0.35 %) and horses (n = 3; 1.73 %). Some Member States

indicated that residue findings on steroid hormones may not be attributable to illegal treatment, as the

source was most likely the endogenous production as reported in previous studies (Clouet et al., 1997;

Samuels et al., 1998).

The legal utilisation of corticosteroids (e.g. dexamethasone, betamethasone and prednisone) in the

therapy of food producing animals in the EU, as for any other veterinary medicine, is strictly regulated

in the EU, with withdrawal periods given between treatment and slaughtering. In previous years, some

Member States included authorised corticosteroids under the group A3, whereas others allocated them

to the subgroup B2f (other pharmacologically active substances). The Member States that included all

corticosteroids in group A3 claimed that in this way they have more legal action power against illegal

use. However in 2012 and 2013, following a move towards a common approach in the reporting of

corticosteroids, all Member States with non-compliant results have allocated them under subgroup B2f

and no longer under A3.

For resorcyclic acid lactones (A4), of 22,733 samples analysed in all animal species and product

categories, 31 were found non-compliant (0.14 %) (31 non-compliant results). The non-compliant

results were for bovines (n = 28), pigs (n = 1), horses (n = 1) and poultry (n = 1).

4.1.2. Beta-agonists

Beta-agonists (A5) are used therapeutically in human and animal medicine for specific effects on

smooth muscle. When misused at higher doses, they can also act as growth promoters by stimulating

the increase of the muscular mass and reducing the adipose tissue. Directive 96/22/EC prohibits the

use of beta-agonists in food producing animals except for well-defined therapeutic purposes and under

strict veterinary control. In 2013, 40,692 targeted samples were analysed for beta-agonists and

19 non-compliant samples (0.05 %) were reported for bovines (n = 16) and pigs (n = 3).

4.1.3. Prohibited substances

This group (A6) includes substances listed in Commission Regulation (EU) No 37/2010 under

prohibited substances for which MRLs cannot be established. These substances are not allowed to be

administered to food-producing animals. Examples of substances belonging to this group are

chloramphenicol, nitrofurans and nitroimidazoles.

In the framework of the 2013 residue monitoring, 74,995 targeted samples were analysed for

prohibited substances and 39 samples (0.05 %) were non-compliant (40 non-compliant results).

Altogether, there were 23 non-compliant results for chloramphenicol, six for nitrofurans, nine for

nitroimidazoles and two for chloroform (Table 2).

The distribution of the non-compliant results by individual substances and Member States is presented

in Appendix A.

17

Table 2: Overview on the non-compliant results for prohibited substances

Substance Species

Number of

non-compliant

results

Member States reporting

non-compliant results

Chloramphenicol bovine 7 CZ, DE, NL, PL, UK

pigs 5 AT, DE, IT, PL

sheep/goats 1 AT

poultry 6 CZ, DE, PL

milk 3 LV, SI, SK

farmed game 1 CZ

Chloroform (Trichlormethane) milk 2 DE

Nitrofurans

SEM (semicarbazide) bovine 2 IE

sheep/goats 1 IE

AMOZ (5-methylmorpholino-3- poultry 2 GR, PT

amino-2-oxazolidone) rabbit 1 IT

Nitroimidazoles

Metronidazole pigs 4 DE, FR

poultry 2 CZ

honey 1 PL

Dimetridazole pigs 1 CZ

Ipronidazole pigs 1 CZ

4.1.4. Antibacterials

The group of antibacterials (B1) includes antibiotics (e.g. beta-lactams, tetracyclines, macrolides,

aminoglycosides) but also sulphonamides and quinolones.

The total number of analyses carried out in 2013 for antimicrobials in targeted samples was 124,262,

of which 258 (0.21 %) were non-compliant (283 non-compliant results) (Table 1). The highest

frequency of non-compliant samples for antibacterials was observed in honey (0.88 %) (Figure 2).

It is important to mention that in some Member States there are specific control programmes which

use microbiological tests (inhibitor tests). In some cases, a positive result in a microbiological test is

sufficient to reject the sample. This may mean that no confirmation by a physico-chemical method is

carried out and thus there is no conclusive identification of the substance concerned. In other cases, a

positive result in the screening test is confirmed by means of an immunochemical or physico-chemical

test and it is then possible to identify the substance and establish whether its concentration is above the

MRL or not.

18

Figure 2: Number of targeted samples analysed and percentage of non-compliant samples for

antibacterials (B1) in animal/product categories

4.1.5. Other veterinary drugs

The group “other veterinary drugs” (B2) includes a variety of veterinary medicinal products classified

according to their pharmacological action in:

• Anthelmintics (B2a)

• Anticoccidials (B2b)

• Carbamates and pyrethroids (B2c)

• Sedatives (B2d)

• Non-steroidal anti-inflammatory drugs (NSAIDs) (B2e) and

• Other pharmacologically active substances (B2f)

In the 2013 monitoring, 95,389 targeted samples were analysed for substances in the group B2 and

107 samples (0.11 %) were non-compliant. The total number of targeted samples analysed for each

subgroup in the group B2 and the percentage of non-compliant samples is presented in Figure 3. It is

important to note that the frequency of analyses for substances in the B2 subgroups follows a different

pattern in each species, depending on their animal specific therapeutic application. For example, in

bovines, the anthelmintics, NSAIDs and other pharmacologically active substances (corticosteroids are

largely represented in this subgroup) were more frequently analysed than anticoccidials or sedatives.

In poultry, anticoccidials was the largest subgroup. An overview of the number of samples analysed

and the percentage of non-compliant samples for the B2 subgroups in the specific animal/product

category is presented in Table 3.

1.931

6

445

1.177

4.730

15.366

1.704

19.769

916

8.663

45.474

24.081

0 20.000 40.000 60.000

Honey

Wild game

Farmed game

Rabbit

Eggs

Milk

Aquaculture

Poultry

Horses

Sheep/goats

Pigs

Bovines

Number of samples analysed

0,88

0,00

0,00

0,85

0,19

0,10

0,06

0,15

0,00

0,31

0,19

0,26

0,00 1,00 2,00

Honey

Wild game

Farmed game

Rabbit

Eggs

Milk

Aquaculture

Poultry

Horses

Sheep/goats

Pigs

Bovines


19

Figure 3: Number of targeted samples analysed within the group “other veterinary drugs” (B2) and

the percentage of non-compliant samples

Table 3: Number of targeted samples analysed for B2 subgroups in different animal categories and

the frequency of non-compliant samples (percentage from the total number of samples analysed in

each animal category)

Group B2a B2b B2c B2d B2e B2f

n % nc n % nc n % nc n % nc n % nc n % nc

Bovines 4,743 0.04 1,874 0.05 1,516 0 2,107 0 4,506 0.16 11,064 0.26

Pigs 7,537 0.07 6,033 0.02 2,224 0.04 6,718 0.03 4,255 0.16 5,868 0.03

Sheep/goats 3,151 0.13 876 0.11 1,031 0 494 0 474 0.63 531 0

Horses 211 0 105 0 99 0 168 0 926 0.11 262 0

Poultry 3,223 0 7,905 0.15 1,727 0 5 0 737 0.27 708 0.14

Aquaculture 661 0 67 0 344 0.29 0.00 0 0 0 135 0

Milk 5,911 0.08 371 0 461 0 56 0 3327 0.03 780 0

Eggs 327 0 4043 0.40 122 0 2 0 17 0 128 0

Rabbit 156 0 292 0.34 72 0 9 0 46 0 51 0

Farmed game 251 0 191 1.05 99 0 13 0 55 0 9 0

Wild game 74 0 0 0 33 0 0 0 0 0 2 0

Honey 54 0 43 0 807 0.12 0 0 0 0 382 0

n: Number of samples analysed; % nc: Percentage of non-compliant samples.

Regarding the number of samples analysed in each B2 subgroup, the highest proportion of

non-compliant samples (0.16 %). was observed for both anticoccidials (B2b) and “other

pharmacologically active substances” (B2f).

For anticoccidials (B2b), non-compliant samples were reported in bovines (0.05 %), pigs (0.02 %),

sheep and goats (0.11 %), poultry (0.15 %), eggs (0.40 %), rabbits (0.34 %) and farmed game

(1.05 %).

For “other pharmacologically active substances” (B2f), non-compliant samples were observed for

bovines (0.26 %), pigs (0.03 %) and poultry (0.14 %). For corticosteroids, 31 non-compliant results

were reported by seven Member States and all except two results were reported for bovines.

26.299

21.800

8.535

9.572

14.343

19.920

0 10000 20000 30000

B2a

B2b

B2c

B2d

B2e

B2f


0,06

0,16

0,04

0,02

0,15

0,16

0,00 0,05 0,10 0,15 0,20

B2a

B2b

B2c

B2d

B2e

B2f


20

Substances identified were dexamethasone (n = 24), prednisolone (n = 5) and flumethasone (n = 2)

(Table 4). It is important to note that recent studies suggest that prednisolone could be produced

endogenously by animals, especially by those found in a state of stress (Pompa et al., 2011; Fidani et

al., 2012).

Table 4: Overview on corticosteroids non-compliant results (B2f)

Substance Substance

group(a)

Species Number of non-

compliant results

Member States reporting


Dexamethasone B2f Bovine 24 DE, ES, IT, NL

Flumethasone B2f Pigs 2 ES

Prednisolone B2f Bovine 5 BE, FR, LT

(a): as detailed in Appendix E.

Non-compliant samples for anthelmintics (B2a) were reported in bovines (0.04 %), pigs (0.07 %),

sheep and goats (0.13 %), and milk (0.08 %).

For pyrethroids (B2c), non-compliant samples were noted for pigs (0.04 %), aquaculture (0.29 %) and

honey (0.12 %).

There were non-compliant samples reported for sedatives (B2d) in pigs (0.03 %).

For non-steroidal anti-inflammatory drugs (B2e), non-compliant samples were reported in bovines

(0.16 %), pigs (0.16 %), sheep and goats (0.63 %), horses (0.11 %), poultry (0.27 %) and milk

(0.03 %).

More details on the number of samples analysed and the non-compliant samples found in each

category are given in Sections 4.2 to 4.13 and in Appendix A.

4.1.6. Other substances and environmental contaminants

The group “other substances and environmental contaminants" (B3) includes the following

subcategories:

• Organochlorine compounds including PCBs (B3a)

• Organophosphorus compounds (B3b)

• Chemical elements (B3c)

• Mycotoxins (B3d)

• Dyes (B3e) and

• Others (B3f)

In the 2013 residues monitoring, 43,956 samples were analysed for substances in group B3 of which

745 samples were non-compliant (1.7 %) (846 non-compliant results). The total number of targeted

samples analysed for each subgroup in group B3 and the percentage of non-compliant samples is

presented in Figure 4. Similar to group B2, the frequency of analyses for certain B3 subgroups is

highly variable with the targeted animal/product category. While chemical contaminants (B3c) are

analysed in all animal/product categories, dyes (B3e) are analysed only in aquaculture products. An

overview of the number of samples analysed and the percentage of non-compliant samples for the B3

subgroups in the specific animal group and animal product category is presented in Table 5.

21

The highest percentage of non-compliant samples was found, in almost all species, in the subgroup

B3c "chemical elements" (3.9 %). Similar to previous years, cadmium, lead, mercury and copper were

the chemical elements frequently identified as responsible for non-compliance.

Instances of non-compliance for organochlorine compounds (B3a) and organophosphorus compounds

(B3b) were 0.16 % and 0.04 %, respectively.

There were non-compliant samples reported in subgroup B3d mycotoxins (n = 96; 1.38 %), for

bovines (n = 44; 4.0 %), pigs (n = 19; 0.96 %), horses (n = 2; 2.6 %) and milk (n = 31; 1.33 %). Those

identified being, zearalenone and derivatives, ochratoxin A, aflatoxin B1 and aflatoxin M1.

Dyes (B3e) were reported in aquaculture (22 non-compliant samples; 1.14 %). Substances found were

brilliant green, malachite green, leuco-malachite green, crystal violet and leuco-crystal violet. There

were no non-compliant samples in the subgroup “others” (B3f).

More details on the number of samples analysed and non-compliant samples in each category are

given in the Sections 4.2 to 4.13 and in Appendix A.

Figure 4: Number of samples analysed within the group “other substances and environmental

contaminants” (B3) and the percentage of non-compliant samples

0,16

0,04

3,9

1,38

1.14

0

0,0 1,0 2,0 3,0 4,0 5,0

B3a

B3b

B3c

B3d

B3e

B3f


16.689

8.065

14.885

6.981

1.930

2.160

0 5000 10000 15000 20000

B3a

B3b

B3c

B3d

B3e

B3f


22

Table 5: Number of targeted samples analysed for B3 subgroups in different animal and product

categories and the frequency of non-compliant samples (percentage from the total number of samples

analysed in each animal/product category)

Group

B3a B3b B3c B3d B3e B3f

n % nc n % nc n % nc n % nc n % nc n % nc

Bovines 2,997 0.13 1,559 0 2,623 6.02 1,101 4.00 0 0 253 0

Pigs 4,016 0.05 2,269 0.04 3,951 3.67 1,969 0.96 0 0 622 0

Sheep/goats 929 0.65 1035 0 876 3.42 215 0 1 0 18 0

Horses 144 0.69 93 0 659 3.95 77 2.60 0 0 9 0

Poultry 2,932 0 908 0 1,846 0.11 943 0 0 0 211 0

Aquaculture 670 0.15 92 0 681 1.03 262 0 1929 1.14 172 0

Milk 1,760 0.11 771 0 965 0.10 2328 1.33 0 0 169 0

Eggs 2,009 0.10 393 0 159 0 8 0 0 0 191 0

Rabbit 146 0 18 0 116 0 17 0 0 0 2 0

Farmed game 182 0.55 40 0 259 5.79 35 0 0 0 36 0

Wild game 296 2.36 47 0 2171 8.75 0 0 0 0 156 0

Honey 608 0 840 0.24 579 1.38 26 0 0 0 321 0

n: number of samples analysed; % nc: percentage of non-compliant samples.

4.1.7. Multi-year comparison

It is important to note that this analysis is based on data that were partially aggregated. In addition, the

number of samples analysed for each substance and animal/product category was not necessarily the

same over the six years. Therefore this analysis should be regarded as having a certain degree of

uncertainty. The purpose of this exercise was to check whether major variations of the proportion of

non-compliant samples occurred at substance group level in the EU. When such variations are noted, a

more in-depth analysis of the monitoring plans per species, country and pattern of substances analysed

has to be carried out in order to identify the trigger for the differences observed and in consequence to

take corrective measures.

An overall picture covering the period 2007 - 2013 (EU 28) is presented in Figure 5. The percentage

of overall non-compliant samples in 2013 (0.31 %) was in the same range as the previous six years

(0.25 % - 0.34 %).

23

Figure 5: Percentage of non-compliant samples reported in relation to the total number of targeted

samples analysed for the respective group in 2007, 2008, 2009, 2010, 2011, 2012 and 2013 (substance

groups are detailed in Appendix E)

Among hormones and prohibited substances (group A) the proportion of non-compliant samples in

2013 (0.10 %) was similar to the previous three years. For the first time in seven years, non-compliant

samples (0.01 %) were reported for stilbenes and derivatives (A1). The percentage of non-compliant

samples was higher in 2013 for antithyroid agents (A2) (0.77 %) and for beta-agonists (A5) (0.05 %),

compared to the previous six years, (0.33 % - 0.63 %) and (0.01 % - 0.03 %), respectively. In 2013,

the percentage of non-compliant samples for steroids (A3) was comparable to that of 2012 and lower

compared to previous years (2007 – 2011). This change is considered to be due to Member States

reporting authorised corticosteroids under group B2f only, instead of also under group A3, since 2012.

The percentage of non-compliant samples reported in 2013 for resorcyclic acid lactones (A4) (0.14 %)

was higher compared to the previous three years (0.07 % - 0.09 %), although lower compared to

2007 - 2009 (0.17 % - 0.23 %). For prohibited substances (A6), the proportion of non-compliant

samples has remained at very low levels over the seven years (0.04 % - 0.09 %).

In the group of antibacterials (B1), the percentage of non-compliant samples in 2013 (0.21 %) was

similar compared to the previous six years (0.18 % - 0.29 %).

In the group B2 (other veterinary drugs), the proportion of non-compliant samples for anthelmintics

(B2a) increased slightly from 0.05 % in 2007 to 0.18 % in 2010, however in 2011 and 2012 the

number of non-compliant samples decreased to 0.08 and 0.09 %, respectively and in 2013 the number

of samples was even lower (0.06 %).

For anticoccidials (B2b), from 2007 - 2011 this subgroup had the highest proportion of non-compliant

samples (0.26 % - 1.6 %), however in 2012 and 2013 the percentage of non-compliant samples was

lower compared to previous years (0.15 % and 0.16 %, respectively). Since 2009 a decrease in the

number of non-compliant samples has been recorded for this group, with the most notable effect

present in poultry where the frequency of non-compliant samples dropped from 2.05 % in 2009, to

0.96 % in 2010, to 0.22 % in 2011, to 0.16 % in 2012 and to 0.15 % in 2013. This development is

most likely the result of the awareness raised by and the measures taken after Commission Directive

2009/8/EC laying down maximum levels of unavoidable carry-over of coccidiostats in non-target feed

entered into force.

Tota

lA A1 A2 A3 A4 A5 A6 B B1 B2 B2a B2b B2c B2d B2e B2f B3 B3a B3b B3c B3d B3e B3f

2007 0,32 0,15 0 0,41 0,27 0,23 0,02 0,09 0,42 0,27 0,30 0,05 1,1 0,01 0,15 0,1 0,17 1,0 0,2 0 2,3 0,39 2,2 0,09

2008 0,34 0,17 0 0,46 0,36 0,22 0,01 0,07 0,45 0,29 0,42 0,12 1,6 0,03 0 0,2 0,22 0,99 0,38 0,03 1,9 0,48 1,5 0,21

2009 0,32 0,18 0 0,46 0,39 0,17 0,01 0,07 0,39 0,21 0,26 0,16 1,0 0,02 0 0,11 0,21 1,1 0,19 0,04 2,6 0,22 1,7 0,05

2010 0,33 0,11 0 0,47 0,19 0,09 0,02 0,05 0,46 0,23 0,21 0,18 0,43 0,01 0 0,19 0,18 1,5 0,10 0,03 3,6 0,14 1,8 0,03

2011 0,28 0,09 0 0,63 0,11 0,08 0,03 0,04 0,40 0,19 0,12 0,08 0,26 0,01 0,01 0,11 0,07 1,5 0,17 0,03 3,4 0,40 1,8 0,04

2012 0,25 0,07 0 0,33 0,09 0,07 0,01 0,05 0,36 0,18 0,14 0,09 0,15 0 0,05 0,16 0,26 1,2 0,21 0,04 2,9 0,33 1,95 0,08

2013 0,31 0,10 0,01 0,77 0,08 0,14 0,05 0,05 0,43 0,21 0,11 0,06 0,16 0,04 0,02 0,15 0,16 1,7 0,16 0,04 3,9 1,38 1,14 0

0

0,5

1

1,5

2

2,5

3

3,5

4

4,5%

Non

-com

pli

ant

sam

ple

s

24

Non-compliant samples for carbamates and pyrethroids (B2c) were found in only a few isolated cases

in the previous five years (0.01 % - 0.03 %), and in 2012 no non-compliant samples were reported. In

2013, the percentage of non-compliant samples was slightly higher compared to previous years

(0.04 %). For sedatives (B2d), no non-compliant samples were reported between 2008 – 2010 and

only one sample was reported in 2011 (0.01 %). In 2012 this number had risen slightly (0.05 %),

however in 2013 the number of non-compliant samples had decreased to 0.02 %.

In the group B2e (non-steroidal anti-inflammatory drugs) the proportion of non-compliant samples has

remained relatively constant over the seven years (around 0.1 % - 0.2 %). For “other

pharmacologically active substances" (B2f), the percentage of non-compliant samples in 2013

(0.16 %) was comparable to the period 2007 – 2010 (0.17 % - 0.22 %). In 2011 the percentage of

non-compliant samples decreased to 0.07 %, however in 2012, the highest percentage of

non-compliant samples was reported (0.26 %) for this subgroup.

In the group of “other substances and environmental contaminants” (B3), the percentage of

non-compliant samples increased from approximately 1 % in 2007 – 2009 to 1.5 % in 2010 and 2011,

however in 2012 the number decreased slightly to 1.2 %. In 2013 the number of non-compliant

samples was slightly higher compared to the previous years (1.7 %).

The highest proportion of non-compliant samples in the group B3 has been noted for chemical

elements (B3c) over the seven years. The non-compliant samples accounted for around 2 % in 2007

and 2008 and for 3.6 % in 2010, 3.4 % in 2011, 2.9 % in 2012 and 3.9 % in 2013. This evolution is

mainly explained by the practice introduced since 2009 with regard to the legal basis applied for

compliance checking for mercury and copper. Commission Regulation (EC) No 1881/2006 specifies

maximum limits for mercury only in aquaculture and does not specify any maximum limits for copper

in food. Since 2009, the maximum limits laid down in Commission Regulation (EC) No 149/200824

amending Regulation (EC) No 396/2005 are applied to evaluate the compliance for copper and

mercury (except for aquaculture) which led to a substantial higher proportion of non-compliant

samples for the two chemical elements. For example, in 2007 and 2008 only 30 and 47 non-compliant

samples, respectively, were reported for mercury in all species and product categories whereas in 2010

and 2011 their number reached 269 and 218, respectively. In 2012 the number had decreased to

170 and in 2013 the number of samples was 189. Similarly, no non-compliant samples were reported

for copper in 2007, 2008 and 2009 but after applying the new legal provision, in 2010, 2011, 2012 and

2013 there were respectively 73, 67, 72 and 64 non-compliant samples for copper.

Non-compliant samples for organochlorine compounds (B3a) were similar in 2007, 2009, 2011

(0.17 % - 0.21 %) and in 2013 the number of samples was also comparable (0.16 %). In 2008 and

2010 the values were seen to vary slightly (0.38 % and 0.10 %, respectively). For organophosphorus

compounds (B3b), the number of non-compliant samples remained very low over the seven years

(zero to three samples per year (0.04 %)). From 2007 - 2012 the percentage of non-compliant samples

for mycotoxins (B3d), ranged from 0.14 % - 0.48 %, in 2013, the number of samples had risen to

1.38 %. The proportion of non-compliant samples for dyes (B3e) was slightly lower in 2013 (1.14 %)

compared to the previous six years (1.5 – 2.2 %). For “other substances” (B3f), from 2007 - 2012, the

percentage of non-compliant samples ranged from 0.03 % - 0.21 %, however in 2013 no

non-compliant samples were reported for this group.

Taking into account the limitations mentioned at the beginning of this section, it appears that in 2013

the frequency of non-compliant samples was higher for stilbenes (A1), antithyroid agents (A2),

beta-agonists (A5), carbamates and pyrethroids (B2c), chemical elements (B3c; mainly metals) and

mycotoxins (B3d) compared to the previous six years. For resorcyclic acid lactones (A4) the number

of non-compliant samples had increased in 2013 compared to the previous 3 years. Noncompliant

samples for anthelmintics (B2a) and dyes (B3e) were lower compared to previous years. No

non-compliant samples were reported in 2013 for “other substances”, however in the previous six

24 Commission Regulation (EC) No 149/2008 of 29 January 2008 amending Regulation (EC) No 396/2005 of the European

Parliament and of the Council by establishing Annexes II, III and IV setting maximum residue levels for products covered

by Annex I thereto. OJ L 58, 1.3.2008, p. 1-348.

25

years, non-compliant sample frequencies ranged from 0.03 % to 0.21 %. In 2012 and 2013, the

frequency of non-compliant samples for steroids (A3) and anticoccidials (B2b) was comparable,

however, lower compared previous years. Compared to 2012, lower frequencies of non-compliant

samples were noted for sedatives (B2d) and “other pharmacologically active substances” (B2f). For

the other substance groups, there were no notable variations over the seven years (see also EC, 2007;

EFSA, 2010a, 2011, 2012, 2013, 2014).

4.2. Bovines

Council Directive 96/23/EC requires that the minimum number of bovine animals to be controlled

each year for all kinds of residues and substances is 0.4 % of the bovine animals slaughtered the

previous year. The minimum requirements for the number of samples were fulfilled in 2013 for the

EU overall (Table 6), and by the majority of Member States (Table 7). Greece and Portugal did not

achieve the minimum sampling frequency for bovines.

Table 6: Production of bovines and number of targeted samples over 2007-2013

Year Production

(animals)

Targeted

samples

% Animals

tested(a)

Minimum

96/23/EC

2007 (EU 27) 27,087,367 129,201 0.47

0.4

2008 (EU 27) 26,898,702 122,648 0.48 2009 (EU 27) 26,677,946 127,897 0.48

2010 (EU 27) 26,267,917 128,130 0.48 2011 (EU 27) 26,566,593 126,540 0.48 2012 (EU 27) 25,759,645 130,554 0.49 2013 (EU 28) 25,481,237 126,307 0.49

(a): in relation to the production of the previous year.

Table 7: Production volume and number of targeted samples collected in bovines

Country

Production

data(a)

(animals)

Number

of samples

2013

Animals

tested

(%)

Country

Production

data(a)

(animals)

Number

of samples

2013

Animals

tested

(%)

Austria 679,772 3,901 0.57 Italy 2,806,324 1,6719 0.60

Belgium 859,391 5,644 0.66 Latvia 8,7628 354 0.40

Bulgaria 27,238 190 0.70 Lithuania 165,381 674 0.41

Croatia 220,596 1,058 0.48 Luxemburg 23,579 96 0.41

Cyprus 16,716 416 2.49 Malta(b) 4,083 26 0.64

Czech Republic 273,426 1,331 0.49 Netherlands 1,931,000 14,616 0.76

Denmark 493,489 1,995 0.40 Poland 1,571,620 6,531 0.42

Estonia 35,196 180 0.51 Portugal 372,756 1,469 0.39

Finland 263,477 1,260 0.48 Romania 134,565 778 0.58

France 4,880,805 19838 0.41 Slovakia 42,744 377 0.88

Germany 3,692,689 14897 0.40 Slovenia 116,598 532 0.46

Greece 226,879 602 0.27 Spain 2,381,233 9,766 0.41

Hungary 97,542 455 0.47 Sweden 420,922 1,780 0.42

Ireland 1,483,848 7390 0.50 United Kingdom 2,628,000 13,432 0.51

Total (EU 28) 25,937,497

126,307 0.49

a: The production data was used for the preparation of the 2013 Residue Control Plan and may pertain to the years 2010,

2011 and/or 2012

b: Incomplete 2013 results submitted by Malta – see Section 4 for further details.

The distribution of samples analysed, non-compliant samples and non-compliant results in bovines are

presented in Table 8. Of the 126,307 samples analysed in this category, 426 (0.34 %) were non-

26

compliant (470 non-compliant results). The non-compliant samples were reported by 19 Member

States.

Table 8: Number of samples analysed, non-compliant samples and non-compliant results in

bovines

Substance group(a)


n(b)

% n(c)

% n(d)

A 75,995 60.2 118 0.16 127 A1 13,720 10.9 2 0.01 2 A2 5,151 4.1 62 1.20 63 A3 25,682 20.3 9 0.04 9 A4 11,726 9.3 28 0.24 28 A5 21,924 17.4 16 0.07 16 A6 15,753 12.5 9 0.06 9

B 56,308 44.6 308 0.55 343 B1 24,081 19.1 63 0.26 74 B2 25,392 20.1 39 0.15 39

B2a 4,743 3.8 2 0.04 2 B2b 1,874 1.5 1 0.05 1 B2c 1,516 1.2 0 0 0

B2d 2,107 1.7 0 0 0 B2e 4,506 3.6 7 0.16 7 B2f 11,064 8.8 29 0.26 29

B3 7,107 5.6 206 2.90 230 B3a 2,997 2.4 4 0.13 11 B3b 1,559 1.2 0 0 0

B3c 2,623 2.1 158 6.02 158 B3d 1,101 0.9 44 4.00 61 B3e 0 0 0 0 0 B3f 253 0.2 0 0 0

Total 126,307 100 426 0.34 470 (a): as detailed in Appendix E;





There were two non-compliant samples reported in group A1 for diethylstilbestrol. In the group A2,

nine Member States reported a total of 62 non-compliant samples, all for thiouracil. In the group A3, a

total of nine non-compliant samples (nine non-compliant results) were reported. The substances

identified were 17-alpha nortestosteron (4 non-compliant results), boldenone-alpha (3 non-compliant

results) and testosterone-17-beta (two non-compliant results). In the group A4, four Member States

reported 28 non-compliant samples (28 non-compliant results) for alpha and beta-zearalanol. There

were 16 non-compliant samples (16 non-compliant results) reported in Group A5: for clenbuterol

(n = 12), ractopamine (n = 3) and isoxsuprine (n = 1) by three Member States. In group A6, six

Member States reported prohibited substances in nine samples (9 non-compliant results). The

substances identified were: chloramphenicol (n = 7) and semicarbazide (n = 2).

For antibacterials (B1), 12 Member States reported a total of 63 non-compliant samples

(74 non-compliant results). Among the substances identified, oxytetracycline was the most frequent

one (17 non-compliant results).

In the group B2, 39 non-compliant samples (39 non-compliant results) were reported by seven

Member States, for anthelmintics (n = 2; B2a), anticoccidials (n = 1; B2b); NSAIDs (n = 7; B2e) and

steroidal anti-inflammatory drugs (n = 29; B2f).

27

In the group B3, there were four non-compliant samples for organochlorine compounds (B3a),

158 non-compliant samples for heavy metals (B3c) and 44 non-compliant samples for mycotoxins

(B3d) (aflatoxin B1, zearalenol-alpha and –beta and zearalenone). Within the 158 non-compliant

samples for heavy metals (158 non-compliant results) there were 96 non-compliant results for copper,

36 for cadmium, 20 for mercury and six for lead.

A detailed presentation on the specific substances identified and the number of non-compliant results

reported by each Member State is given in Appendix A.

4.3. Pigs

Council Directive 96/23/EC requires that the minimum number of pigs that have to be controlled each

year for all kinds of residues and substances is 0.05 % of the pigs slaughtered the previous year. The

minimum requirements for the number of samples to be taken were fulfilled in 2013 for the EU overall

(Table 9), and by the majority of Member States (Table 10). Greece did not achieve the minimum

sampling frequency for pigs.

Table 9: Production of pigs and number of targeted samples over 2007-2013

Year Production

(animals)

Targeted

samples

% Animals

tested(a)

Minimum

96/23/EC

2007 (EU 27) 241,501,638 144,378 0.06

0.05

2008 (EU 27) 244,965,996 137,281 0.06 2009 (EU 27) 242,260,526 138,137 0.06 2010 (EU 27) 245,149,546 136,792 0.06

2011 (EU 27) 249,082,904 133,255 0.05 2012 (EU 27) 246,691,569 135,745 0.05 2013 (EU 28) 243,680,241

131,565 0.05


Table 10: Production volume and number of targeted samples collected in pigs

Country Production

data(a)

(animals)

Number

of samples

2013

Animals

tested

(%)

Country Production

data(a)

(animals)

Number

of samples

2013

Animals

tested

(%)

Austria 5,396,345 3,301 0.06 Italy 13,097,493 8,338 0.06

Belgium 11,801,106 5,587 0.05 Latvia 309,423 153 0.05


Croatia 1,054,104 579 0.05 Luxemburg 138,876 78 0.06

Cyprus 651,094 1,350 0.21 Malta(b) 68,688 25 0.04

Czech Republic 3,129,970 1,794 0.06 Netherlands 14,310,000 8,280 0.06

Denmark 19,521,383 10,413 0.05 Poland 19,886,790 10,205 0.05

Estonia 402,428 619 0.15 Portugal 4,476,828 2,184 0.05

Finland 2,242,704 1,417 0.06 Romania 3,531,669 2,551 0.07

France 24,121,965 12,589 0.05 Slovakia 641,325 500 0.08

Germany 58,509,437 29,781 0.05 Slovenia 252,894 175 0.07

Greece 1,728,686 581 0.03 Spain 40,671,703 18,655 0.05

Hungary 4,309,759 2,121 0.05 Sweden

United Kingdom

2,591,839 1,350 0.05

Ireland 3,042,037 2,547 0.08 9,570,000 5,270 0.06

Total (EU 28) 247,104,348 131,565 0.05


2011 and/or 2012


28

The distribution of samples analysed, non-compliant samples and non-compliant results in pigs are

presented in Table 11. Of the 131,565 samples analysed in this category, 317 (0.24 %) were non-


States.


in pigs

Substance group(a)


n(b)

% n(c)

% n(d)

A 56,029 42.6 43 0.08 45 A1 8,184 6.2 1 0.01 1 A2 3,012 2.3 9 0.30 10

A3 10,410 7.9 19 0.18 19 A4 6,326 4.8 1 0.02 1 A5 11,301 8.6 3 0.03 3 A6 24,793 18.8 10 0.04 11

B 86,648 65.9 274 0.32 329 B1 45,474 34.6 85 0.19 89

B2 31,845 24.2 19 0.06 18 B2a 7,537 5.7 5 0.07 5 B2b 6,033 4.6 1 0.02 1 B2c 2,224 1.7 1 0.04 1 B2d 6,718 5.1 2 0.03 2 B2e 4,255 3.2 7 0.16 7

B2f 5,868 4.5 2 0.03 2 B3 10,799 8.2 174 1.61 222

B3a 4,016 3.1 2 0.05 7 B3b 2,269 1.7 1 0.04 1 B3c 3,951 3.0 145 3.67 181 B3d 1,969 1.5 19 0.96 33

B3e 0 0 0 0 0 B3f 622 0.5 0 0 0

Total 131,565 100 317 0.24 374

(a): as detailed in Appendix E;





There was one non-compliant sample reported in group A1 for hexestrol. In the group A2, six Member

States reported a total of nine non-compliant samples, all for thiouracil. In the group A3, five Member

States reported 19 non-compliant samples and results (ten for 17-beta-nortestosteron, four for

nandrolone, two each for 17-alpha nortestosterone and boldenone and one for 17-alpha trenbolon). In

group A6, six Member States reported prohibited substances in ten samples (11 non-compliant

results): five for chloramphenicol, four for metronidazole and one each for dimetridazole and

ipronidazole.

For antibacterials (B1), 17 Member States reported a total of 85 non-compliant samples

(89 non-compliant results). The most frequent substances reported were: sulfonamides (n = 32),

dihydrostreptomycin (n =11), doxycycline (n = 11) and enrofloxacin (n = 8).

In the group B2, eight Member States reported 19 non-compliant samples (18 non-compliant results).

They were distributed as follows: five for anthelmintics (B2a), one for anticoccidials (B2b), one for

pyrethroids (B2c), two for sedatives (B2d), seven for NSAIDs (B2e) and two for flumethasone (B2f).

In the group B3, there were 174 non-compliant samples (222 non-compliant results). The

non-compliant results were distributed as follows: seven for organochlorine compounds (B3a), one for

29

organophosphorus compounds (B3b), 181 for heavy metals (B3c), 33 for mycotoxins (B3d) (13 for

ochratoxin A, 11 for zearalenol-alpha, five for zearalenone, three for zearalenol-beta and one for

aflatoxin B1. Of the 181 non-compliant results for heavy metals, 106 were reported as non-compliant

for mercury, 57 for copper, 13 for cadmium and five for lead.

The specific substances identified and the number of non-compliant results reported by each Member

State, are presented in Appendix A.

4.4. Sheep and goats

Council Directive 96/23/EC requires that the minimum number of sheep and goats that have to be

controlled each year for all kinds of residues and substances is 0.05 % of the sheep and goats

slaughtered the previous year. The minimum requirements for the number of samples were fulfilled in

in 2013 for the EU overall (Table 12), and by the majority of Member States (Table 13). Greece did

not achieve the minimum sampling frequency for sheep and goats.

Table 12: Production of sheep and goats and number of targeted samples over 2007-2013

Year Production

(animals)

Targeted

samples

% Animals

tested(a)

Minimum

96/23/EC

2007 (EU 27) 40,935,665 26,599 0.06

0.05

2008 (EU 27) 41,435,268 24,320 0.06 2009 (EU 27) 39,584,954 26,265 0.06 2010 (EU 27) 36,121,283 23,894 0.06 2011 (EU 27) 37,217,484 23,112 0.06 2012 (EU 27) 36,558,080 23,441 0.06 2013 (EU 28) 35,831,474 22,761 0.06


Table 13: Production volume and number of targeted samples collected in sheep and goats

Country

Production

data(a)

(animals)

Number

of samples

2013

Animals

tested

(%)

Country Production

data(a)

(animals)

Number of

samples

2013

Animals

tested

(%)

Austria 135,903 381 0.28 Italy 551,401 969 0.18

Belgium 133,951 259 0.19 Latvia 11,246 19 0.17


Croatia 26,484 30 0.11 Luxemburg 4,170 10 0.24

Cyprus 280,882 607 0.22 Malta(b) 4,714 8 0.17

Czech Republic 12,993 58 0.45 Netherlands 686,000 471 0.07

Denmark 82,369 53 0.06 Poland 28,381 100 0.35

Estonia 7,922 18 0.23 Portugal 998,677 513 0.05

Finland 40,542 41 0.10 Romania 200,476 176 0.09

France 4,277,775 2,315 0.05 Slovakia 74,340 123 0.17

Germany 1,061,665 575 0.05 Slovenia 10,226 34 0.33

Greece 1,282,969 467 0.04 Spain 8,513,596 4,771 0.06

Hungary 18,124 83 0.46 Sweden 260,164 132 0.05

Ireland 2,537,516 1,936 0.08 United Kingdom 15,185,000 8,532 0.06

Total (EU 28) 36,510,224 22,761 0.06


2011 and/or 2012


The distribution of samples analysed, non-compliant samples and non-compliant results in sheep and

goats is presented in Table 14. Of the 22,761 samples analysed in this category, 78 (0.34 %) were non-

30


States.


in sheep and goats

Substance group(a)


n(b)

% n(c)

% n(d)

A 5,057 22.2 7 0.14 7 A1 788 3.5 0 0 0 A2 274 1.2 1 0.36 1 A3 1,151 5.1 4 0.35 4 A4 396 1.7 0 0 0 A5 1,064 4.7 0 0 0 A6 1,714 7.5 2 0.12 2

B 17,900 78.6 71 0.40 85 B1 8,663 38.1 27 0.31 33 B2 6,478 28.5 8 0.12 8

B2a 3,151 13.8 4 0.13 4 B2b 876 3.8 1 0.11 1 B2c 1,031 4.5 0 0 0

B2d 494 2.2 0 0 0 B2e 474 2.1 3 0.63 3 B2f 531 2.3 0 0 0

B3 2,805 12.3 36 1.28 44 B3a 929 4.1 6 0.65 12 B3b 1,035 4.5 0 0 0

B3c 876 3.8 30 3.42 32 B3d 215 0.9 0 0 0 B3e 1 0 0 0 0 B3f 18 0.1 0 0 0

Total 22,761 100 78 0.34 92 (a): as detailed in Appendix E;





In group A, one non-compliant sample was reported against antithyroid agents (A2) for thiouracil. For

steroids (A3), three non-compliant samples were reported for 17-alpha nortestosteron. In the group

A6, two Member States reported prohibited substances in two samples: one each for chloramphenicol

and semicarbazide.

For antibacterials (B1), four Member States reported a total of 27 non-compliant samples

(33 non-compliant results). The substance with the highest number of non-compliant results was

sulfadiazine (n = 15).

In the group B2, non-compliant samples were reported for anthelmintics (B2a) (n = 4), anticoccidials

(B2b) (n = 1) and NSAIDs (B3e) (n = 3).

In the group B3, there were 36 non-compliant samples (44 non-compliant results). The non-compliant

results were distributed as follows: 12 for organochlorine compounds (B3a) and 32 for heavy metals

(B3c): 14 for mercury, 9 for cadmium, six for lead and three for copper.



31

4.5. Horses

For horses, Council Directive 96/23/EC requires that the number of samples is to be determined by

each Member State in relation to the identified problem. The number of targeted samples taken in

2013 at EU level was slightly higher compared to previous years (Table 15). The percentage of

targeted samples taken in each Member State for the reported horse production is presented in Table

16. Cyprus, Greece and Luxembourg did not report horse production and thus no samples have been

taken.

Table 15: Production of horses and number of targeted samples over 2007-2013

Year Production

(animals)

Targeted

samples

% Animals

tested(a)

Minimum

96/23/EC

2007 (EU 27) 312,969 3,115 1.16

Not specified

2008 (EU 27) 386,302 2,545 0.81 2009 (EU 27) 264,538 3,000 0.78

2010 (EU 27) 258,362 3,094 1.17 2011 (EU 27) 249,403 3,309 1.28 2012 (EU 27) 272,286 3,850 1.54 2013 (EU 28) 284,035 4,453 1.63


Table 16: Production volume and number of targeted samples collected for horses

Country

Production

data(a)

(animals)

Number of

samples

2013

Animals

tested

(%)

Country

Production

data(a)

(animals)

Number of

samples

2013

Animals

tested

(%)

Austria 933 61 6.5 Italy 62,235 532 0.9

Belgium 9,669 353 3.7 Latvia 519 17 3.3

Bulgaria 40 25 62.5 Lithuania 1,887 20 1.1

Croatia 299 18 6.0 Luxemburg 0 0 NA

Cyprus 0 0 NA Malta(b) 18 6 33.3

Czech Republic 395 42 10.6 Netherlands 8,319 343 4.1

Denmark 1,673 92 5.5 Poland 39,153 348 0.9

Estonia 11 0 0 Portugal 3,178 89 2.8

Finland 1,815 49 2.7 Romania 26,270 255 1.0

France 17,085 692 4.1 Slovakia 0 4 NA

Germany 11,527 224 1.9 Slovenia 1,827 43 2.4

Greece 0 0 NA Spain 49,295 328 0.7

Hungary 1,354 42 3.1 Sweden 4,352 257 5.9

Ireland 21,630 482 2.2 United Kingdom 9,101 131 1.4

Total (EU 28) 272,585 4,453 1.63

NA: not applicable.


2011 and/or 2012


The distribution of samples analysed, non-compliant samples and non-compliant results in horses is

presented in Table 17. Of the 4,453 samples analysed in this category, 34 samples (0.76 %) were

non-compliant (45 non-compliant results). The non-compliant samples were reported by 12 Member

States.

32


in horses

Substance group(a)


n(b)

% n(c)

% n(d)

A 971 21.8 4 0.41 6 A1 109 2.4 0 0 0 A2 78 1.8 0 0 0 A3 173 3.9 3 1.73 5 A4 106 2.4 1 0.94 1

A5 194 4.4 0 0 0 A6 364 8.2 0 0 0

B 3,581 80.4 30 0.84 39 B1 916 20.6 0 0 0 B2 1,751 39.3 1 0.06 1

B2a 211 4.7 0 0 0

B2b 105 2.4 0 0 0 B2c 99 2.2 0 0 0 B2d 168 3.8 0 0 0 B2e 926 20.8 1 0.11 1 B2f 262 5.9 0 0 0

B3 962 21.6 29 3.01 38

B3a 144 3.2 1 0.69 2 B3b 93 2.1 0 0 0 B3c 659 14.8 26 3.95 30 B3d 77 1.7 2 2.60 6 B3e 0 0 0 0 0

B3f 9 0.2 0 0 0

Total 4,453 100 34 0.76 45






In the group A, there were three non-compliant samples (five non-compliant results) for steroids (A3).

The substances identified were epinandrolone (n = 2 results) and nandrolone (n = 3 results). For

resorcyclic acid lactones (A4) one non-compliant sample and result was reported for zeranol. No

non-compliant samples were reported for the groups A1, A2, A5, A6 and B1.

In the group B2, only one non-compliant sample was noted for NSAIDs (B2e). There were no other

non-compliant samples reported for the other subgroups in B2.

In the group B3, the highest number of non-compliant samples was reported for the heavy metal

subgroup B3c: 26 for cadmium and four for mercury. Non-compliant samples were also noted for

organochlorine compounds (B3a) (n = 1 non-compliant sample) and mycotoxins (B3d)

(n = 2 non-compliant samples). For mycotoxins, six non-compliant results (two each for

zearalenol-alpha, zearalenol-beta and zearalenone) were reported by two Member States.



4.6. Poultry

According to Directive 96/23/EC, the minimum number of samples for each category of poultry must

be one per 200 t of annual production, with a minimum of 100 samples for each group of substances

33

where annual production in the category concerned is over 5,000 t. The minimum requirement of one

sample analysed per 200 t production was achieved in 2013 for the EU overall (Table 18).

Percentage of targeted samples taken in each Member State for the reported production of poultry is

given in Table 19. Greece and Hungary did not achieve this requirement. Luxembourg did not report

poultry production and as a result no samples were taken in 2013.

Table 18: Production of poultry and number of targeted samples over 2007-2013

Year Production (t) Targeted

samples

% Samples

tested/200 t(a)

tested(a)

Minimum

96/23/EC

2007 (EU 27) 10,912,500 62,101 1.15

1/200 t

2008 (EU 27) 12,421,566 60,406 1.11 2009 (EU 27) 11,383,434 61,989 1.00 2010 (EU 27) 11,804,262 61,259 1.08 2011 (EU 27) 12,417,108 65,942 1.12 2012 (EU 27) 12,845,333 68,770 1.11 2013 (EU 28) 12,930,555 71,186 1.11


Table 19: Production volume and number of targeted samples collected for poultry

Country

Production

data(a)

(t)

Number

of samples

2013

Samples

tested/

200 t

Country

Production

data(a)

(t)

Number of

samples

2013

Samples

tested/

200 t

Austria 108,541 827 1.5 Italy 1,232,200 6,480 1.1

Belgium 397,136 2,490 1.3 Latvia 23,000 197 1.7


Croatia 7,1745 459 1.3 Luxemburg 0 0 NA

Cyprus 20,984 746 7.1 Malta(b) 4,251 123 5.8

Czech Republic 156,332 836 1.1 Netherlands 891,400 4,723 1.1

Denmark 142,281 772 1.1 Poland 1,358,668 7,004 1.0

Estonia 17,344 200 2.3 Portugal 295,201 1,701 1.2

Finland 98,739 653 1.3 Romania 704,168 3,618 1.0

France 1,665,547 8,835 1.1 Slovakia 67,551 461 1.4


Greece 193,122 346 0.4 Spain 1,344,621 6,985 1.0

Hungary 530,470 2,495 0.9 Sweden 117,110 570 1.0

Ireland 167,755 1,291 1.5 United Kingdom 1,610,000 9,546 1.2

Total (EU 28) 12,849,527 71,186 1.11

NA: not applicable.


2011 and/or 2012


The distribution of samples analysed, non-compliant samples and non-compliant results in poultry are

presented in Table 20. Of the 71,186 samples analysed in this category 58 (0.08 %) were


States.

34


in poultry

Substance group(a)


n(b)

% n(c)

% n(d)

A 35,333 49.6 11 0.03 11 A1 3,865 5.4 0 0 0 A2 950 1.3 0 0 0 A3 4,847 6.8 0 0 0 A4 4,000 5.6 1 0.03 1 A5 5,760 8.1 0 0 0 A6 18,916 26.6 10 0.05 10

B 39,120 55.0 47 0.12 47 B1 19,769 27.8 30 0.15 30 B2 14,106 19.8 15 0.11 15

B2a 3,223 4.5 0 0 0 B2b 7,905 11.1 12 0.15 12 B2c 1,727 2.4 0 0 0

B2d 5 0.01 0 0 0 B2e 737 1.0 2 0.27 2 B2f 708 1.0 1 0.14 1

B3 5,682 8.0 2 0.04 2 B3a 2,932 4.1 0 0 0 B3b 908 1.3 0 0 0

B3c 1,846 2.6 2 0.11 2 B3d 943 1.3 0 0 0 B3e 0 0 0 0 0 B3f 211 0.3 0 0 0

Total 71,186 100 58 0.08 58






No non-compliant samples were reported in the groups A1, A2, A3 and A5. In the group A4

(resorcyclic acid lactones), one non-compliant sample was reported for zeranol. For prohibited

substances (A6), ten non-compliant samples (ten non-compliant results) were reported by five

Member States. They included chloramphenicol (n = 6) and metronidazole (n = 2) AMOZ

(5-methylmorpholino-3-amino-2-oxazolidone) (n = 2),

For antibacterials (B1), ten Member States reported a total of 30 non-compliant samples

(30 non-compliant results). Similar to previous years, the most frequent substance reported was

doxycycline (n = 11).

In the group B2, the highest number of non-compliant samples reported was for anticoccidials (B2b):

12 non-compliant samples and results from eight Member States. Other non-compliant results reported

in the group B2 were for non-steroidal anti-inflammatory drugs (B2e) (n = 2) and other

pharmacologically active substances (B2f) (n = 1 for nicotine). No non-compliant samples were

reported in the groups B2a, B2c and B2d.

In the group B3, there were two non-compliant samples reported under chemical elements (B3c) (one

for copper and 1 for lead). No non-compliant samples were reported in the groups B3a, B3b B3d, B3e

and B3f.


State are presented in Appendix A.

35

4.7. Aquaculture

Directive 96/23/EC specifies that the minimum number of samples to be collected each year must be

at least one per 100 t of annual production. The minimum requirements for the number of samples to

be taken were fulfilled in 2013 for the EU overall (Table 21) and by the vast majority of Member

States. The production volume and the number of samples analysed in each Member State are given in

Table 22. Only Greece did not analyse at least one sample/100 t of production. Luxembourg did not

report aquaculture production and consequently no samples were taken.

Table 21: Production of aquaculture and number of targeted samples over 2007-2013


samples

% Samples

tested/100 t(a)

Minimum

96/23/EC

2007 (EU 27) 602,555 9,257 1.5

1/100 t

2008 (EU 27) 644,875 8,751 1.4 2009 (EU 27) 627,109 8,606 1.3

2010 (EU 27) 622,032 8,668 1.4 2011 (EU 27) 655,772 8,241 1.3 2012 (EU 27) 631,117 8,264 1.3 2013 (EU 28) 614,191 7,971 1.3

(a): related to the production of the previous year.

Table 22: Production volume and number of targeted samples collected for aquaculture

Country

Production

data(a)

(t)

Number of

samples

2013

Samples

tested/

100 t

Country

Production

data(a)

(t) Number

of samples

2013

Samples

tested/

100 t

Austria 2,919 184 6.3 Italy 64,000 770 1.2

Belgium 2,000 160 8.0 Latvia 545 10 1.8


Croatia 0 172 NA Luxemburg 0 0 NA

Cyprus 4,213 235 5.6 Malta(b) 7,000 39 0.6

Czech Republic 21,000 241 1.1 Netherlands 6,000 83 1.4

Denmark 36,000 343 1.0 Poland 26,900 553 2.1

Estonia 393 16 4.1 Portugal 4,676 48 1.0

Finland 11,275 200 1.8 Romania 6,391 99 1.5

France 49,673 492 1.0 Slovakia 669 115 17.2


Greece 104,077 600 0.6 Spain 47,075 532 1.1

Hungary 4,427 59 1.3 Sweden 10,000 103 1.0

Ireland 13,396 137 1.0 United Kingdom 153,074 1,538 1.0

Total (EU 28) 630,448 7,971 1.3

NA: not applicable.


2011 and/or 2012


The distribution of samples analysed, non-compliant samples and non-compliant results in aquaculture

are presented in Table 23. Of the 7,971 samples analysed for aquaculture 32 samples (0.40 %) were


States.

36


in aquaculture.

Substance group (a)


n(b)

% n(c)

% n(d)

A 2,231 28.0 0 0 0 A1 206 2.6 0 0 0 A2 0 0 0 0 0 A3 407 5.1 0 0 0

A4 71 0.9 0 0 0 A5 62 0.8 0 0 0 A6 1,635 20.5 0 0 0

B 5,969 74.9 32 0.54 37 B1 1,704 21.4 1 0.06 1 B2 981 12.3 1 0.10 1

B2a 661 8.3 0 0 0 B2b 67 0.8 0 0 0 B2c 344 4.3 1 0.29 1 B2d 0 0 0 0 0 B2e 0 0 0 0 0 B2f 135 1.7 0 0 0

B3 3,593 45.1 30 0.83 35 B3a 670 8.4 1 0.15 5 B3b 92 1.2 0 0 0 B3c 681 8.5 7 1.03 7 B3d 262 3.3 0 0 0

B3e 1,929 24.2 22 1.14 23 B3f 172 2.2 0 0 0

Total 7,971 100 32 0.40 37






No non-compliant samples were reported in the groups A1, A2, A3, A4, A5 and A6. For antibacterials

(B1), one non-compliant sample was reported.

In the group B2, one non-compliant sample was reported for carbamates (B2c). There were no

non-compliant samples in the groups B2a B2b, B2d, B2e and B2f. No monitoring is required for

substances in the groups B2d (sedatives) and B2e (non-steroidal anti-inflammatory drugs) in

aquaculture (Annex II to Council Directive 96/23/EC).

In the group B3, there were 30 non-compliant samples (35 non-compliant results). The non-compliant

results were distributed as follows: one for organochlorine compounds (B3a), four for mercury, two

for arsenic and one for lead (B3c), and 23 for dyes (B3e) (brilliant green, malachite green, malachite

green-leuco, crystal violet and crystal violet- leuco). With 1.14 % non-compliant samples in group

B3e, residues of dyes are again the most frequently found residues in aquaculture.


State are presented in Appendix A.

4.8. Milk

Commission Decision 97/747/EC lays down that the annual number of samples taken should be one

per 15,000 t of annual milk production, with a minimum of 300 samples. The minimum requirements

for the number of samples to be taken were fulfilled in 2013 by all Member States (Table 24). The

production volume and the number of samples analysed in each Member State are given in Table 25.

37

Table 24: Production of milk and number of targeted samples over 2007-2013


samples

Samples

tested/15 000 t(a)

Minimum

96/23/EC

2007 (EU 27) 142,461,705 51,571 5.3

1/15 000 t

2008 (EU 27) 145,006,173 53,333 5.6

2009 (EU 27) 141,669,974 54,063 5.6 2010 (EU 27) 144,705,166 30,372 3.2 2011 (EU 27) 143,022,677 29,592 3.1 2012 (EU 27) 149,086,701 30,748 3.2 2013 (EU 28) 146,446,811 29,788 3.0


Table 25: Production volume and number of targeted samples collected for milk

Country

Production

data(a)

(t)

Number of

samples

2013

Samples

tested/

15000 t

Country

Production

data(a)

(t)

Number of

samples

2013

Samples

tested/

15000 t

Austria 3,317,702 350 1.6 Italy 11,093,491 2,220 3.0

Belgium 3,259,187 727 3.3 Latvia 845,000 721 12.8

Bulgaria 547,989 909 24.9 Lithuania 1,371,093 299 3.3

Croatia 0 1,477 NA Luxemburg 287,000 300 15.7

Cyprus 153,947 3,549 345.8 Malta(b) 46,050 78 25.4

Czech Republic 2,600,000 394 2.3 Netherlands 11,852,000 1,892 2.4

Denmark 4,500,000 295 1.0 Poland 12,298,800 2,670 3.3

Estonia 692,987 653 14.1 Portugal 1,918,517 719 5.6

Finland 2,188,383 296 2.0 Romania 1,293,605 611 7.1

France 26,048,594 1,998 1.2 Slovakia 1,192,058 562 7.1


Greece 1,833,842 652 5.3 Spain 7,002,499 953 2.0

Hungary 1,346,617 271 3.0 Sweden 2,861,000 300 1.6

Ireland 5,420,324 1,208 3.3 United Kingdom 13,850,573 3,402 3.7

Total (EU 28) 147,894,643 29,788 3.0

NA: not applicable.


2011 and/or 2012


The distribution of samples analysed, non-compliant samples and non-compliant results in milk and

the number of Member States reporting non-compliant results is presented in Table 26. Of the

29,788 milk samples analysed 61 (0.20 %) were non-compliant (61 non-compliant results). The non-

compliant samples were reported by 17 Member States.

38


in milk

Substance group (a)


n(b)

% n(c)

% n(d)

A 6,744 22.6 5 0.07 5 A1 0 0.0 0 0 0 A2 22 0.1 0 0 0

A3 51 0.2 0 0 0 A4 0 0 0 0 0 A5 153 0.5 0 0 0 A6 6,615 22.2 5 0.08 5

B 25,893 86.9 56 0.22 56 B1 15,366 51.6 16 0.10 16

B2 8,135 27.3 6 0.07 6 B2a 5,911 19.8 5 0.08 5 B2b 371 1.2 0 0 0 B2c 461 1.5 0 0 0 B2d 56 0.2 0 0 0 B2e 3,327 11.2 1 0.03 1

B2f 780 2.6 0 0 0 B3 5,624 18.9 34 0.60 34

B3a 1,760 5.9 2 0.11 2 B3b 771 2.6 0 0 0 B3c 965 3.2 1 0.10 1 B3d 2,328 7.8 31 1.33 31

B3e 0 0 0 0 0 B3f 169 0.6 0 0 0

Total 29,788 100 61 0.20 61






In the group A, there were five non-compliant samples (five non-compliant results) in group A6 for

chloramphenicol (n = 3) and chloroform (n = 2). According to Annex II to Council Directive 96/23/EC

there is no requirement for residue monitoring of the substances in groups A1, A2, A3, A4 and A5 in

milk.

For antibacterials (B1), seven Member States reported a total of 16 non-compliant samples

(16 non-compliant results).

In the group B2, there were six non-compliant samples (five non-compliant results): five for

anthelmintics (B2a) and one for non-steroidal anti-inflammatory drugs (B2e).

In the group B3, there were 34 non-compliant samples (34 non-compliant results) in total: two for

organochlorine compounds (B3a), one for chemical elements (B3c) and 31 for mycotoxins (B3d) (all

aflatoxin M1).

More information on the specific substances identified and the number of non-compliant results


4.9. Eggs

The number of samples to be taken each year must be at least equal to one per 1,000 t of annual egg

production, with a minimum of 200 samples. The minimum requirements for the number of samples to

be taken were fulfilled in 2013 for the EU overall (Table 27) and by the majority of Member States.

39

Only Greece did not analyse at least one sample/1000 t of production. The production volume and the

number of samples analysed in each Member State are given in Table 28.

Table 27: Production of eggs and number of targeted samples over 2007-2013

Year Production (t) Targeted samples Samples

tested/1000 t (a)

Minimum

96/23/EC

2007 (EU 27) 6,114,369 13,685 2.3

1/1000 t

2008 (EU 27) 6,021,476 10,859 1.8 2009 (EU 27) 6,137,732 13,031 2.2 2010 (EU 27) 6,101,039 12,715 2.1

2011 (EU 27) 6,136,691 12,248 2.0 2012 (EU 27) 6,070,174 12,596 2.1 2013 (EU 28) 6,070,334 13,323 2.2


Table 28: Production volume and number of targeted samples collected for eggs

Country

Production

data(a)

(t)

Number of

samples

2013

Samples

tested/

1000 t

Country

Production

data(a)

(t)

Number of

samples

2013

Samples

tested/

1000 t

Austria 102,678 221 2.2 Italy 804,890 1,086 1.3

Belgium 162,240 252 1.6 Latvia 39,900 472 11.8


Croatia 0 736 NA Luxemburg 1,300 200 153.8

Cyprus 6,183 421 68.1 Malta(b) 3,942 136 34.5

Czech Republic 120,000 260 2.2 Netherlands 612,000 1,492 2.4

Denmark 59,908 196 3.3 Poland 413,035 642 1.6

Estonia 11,581 200 17.3 Portugal 102,159 429 4.2

Finland 62,200 200 3.2 Romania 132,005 191 1.4

France 765,566 1,135 1.5 Slovakia 44,268 240 5.4


Greece 138,790 71 0.5 Spain 825,167 839 1.0

Hungary 71,643 171 2.4 Sweden 97,800 200 2.0

Ireland 24,400 281 11.5 United Kingdom 623,700 1,599 2.6

Total (EU 28) 6,025,906 13,323 2.2

NA: not applicable.


2011 and/or 2012


The distribution of samples analysed, non-compliant samples and non-compliant results in eggs is

presented in Table 29. Of the 13,323 egg samples analysed, 26 (0.20 %) were non-compliant

(30 non-compliant results). The non-compliant samples were reported by 12 Member States.

40


in eggs

Substance group(a)


n(b)

% n(c)

% n(d)

A 3,658 27.5 0 0 0 A1 0 0 0 0 0 A2 0 0 0 0 0

A3 0 0 0 0 0 A4 0 0 0 0 0 A5 0 0 0 0 0 A6 3,675 27.6 0 0 0

B 10,728 80.5 26 0.24 30 B1 4,730 35.5 9 0.19 11

B2 4,506 33.8 14 0.31 16 B2a 327 2.5 0 0 0 B2b 4,043 30.3 16 0.40 16 B2c 122 0.9 0 0 0 B2d 2 0.02 0 0 0 B2e 17 0.1 0 0 0

B2f 128 1.0 0 0 0 B3 2,360 17.7 2 0.08 3

B3a 2,009 15.1 2 0.10 3 B3b 393 2.9 0 0 0 B3c 159 1.2 0 0 0 B3d 8 0.1 0 0 0

B3e 0 0 0 0 0 B3f 191 1.4 0 0 0

Total 13,323 100 26 0.20 30






Directive 96/23/EC, Annex II requires Member States to monitor in the group A only the residues of

prohibited substances (A6). Although 3,658 samples were analysed for one or more substances in this

group (3,675 analyses), no non-compliant samples were reported.

For antibacterials (B1), nine non-compliant samples (11 non-compliant results) were reported by six

Member States. Substances found were: enrofloxacin (n = 3), oxytetracycline (n = 2), ciprofloxacin

(n =1), trimethoprim (n =1), sulfamonomethoxine (n = 1) and sulfadiazine (n = 3).

In the group B2, 16 non-compliant samples were found (16 non-compliant results) for anticoccidials

(B2b). Substances found were lasalocid (n = 12), narasin (n = 2) and salinomycin (n = 2).

In the group B3, two non-compliant samples (three non-compliant results) were reported for dioxins

and PCBs (B3a) by two Member States.

More details on the specific substances identified and the number of non-compliant results reported by

each Member State are given in Appendix A.

4.10. Rabbit meat

The number of samples to be taken each year must be equal to 10 per 300 t of annual production (dead

weight) for the first 3,000 t, plus one sample for each additional 300 t. The rate between the total

targeted samples reported and the minimum number of samples that should be collected for the

reported production, as specified in Commission Decision 97/747/EC, was calculated.

41

Table 30: Production of rabbit meat and number of targeted samples over 2007-2013

Year Production (t) Targeted samples

2007 (EU 27) 189,932 4,480 2008 (EU 27) 187,389 3,625 2009 (EU 27) 199,655 3,691 2010 (EU 27) 172,353 3,885 2011 (EU 27) 176,315 3,737 2012 (EU 27) 173,626 3,471 2013 (EU 28) 164,664 2,796

To calculate the total number of samples that should be collected, two different equations were applied

depending on the production volume, as follows:

a) For countries with production above 3000 t

Total samples required = {(10/300x3000) + [(Production reported in tonnes -3000) x (1/300)]}

b) For countries with production below 3000 t

Total samples required = Production reported in t x (10/300)

Countries with a rate equal to one or above completely fulfilled the requirements for sampling

frequency. Countries with a value below 1.0 did not.

Production volume and number of targeted samples broken down by Member States are presented in

Table 31. Greece and Portugal did not achieve the minimum sampling frequency requirement. Austria,

Denmark, Estonia, Finland, Ireland, Romania, Slovakia, Sweden and the United Kingdom did not

report rabbit meat production and as a consequence no rabbit meat samples were taken in 2013.

Table 31: Production volume and number of targeted samples collected for rabbit meat

Country

Production

data(a)

(t)

Number of

samples

2013

Samples

tested/

required

Country

Production

data(a)

(t)

Number of

samples

2013

Samples

tested/

required

Austria 0 0 NA Italy 35,333 412 2.0

Belgium 4,258 0 0 Latvia 3 15 150.0

Bulgaria 15 21 42.0 Lithuania 31 14 13.5

Croatia 0 20 NA Luxemburg 8 13 48.8

Cyprus 228 243 32.0 Malta(b) 100 7 2.1

Czech Republic 1,068 39 1.1 Netherlands 63 30 14.3

Denmark 0 0 NA Poland 2,854 107 1.1

Estonia 0 0 NA Portugal 7,128 97 0.9

Finland 0 0 NA Romania 0 0 NA

France 45,688 445 1.8 Slovakia 0 0 NA

Germany 423 24 1.7 Slovenia 17 17 30.0

Greece 2,438 38 0.5 Spain 63,882 1078 3.6

Hungary 10,089 176 1.4 Sweden 0 0 NA

Ireland 0 0 NA United Kingdom 0 0 NA

Total (EU 28) 173,626 2,796 NA

NA: not applicable.


2011 and/or 2012


The distribution of samples analysed, non-compliant samples and non-compliant results in rabbit meat

are presented in Table 32. Of the 2,796, samples analysed for rabbits, 13 (0.46 %) were non-compliant

(13 non-compliant results). The non-compliant samples were reported by seven Member States.

42


in rabbit meat

Substance group(a)


n(b)

% n(c)

% n(d)

A 772 27.6 2 0.26 2 A1 52 1.9 0 0 0 A2 21 0.8 1 4.76 1

A3 60 2.1 0 0 0 A4 51 1.8 0 0 0 A5 109 3.9 0 0 0 A6 527 18.8 1 0.19 1

B 2,063 73.8 11 0.53 11 B1 1,177 42.1 10 0.85 10

B2 625 22.4 1 0.16 1 B2a 156 5.6 0 0 0 B2b 292 10.4 1 0.34 1 B2c 72 2.6 0 0 0 B2d 9 0.3 0 0 0 B2e 46 1.6 0 0 0

B2f 51 1.8 0 0 0 B3 276 9.9 0 0 0

B3a 146 5.2 0 0 0 B3b 18 0.6 0 0 0 B3c 116 4.1 0 0 0 B3d 17 0.6 0 0 0

B3e 0 0 0 0 0 B3f 2 0.1 0 0 0

Total 2,796 100 13 0.46 13






In the group A, a non-compliant sample was reported for thiouracil (A2) and AMOZ (A6).

In the group B, there were ten non-compliant samples for antibacterials (B1), one non-compliant

sample for anticoccidials (B2b).



4.11. Farmed game

European Commission Decision 97/747/EC requires that the number of samples to be taken each year

in the Member States to be at least 100. The minimum number of samples was set as a provisional rule

to be reviewed in light of the information provided by the Member States on their production figures.

For farmed game, a total of 2,072 targeted samples were collected in 2013 in the EU (Table 33).

Estonia, Luxembourg and Malta did not report farmed game production (Table 34).

43

Table 33: Production of farmed game and number of targeted samples over 2007-2013


2007 (EU 27) 40,895 2,286 2008 (EU 27) 18,485 1,959 2009 (EU 27) 84,482 1,975 2010 (EU 27) 25,449 2,157

2011 (EU 27) 24,991 2,575 2012 (EU 27) 25,348 2,334 2013 (EU 28) 26,356 2,072

Table 34: Production volume and number of targeted samples collected for farmed game

Country Production

data(a)

(t)

Number of

samples 2013

Country

Production

data(a)

(t)

Number of

samples 2013

Austria 317 182 Italy 3,408 213

Belgium 175 134 Latvia 15 24

Bulgaria 0 120 Lithuania 21 28

Croatia 40 21 Luxemburg 0 0

Cyprus 17 55 Malta(b) 0 0

Czech Republic 140 100 Netherlands 123 42

Denmark 46 21 Poland 83 79

Estonia 0 0 Portugal 1,272 30

Finland 1,957 130 Romania 14 78

France 10,775 115 Slovakia 77 100

Germany 2,568 104 Slovenia 0 12

Greece 109 41 Spain 74 35

Hungary 38 75 Sweden 1,596 89

Ireland 43 107 United Kingdom 2,403 137

Total (EU 28) 25,311

2,072


2011 and/or 2012


The distribution of samples analysed, non-compliant samples and non-compliant results in farmed

game are presented in Table 35. Of the 2,072 samples analysed for farmed game, 19 (0.92 %) were

non-compliant (19 non-compliant results). The non-compliant samples were reported by five Member

States.

44


in farmed game

Substance group(a)


n(b)

% n(c)

% n(d)

A 593 28.6 1 0.17 1 A1 54 2.6 0 0 0 A2 28 1.4 0 0 0 A3 61 2.9 0 0 0 A4 56 2.7 0 0 0 A5 121 5.8 0 0 0 A6 294 14.2 1 0.34 1

B 1,501 72.4 18 1.20 18 B1 445 21.5 0 0 0 B2 582 28.1 2 0.34 2

B2a 251 12.1 0 0 0 B2b 191 9.2 2 1.05 2 B2c 99 4.8 0 0 0

B2d 13 0.6 0 0 0 B2e 55 2.7 0 0 0 B2f 9 0.4 0 0 0

B3 487 23.5 16 3.29 16 B3a 182 8.8 1 0.55 1 B3b 40 1.9 0 0 0

B3c 259 12.5 15 5.79 15 B3d 35 1.7 0 0 0 B3e 0 0 0 0 0 B3f 36 1.7 0 0 0

Total 2,072 100 19 0.92 19






There was one non-compliant sample in group A6, for chloramphenicol.

In the group B2, non-compliant samples were reported for anticoccidials (B2b) (n = 2).

In the group B3, there were 16 non-compliant samples (16 non-compliant results), which were

distributed as follows: one for organochlorine compounds (B3a) and 15 for heavy metals (B3c) (13 for

cadmium, one for mercury and one for copper).



4.12. Wild game

European Commission Decision 97/747/EC requires that the number of samples to be taken each year

in the Member States to be at least 100 samples. Samples must be taken to analyse residues of

chemical elements. For wild game, a total of 2,694 targeted samples were collected in 2012 in the EU

(Table 36). Cyprus did not report wild game production thus no samples were taken in 2013 (Table

37).

45

Table 36: Production of wild game and number of targeted samples over 2007-2013


2007 (EU 27) 270,704 2,360 2008 (EU 27) 316,541 2,443 2009 (EU 27) 252,328 2,488 2010 (EU 27) 147,097 2,395

2011 (EU 27) 263,860 2,674 2012 (EU 27) 209,607 2,600 2013 (EU 28) 204,013 2,694

Table 37: Production volume and number of targeted samples collected for wild game

Country Production

data(a)

(t)

Number of

samples 2013

Country

Production

data(a)

(t)

Number of

samples 2013

Austria 8,751 162 Italy 3,300 94

Belgium 1,566 166 Latvia 124 95

Bulgaria 19 198 Lithuania 149 40

Croatia 0 13 Luxemburg 360 100

Cyprus 0 0 Malta(b) 0 0

Czech Republic 7,737 157 Netherlands 685 34

Denmark 321 14 Poland 16,295 201

Estonia 417 99 Portugal 1400 35

Finland 56 38 Romania 88 62

France 31,913 131 Slovakia 4,955 110

Germany 66,132 97 Slovenia 1,784 101

Greece 50 25 Spain 7,596 208

Hungary 50,036 154 Sweden 0 100

Ireland 368 160 United Kingdom 550 100

Total (EU 28) 204,652 2,694


2011 and/or 2012


The distribution of samples analysed, non-compliant samples and non-compliant results in wild game

are presented in Table 38. Of the 2,694 samples analysed for wild game, 206 (7.65 %) were non-


States.

46


in wild game

Substance group(a)


n(b)

% n(c)

% n(d)

A 75 2.8 0 0 0 A1 0 0 0 0 0 A2 2 0.1 0 0 0 A3 4 0.1 0 0 0 A4 1 0.04 0 0 0

A5 4 0.1 0 0 0 A6 64 2.4 0 0 0

B 2,619 97.2 206 7.87 212 B1 6 0.2 0 0 0 B2 107 4.0 0 0 0

B2a 74 2.7 0 0 0

B2b 0 0 0 0 0 B2c 33 1.2 0 0 0 B2d 0 0 0 0 0 B2e 0 0 0 0 0 B2f 2 0.1 0 0 0

B3 2,540 94.3 206 8.11 212

B3a 296 11.0 7 2.36 7 B3b 47 1.7 0 0 0 B3c 2,171 80.6 190 8.75 205 B3d 0 0 0 0 0 B3e 0 0 0 0 0

B3f 156 5.8 0 0 0

Total 2,694 100 206 7.65 212






The vast majority of the non-compliant results (n = 205) were reported for heavy metals (B3c) (83 for

lead, 79 for cadmium, 41 for mercury and 2 for copper). The only other non-compliant samples (n = 7)

were reported for organochlorine compounds (B3a).

4.13. Honey

The number of samples to be taken must be at least 10 per 300 t of annual production for the first

3 000 t, plus one sample for each additional 300 t. In order to check the fulfilment of this requirement

the same equations were applied as described in Section 4.10.

Where the rate between the total targeted samples reported and the number of samples to be collected

for the reported production is equal to 1.0 or higher, Member States completely fulfilled the

requirements for sampling frequency. Member States with a value below 1.0 did not.

In 2013, 4,612 targeted samples were collected for honey in the EU (Table 39). Production volume

and number of targeted samples broken down by Member State are presented in Table 40. The

minimum requirements for the number of samples to be taken were fulfilled in 2013 by all Member

States.

47

Table 39: Production of honey and number of targeted samples over 2007-2013


2007 (EU 27) 188,945 5,850 2008 (EU 27) 158,694 5,257 2009 (EU 27) 162,213 4,826 2010 (EU 27) 191,501 4,720 2011 (EU 27) 215,141 4,684

2012 (EU 27) 215,101 4,820 2013 (EU 28) 205,466 4,612

Table 40: Production volume and number of targeted samples collected for honey

Country

Production

data(a)

(t)

Number

of samples

2013

Samples

tested/

required

Country

Production

data(a)

(t)

Number

of samples

2013

Samples

tested/

required

Austria 5,600 174 1.6 Italy 22,000 417 2.6

Belgium 1,500 110 2.2 Latvia 842 27 1.0


Croatia 0 203 NA Luxemburg 120 24 6.0

Cyprus 420 124 8.9 Malta(b) 15 8 16.0

Czech Republic 7,500 126 1.1 Netherlands 100 19 5.7

Denmark 2,000 87 1.3 Poland 12,180 313 2.4

Estonia 694 24 1.0 Portugal 7,792 119 1.0

Finland 1,700 57 1.0 Romania 16,792 171 1.2

France 13,788 222 1.6 Slovakia 2,815 164 1.7


Greece 14,900 231 1.7 Spain 33,589 621 3.1

Hungary 24,195 385 2.3 Sweden 3,000 115 1.2

Ireland 120 110 27.5 United Kingdom 3,321 154 1.5

Total (EU 28) 212,286 4,612 NA

NA: not applicable.


2011 and/or 2012


The distribution of samples analysed, non-compliant samples and non-compliant results in honey are

presented in Table 41. Of the 4,612 samples analysed for honey 29 (0.63 %) were non-compliant

(32 non-compliant results). The non-compliant samples were reported by nine Member States.

48


in honey

Substance group(a)


n(b)

% n(c)

% n(d)

A 611 13.2 1 0.16 1 A1 0 0 0 0 0 A2 0 0 0 0 0

A3 0 0 0 0 0 A4 0 0 0 0 0 A5 0 0 0 0 0 A6 645 14.0 1 0.16 1

B 4,144 89.9 28 0.68 31 B1 1,931 41.9 17 0.88 19

B2 881 19.1 1 0.11 2 B2a 54 1.2 0 0 0 B2b 43 0.9 0 0 0 B2c 807 17.5 1 0.12 2 B2d 0 0 0 0 0 B2e 0 0 0 0 0

B2f 382 8.3 0 0 0 B3 1,721 37.3 10 0.58 10

B3a 608 13.2 0 0 0 B3b 840 18.2 2 0.24 2 B3c 579 12.6 8 1.38 8 B3d 26 0.6 0 0 0

B3e 0 0 0 0 0 B3f 321 7.0 0 0 0

Total 4,612 100 29 0.63 32






The majority of the non-compliant results (n = 19) were for antibacterials (B1). Other non-compliant

results were reported under the subgroup A625 (n = 1) for metronidazole, B2c (n = 2) for allethrin and

permethrin, B3b (n = 2) for chlorfenvinphos and B3c (n = 8) for cadmium and lead.



4.14. Suspect, import and other samples

In addition to the targeted samples collected in conformity with the specification of the NRCP for

2013, Member States also reported results on samples collected through sampling strategies other than

targeted. According to Directive 96/23/EC in case of infringements of maximum residue limits when

animals or animal products are placed on the market, intensified checks on the animals and products

from the farm and/or establishment in question must be carried out by the competent authorities. Also,

in the event of possession or presence of prohibited substances at any point during manufacture,

storage, distribution or sale through the food and feed production chain, or suspicion or evidence of

illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary

product the competent authorities have to apply special measures including repeated sampling in the

farm or establishment concerned. Thus, these samples are not representative for the assessment of the

25 For honey, sampling for Group A substances is not a requirement of Council Directive 96/23/EC and Commission

Decision 97/474/EC.

49

residue situation in the Member States and therefore they are reported separately in the residue

database as “suspect samples”, as part of the follow-up measure taken in case of infringements.

In 2013, 17,561 suspect samples were reported of which 706 (4.0 %) were non-compliant

(773 non-compliant results). It is to note that the number of non-compliant results from suspect

sampling reported by a Member State does not accurately reflect the residue situation in that Member

State. The suspect samples are taken as follow-up of non-compliance of targeted samples or evidence

of possession and use of prohibited substances. In addition, the sampling procedure applied in case of

suspicion might be different among Member States. For example, in Belgium, at slaughterhouse each

injection site must be sampled together with a sample of muscle which are then analysed by a

multi-residue method. This approach results in a higher probability that a suspect sample is found

non-compliant for more than one substance. An overview on the number of suspect samples analysed

for the different animal species/product categories and the frequency of non-compliant samples is

presented in Table 42. Further details on the substances identified and Member States which reported

non-compliant results are given in Appendix B.

Apart from the data submitted in accordance to NRCPs, Member States reported a relatively limited

number of results on samples checked at import (n = 3,329). As the control of samples at import is

more linked to the third country monitoring than to residue monitoring in the EU, Member States

report those results to the EC using the TRACES and RASFF tools. Therefore, those data are of

limited value and are not representative of the overall situation of residue control at import. An

overview on the number of import samples analysed for the different animal species/product

categories and the frequency of non-compliant samples is presented in Table 42. Further details on the

substances identified and Member States which reported non-compliant results are given in

Appendix C.

In total, 565,417 samples were collected in the framework of other monitoring programmes developed

under the national legislation. An overview on the number of ‘other’ samples analysed for the different

animal species/product categories and the frequency of non-compliant samples is presented in Table

42. Further details on the substances identified and Member States which reported non-compliant

results are given in Appendix D.

Table 42: Number of suspect, import and other samples analysed and frequency of non-compliant

samples and in all species and product categories

Group

Sampling type

Suspect Import Other sampling

n nc n nc n nc

Bovines 12,505 278 428 3 53,601 288

Pigs 2,171 127 76 1 499,729 888

Sheep/goats 572 16 108 0 5,975 18

Horses 51 0 53 0 413 0

Poultry 261 13 623 12 602 2

Aquaculture 145 14 1,631 58 201 4

Milk 1,604 225 7 0 4,079 64

Eggs 53 4 9 0 99 4

Rabbit 62 0 28 0 202 2

Farmed game 10 0 27 0 28 0

Wild game 11 3 22 0 3 1

Honey 116 26 317 8 485 0

Total 17,561 706 3,329 82 565,417 1,271

Percentage non-compliant

samples 4.0 2.46 0.22

n: number of samples analysed; nc: number of non-compliant samples.

50

CONCLUSIONS

In 2013, 28 European Union (EU) Member States reported in the framework of the residue

monitoring the results for 1,005,835 samples. A total of 419,528 targeted samples and 17,561

suspect samples were reported under Council Directive 96/23/EC. Additionally, 565,417

samples collected in the framework of other programmes developed under the national

legislation and 3,329 samples checked at import were reported.

The majority of Member States fulfilled the requirements for sampling frequency laid down in

Council Directive 96/23/EC and in Commission Decision 97/747/EC.

There were 1,299 or 0.31 % of non-compliant samples out of the 419,528 targeted samples in

2013.

Non-compliant samples were reported for stilbenes and derivatives (A1) in bovines and pigs

(both 0.01 %).

For antithyroid agents (A2), there were 0.77 % non-compliant samples, all for thiouracil, most

likely due to feeding diets rich in cruciferous plants.

In the group of steroids (A3), non-compliant samples (all for anabolic steroids) were found in

bovines (0.04 %), pigs (0.18 %), sheep and goats (0.35 %) and horses (1.73 %).The relatively

high percentage of non-compliant results in pigs was most likely the endogenous production.

For corticosteroids, non-compliant results for authorised substances were reported under

“other pharmacologically active substances” (B2f) in 2013.

In the group of resorcyclic acid lactones (A4), 0.14 % of the samples were non-compliant for

zearalanone and derivatives. For beta-agonists (A5), there were 0.05 % non-compliant

samples.

Prohibited substances (A6) were found in 0.05 % of samples. Substances identified were

chloramphenicol (n = 23), nitroimidazoles (n = 9), nitrofurans (n = 6) and chloroform (n = 2).

For antibacterials (B1), 0.21 % of the samples analysed under the Directive 96/23/EC

monitoring were non-compliant. The highest frequency of non-compliant samples for

antibacterials was found in honey (0.88 %).

In group B2 (other veterinary drugs), the highest proportion of non-compliant samples was

found for anticoccidials (B2b) and “other pharmacologically active substances” (B2f) (both

0.16 %).

For anticoccidials (B2b) across the different species, the non-compliant results were reported

as follows; bovines (0.05 %), pigs (0.02 %), sheep and goats (0.11 %), poultry (0.15 %), eggs

(0.40 %), rabbits (0.34 %) and farmed game (1.05 %).

An important decrease has been observed in the frequency of non-compliant samples for

anticoccidials in poultry (0.16 % in 2013 and 0.15 % in 2012, compared to 0.22 % in 2011,

0.96 % in 2010 and 2.05 % in 2009).

The decrease in the frequency of non-compliant samples for anticoccidials is most likely the

result of the awareness and the measures that followed the implementation of the Commission

Directive 2009/8/EC setting up maximum levels of unavoidable carry-over of coccidiostats in

non-target feed.

Non-compliant samples were observed for “other pharmacologically active substances” (B2f),

in bovines (0.26 %), pigs (0.03 %) and poultry (0.14 %).

51

Instances of non-compliance for anthelmintics (B2a) were reported in bovines (0.04 %), pigs

(0.07 %), sheep and goats (0.13 %) and milk (0.08 %).

For pyrethroids (B2c), non-compliant samples were for reported in pigs (0.04 %), aquaculture

(0.29 %) and honey (0.12 %).

Non-compliant samples were reported for sedatives (B2d) in pigs (0.03 %).

For non-steroidal anti-inflammatory drugs (B2e), non-compliant samples were found in

bovines (0.16 %), pigs (0.16 %), sheep and goats (0.63 %), horses (0.11 %), poultry (0.27 %)

and milk (0.03 %).

In the group B3 (other substances and environmental contaminants), the chemical elements

(B3c) had the highest overall percentage of non-compliant samples (3.9 %), with cadmium,

lead, mercury and copper being most frequently identified.

Non-compliant samples were reported for organochlorine compounds (B3a) and

organophosphorus compounds (B3b); 0.16 % and 0.04 %, respectively.

For mycotoxins (B3d), there were non-compliant samples in bovines (4.0 %), pigs (0.96 %),

horses (2.6 %) and milk (1.33 %). Those identified being, zearalenone and derivatives,

ochratoxin A, aflatoxin B1 and aflatoxin M1.

Prevalence of dyes (B3e) in aquaculture samples was lower in 2013 (1.14 %) compared to the

previous six years (1.5 % - 2.2 %). Substances found were brilliant green, malachite green,

malachite green-leuco, crystal violet and crystal violet-leuco.

No non-compliant samples were noted for “other substances” (B3f).

The overall frequency of non-compliant samples in 2013 (0.31 %), was comparable to the

previous six years (0.25 % - 0.34 %).

The frequency of non-compliant samples in 2013 was higher for stilbenes (A1), antithyroid

agents (A2), beta-agonists (A5), carbamates and pyrethyroids (B2c), chemical elements (B3c;

mainly metals) and mycotoxins (B3d), compared to the previous six years. For resorcyclic

acid lactones (A4) the number of non-compliant samples had increased in 2013 compared to

the previous 3 years.

Noncompliant samples for anthelmintics (B2a) and dyes (B3e) were lower compared to

previous years. No non-compliant samples were reported in 2013 for “other substances”(B3f),

however in the previous six years, non-compliant sample frequencies ranged from 0.03 % to

0.21 %.

In 2012 and 2013, the frequency of non-compliant samples for steroids (A3) and

anticoccidials (B2b) were comparable, however, lower compared previous years. Compared to

2012, lower frequencies of non-compliant samples were noted for sedatives (B2d) and “other

pharmacologically active substances” (B2f).

The sampling plans and the pattern of substances analysed are not necessarily the same every

year and the prescribing patterns of veterinary medicines vary between species. Therefore, the

outcome of the data analysis at EU level may not accurately reflect the residue situation in

each individual EU Member State and for each species or product category.

52

REFERENCES

Clouet AS, Le Bizec B, Montrade MP, Monteau F and André F, 1997. Identification of endogenous

19-nortestosterone in pregnant ewes by Gas-Chromatography-Mass Spectrometry. Analyst, 122,

471-474.

(EC) European Commission, 2007. European Commission Staff Working Document on the

implementation of National Residue Monitoring Plans in the Member States in 2007. Available

online: http://ec.europa.eu/food/food/chemicalsafety/residues/workdoc_2007_en.pdf

EFSA (European Food Safety Authority), 2010a. Report for 2008 on the results from the monitoring

of veterinary medicinal product residues and other substances in food of animal origin in the

Member States. EFSA Journal 2010;8:1559, 55 pp. doi:10.2903/j.efsa.2010.1559

EFSA (European Food Safety Authority), 2010b. Technical report of EFSA: Evaluation of the data

collection performed in the framework of Directive 96/23/EC. 20 pp. Available online:

http://www.efsa.europa.eu/en/supporting/doc/103e.pdf

EFSA (European Food Safety Authority), 2011. Technical report of EFSA: Report for 2009 on the

results from the monitoring of veterinary medicinal product residues and other substances in live

animals and animal products. Supporting Publications 2011:158, 70 pp. Available online:




animals and animal products. Supporting Publications 2012:212, 65 pp. Available online:

http://www.efsa.europa.eu/en/search/doc/212e.pdf



animals and animal products. EFSA supporting publications 2013:EN-363, 65 pp. Available online:




animals and animal products. EFSA supporting publications 2014:EN-540, 65 pp. Available online:

http://www.efsa.europa.eu/en/supporting/pub/540e.htm

Fidani M, Pompa G, Mungiguerra F, Casati A, Fracchiolla ML and Arioli F, 2012. Investigation of the

presence of endogenous prednisolone in equine urine by high-performance liquid chromatography

mass spectrometry and high-resolution mass spectrometry. Rapid Communications in Mass

Spectrometry, 26, 879-86.

Pinel G, Mathieu S, Cesbron N, Maume D, De Brabander HF, André F and Le Bizec B, 2006.

Evidence that urinary excretion of thiouracil in adult bovine submitted to a cruciferous diet can

give erroneous indications of the possible illegal use of thyrostats in meat production. Food

Additives and Contaminants, 23, 974-980.

Pompa G, Arioli F, Casati A, Fidani M, Bertocchi L and Dusi G, 2011. Investigation of the origin of

prednisolone in cow urine. Steroids, 76, 104-110.

Samuels TP, Nedderman A, Seymour MA and Houghton E, 1998. Study of the metabolism of

testosterone, nandrolone and estradiol in cattle. Analyst, 123, 2401-2404.

http://ec.europa.eu/food/food/chemicalsafety/residues/workdoc_2007_en.pdf


53

APPENDICES

Appendix A. LIST OF NON-COMPLIANT RESULTS: TARGETED SAMPLING

Category Group Substances MS

Number

of samples

analysed(a)

Non-compliant

results

N %

Bovines A1 Diethylstilbestrol (Stilbestrol) FR 1828 2 0.1

Sub-total for A1 1

2

A2 5-Methyl-2-thiouracil IE 127 1 0.8

PT 69 1 1.4

5-Propyl-2-thiouracil PT 60 3 5.0

Thiouracil AT 42 1 2.4

ES 338 1 0.3

HR 81 12 14.8

IE 243 18 7.4

LT 27 4 14.8

NL 360 10 2.8

PL 107 1 0.9

UK 404 11 2.7

Sub-total for A2 9

63

A3 17-Alpha nortestosteron HR 51 4 7.8

Boldenone-Alpha NL 914 3 0.3

Testosterone-17-Beta DE 160 1 0.6

NL 166 1 0.6

Sub-total for A3 3

9

A4 Alpha-Zeralanol (Zeranol) UK 377 10 2.7

Beta Zearalanol (Taleranol) DE 504 4 0.8

HR 119 0 0.0

IT 366 1 0.3

UK 377 13 3.4

Sub-total for A4 4

28

A5 Clenbuterol IT 1494 3 0.2

PT 325 9 2.8

Isoxsuprine HR 56 1 1.8

Ractopamine PT 133 3 2.3

Sub-total for A5 3

16

A6 Chloramphenicol CZ 49 1 2.0

DE 1299 1 0.1

NL 311 1 0.3

PL 571 3 0.5

UK 529 1 0.2

SEM (semicarbazide) IE 197 2 1.0

Sub-total for A6 6

9

B1 Benzylpenicillin (Penicillin G) ES 123 1 0.8

FR 2184 3 0.1

LT 127 1 0.8

Chlortetracyclin FR 2966 1 0.0

Ciprofloxacin LT 127 1 0.8

PL 509 1 0.2

Dihydrostreptomycin CZ 177 1 0.6

ES 1 1 100.0

FR 2184 6 0.3

HR 150 1 0.7

PL 509 2 0.4

UK 1702 1 0.1

Doxycycline ES 557 1 0.2

UK 1702 2 0.1

54


Number

of samples

analysed(a)

Non-compliant

results

N %

Enrofloxacin FR 2381 1 0.0

LT 127 1 0.8

PL 509 1 0.2

Gamithromycin UK 1702 1 0.1

Gentamicin DE 373 1 0.3

NL 1874 3 0.2

Marbofloxacin FR 2381 2 0.1

Neomycin CZ 177 1 0.6

FR 293 1 0.3

NL 1874 4 0.2

PL 509 3 0.6

Oxytetracycline BG 20 1 5.0

FR 2966 13 0.4

PL 509 3 0.6

Spiramycin BG 20 1 5.0

Sulfadiazine UK 1702 1 0.1

Sulfadimethoxine BE 551 1 0.2

FR 2920 1 0.0

Sulfadimidine BE 551 1 0.2

FR 2920 2 0.1

IT 1798 1 0.1

Sulfadoxine BE 551 1 0.2

DE 867 1 0.1

Sulfamethoxypyridazine FR 2920 1 0.0

Sulfapyridin IT 1798 1 0.1

Trimethoprim BE 551 1 0.2

Tulathromycin FR 2184 1 0.0

UK 1702 1 0.1

Sub-total for B1 12

74

B2a Closantel UK 772 1 0.1

Doramectin FR 482 1 0.2

Sub-total for B2a 2

2

B2b Halofuginone UK 20 1 5.0

Sub-total for B2b 1

1

B2e Antipyrin-4-Methylamino DE 248 1 0.4

Meloxicam BE 158 1 0.6

DE 373 1 0.3

FR 578 2 0.3

Phenylbutazone DE 1302 1 0.1

UK 717 1 0.1

Sub-total for B2e 4

7

B2f Dexamethasone DE 850 9 1.1

ES 653 2 0.3

IT 2872 12 0.4

NL 560 1 0.2

Prednisolone BE 3509 2 0.1

FR 423 2 0.5

LT 2 1 50.0

Sub-total for B2f 7

29

B3a DDE, pp'- AT 34 1 2.9

PCB 118 AT 34 1 2.9

PCB 138 AT 34 1 2.9

ES 31 1 3.2

PCB 153 AT 34 1 2.9

ES 31 1 3.2

PCB 180 AT 34 1 2.9

55


Number

of samples

analysed(a)

Non-compliant

results

N %

ES 31 1 3.2

PCB sum CZ 100 1 1.0

WHO-PCDD/F-PCB-TEQ CZ 6 2 33.3

Sub-total for B3a 3

11

B3c Cadmium Cd CZ 47 2 4.3

DE 316 9 2.8

ES 238 2 0.8

FR 540 1 0.2

HR 22 9 40.9

HU 12 1 8.3

LV 10 3 30.0

SI 11 1 9.1

UK 107 8 7.5

Copper Cu DE 142 96 67.6

Lead Pb AT 233 2 0.9

DE 316 2 0.6

UK 107 2 1.9

Mercury Hg CZ 47 1 2.1

DE 316 19 6.0

Sub-total for B3c 10

158

B3d Aflatoxin B1 IT 108 1 0.9

Zearalenol-alpha HR 119 3 2.5

RO 2 2 100.0

Zearalenol-beta HR 119 37 31.1

RO 4 4 100.0

Zearalenone (Mycotoxin F) HR 119 10 8.4

RO 4 4 100.0

Sub-total for B3d 3

61

Total in Bovines 19 470

Pigs A1 Hexestrol DE 922 1 0.1

Sub-total for A1 1

1

A2 6-Methyl-2-thiouracil LT 16 1 6.3

Thiouracil EE 9 1 11.1

LT 16 3 18.8

NL 153 1 0.7

PL 34 2 5.9

PT 97 1 1.0

UK 97 1 1.0

Sub-total for A2 6

10

A3 17-Alpha nortestosteron NL 597 2 0.3

17-Alpha trenbolon HR 11 1 9.1

17-Beta nortestosteron CZ 67 1 1.5

NL 597 9 1.5

Boldenone ES 20 1 5.0

PL 1 1 100.0

Nandrolone PL 696 4 0.6

Sub-total for A3 5

19

A4 Alpha-Zeralanol (Zeranol) HR 52 1 1.9

Sub-total for A4 1

1

A5 Ractopamine PT 206 2 1.0

Salbutamol (albuterol) FR 574 1 0.2

Sub-total for A5 2

3

A6 Chloramphenicol AT 367 1 0.3

DE 2456 2 0.1

IT 673 1 0.1

PL 609 1 0.2

56


Number

of samples

analysed(a)

Non-compliant

results

N %

Dimetridazole CZ 6 1 16.7

Ipronidazole CZ 6 1 16.7

Metronidazole DE 3287 3 0.1

FR 294 1 0.3

Sub-total for A6 6

11

B1 Amoxycillin ES 1858 2 0.1

PL 465 1 0.2

PT 565 1 0.2

Benzylpenicillin (Penicillin G) DK 783 1 0.1

PL 465 1 0.2

Beta-lactams BG 116 5 4.3

Chlortetracyclin PL 465 1 0.2

UK 1720 1 0.1


EE 431 2 0.5

NL 2423 2 0.1

PL 465 1 0.2

Doxycycline BE 1454 1 0.1

ES 1728 1 0.1

NL 2423 1 0.0

PL 465 7 1.5

PT 565 1 0.2

Enrofloxacin CZ 377 1 0.3

DE 3988 1 0.0

ES 1774 4 0.2

FR 2018 1 0.0

NL 2423 1 0.0

Inhibitors DE 42 1 2.4

Lincomycin CY 946 4 0.4

Neomycin NL 2423 1 0.0

Oxytetracycline IE 1357 1 0.1

IT 1197 1 0.1

NL 2423 2 0.1

Sulfadiazine BE 1661 5 0.3

DE 3927 3 0.1

ES 2221 4 0.2

FR 3062 2 0.1

NL 2423 1 0.0


DE 3955 1 0.0

FR 3062 2 0.1

IT 1493 7 0.5

Sulfadimidine DE 3956 1 0.0

GR 164 1 0.6

IT 1493 1 0.1

RO 1 1 100.0

Trimethoprim DE 3374 4 0.1

DK 783 1 0.1

Tulathromycin NL 2423 1 0.0

Sub-total for B1 17

89

B2a Albendazol UK 504 1 0.2

Levamisole BE 81 1 1.2

LT 26 1 3.8

NL 437 2 0.5

Sub-total for B2a 4

5

B2b Lasalocid PL 101 1 1.0

57


Number

of samples

analysed(a)

Non-compliant

results

N %

Sub-total for B2b 1

1

B2c Tetramethrin HR 31 1 3.2

Sub-total for B2c 1

1

B2d Xylazine DE 1032 2 0.2

Sub-total for B2d 1

2

B2e Antipyrin-4-Methylamino DE 699 1 0.1

Diclofen (Diclofenac) LT 9 5 55.6

Ibuprofen UK 37 1 2.7

Sub-total for B2e 3

7

B2f Flumethasone ES 1082 2 0.2

Sub-total for B2f 1

2

B3a PCB 101 FR 322 1 0.3

PCB 138 FR 322 1 0.3

PCB 153 FR 322 1 0.3

PCB 180 FR 322 1 0.3

PCB 28 FR 322 1 0.3

PCB 52 FR 322 1 0.3


Sub-total for B3a 2

7

B3b Diazinon ES 223 1 0.4

Sub-total for B3b 1

1


DE 1432 8 0.6

ES 425 4 0.9


Lead Pb DE 1432 3 0.2

IT 291 1 0.3

PT 60 1 1.7


DE 1432 97 6.8

NL 258 1 0.4

Sub-total for B3c 6

181


Ochratoxin A AT 32 1 3.1

GR 59 12 20.3

Zearalenol-alpha FI 58 7 12.1

HR 52 4 7.7



Sub-total for B3d 5

33

Total in Pigs 21 374

Sheep/Goats A2 Thiouracil UK 76 1 1.3

Sub-total for A2 1

1

A3 17-Alpha nortestosteron HR 2 1 50.0

NL 44 3 6.8

Sub-total for A3 2

4

A6 Chloramphenicol AT 26 1 3.8

SEM (semicarbazide) IE 25 1 4.0

Sub-total for A6 2

2

B1 Chlortetracyclin ES 575 5 0.9

Ciprofloxacin ES 484 1 0.2

Dihydrostreptomycin FR 479 1 0.2


Enrofloxacin ES 485 2 0.4

Neomycin C NL 147 2 1.4

Oxytetracycline ES 577 2 0.3

58


Number

of samples

analysed(a)

Non-compliant

results

N %

FR 674 1 0.1

GR 138 1 0.7

Penicillin V

(Phenoxymethylpenicillin) ES 159 1

0.6

Spiramycin FR 479 1 0.2

Sulfadiazine ES 868 15 1.7

Sub-total for B1 4

33

B2a Closantel IE 273 1 0.4

Fenbendazole IE 273 2 0.7

UK 1757 1 0.1

Sub-total for B2a 2

4

B2b Monensin FR 50 1 2.0

Sub-total for B2b 1

1

B2e Antipyrin-4-Methylamino IE 40 2 5.0

Ibuprofen UK 50 1 2.0

Sub-total for B2e 2

3

B3a DDD, pp'- ES 140 1 0.7

DDE, pp'- ES 168 3 1.8

DDT, pp'- ES 146 3 2.1

WHO-PCB-TEQ CZ 3 2 66.7


WHO-PCDD/F-TEQ BE 15 1 6.7

Sub-total for B3a 3

12


DE 44 2 4.5

GR 114 1 0.9

HU 6 2 33.3

NL 10 1 10.0

UK 53 2 3.8


Lead Pb ES 139 2 1.4

PT 32 3 9.4

UK 53 1 1.9

Mercury Hg DE 44 14 31.8

Sub-total for B3c 8

32

Total in Sheep/Goats 13 92

Horses A3 Epinandrolone (19-

Norepitestosterone) DE 8 2

25.0

Nandrolone DE 8 2 25.0

PL 17 1 5.9

Sub-total for A3 2

5

A4 Alpha-Zeralanol (Zeranol) HR 1 1 100.0

Sub-total for A4 1

1

B2e Phenylbutazone AT 17 1 5.9

Sub-total for B2e 1

1

B3a WHO-PCDD/F-PCB-TEQ DK 4 1 25.0

WHO-PCDD/F-TEQ DK 4 1 25.0

Sub-total for B3a 1

2


DE 8 7 87.5

FR 136 1 0.7

HU 8 8 100.0

IT 219 3 1.4

PL 136 1 0.7

SI 5 4 80.0

UK 1 1 100.0

59


Number

of samples

analysed(a)

Non-compliant

results

N %


DE 8 3 37.5

Sub-total for B3c 8

30

B3d Zearalenol-alpha HR 1 1 100.0

RO 1 1 100.0


RO 1 1 100.0


RO 1 1 100.0

Sub-total for B3d 2

6

Total in Horses 12 45

Poultry A4 Alpha-Zeralanol (Zeranol) HR 32 1 3.1

Sub-total for A4 1

1

A6

AMOZ (5-methylmorpholino-3-

amino-2-oxazolidone) GR 62 1

1.6

PT 318 1 0.3

Chloramphenicol CZ 31 1 3.2

DE 2254 3 0.1

PL 421 2 0.5

Metronidazole CZ 14 2 14.3

Sub-total for A6 5

10

B1 Amoxycillin UK 2634 1 0.0

Beta-lactams BG 98 2 2.0

Chlortetracyclin UK 2634 3 0.1

Dihydrostreptomycin HR 63 1 1.6

Doxycycline BE 491 1 0.2

DE 1529 1 0.1

ES 235 1 0.4

NL 1266 5 0.4

PL 406 3 0.7

Enrofloxacin AT 54 1 1.9

DE 935 1 0.1

ES 288 6 2.1

IT 983 1 0.1

Sulfonamides BG 98 2 2.0


Sub-total for B1 10

30

B2b Decoquinate CZ 90 1 1.1

Lasalocid BE 225 1 0.4

FR 184 1 0.5

UK 794 1 0.1

Monensin PT 121 1 0.8

Narasin IE 219 1 0.5

Salinomycin PL 739 2 0.3

PT 121 1 0.8

UK 794 1 0.1

Toltrazurilsulfon DE 515 1 0.2

IE 219 1 0.5

Sub-total for B2b 8

12

B2e Antipyrin-4-Methylamino BE 135 1 0.7

Flunixin AT 12 1 8.3

Sub-total for B2e 2

2

B2f Nicotine DE 99 1 1.0

Sub-total for B2f 1

1

B3c Copper Cu DE 23 1 4.3

Lead Pb PT 41 1 2.4

60


Number

of samples

analysed(a)

Non-compliant

results

N %

Sub-total for B3c 2

2

Total in Poultry 15 58

Aquaculture B1 Inhibitors DE 48 1 2.1

Sub-total for B1 1

1

B2c Prosulfocarb DE 1 1 100.0

Sub-total for B2c 1

1

B3a DDD, pp'- DE 69 1 1.4

DDE, pp'- DE 69 1 1.4

DDT: Sum DDT, DDE, DDD DE 69 1 1.4

HCB (Hexachlorbenzene) DE 69 1 1.4

Heptachlor epoxide-Cis DE 69 1 1.4

Sub-total for B3a 1

5

B3c Arsenic As ES 13 2 15.4

Lead Pb HR 36 1 2.8

Mercury Hg ES 76 3 3.9

HR 36 1 2.8

Sub-total for B3c 2

7

B3e Brilliant Green ES 18 1 5.6

Cristal Violet DK 60 1 1.7

Cristal Violet-Leuco DE 391 2 0.5

PL 178 1 0.6

Malachite Green CZ 80 1 1.3

Malachite Green-Leuco BG 67 1 1.5

CZ 80 8 10.0

NL 35 2 5.7

PL 178 3 1.7

SK 70 2 2.9

UK 209 1 0.5

Sub-total for B3e 9

23

Total in Aquaculture 10 37

Milk A6 Chloramphenicol LV 256 1 0.4

SI 38 1 2.6

SK 20 1 5.0

Chloroform (Trichlormethane) DE 42 2 4.8

Sub-total for A6 4

5

B1 Amoxycillin PL 1783 1 0.1

UK 1646 1 0.1

Ampicillin CY 2920 1 0.0

Benzylpenicillin (Penicillin G) DE 445 1 0.2

PL 1783 1 0.1

Cloxacillin IE 312 1 0.3

SI 144 1 0.7


Inhibitors CY 2920 4 0.1

Penicillin UK 1646 2 0.1

Sub-total for B1 7

16


Ivermectin UK 768 1 0.1

Nitroxinil UK 768 1 0.1

Rafoxanide IE 310 1 0.3

Triclabendazole UK 768 1 0.1

Sub-total for B2a 2

5

B2e Ketoprofen BG 41 1 2.4

Sub-total for B2e 1

1

B3a Dioxins IT 249 1 0.4

PCB sum IT 185 1 0.5

61


Number

of samples

analysed(a)

Non-compliant

results

N %

Sub-total for B3a 1

2

B3c Lead Pb PT 20 1 5.0

Sub-total for B3c 1

1

B3d Aflatoxin M1 BG 57 5 8.8

ES 70 1 1.4

FI 96 1 1.0

GR 158 2 1.3

HR 268 11 4.1

HU 24 2 8.3

IT 425 7 1.6

PT 42 1 2.4

RO 1 1 100.0

Sub-total for B3d 9

31

Total in Milk 17 61

Eggs B1 Ciprofloxacin ES 121 1 0.8

Enrofloxacin CZ 10 1 10.0

ES 121 2 1.7

Oxytetracycline UK 509 2 0.4

Sulfadiazine CY 232 1 0.4

FR 203 1 0.5

UK 509 1 0.2

Sulfamonomethoxine HR 244 1 0.4

Trimethoprim HR 244 1 0.4

Sub-total for B1 6

11

B2b Lasalocid CY 21 1 4.8

DE 253 1 0.4

HR 244 2 0.8

LT 140 3 2.1

UK 575 5 0.9

Narasin SI 192 2 1.0

Salinomycin LV 137 1 0.7

PL 112 1 0.9

Sub-total for B2b 8

16

B3a gamma-HCH (HCH, Lindane) AT 11 1 9.1

PCB sum DE 81 1 1.2

WHO-PCDD/F-PCB-TEQ DE 81 1 1.2

Sub-total for B3a 2

3

Total in Eggs 12 30

Rabbit A2 Thiouracil LT 1 1 100.0

Sub-total for A2 1

1

A6

AMOZ (5-methylmorpholino-3-

amino-2-oxazolidone) IT 24 1

4.2

Sub-total for A6 1

1

B1 Doxycycline ES 66 1 1.5


Sulfadimethoxine FR 448 7 1.6

PT 24 1 4.2

Sub-total for B1 4

10

B2b Salinomycin CZ 10 1 10.0

Sub-total for B2b 1

1

Total in Rabbit 7 13

Farmed

Game A6 Chloramphenicol CZ 3 1

33.3

Sub-total for A6 1

1

B2b Lasalocid FR 18 1 5.6

UK 16 1 6.3

62


Number

of samples

analysed(a)

Non-compliant

results

N %

Sub-total for B2b 2

2

B3a PCB sum CZ 12 1 8.3

Sub-total for B3a 1

1

B3c Cadmium Cd FI 34 13 38.2



Sub-total for B3c 2

15

Total in Farmed Game 5 19

Wild game B3a DDT: Sum DDT, DDE, DDD CZ 29 1 3.4

DE 63 2 3.2

HCH-Beta DE 62 1 1.6


Sub-total for B3a 2

7

B3c Cadmium Cd FI 29 12 41.4

LU 100 8 8.0

LV 95 57 60.0

PL 131 2 1.5


Lead Pb AT 122 3 2.5

CZ 105 10 9.5

EE 54 1 1.9

GR 25 4 16.0

HR 13 1 7.7

HU 104 1 1.0

IE 122 4 3.3

LU 100 9 9.0

LV 95 32 33.7

NL 34 5 14.7

PL 131 10 7.6

PT 35 3 8.6


DE 78 35 44.9

HU 104 1 1.0

PL 131 4 3.1

Sub-total for B3c 14

205

Total in Wild game 14 212

Honey A6 Metronidazole PL 5 1 20.0

Sub-total for A6 1

1

B1 Oxytetracycline GR 103 1 1.0


LT 33 1 3.0

Sulfanilamide AT 121 1 0.8

Sulfathiazole AT 121 1 0.8

ES 13 1 7.7

LT 33 1 3.0

Sulfonamides PL 185 5 2.7

Tetracycline BG 61 3 4.9

GR 103 1 1.0

IT 91 1 1.1

Trimethoprim LT 33 1 3.0

Sub-total for B1 8

19

B2c Allethrin HR 42 1 2.4

Permethrin HR 42 1 2.4

Sub-total for B2c 1

2

B3b Chlorfenvinphos PT 22 2 9.1

Sub-total for B3b 1

2

63


Number

of samples

analysed(a)

Non-compliant

results

N %

B3c Cadmium Cd GR 23 3 13.0

Lead Pb GR 23 5 21.7

Sub-total for B3c 1

8

Total in Honey 9

32

Total in all categories 1443 (a): The number of samples analysed for the individual substances was reported by the Member States only if there was at least one non-

compliant sample for the substance in question. In case that all samples were compliant, the number of samples analysed was not

reported. Furthermore, in case of animals controlled at farm and slaughterhouse, the number of samples may include either samples

taken at farm or slaughterhouse depending where the non-compliant samples were found. Where non-compliant samples were found at

both farm and slaughterhouse, the number of samples represents the sum of samples taken at both sampling points.

64

Appendix B. LIST OF NON-COMPLIANT RESULTS: SUSPECT SAMPLING


Number of

samples

analysed(a)

Non-compliant

results

N %

Bovines A2 Thiouracil UK 8 4 50.0

Sub-total for A2 1

4

A4 Alpha-Zeralanol (Zeranol) UK 20 1 5.0

Beta Zearalanol (Taleranol) UK 26 4 15.4

Zearalanone UK 6 3 50.0

Sub-total for A4 1

8

A5 Clenbuterol PT 132 13 9.8

Ractopamine PT 126 11 8.7

Sub-total for A5 1

24

A6 Chloramphenicol BE 174 1 0.6

Sub-total for A6 1

1

B1 Amoxycillin BE 174 2 1.1

UK 128 1 0.8

Ampicillin IT 78 1 1.3

UK 128 1 0.8

Antibacterials NL 5209 83 1.6

Benzylpenicillin (Penicillin G) BE 174 8 4.6

ES 8 1 12.5

IE 3333 1 0.0

IT 78 2 2.6

Ceftiofur BE 174 2 1.1

Chlortetracyclin BE 174 1 0.6

Ciprofloxacin BE 174 1 0.6

ES 125 3 2.4

IE 3333 1 0.0

IT 81 1 1.2

Dihydrostreptomycin BE 174 2 1.1


Enrofloxacin BE 174 3 1.7

ES 125 3 2.4

IE 3333 1 0.0

IT 81 1 1.2

Gentamicin BE 174 1 0.6

Lincomycin BE 174 1 0.6

Marbofloxacin BE 174 1 0.6

IE 3333 2 0.1

IT 81 2 2.5

UK 128 2 1.6

Neomycin BE 174 1 0.6

Oxytetracycline BE 174 5 2.9

ES 107 3 2.8

IE 3333 4 0.1

IT 78 2 2.6

UK 128 13 10.2

Spiramycin BE 174 2 1.1

Streptomycin BE 174 2 1.1



Sulfadimidine IT 42 1 2.4


Sulfamethazine UK 128 2 1.6

Tetracycline BE 174 1 0.6

Tilmicosin BE 174 1 0.6

65


Number of

samples

analysed(a)

Non-compliant

results

N %


Tulathromycin BE 174 2 1.1

UK 128 1 0.8

Tylosin, Tylosin A BE 174 3 1.7

Sub-total for B1 6

183


Doramectin BE 174 1 0.6

Levamisole UK 41 1 2.4

Moxidectin BE 174 1 0.6

Nitroxinil BE 174 1 0.6

UK 41 2 4.9

Sub-total for B2a 2

7

B2e Carprofen BE 115 1 0.9

FI 1 1 100.0

Flunixin BE 115 3 2.6

Ketoprofen BE 115 1 0.9


Metamizole (Dipyrone

Monohydrate) BE 115 2

1.7

Phenylbutazone BE 115 1 0.9

DE 125 40 32.0

Tolfenamic acid BE 115 6 5.2

Sub-total for B2e 3

61

B2f Dexamethasone BE 267 4 1.5

IT 375 3 0.8

Methylprednisolone BE 267 1 0.4

Prednisolone BE 267 1 0.4

Prednisone BE 267 1 0.4

Sub-total for B2f 2

10



Sub-total for B3a 1

7


DE 8 2 25.0

UK 28 4 14.3


Lead Pb DE 8 1 12.5


Sub-total for B3c 3

19


Pigs A5 Ractopamine PT 61 38 62.3

Sub-total for A5 1

38

A6 Chloramphenicol BE 51 1 2.0

DE 9 2 22.2

Sub-total for A6 2

3

B1 Amoxycillin BE 57 3 5.3

PL 12 1 8.3

Ampicillin BE 57 3 5.3

Antibacterials NL 789 19 2.4

Benzylpenicillin (Penicillin G) BE 57 4 7.0

Chlortetracyclin IE 333 1 0.3

Ciprofloxacin BE 57 1 1.8

PL 12 1 8.3


PL 12 1 8.3

Enrofloxacin BE 57 3 5.3

66


Number of

samples

analysed(a)

Non-compliant

results

N %

PL 12 1 8.3

Florfenicol BE 57 1 1.8

Gentamicin BE 57 1 1.8

Oxytetracycline BE 57 5 8.8



Tetracycline BE 57 3 5.3


Sub-total for B1 6

52


Fenbendazole BE 51 1 2.0

Oxfendazole BE 51 1 2.0

Oxfendazole sulfon BE 51 1 2.0

Sub-total for B2a 2

6

B2d Azaperol BE 51 1 2.0

Azaperone BE 51 1 2.0

Sub-total for B2d 1

2

B2e Flunixin BE 51 3 5.9


Metamizole (Dipyrone

Monohydrate) BE 51 2

3.9

Sub-total for B2e 1

6

B2f Dexamethasone BE 51 1 2.0

Sub-total for B2f 1

1


Sub-total for B3a 1

5

B3c Copper Cu DE 2 1 50.0


DE 11 7 63.6

Sub-total for B3c 2

19


Ochratoxin A GR 12 6 50.0

Zearalenol-alpha FI 14 3 21.4

HR 1 1 100.0



Sub-total for B3d 4

13

Total in Pigs 12 145

Sheep/Goats B1 Antibacterials NL 32 3 9.4

Oxytetracycline UK 9 1 11.1

Sulfadiazine ES 307 4 1.3

Sub-total for B1 3

8


Sub-total for B2a 1

6

B3a WHO-PCB-TEQ CZ 2 2 100.0


Sub-total for B3a 1

4


Poultry A6 AMOZ (5-methylmorpholino-3-

amino-2-oxazolidone) GR 6 4

66.7

AOZ (3-amino-2-oxazolidone) GR 6 2 33.3

Sub-total for A6 1

6

B1 Doxycycline NL 64 1 1.6


Trimethoprim UK 6 2 33.3

67


Number of

samples

analysed(a)

Non-compliant

results

N %

Sub-total for B1 2

5

B2b Salinomycin MT 21 1 4.8

Sub-total for B2b 1

1


Sub-total for B3d 1

1


Aquaculture B3e Cristal Violet-Leuco SK 3 1 33.3

Malachite Green CZ 5 1 20.0

Malachite Green-Leuco BG 5 5 100.0

CZ 5 2 40.0

NL 36 4 11.1

PL 7 1 14.3

SK 3 2 66.7

Sub-total for B3e 5

16


Milk B1 Benzylpenicillin (Penicillin G) DE 11 1 9.1

Oxytetracycline DE 123 1 0.8

IT 140 1 0.7

Sub-total for B1 3

3

B2e Diclofen (Diclofenac) DE 113 1 0.9

Phenylbutazone DE 113 14 12.4

Sub-total for B2e 1

15

B3a Dioxins IT 8 1 12.5

HCH-Beta IT 9 4 44.4

PCB sum IT 16 1 6.3

Sub-total for B3a 1

6

B3d Aflatoxin M1 BG 10 5 50.0

ES 7 1 14.3

HR 12 1 8.3

HU 177 10 5.6

IT 468 39 8.3

PT 273 144 52.7

Sub-total for B3d 7

200

Total in Milk 8 224

Eggs B1 Enrofloxacin ES 7 1 14.3

Sub-total for B1 1

1

B2b Lasalocid DE 2 2 100.0

Sub-total for B2b 1

2

B3a gamma-HCH (HCH, Lindane) AT 1 1 100.0

Sub-total for B3a 1

1

Total in Eggs 3 4

Wild game B3a PCB sum CZ 6 2 33.3

Sub-total for B3a 1

2

B3c Lead Pb CZ 3 1 33.3

Sub-total for B3c 1

1


Honey A6 Metronidazole PL 3 1 33.3

Sub-total for A6 1

1

B1 Oxytetracycline GR 1 1 100.0

IT 4 1 25.0


Sulfathiazole AT 11 1 9.1

LT 2 1 50.0

Sulfonamides PL 37 9 24.3

Tetracycline IT 11 4 36.4

68


Number of

samples

analysed(a)

Non-compliant

results

N %

Tetracyclines BG 3 1 33.3

Sub-total for B1 7

20

B2c Permethrin HR 5 2 40.0

Sub-total for B2c 1

2

B3c Lead Pb IE 8 2 25.0

PL 1 1 100.0

Sub-total for B3c 2

3

Total in Honey 8 26

Total in all categories 773 (a): The number of samples analysed for the individual substances was reported by the Member States only if there was at

least one non-compliant sample for the substance in question. In case that all samples were compliant, the number of

samples analysed was not reported. Furthermore, in case of animals controlled at farm and slaughterhouse, the number

of samples may include either samples taken at farm or slaughterhouse depending where the non-compliant samples

were found. Where non-compliant samples were found at both farm and slaughterhouse, the number of samples

represents the sum of samples taken at both sampling points.

69

Appendix C. LIST OF NON-COMPLIANT RESULTS: IMPORT SAMPLING


Number

of samples

analysed(a)

Non-compliant

results

N %

Bovines B2a Abamectin (Avermectin B1) IE 15 1 6.7

Ivermectin IE 15 2 13.3

Sub-total for B2a 1

3


Pigs B3c Mercury Hg PL 7 1 14.3

Sub-total for B3c 1

1

Total in Pigs 1 1

Poultry B1 Doxycycline NL 84 1 1.2

Sub-total for B1 1

1

B2b Chlopidol CY 1 1 100.0

DE 74 4 5.4

Sub-total for B2b 2

5

B3c Mercury Hg DE 45 6 13.3

Sub-total for B3c 1

6


Aquaculture A6 AOZ (3-amino-2-oxazolidone) DE 56 5 8.9

DK 13 1 7.7

Chloramphenicol DK 26 5 19.2

SEM (semicarbazide) DK 13 1 7.7

Sub-total for A6 2

12

B1 Chlortetracyclin DK 24 2 8.3

Oxytetracycline DK 24 1 4.2

IE 5 1 20.0

Sulfadiazine BE 35 1 2.9

Sub-total for B1 3

5

B3c Arsenic As PL 63 1 1.6

Cadmium Cd DE 170 14 8.2

Lead Pb GR 95 1 1.1

Mercury Hg CY 81 1 1.2

DE 174 28 16.1

EE 13 1 7.7

PL 63 1 1.6

SI 6 1 16.7

Sub-total for B3c 6

48


Honey A6 SEM (semicarbazide) BE 34 1 2.9

Sub-total for A6 1

1

B1 Epi-Tetracycline DE 31 2 6.5


Sulfamethazine BG 2 1 50.0

Sulfamethoxazole DE 32 1 3.1

Tetracycline DE 32 2 6.3

Sub-total for B1 2

9

B2f Amitraz (Formamidine) DE 20 1 5.0

Sub-total for B2f 1

1

Total in Honey 3 11

Total in all categories 92 (a): The number of samples analysed for the individual substances was reported by the Member States only if there was at

least one non-compliant sample for the substance in question. In case that all samples were compliant, the number of

samples analysed was not reported. Furthermore, in case of animals controlled at farm and slaughterhouse, the number

of samples may include either samples taken at farm or slaughterhouse depending where the non-compliant samples

were found. Where non-compliant samples were found at both farm and slaughterhouse, the number of samples

represents the sum of samples taken at both sampling points.

71

Appendix D. LIST OF NON-COMPLIANT RESULTS: OTHER SAMPLING


Number

of samples

analysed(a)

Non-compliant

results

N %

Bovines B1 Amoxycillin DE 97 4 4.1


Cefalonium DE 17 1 5.9

Chlortetracyclin DE 108 1 0.9

Ciprofloxacin DE 124 8 6.5

Dihydrostreptomycin DE 114 3 2.6

Doxycycline DE 137 1 0.7

Enrofloxacin DE 89 9 10.1

Epi-Tetracycline DE 26 1 3.8



Josamycin DE 69 2 2.9

Marbofloxacin DE 136 4 2.9

Neomycin DE 114 3 2.6


Sulfadiazine DE 133 1 0.8


IT 142 1 0.7


Sub-total for B1 2

177

B2e Flunixin DE 32 2 6.3

Meloxicam DE 32 1 3.1

Sub-total for B2e 1

3


IT 501 7 1.4

Sub-total for B2f 2

11


Pigs B1 Amoxycillin DE 318 8 2.5

Ampicillin DE 416 2 0.5


Chlortetracyclin DE 426 11 2.6

Ciprofloxacin DE 372 3 0.8

Dihydrostreptomycin DE 279 9 3.2

Doxycycline DE 460 42 9.1

IT 255 2 0.8

Enrofloxacin DE 379 17 4.5

IT 249 1 0.4

Epi-Chlortetracycline DE 221 1 0.5



Marbofloxacin DE 437 3 0.7

IT 249 1 0.4

Neomycin DE 272 1 0.4


Spectinomycin DE 263 1 0.4

Sulfadiazine DE 425 4 0.9

Sulfadimethoxine DE 424 2 0.5

IT 164 2 1.2


Sulfamethoxazole DE 264 1 0.4

Sulfonamides DE 28 1 3.6


72


Number

of samples

analysed(a)

Non-compliant

results

N %


Tulathromycin DE 246 1 0.4

Sub-total for B1 2

531

B2a 2-Aminoflubendazole DE 161 1 0.6

Flubendazole DE 5 1 20.0

Sub-total for B2a 1

2

B2e Flunixin DE 165 2 1.2

Sub-total for B2e 1

2


Sub-total for B2f 1

2

Total in Pigs 2 537

Sheep/Goats B1 Benzylpenicillin (Penicillin G) DE 10 1 10.0



Sub-total for B1 1

8

B3a WHO-PCDD/F-PCB-TEQ BE 10 4 40.0

WHO-PCDD/F-TEQ BE 10 2 20.0

Sub-total for B3a 1

6


Poultry B1 Colistin IT 43 1 2.3

Erythromycin (Erythromycin

A) IT 46 1 2.2

Sub-total for B1 1

2


Aquaculture B1 Inhibitors DE 48 1 2.1

Sub-total for B1 1

1

B3c Cadmium Cd GR 96 2 2.1

Lead Pb GR 96 1 1.0

Sub-total for B3c 1

3


Milk B1 Ampicillin IT 110 1 0.9

Benzylpenicillin (Penicillin G) IT 110 1 0.9

Sub-total for B1 1

2

B3a HCH-Beta IT 206 2 1.0

Sub-total for B3a 1

2

B3d Aflatoxin M1 IT 3485 60 1.7

Sub-total for B3d 1

60

Total in Milk 1 64

Eggs B3a Dioxins IT 25 2 8.0

PCB sum IT 16 2 12.5

Sub-total for B3a 1

4

Total in Eggs 1 4

Rabbit B1 Inhibitors DE 9 1 11.1

Sub-total for B1 1

1

Total in Rabbit 1 1

Wild game B3c Lead Pb IT 3 1 33.3

Sub-total for B3c 1

1


Total in all categories 818 (a): The number of samples analysed for the individual substances was reported by the Member States only if there was at least one non-

compliant sample for the substance in question. In case that all samples were compliant, the number of samples analysed was not

reported. Furthermore, in case of animals controlled at farm and slaughterhouse, the number of samples may include either samples

taken at farm or slaughterhouse depending where the non-compliant samples were found. Where non-compliant samples were found at

both farm and slaughterhouse, the number of samples represents the sum of samples taken at both sampling points.

74

Appendix E. ANNEX I TO DIRECTIVE 96/23/EC

GROUP A – Substances having anabolic effect and unauthorised substances

A.1. Stilbenes, stilbene derivatives, and their salts and esters

A.2. Antithyroid agents

A.3. Steroids

A.4. Resorcyclic acid lactones, including zeranol

A.5. Beta-agonists

A.6. Compounds included in Annex IV to Council Regulation (EEC) N° 2377/90 of 26 June 199026

GROUP B – Veterinary drugs and contaminants

B.1. Antibacterial substances, including sulphonamides, quinolones

B.2. Other veterinary drugs

a) Anthelmintics

b) Anticoccidials

c) Carbamates and pyrethroids

d) Sedatives

e) Non-steroidal anti-inflammatory drugs (NSAIDs)

f) Other pharmacologically active substances

B.3. Other substances and environmental contaminants

a) Organochlorine compounds, including PCBs

b) Organophosphorus compounds

c) Chemical elements

d) Mycotoxins

e) Dyes

f) Others

26 Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of

maximum residue limits of veterinary medicinal products in foodstuffs of animal origin. OJ L 224, 18.8.1990, p. 1

75

ABBREVIATIONS

Country Codes

AT Austria

BE Belgium

BG Bulgaria

HR Croatia

CY Cyprus

CZ Czech Republic

DK Denmark

EE Estonia

FI Finland

FR France

DE Germany

GR Greece

HU Hungary

IE Ireland

IT Italy

LV Latvia

LT Lithuania

LU Luxembourg

MT Malta

NL Netherlands

PL Poland

PT Portugal

RO Romania

SK Slovakia

SI Slovenia

ES Spain

SE Sweden

UK United Kingdom

Other abbreviations

AMOZ 5-methylmorpholino-3-amino-2-oxazolidone

DG SANCO Directorate General for Health and Consumers

EC European Commission

EFSA European Food Safety Authority

MRL Maximum residue limit

MRPL Minimum Required Performance Limit

NCRP National Residue Control Plans

NSAIDs Non-steroidal anti-inflammatory drugs

RASFF Rapid Alert System for Food and Feed

SEM Semicarbazide

TRACES Trade Control and Expert System

76

Part III/III – Actions taken as a consequence of non-compliant results including

modification of the national residue plan for 2013

77

QUESTIONNAIRE ON THE ACTIONS TAKEN

AS A CONSEQUENCE OF NON-COMPLIANT RESULTS IN 2013

Member State AUSTRIA

Group A substances

Modification of national residue plan

Information with regard to the

recommendations of the EURL

RIKILT

See Plan Data Information of Plan 2014



Berlin


Accreditation and validation of

Group A substances or forbidden

substances according to Council

Decision 2002/657/EC


New in the plan 2014 See Plan Data Information of Plan 2014

Due to compliant results over a two

or more years period, the number of

samples will be decreased


Due to non-compliant results in

2013, the number of samples will be

increased


The non-compliant results in 2013 (except wild game)

have been taken into account regarding the 2014 plan

General information See Plan Data Information of Plan 2014

Non-compliant results Follow-up actions

Bovine

1 Thiouracil – 66,10 µg/l (ppb) –

urine – veal calf (targeted sample,

farm)

Investigations on the farm of origin by official

veterinarian including verification of records;

The source of non-compliance could not be

established but it is considered that the animals

were fed on a milk or whey fro, cows fed with

feed rich in brassica;

The farm will be part of the plan 2014

Ovine & caprine

1 Chloramphenicol – 2,05 µg/kg

(ppb) – muscle – lamb (targeted

sample, slaughterhouse)

Investigations on the farm of origin with 69 ewes,

rams and lambs (29) by official veterinarian

including verification of records;

The farm was placed under official control

(10/10/2013 – 17/10/2013) by the Provincial

Governor (official veterinarian) in accordance

with Article 58 of the Food Safety and Consumer

Protection Act;

11 follow-up samples (10 blood samples and one

78

feed sample); all samples were compliant;

No verification of an illegal use of Chloramphenicol

Porcine

1 Chloramphenicol – 0,16 µg/kg

(ppb) – muscle – fattening pig

(targeted sample, slaughterhouse)

Investigations on the farm of origin (breeding and

fattening farm) with 704 pigs (sows and fattening

pigs)by official veterinarian including verification

of records;

The farm was placed under official control

(18/03/2013-21/03/2013) by the Provincial

Governor (official veterinarian) in accordance

with Article 58 of the Food Safety and Consumer

Protection Act;

Insufficient documentation of the administration

of veterinary medicinal products

The check of the veterinary practitioner`s

dispensary of the veterinarian in charge of the

farm is scheduled;

18 follow-up samples (18 blood samples); all

samples were compliant;

Sampling in 2014 showed a negative test result;

Administrative proceedings were started against

the farmer.

No verification of an illegal use of Chloramphenicol

Equine – Poultry – Aquaculture – Milk –

Eggs – Rabbit – Farmed game – Honey

None None

Group B substances




Berlin (plan 2012)

-

New in the plan 2014 See Plan Data Information of Plan 2014

General information See Plan Data Information of Plan 2014

Due to compliant results over a two

or more year period, the number of

samples will be decreased


Due to non-compliant results in

2013, the number of samples will be

increased


79


Bovine

1 PCB 118 – 0,006 mg/kg

PCB 138 – 0,042 mg/kg

PCB 153 – 0,044 mg/kg

PCB 180 – 0,030 mg/kg and

pp-DDE – 0,012 mg/kg – young

bovine (targeted sample,

slaughterhouse)

The young bovine was slaughtered in Austria, but

originated from the Czech Republic;

The State Veterinary Administration of the Czech

Republic was informed by letter (BMG-74320/0012-

II/B/12/2013).

1 lead – 0,83 mg/kg (ppm) –

muscle – young bovine (targeted


Investigations and verification of the records on the

farm of origin (farm of bulls);

8 follow-up samples (6 samples of muscle and two

feed samples, one of these feed samples was feeding

lime); all samples were compliant;

It was not possible to verify the reason of the

contamination with lead (no lead paint, no pipes

containing lead were used, no fertilisation using

sludge, etc.).

1 lead – 0,81 mg/kg (ppm) –

muscle – cow (targeted sample,

slaughterhouse)

Investigations and verification of the records on the

farm of origin (small farm) with 12 bovine animals, 6

of them were cows;

7 follow-up samples (6 samples of muscle and one

feed samples); all samples were compliant;

It was not possible to verify the reason of the

contamination with lead (no lead paint, no pipes

containing lead was used, etc.).

Porcine

1 Ochratoxin A – 14,0 µg/kg (ppb) –

kidney – fattening pigs (targeted



veterinarian including verification of records;

On the farm 100 porcine animals were kept (breeding

pigs, fattening pigs and piglets);

The storage of the feeding stuffs was according to

GMP, the storage was dry and well ventilated;

The follow-up sample of feed was compliant.

It was not possible to identify the reason of this

contamination.

Equine

1 Phenylbutazone – 16,43 µg/kg

(ppb) – muscle – other horse

(targeted sample, slaughterhouse)

The carcass was declared unfit for human consumption

and then disposed of in accordance with Regulation

(EC) No 1069/2009;

The veterinarian prescribed Phenylbutazone without

checking that this horse was intended for slaughter;

The results of the check of the veterinary practitioner`s

dispensary of the veterinarian are pending;

Administrative proceedings were started against the

owner of the horse.

80

Poultry

1 Enrofloxacin – 143,10 µg/kg

(ppb) – muscle – turkey (targeted



veterinarian including verification of records; The

farmer is a member of the Poultry Health Service;

Control of the veterinary practitioner's dispensary of

the veterinarian in charge of the farm;

The carcass was disposed of according to Regulation

(EC) No 1069/2009;

Follow-up sample showed a negative test result.

1 Flunixin – 1,35 µg/kg (ppb) –

muscle – turkey (targeted sample,

slaughterhouse)

The turkey was slaughtered in Austria, but originated

from the Republic of Slovenia;

The Veterinary Administration of the Federal Ministry

of Agriculture and Environment of Slovenia was

informed by letter (BMG-74320/0017-II/B/12/2013).

Eggs

1 gamma-HCH (Lindan) –

0,295 mg/kg (ppm) (targeted

sample)

Eggs were from a free range flock;

Prohibition of placing the eggs on the market;

Lindane is forbidden since 2007;

Control of the use of pesticides by the competent

authority; the farmer used various pesticides, but all of

them were authorised officially;

The laying hens moved freely and therefore the

ingestion of contaminated material might be possible;

As a consequence of the non-compliant targeted

sample, a follow-up sample of eggs was taken, the

sample was again non-compliant; two samples of feed

were compliant;

All eggs were disposed of in accordance with

Regulation (EC) No 1069/2009;

All hens (40) were killed and disposed of in

accordance with Regulation (EC) No 1069/2009;


farmer.

It was not possible to identify the reason of the

contamination

1 gamma-HCH (Lindane) – 0,254

mg/kg (ppm) (suspect sample)

One follow-up sample of above-mentioned non-

compliant egg sample (Lindane 0,295 mg/kg)

Wild game

1 lead – 13,8 mg/kg (ppm) – muscle

– deer

1 lead – 0,44 mg/kg (ppm) – muscle

– wild boar and 1 lead 0,45 mg/kg

(ppm) – muscle – rabbit (targeted

samples)

In wild game the detection of lead can be mostly

traced back to environmental pollution and sometimes

to bullets (to some extent depending on the modern

construction of bullets and the type of bullets); the

contamination of the meat also depends on the way the

bullets penetrate the body of the animals.

81

Honey

1 Sulfathiazole – 1.358,00 µg/kg

(targeted sample)

Honey was produced by 145 bee hives;

Investigation of the farm;

No documentation of the administration of VMPs;

The bee-hives and the honey (2.070 kg) were placed

under official control (10/09/2013-07/11/2013) by the

Provincial Governor in accordance with Article 39 of

the Food Safety and Consumer Protection Act;

As a consequence of the detection of Sulfathiazole,

eight follow-up samples were taken, one sample was

non-compliant (please refer to information below);

The contaminated honey (200 kg) was processed in a

category 1 processing plant;


farmer.

No verification of the illegal use of Sulfathiazole.

1 Sulfathiazole – 87,00 µg/kg

(suspect sample)

One follow-up sample of above-mentioned non-

compliant honey sample (Sulfathiazole

1.358,00 µg/kg).

1 Sulfanilamide – 75,80 µg/kg

(targeted sample)

Honey was produced at two different locations (about

110 hives);

Investigation of the apiary was carried out;

As a consequence of the detection of Sulfanilamide,

three follow-up samples were taken, all samples were

compliant; no verification of an illegal use of VMPs;

Sulfanilamide might be a degradation product of

Asulam, a herbicide;

Report of the possibility of illegal use of Asulam to the

Chamber of Agriculture.

An illegal use of Asulam in the region can be assumed.

Ovine & caprine – Aquaculture –

Milk – Rabbit – Farmed game

None None

82



Member State BELGIUM

Group A substances


In total, the number of samples analysed for group A substances decreased.

Nevertheless, additional sampling is foreseen :

- Hair samples taken on farms to search for esters of androgens/oestrogens (bovine : 100

samples, calves : 100 samples instead of 40)

- Urine samples taken on pig farms to search for anabolic substances

- Plasma samples (15) taken on pheasant farms to search for nitro-imidazoles (game bird

illegally release free for hunting)

- Increase of bovine/calves thyroid samples to search for antithyroid agents


Bovine

1/ Prednisolone (5,7 ppb) – urine –

target sample – slaughterhouse –

bull

Investigation on farm. The bull was sold twice within

2 weeks before slaughter. The origin of the presence of

prednisolone was not identified.

2/ Prednisolone (4,8 ppb) – faeces –

target sample – farm – calf

Investigation on farm. Samples of animal matrices and

material were taken. Fattening animals were put under

temporary seizure. Material samples non-compliant.

See 3.

3/ Progesterone, methylboldenone,

fluoxymesterone, dexamethasone,

methyltestosterone, hydrocortisone

acetate, betamethasone, cortisol,

prednisolone – suspect samples –

materials – farm.

The bovine farm was investigated due to prednisolone

in feces on farm (see 2). Reinforced control type H put

in place.

4/ Dexamethasone +

methylprednisolone – injection site –

suspect sampling – bull –

slaughterhouse

Investigation on farm. Check of the VMP register.

Interview of the holder. Part of carcass destroyed.

6/ Chloramphenicol – injection site –

suspect sampling – bovine –

slaughterhouse



8/ Prednisolone + prednisone –

injection site – suspect sampling –

bovine – slaughterhouse



9/ Dexamethasone – injection site –


slaughterhouse

See also 32 under group B substances.



slaughterhouse


83

11/ Dexamethasone +

dexamethasone isonicotinoate –

injection site – suspect sample –


See also 4 under Group B substances

Porcine

5/ Chloramphenicol – injection site –

suspect sampling – pig –

slaughterhouse




suspect sampling – pig –

slaughterhouse


Ovine & caprine – Equine – Poultry – Aquaculture –

Milk – Eggs – Rabbit – Farmed game – Honey

None None

Administrative measures

A new system of reinforced controls entered in force in 2013. According to the seriousness of

the non-compliance, 6 different types of reinforced controls are foreseen. The different types

differ from each other by duration and control measures put in place (on farm inspections,

sampling on farm, sampling at slaughterhouse, products sampling).

2 H-status were allocated in 2013 due to presence of corticosteroids and/or hormones in

materials on bovine farms.

Criminal penalties: In all cases of infringements relating to group A substances (except A6), a

Pro Justitia is sent to prosecutor who decides whether prosecution or not (Law 15 July 1985

Hormones1).

1 Loi du 15 Juillet 1985 relative à l’utilisation de substances à effet hormonal, à effet anti-hormonal, à effet beta-adrénergique ou à effet

stimulateur de production chez les animaux.

Group B substances


In total, the number of samples analysed for group B substances slightly decreased.

Number of milk/eggs/poultry meat/pig meat samples to search for quinolones increased


Bovine

1/ Meloxicam – muscle – target

sample – calf – slaughterhouse


Interview of the holder.

2/ Sulfadimidine + sulfadoxine +

sulfadimethoxine + trimethoprim

(> LMR) – muscle – target sample –

slaughterhouse – calf


Interview of the holder. RASFF.

3/ Ciprofloxacin (> 200 ppb) +

enrofloxacin (> 200 ppb) – injection

site – bovine – suspect sample –

slaughterhouse



84

4/ Ketoprofen + Sulfadiazine

(1.473 ppb) + sulfadoxine (225 ppb)

+ trimethoprim (301 ppb) – injection

site – bovine – suspect sample –

slaughterhouse


Interview of the holder. Carcass destroyed. See also 11

under Group A substances

Sulfadiazine (726 ppb) – muscle –

bovine – suspect sample –

slaughterhouse

5/ Enrofloxacin (> 200 ppb) –

injection site – bovine – suspect

sample – slaughterhouse



6/ Tolfenamic acid – injection site –

bovine – suspect sample –

slaughterhouse



7/ Lincomycin (2.430 ppb) +

benzylpenicillin (320.000 ppb) –


bovine –slaughterhouse


Interview of the holder. Carcass destroyed.

Lincomycin (2.850 ppb) +

spectinomycin (930 ppb) – injection

site – suspect sample – bovine –

slaughterhouse

8/ Chlortetracycline (739 ppb) –





9/ Benzylpenicillin (50.737 ppb) –





10/ Benzylpenicillin (271 ppb) –





11/ Spiramycin (1.362 ppb) –




Interview of the holder. R-status allocated. Part of

carcass destroyed.

12/ Meloxicam – injection site –

suspect sample – bovine –

slaughterhouse



13/ Trimethoprim (22.083 ppb) +

sulfadimethoxine (28.797 ppb) –





14/ Ceftiofur (3.834 ppb) +

Carprofen – injection site – suspect

sample – bovine – slaughterhouse



15/ Meloxicam – injection site –


slaughterhouse



85

16/ Nitroxinil (3.865 ppb) +

doramectine – injection site –


slaughterhouse



Doramectin – muscle – suspect


17/ Moxidectin – injection site –


slaughterhouse



18/ Tylosin (> 200 ppb) + neomycin

( 1.467 ppb) + flunixine +

meloxicam –injection site – suspect




Tylosin (169 ppb) – muscle –


slaughterhouse

19/ Flunixine – injection site –


slaughterhouse



20/ Enrofloxacin (> 200 ppb ppb) +

marbofloxacin (170 ppb) – injection


slaughterhouse



21/ Tulathromycin (> 20.000 ppb) –


bovine –slaughterhouse



Tulathromycin (700 ppb) – muscle –


slaughterhouse



slaughterhouse



23/ Tolfenamic acid – injection site

– suspect sample – bovine –

slaughterhouse



24/ Amoxycillin (> 125 ppb) –





25/ Benzylpenicillin (> 125 ppb) –





26/ Oxytetracycline (> 200 ppb) +

tetracycline (> 200 ppb) – injection


slaughterhouse



86

27/ Trimethoprim (77 ppb) +

amoxicillin (> 125 ppb) – injection


slaughterhouse



28/ Oxytetracycline (> 200 ppb)+

meloxicam + metamizole – injection


slaughterhouse



Meloxicam – muscle – suspect


29/ Gentamycin (84,8 ppb) –





30/ Oxytetracycline (> 200 ppb) –




Interview of the holder. Carcass destroyed. Reinforced

control type R put in place.

Oxytetracycline (> 200 ppb) –

muscle – suspect sample – bovine –

slaughterhouse



slaughterhouse



32/ Dihydrostreptomycin

(> 1.500 ppb) + trimethoprim

(> 100 ppb) + benzylpenicillin

(> 125 ppb) + sulfadoxine

(> 200 ppb) + meloxicam – injection


slaughterhouse


Interview of the holder. Carcass destroyed. See also 9

under Group A substances.

Benzylpenicillin (> 125 ppb) +

sulfadoxine (> 200 ppb) +

meloxicam – injection site – suspect




slaughterhouse



34/ Metamizol – injection site –


slaughterhouse


Interview of the holder. See also 10 under Group A

substances. Carcass destroyed.

Metamizol – muscle – suspect







36/ Tylosin (480 ppb) – injection site


slaughterhouse



87

37/ Ceftiofur (> 2.500 ppb) –





38/ Spectinomycin (> 900 ppb) +

tylosin ( 160 ppb) + meloxicam –




Interview of the holder. Carcass destroyed. Reinforced

control type R put in place.

Spectinomycin (460ppb) +

sulfadiazine (136 ppb) + meloxicam

– injection site – suspect sample –




slaughterhouse








41/ 4-epi-oxytetracycline (>200 ppb)

+ oxytetracycline (> 200 ppb) –










43/ 4-epi-oxytetracycline (30 ppb) +

oxytetracycline (120 ppb) – injection


slaughterhouse



44/ Dihydrostreptomycin

(> 1.500 ppb) – injection site –


slaughterhouse



45/ Tilmicosin (66 ppb) +

tulathromycin (> 20 ppb) – injection


slaughterhouse




– suspect sample – cow –

slaughterhouse



47/ Phenylbutazone – injection site –


slaughterhouse



Phenylbutazone – muscle – suspect


Ovine & caprine

Dioxins (3,6 pg TEE/g fat) – fat –

sheep – target sample –

slaughterhouse

None

88

Porcine

1/ Doxycycline (230 ppb) – muscle –

target sample – pig – slaughterhouse


Interview of the holder. Products still at

slaughterhouse put under official detention (1.641 kg).

RASFF. Reinforced control R type put in place.

2/ Sulfadiazine (> 200 ppb) – muscle

– target sample – sow –

slaughterhouse



3/ Sulfadimethoxine (> 200 ppb) –

muscle – target sample – sow –

slaughterhouse



4/ Sulfadiazine (130 ppb) – muscle –

target sample – sow –

slaughterhouse


Interview of the holder. RASFF. Reinforced control

type R put in place.

5/ Sulfadiazine (> LMR) – muscle –

target sample – sow –

slaughterhouse


Interview of the holder. Reinforced control type R put

in place.

6/ Sulfadiazine (> 200 ppb)-muscle

– target sample – pig –

slaughterhouse



7/ Sulfadiazine (> 200 ppb) – muscle

– target sample – pig –

slaughterhouse



8/ Levamisole (> 20 ppb) – muscle –

target sample – pig – slaughterhouse


Interview of the holder. Products still at

slaughterhouse put under official detention. RASFF.

9/ Trimethoprim (2.529 ppb) +

sulfadoxine (113 ppb) + flunixine +

metamizol – injection site – suspect

sample – sow – slaughterhouse






injection site – suspect sample – pig

– slaughterhouse





– slaughterhouse



12/ Oxytetracycline (7.499 ppb) –


– slaughterhouse



13/ Enrofloxacin (> 200 ppb) –

injection site – suspect sample – sow

– slaughterhouse



14/ Oxytetracycline (3.892.000 ppb)

+ tetracycline (14.400 ppb) –


– slaughterhouse



89

Oxytetracycline (834 ppb) – muscle

– suspect sample – sow –

slaughterhouse



– slaughterhouse




suspect sample – pig –

slaughterhouse


Interview of the holder. R-status allocated. Part of

carcass destroyed.

17/ Gentamycin (> 500 ppb) –


– slaughterhouse



18/ Ampicillin (127 ppb) – injection

site – suspect sample – pig –

slaughterhouse



19/ Ampicillin (> 125 ppb) + 4-epi

tetracycline (> 200 ppb) + 4-epi

oxytetracycline (> 200 ppb) +

oxytetracycline (> 200 ppb) +

tetracycline (> 200 ppb) +

meloxicam – injection site – suspect





muscle – suspect sample – sow –

slaughterhouse

20/ Flunixin – injection site –

suspect sample – sow –

slaughterhouse



21/ Benzylpenicillin (> 125 ppb) +

fenbendazole (28 ppb) +

oxfendazole (26 ppb) +

oxfendazolesulfone (45 ppb) –


– slaughterhouse


Interview of the holder. See also 7 under Group A

substances. Carcass destroyed.

Fenbendazole (17 ppb) +

oxfendazole (31 ppb) +

oxfendazolesulfone (41 ppb) –

muscle – pig – slaughterhouse

22/ Ciprofloxacin (70 ppb) +

enrofloxacin (13.000 ppb) + 4-epi-

oxytetracycline (200 ppb) +

oxytetracycline (3.000 ppb) –


– slaughterhouse



in place. Carcass destroyed.

Ciprofloxacin (27 ppb) +

enrofloxacin (140 ppb) – muscle –

suspect sample – pig –

slaughterhouse

90

23/ Amoxicillin (> 125 ppb) –


– slaughterhouse



in place. Part of carcass destroyed.

24/ Ampicillin (> 125 ppb) –


– slaughterhouse



25/ Florfenicol (> 750 ppb) +

florfenicol amine (> 750 ppb) +

amoxicillin (> 125 ppb) – injection

site – suspect sample – sow –

slaughterhouse



in place. Carcass destroyed.

Florfenicol (700 ppb) + florfenicol

amine (150 ppb) – muscle – suspect


26/ Amoxicillin (> 125 ppb) –


– slaughterhouse



27/ Azaperol (> 120 ppb) +

azaperone (> 120 ppb) – injection

site – suspect sample – pig –

slaughterhouse



28/ Oxytetracycline (> 200 ppb) +

tetracycline (> 200 ppb) – injection

site – suspect sample – sow –

slaughterhouse




muscle – suspect sample – sow –

slaughterhouse

29/ Metamizol – injection site –

suspect sample – sow –

slaughterhouse





Poultry

4-methylaminoantipyrin (61 ppb) –

muscle – turkey – target sample –

slaughterhouse



Doxycycline (> 200 ppb) – muscle –

broiler – target sample –

slaughterhouse



Lasalocid – muscle – broiler – target




Equine – Aquaculture – Milk – Eggs – Rabbit –

Wild game – Farmed game – Honey

No non-compliant results None

91

Administrative measures

A new system of reinforced controls entered in force in 2013. According to the seriousness of

the non-compliance, 6 different types of reinforced controls are foreseen. The different types

differ from each other by duration and control measures put in place (on farm inspections,

sampling on farm, sampling at slaughterhouse, products sampling).

R-status/reinforced control type R were allocated to bovine farms : 3

R-status/reinforced control type R were allocated to pig farms : 8

Official reports sent to the legal service for the attribution of administrative penalty. In cases,

fine is not paid, the report is sent to the prosecutor for follow-up.

92



Member State BULGARIA

Group A substances


None


Bovine – Ovine & caprine – Porcine – Equine – Poultry –

Aquaculture – Milk – Eggs – Rabbit – Farmed game – Honey

None None

Group B substances


On basis of non-compliances in the 2013 control plan of VMP and residues, for 2014 the

following is planned:

- 43 % of the total planned samples for substances of group В, which will be taken from

bovines from a slaughterhouse will be analyzed for substances of group В1;


pigs from a slaughterhouse will be analyzed for substances of group В1;


poultry from a slaughterhouse will be analyzed for substances of group В1;

- 40 % of the total planned samples for substances of group B3, which will be taken from

fish will be analyzed for substances of group B3 (e);

- 30 % of the total planned milk samples for A 6, B1, and B2 groups will be taken and will

be analyzed for substances of group B2 (e);

- 18 % of the total planned samples for substances of group B3, which will be taken from

milk will be analyzed for substances of group B3 (d);

- 40% of the total planned honey samples for A6, B1 and B2 will be taken and will be

analyzed for substances of group B1.


Bovine

Oxytetracycline – 1 targeted sample

– 177,6 µg/kg in muscle –

2.141 µg/kg in kidney. Sampling

from 31 month old bovine –

slaughterhouse

When a tracking of origin is conducted – the animal

has been treated with “Mastijet Forte” and

Dexametazon (it is not registered for large animals).

The treatment is written in the ambulatory journal of

the farm but the withdrawal periods were not recorded.

Limoksin 200 LA with an active base oxytetracycline

has been found in the farm. The container quantity

compared to the expended quantity does not comply

with the information written in the ambulatory journal.

A measure for an administrative infraction was issued.

When a slaughterhouse was checked – stocks of the

slaughter batch were not found.

93

Three suspect samples (milk) were consistently taken

at different intervals of time – negative result for the

presence of group B1 substances.

Spiramycine – 1 targeted sample –

1.445 µg/kg in kidney – 97,8 µg/kg

in muscle. Sampling from bovine

under two years of age –

slaughterhouse

The inspection of the farm of origin established

treatment with VMP of uncertain origin. The farm was

placed under restriction and a measure for an

administrative infraction has been issued.

The performed inspection in the slaughterhouse has

not found quantities of the batch. Collection of a

suspect sample is forthcoming.

The farms in items І and ІІ are under increased

monitoring. The samples were paid by the owner of the

farm.

Porcine

ß-lactams in five targeted kidney

samples – sampling from

slaughterhouse

Inspections in the farms of origin were carried out. The

following gaps were identified:

- There is no clear traceability of the treated animals

and when the treatment was completed;

- Gaps in the ambulatory journals were identified – not

all treatments are recorded regularly;

- The withdrawal periods of used VMP are not

correctly recorded.

Four feed samples were taken for the presence of

group B1 substances – negative result.

Prescriptions have been prepared.

The farm is put under increased monitoring in 2014.

ß-lactams in first targeted muscle

sample – sampling from

slaughterhouse

When inspection in a slaughterhouse was carried out –

quantities of slaughter batches were not found. A total

of 10 suspect samples were taken. The sampling

batches are placed under restriction pending laboratory

analysis. The results of the suspect samples are

negative.

The samples were paid by the owner of the farm.

Poultry

ß-lactams in matrix muscle and liver,

sulphonamides in matrix liver

An inspection in a farm of origin established treatment

of birds with Syvaquinol and Sulfachlorpyrazin. The

treatment is not written in the ambulatory journal.

Prescription has been prepared.

The farm is put under increased monitoring.

ß-lactams in matrix muscle and liver,

sulphonamides in matrix liver.

An inspection in a slaughterhouse found quantities

(968,655 kg) from one of the two batches of

slaughtered poultry, these been placed under restriction

and destroyed in an incinerator.

Two suspect samples were consistently taken –

negative results for group B1 substances.

The samples were paid by the owner of the farm.

94

Aquaculture

In the target fish sample (sturgeon)

for the presence of leuco malachite

green – 14,68 µg/kg.

The fish farm was inspected for presence of veterinary

medicinal products and colorants and the result is

negative. A conversation with the owner was held.

Five suspect samples were taken. The analyses showed

presence of leuco malachite green:

1. 33,75 µg/kg

2. 27,5 µg/kg;

3. 22,56 µg/kg

4. 17,01 µg/kg;

5. 4,24 µg/kg.

Prescription has been prepared. The establishment is

put under increased monitoring. The samples were

paid by the owner of the fishpond.

Milk

Targeted sample with presence of

Ketoprofen (26,9 µg/kg)

The target sample is from raw

sheep's milk from the farm.

The non-compliance is for one target sample (raw

sheep milk) from a farm. A conversation with the

owner was held. No NSAIDs were established in the

farm. All VMPs are bought with a prescription, issued

by a veterinarian, there were no gaps in the ambulatory

journal. A prescription was issued. One suspect sample

was taken – it showed a negative result. The milk is

placed under restriction until the outcome of the

laboratory analysis.

Five non – compliances in target

samples from raw cow milk taken

from a farm with detected presence

of Aflatoxin M1 over 0,05 µg/kg.

The non-compliance relates to 5 farms. Conversation

with the owners was held. The farms are under

restriction. From one farm a total of 10 suspect

samples were taken in different periods of time:

1. The first 5 suspect samples:

- Three of them are with a confirmatory results for

aflatoxin M1 (0,45 μg/kg; 0,11 μg/kg; 0,062 μg/kg);

- The other two are with negative results;

The farms are exempt from restriction. The banned

quantity of milk was destroyed.

2. From 3 of the farms suspect samples were taken

again.

One showed presence of Aflatoxin M1 (0,072 μg/kg),

the other two were with negative results. In one of the

farms the restriction was lifted. The banned quantity of

milk was destroyed.

3. From two farms suspect samples (milk) were taken

for the third time. They showed negative results.

4. One sample from a dairy product was taken, it

showed negative result. All suspect samples are

confirmed by LC/MS/MS. For the period of the study,

the produced milk and the production were placed

under restriction and destroyed.

In this period the animals were raised in barns. 10 feed

95

samples were taken from 3 farms. Four of them

showed presence of Aflatoxin B1. The feed was placed

under restriction and was destroyed. The farms were

subject of increased levels of official and self-

monitoring.

The suspect samples were paid by the owners.

Honey

Three non-compliances in target

samples with presence of

Tetracycline – over 20 µg/kg.

The apiary was put under ban. Inspection was

performed for presence of antibacterial substances. No

presence of such substances was discovered in the

batch from which the target sample was taken.

Conversations with the owner of the apiary were held.

From the present quantity of honey, three suspect

samples were taken:

- Two suspect samples – negative results.

Apiaries are exempt from restriction.

- One suspect sample is non-compliant: over 20 µg/kg.

The honey was disposed in rendering plant and

document for disposal was issued. A measure for an

administrative infraction was issued to the owner. The

establishment is put under increased monitoring in

2014.

The samples were paid by the owners of the apiary.

Ovine & caprine – Equine – Eggs –

Rabbit – Wild game – Farmed game

None None

96



Member State CROATIA

Group A substances

Modification of National Residue Plan

Modifications 2012

A1 – Stilbenes + A4 – Resorcylic acid lactones = in urine = one confirmatory multi

method (LC-MS/MS) = CVI Zagreb.

A3 – Steroids (N+T+S+M+B) = in urine = one confirmatory method (LC-MS/MS) = CVI

Zagreb.

A5 – Beta-agonists = in urine and liver:

a) added Ritodrin & Tulobuterol

b) one confirmatory method (LC-MS/MS) = CVI Zagreb

A6 – Compounds included in Table II Commission Regulation No. 37/2010:

c) Chloramphenicol = in water = one confirmatory method (LC-MS/MS) = CVI Zagreb

d) Nitrofurans = in muscle, skin+ muscle, milk & eggs = one confirmatory method (LC-

MS/MS) = CVI Zagreb

Some changes are made due to changes in production numbers and/or non-compliant

results in previous year

Somewhere new information on CC- alfa and/or CC-beta values are added to the plan


Bovine

Thiouracil (CAS No 141-90-2);

synonym = 2-Thiouracil – Urine

(CCα = 13,05 µg/l): 12 non-

compliant results: 8 in

slaughterhouses and 4 on farms.

Eight target samples taken in slaughterhouses

confirmed non-compliant for Thiouracil at the

following levels:

1. A 32428 = 17,86 µg/l (Osijek 28/02/2013), farm in

Osijek, one suspect sample (B 7008) as well as one

flow up sample (A 34835) that were taken on the farm

were compliant;

2. A 32530 = 25,77 µg/l (SL Brod 05/03/2013)

3. A 32529 = 36,85 µg/l (SL Brod 06/03/2013)

4. A 33474 = 16,61 µg/l (Zagreb 12/03/2013) farm in

Varaždin, one follow-up sample (A 35518) taken on

farm was compliant.

5. A 33335 = 70,43 µg/l (Zagreb 13/03/2013; farm in

Bjelovar; two follow-up samples (A 34603 + 36010)

taken on the farm were compliant.

6. A 32662 = 15,42 µg/l (Rijeka 23/04/2013; farm in

Bjelovar; two follow-up samples (A 35953 + 36012)

taken on the farm were compliant)

7. A 32958 = 14,36 µg/l (Split 25/04/2013; farm in

Bjelovar; two follow-up samples taken on the farm,

one was compliant (A 35954) and sample No. A 36011

was non-compliant.

97

8. A 35058 = 13,05 µg/l (Rijeka 16/07/2013; farm in

Zagreb).

Four target samples taken on farms confirmed non-

compliant for Thiouracil at the following levels:

1. A 34835 = 20,46 µg/l (Osijek 17/10/2013) the

sample was taken on the same farm as sample No. A

32428, after this non-compliant result two suspect

samples were taken on the farm and one of them was

non-compliant again (sample No. B 7009 = 19,27 µg/l

taken on 17/12/2013); and sample No B 7010 was

compliant. This sample was taken on 12/03/2014.

2. A 36011 = 13,66 µg/l (Bjelovar 11/09/2013) the

sample was taken on the same farm as sample No. A

32958, after these non-compliant result one suspect

samples was taken on the farm and was non-compliant

again (sample No. B 6912 = 12,04 µg/l taken on

26/11/2013).

3. A 33138 = 14,85 µg/l (Varaždin 06/03/2013)

sample taken on the same farm after this non-

compliant result (A 35520) was non-compliant on B3d

(β zearalenol).

6. A 33137 = 30,05 µg/l (Varaždin 20/03/2013)

sample taken on the same farm after this non-

compliant result (A 35524) was compliant.

Follow-up investigations were initiated at farm level in

all cases. The records on use of medical products have

been checked. No evidence of illegal use was

identified or violation of medication. Quality of feed

was probable case of these findings. Veterinary

inspectors issued instructions how to improve quality

of feed. Also sampling on these farms was intensified.

Group A3 – Steroids:

17-Alpha nortestosteron

(CAS No 4409-34-1)

Urine

4 non-compliant results on farms

Four target samples taken on farms confirmed non-

compliant for 17-Alpha nortestosteron (Cα =

0,61 µg/l) at the following levels:

1. A 34609 = 7,52 µg/l (Bjelovar 09/07/2013).

Follow up investigation was initiated at the farm level.

The sample was taken from cow that was pregnant.

During investigation additional four suspect samples

(B 5385 + 5384 + 5383 + 5386) of urine were taken

and they were compliant. Sampling on this farm was

intensified. In the next three months on the same farm

four (A34641, 34642, 34643 + 34644) extra samples

were taken. One of them A 34643 was non-compliant

= 1,65 µg/l (Bjelovar 20/11/2013). During

investigation on the farm it was found that urine was

taken from cow that was in oestrus.

2. A 34611 = 4,53 µg/l (Bjelovar 28/09/2013). Follow-

up investigation was initiated at the farm level. The

98

sample was taken from cow that was pregnant. During

investigation additional two samples of urine were

taken. One was taken from same cow B 6902 =

8,92 µg/l (15/11/2013) that gave birth on 21/11/2013.

The other sample B 6903 = 1,21 µg/l (15/11/2013) was

taken from other cow that during post-mortem

investigation in slaughterhouse the cists on ovaries

where found. Sampling on this farm was also

intensified.

3. A 34765 = 3,88 µg/l (Osijek 05/07/2013). Follow-

up investigation was initiated at the farm level. The

sample was taken from cow that was pregnant. During

investigation additional sample of urine was taken

16.08.2013 from the same cow (B 7013) and was

compliant. This cow gave birth on 26/07/2013.

Follow-up investigation was initiated at the all farms.

The records on use of medical products have been

checked. No evidence of illegal use was identified or

violation of medication. Veterinary inspectors

concluded that original samples were taken from

animals that where pregnant or in oestrus or that had

ovarian cists. Regardless of this conclusion sampling

on these farms was intensified.

Group A5 – Beta agonists:

isoxsuprine (CAS No 395-28-8)

Liver

1 non-compliant result

One target sample taken in slaughterhouse confirmed

non-compliant for isoxsuprine (CCα = 0,15 µg/kg) at

the following level A 32432 = 4,01 µg/kg

(12/03/2013). During investigation in the

slaughterhouse it was found that the sample was taken

from young bovine that came from Romania on

28/02/2013 and was slaughter on 12/03/2013.

Accordingly to the Regulation No. 37/2010, no MRL

is required for bovine if there is evidence that

isoxsuprine was used only for therapeutic use in

accordance with Council Directive 96/22/EC. As

during inspection in the slaughterhouse no evidence of

illegal use was identified or violation of medication

and as the bovine was in the slaughterhouse more than

15 days no further action was taken. Sampling in this

slaughterhouse was intensified.

Bovine – In 2013 number of samples for group A has been increased due to non-compliant

results in 2012 on 552 samples (422 in 2012);

1. Group A1 + A4 = 112 samples (80 in 2012)

2. Group A2 = 80 samples (42 in 2012)

3. Group A5 = 112 samples (42 in 2012)

4. Group A6 – Nitroimidazoles = 70 samples (30 in 2012)

99

Ovine & caprine


17-Alpha nortestosteron

(CAS No 4409-34-1)

Urine

1 non-compliant result on farm

One target sample taken on farm confirmed non-

compliant for 17-Alpha nortestosteron, (CCα =

0,61 µg/l)] A 34645 = 8,04 µg/l (Bjelovar 30/12/2013).

This sample was taken on the farm as part of

intensified sampling due to non-compliant result on17-

Alpha trenbolone in pigs (A 35036). During

investigation additional three samples of urine were

taken (B 5377, 5378 & 5379). One from sheep, one

from pig and one from young bovine. All this samples

where compliant. Sampling on this farm is also

intensified.

Porcine


17-Alpha trenbolone (CAS No

80657-17-6)

Urine

1 non-compliant results in

slaughterhouse

One target sample taken in slaughterhouse confirmed

non-compliant on 17-Alpha trenbolone (CCα =

1,35 µg/l) at the following level A 35036 = 3,51 µg/l

(12/06/2013).

During investigation in the slaughterhouse it was

found that no assurance can be given that the sample

was taken from pigs or it could have been

contaminated with bovine urine next day. Corrective

measures were taken against veterinarians that have

taken sample in slaughterhouse.

During investigation on the farm from where pigs

originated the records on use of medical products have


identified or violation of medication. Two additional

samples of urine where taken (B5374 – from calf &

B5376 – from pigs) and they were compliant.

Sampling on this farm was intensified. In the next four

months on the same farm four extra samples were

taken [one from pig (A34648), two from bovine (A

34646 + 34647) and one from sheep (A34645)]. All

this samples where compliant except the last one A

34645 taken from sheep that was non-compliant on 17-

Alpha nortestosteron, = 8,04 µg/l (30/12/2013).

Group A4 – Resorcylic acid lactones

& B3d – Mycotoxins:

Urine

1 non-compliant result in the

slaughterhouse

One target sample A 32549 taken in the

slaughterhouse confirmed non-compliant for

1. group A4 = Taleranol (CCα = 1,15 µg/l) = 3,7 µg/l;

and

2. group B3d ( Mycotoxin F):

- α-zearalenol = 6,56 µg/l (CCα = 1,51 µg/l)

- β-zearalenol = 29,26 µg/l (CCα = 1,27 µg/l)

- Zearalenon = 18,35 µg/l (CCα = 1,62 µg/l)

Follow-up investigation was initiated at the farm (in

Osijek 16/04/2013). The records on use of medical

products have been checked. No evidence of illegal

use was identified or violation of medication.

100

Veterinary inspector concluded that residues resulted

from fungal contamination of feed. The instructions on

good agricultural practice as to avoid fungal

contamination of feed where issued. Also sampling on

this farm was intensified. There were no further non-

compliant findings.

Pigs – In 2013 number of samples for group A4 has been increased due to non-compliant

results in 2012 to 50 samples (35 in 2012).

Equine

Group A4 – Resorcylic acid lactones

& B3d – Mycotoxins:

Urine

1 non-compliant result in the

slaughterhouse

One target sample A 33255 taken in the

slaughterhouse confirmed non-compliant for

1. group A4 = α-Zearalanol (CCα = 1,16 µg/l) =

1,99 µg/l; and

2. group B3d ( Mycotoxins):

- α-zearalenol = 40,39 µg/l (CCα = 1,51 µg/l)

- β-zearalenol = 37,67 µg/l (CCα = 1,27 µg/l)

- Zearalenon = 5,13 µg/l (CCα = 1,62 µg/l)

Follow-up investigation was initiated at the farm (in

Zagreb 20/11/2013). The records on use of medical






contamination of feed where issued. Also sampling on

this farm was intensified.

Poultry

In 2013 number of samples for group A5 has been increased for turkeys due to non-compliant

result in 2012 to 15 samples (10 in 2012 when total number of samples from turkey was 200

samples).


None None

Group B substances

Modification of National Residue Plan

Modifications 2012 2013

B1 – Antibacterial substances:

a) in muscle & milk = added two new substances (Gentamicin & Neomycin);

b) Sulphonamides = in honey = one confirmatory method (LC-MS/MS) = CVI Zagreb

B2a – Anthelmintics:

a) in liver, muscle & skin, milk = one confirmatory method (HPLC-FLD) = CVI Split

b) in milk added one new substance (Nemadectin);

B2c – Carbamates & pyrethroids = in fat tissue, muscle & skin, honey = new substances

added = one confirmatory method (GC-MS/MS) = CVI Zagreb

B2f – Other pharmacologically active substances:

a) Carbadox = in muscle = one confirmatory method (LC-MS/MS) = RIKILT

101

b) Amitraz (Formamidine) = in honey = one confirmatory method (GC-MS/MS) = CVI

Zagreb

B3a – Organochlorine compounds = in fat tissue, muscle & skin, milk, eggs, honey = new

substances added = one confirmatory method (GC-MS/MS) = CVI Zagreb

B3b – Organophosphorus compounds = in fat tissue, milk, honey = new substances added

= one confirmatory method (GC-MS/MS) = CVI Zagreb

Some changes are made due to changes in production numbers and/or non-compliant

results in previous year

Somewhere new information on CC- alfa and/or CC-beta values are added to the plan

Bovine


Group B1 – Antibacterial

substances:

Dihydrostreptomycin

Muscle

1 Non-compliant result

One target sample taken at slaughterhouses confirmed

non-compliant for dihydrostreptomycin (MRL = 500

µg/kg; CCα = 580 µg/kg) at the following level A

33482 = 121,5 µg/kg (Zagreb 27/02/2013). The non-

compliant result was received on 15/04/2013,

1,5 months after the samples was taken. The sample

was taken from cow 7 years old. Follow-up

investigations were initiated at slaughterhouse and at

the farm level.

The sausages that where made from that cow and

where still on the market where withdrawn from it

(3 kg) and destroyed.

Investigation on the farm of origin revealed that this

farm keeps bovines on open without treating them.

Animals are kept free and not used to be handled by

humans, only calves are kept in stables. On the farm

the records on use of medical products have been

checked and in this period they have used veterinary

medicinal products with dihydrostreptomycin

(“Sustrapen”) but no records on treating this cow could

be found. This farm has its own veterinary service.

This cow was losing weight and therefore it was send

to slaughter. Sampling on this farm was intensified.

Two extra samples were taken (A 35804 + 35806). All

this samples where compliant.

Group B3c – Chemical elements:

Cadmium (Cd)

Kidney

9 Non-compliant results

On heavy metals in bovine animals last three years for

the NRCP we sample muscle and kidney from same

animal. All target samples of muscle where compliant

but nine samples of kidney where non-compliant on

cadmium (MC < 1 mg/kg; LOQ = 0,0014 mg/kg) at

the following levels:

1. A 32454 = 2,47 mg/kg (farm in Bjelovar;

06.05.2013, = 6,5 years old);

2. A 35848 = 2,3 mg/kg (farm in Bjelovar; 04/12/2013,

= 5 years old);

3. A 32452 = 2,2 mg/kg (farm in Osijek; 08/04/2013, =

5 years old);

102

4. A 36109 = 1,89 mg/kg (farm in Osijek; 24/10/2013,

= 7 years old);

5. A 36110 = 1,72 mg/kg (farm in Osijek; 20/12/2013,

= 5 years old);

6. A 35396 = 1,16 mg/kg (farm in Zagreb; 20/11/2013,

= 6 years old);


= 12 years old);


= 6 years old);


= 8 years old);

Most slaughterhouses don’t use bovine kidney for

human consumption especially if it comes from very

old animals.

Follow-up investigations were initiated at farm level.

The farmers were informed about non-compliant

results and advice was given how to avoid heavy metal

contamination in future.

Group B3d – Mycotoxins:

Urine

39 non-compliant results:

- 14 in slaughterhouses

- 25 on farms


Urine



- 25 on farms

This analysis is done as one method together with

group A4. In 2013. There were 39 non-compliant

results in bovine animals in urine. 14 samples were in

slaughterhouses and 25 on farms.

A. samples non-compliant only on zearalenol-beta

(CCα = 1,27 µg/l):

1. A 32249 = 1,4 µg/l (Bjelovar F 23/03/2013; sample

from the same farm was also non-compliant in 2012

on the same group)

2. A 32250 = 5,34 µg/l (Bjelovar F 10/04/2013,

sample from the same farm was also non-compliant in

2012 on the same group)

3. A 32253 = 7,22 µg/l (Bjelovar F 27/03/2013,



4. A 36001 = 15,2 µg/l (Bjelovar F 15/10/2013,

sample taken on same farm as A 32249)

5. A 36002 = 2,51 µg/l (Bjelovar F 17/12/2013,


6. A 32398 = 2,37 µg/l (Osijek F 27/02/2013)

7. A 32400 = 16,44 µg/l (Osijek F 07/03/2013)

8. A 34754 = 3,84 µg/l (Osijek F 23.07.2013)

9. A 34786 = 6,15 µg/l (Osijek S 19/09/2013, farm is

also in Osijek)

10. A 36088 = 2,94 µg/l (Osijek S 24/10/2013, farm is

also in Osijek)

11. A 34923 = 1,71 µg/l (Slavonski Brod S

06/08/2013, farm is also in Slavonski Brod)

12. A 36251 = 14,26 µg/l (Slavonski Brod F

103


Urine



- 25 on farms


Urine

39 non-compliant results

17/10/2013, sample taken on same farm as A 34923)

13. A 36201 = 2,12 µg/l (Slavonski Brod S

28/10/2013, farm is also in Slavonski Brod)

14. A 32661 = 1,08 µg/l (Rijeka S 07/02/2013, farm is

in Osijek)

15. A 32794 = 3,47 µg/l (Šibenik F 22/04/2013)

16. A 32799 = 1,48 µg/l (Šibenik S 21/03/2013, farm

is in Bjelovar)

17. A 32947 = 8,75 µg/l (Split F 18/02/2013, sample


on the same group)

18. A 32953 = 2,26 µg/l (Split S 29/03/2013, farm is in

Bjelovar)


Zagreb)


Osijek)

21. A 33133 = 4,24 µg/l (Varaždin F 11/04/2013,



22. A 33135 = 1,66 µg/l (Varaždin F 03/04/2013)

23. A 35519 = 3,72 µg/l (Varaždin F 26/06/2013)

24. A 35520 = 2,02 µg/l (Varaždin F 18/07/2013,


25. A 35523 = 4,0 µg/l (Varaždin S 19/12/2013, farm

is in Bjelovar)

26. A 33321 = 1,83 µg/l (Zagreb F 24/04/2013, sample


on the same group)

27. A 35785 = 4,51 µg/l (Zagreb S 22/10/2013, farm is

also in Zagreb).

B. sample non-compliant only for zearalenone

(mycotoxin F; CCα = 1,62 µg/l):

1. A 36004 = 2,13 µg/l (Bjelovar F 18/12/2013,


C. sample non-compliant on zearalenol-alpha (CCα =

1,51 µg/l) and zearalenol-beta (CCα = 1,27 µg/l):

1. A 35663 = α-zearalenol = 6,45 + β-zearalenol =

42,2 µg/l (Zagreb S 02/10/2013, farm is also in

Zagreb)

D. samples non-compliant on zearalenol-beta (CCα =

1,27 µg/l) and zearalenone (mycotoxin F; CCα =

1,62 µg/l)):

1. A 36003 = β-zearalenol = 8,67 + zearalenone =

2,7 µg/l (Bjelovar F 30/12/2013, sample taken on same

104

farm as A 32250)


2,72 µg/l (Bjelovar S 28/10/2013, farm is also in

Bjelovar)


2,3 µg/l (Bjelovar F 29/01/2013, sample taken on same

farm as A 32253)


6,1 µg/l (Osijek F 18/10/2013, sample taken on same

farm as A 32398)


2,8 µg/l (Osijek F 18/11/2013, sample taken on same

farm as A 32400)


1,59 µg/l (Split S 07/02/2013, farm is in Bjelovar)


5,35 µg/l (Zagreb F 11/12/2013, farm is also in

Zagreb, sample taken on same farm as A 33321)


12,6 µg/l (Zagreb F 17/01/2013, farm is also in

Zagreb, sample taken on same farm as A 32955)

E. samples non-compliant on zearalenol-alpha (CCα =

1,51 µg/l), zearalenol-beta (CCα = 1,27 µg/l) and

zearalenone (mycotoxin F; CCα = 1,62 µg/l)):


43,19 + zearalenone = 16,47 µg/l (Bjelovar F



21,1 + zearalenone = 7,57 µg/l (Bjelovar F



all cases. On same farms additional samples of feed or

urine were taken when feed on the farm was suspect of

fungal contamination. The records on use of medical






contamination of feed where issued.

Bovine – Due to non-compliant results in 2012 number of samples in 2013 has been increased

for:

1. Group B1 = 149 samples (114 in 2012);

2. Group B3c = 22 samples (19 in 2012).

105

Porcine

Group B2c – Carbamates &

pyrethroids:

Tetramethrin (CAS No. 7696-12-0 )

Fatty tissue

One target sample taken at slaughterhouse from

fattening pig confirmed non-compliant for tetramethrin

(LOQ = 0,001 mg/kg; MRL = presence) at the

following level:

A 32828 = 0,009 mg/kg (Šibenik S 14/05/2013).

Tetramethrin is not registered as pesticide for animals.

Follow-up investigation was initiated at the farm level.

Farm is in Bjelovar territory and has 18 bovine and 70

pigs. The records on use of medical products have

been checked. On the farm two products that have

tetramethrin (“Pertin-S” and “Amplat”) where found.

These products are registered for use on plants but not

on animals. Farmer was using them on walls and

ceilings of the stables while there were animals in

them not knowing this product should not be used in

such way. Veterinary inspector gave instructions

which product can be used in stables. Sampling on this

farm was intensified. One extra sample was taken (A

34650) and was compliant.


Urine


slaughterhouses


- 1 on farm


Urine


slaughterhouses


This analysis is done as one method together with

group A4. In 2013. There were 5 non-compliant results

in pig animals in urine.

A. sample non-compliant only for zearalenone

(mycotoxin F; CCα = 1,62 µg/l):

1. A 33371 = 1,75 µg/l (Zagreb S 25/04/2013, farm is

in Varaždin)

B. sample non-compliant on zearalenol-alpha (CCα =

1,51 µg/l) and zearalenone (mycotoxin F; CCα =

1,62 µg/l)):

1. A 35628 = α-zearalenol = 3,66 + zearalenone =

3,77 µg/l (Zagreb S 10/07/2013, farm is also in

Zagreb)

C. samples non-compliant on zearalenol-alpha (CCα =

1,51 µg/l), zearalenol-beta (CCα = 1,27 µg/l) and

zearalenone (Mycotoxin F; CCα = 1,62 µg/l)):

1. A 33160 = α-zearalenol = 3,23 + β-zearalenol = 3,6

+ zearalenone = 3,56 µg/l (Varaždin S 17/04/2013,

farm is also in Varaždin)

2. A 32677 = α-zearalenol = 13,5 + β-zearalenol = 2,1

+ zearalenone = 17,2 µg/l (Rijeka S 25.04.2013,

sample taken from same farm as A 33160)

3. A 35811 = α-zearalenol = 5,2 + β-zearalenol = 1,7 +

zearalenone = 10,5 µg/l (Zagreb F 19/12/2013, sample

taken on same farm as A 35628)




106

identified or violation of medication. Veterinary

inspector concluded that residues resulted from fungal

contamination of feed. The instructions on good

agricultural practice as to avoid fungal contamination

of feed where issued.

Poultry


substances:

Dihydrostreptomycin

Muscle



substances:

Dihydrostreptomycin

Muscle


One target sample taken at slaughterhouses confirmed

non-compliant for dihydrostreptomycin (NDK =

presence; CCα = 12,1 µg/kg) at the following level A

33191 = 683,9 µg/kg (Varaždin 23/04/2013). The non-

compliant result was received on 17/05/2013. The

sample was taken from broiler. Products that contain

dihydrostreptomycin are not allowed for poultry.

Follow-up investigations were initiated at

slaughterhouse, at the farm and in the feed mill.

Investigation in the slaughterhouse revealed that one

person was at post-mortem inspection and other was

signed on sampling document. Both veterinarians

denied that sample by mistake could come from other

farm.

During investigation on the farm records on use of

medical products have been checked as well as feed.

No evidence of illegal use was identified or violation

of medication. No evidence of usage of product that

contained dihydrostreptomycin could be found. Farmer

is only using feed that is produced by one feed mill.

Investigation in the feed mill reviled that this feed mill

didn’t produce any medicated feed in last three years,

and also didn’t use dihydrostreptomycin. Therefore

possible contamination of feed with

dihydrostreptomycin was ruled out. As inspectors

could not found any lead, sampling on this farm was

intensified. Three extra samples were taken (A 35478,

35537 + 35538). All these samples where compliant.

Chicken – Due to non-compliant result in 2012 number of samples in 2013 has been increased

for Group B2b = 50 samples (45 in 2012).



zearalenol-alpha in duck liver

One sample was non-compliant on zearalenol-alpha

(CCα = 0,55 µg/kg):

1. A 33277 = 2,02 µg/kg (Zagreb S 05/12/2013, farm

is also in Zagreb)

Ducks – Due to non-compliant result in 2012 number of samples in 2013 has been increased

for Group B2b = 6 samples (5 in 2012).

107

Milk

Group B3d – Mycotoxins (aflatoxin

M1)

Bovine milk


Ovine milk


During 2013, there were 10 non-compliant samples of

bovine milk and one of ovine milk on aflatoxin M1

(LOQ = 0,01 µg/kg; MC < 0,05 µg/kg).

These samples where non-compliant at the following

levels:

1. A 32386 = 0,324 µg/kg [(farm in Osijek

03/04/2013), two suspect samples were taken and they

were non-compliant: B7005 = 0,179 (15/05/2013) and

Z-26528/13 = 0,083 µg/kg (03/06/2013); third suspect

sample was compliant Z-28905/13 (17/06/2013)];

2. A 32385 = 0,093 µg/kg (farm in Osijek 09/04/2013,

one suspect sample was taken Z-26500/13 and it was

compliant);

3. A 32387 = 0,31 µg/kg [(farm in Osijek 12/04/2013),

one suspect sample was non-compliant Z-26891/13 =

0,096 µg/kg (05/06/2013), but second suspect sample

was compliant Z-32796/13 (16/07/2013)];

4. A 34680 = 0,307 µg/kg (farm in Osijek 11/06/2013;

one suspect sample was taken (07/08/2013) and it was

compliant Z-35099/13);

5. A 34699 = 0,08 µg/kg (farm in Osijek 17/07/2013,

one suspect samples was taken (19/08/2013) and it was


6. A 34679 = 0,162 µg/kg (farm in Osijek 25/07/2013;

one suspect samples was taken (26/08/2013) and it was


7. A 35602 = 0,053 µg/kg (farm in Zagreb;

18/09/2013; one suspect sample was taken

(30/09/2013) and it was compliant B 5178];

8. A 34683 = 1,29 µg/kg (farm in Osijek 19/09/2013);

9. A 36165 = 0,075 µg/kg (farm in Osijek

23/10/2013);

10. A 36033 = 0,063 µg/kg [farm in Bjelovar

11/12/2013; two suspect samples were taken B 6920 +

6921 (23/01/2014) and they were compliant];

11. ovine milk A 32624 = 3,66 µg/kg [farm in Rijeka

28/08/2013, one suspect sample of cheese was taken

(12/09/2013) and it was compliant B 7145];



been checked, as well as quality of feed. The

instructions on good agricultural practice as to avoid

fungal contamination of feed where issued.

108

Bovine milk – Due to non-compliant results in 2012, the number of samples in 2013 has been

increased for Group B1 = 255 samples (240 in 2012).

Due to non-compliant results on aflatoxin M1 at the beginning of year number of samples on

this group was increased. In bovine milk, 223 samples were analysed on the aflatoxin M1; in

ovine milk 37 samples and in goat milk 43 samples.

Eggs

Group B1 – Antibacterial substances

+ B2b – Anticoccidials:

Chicken eggs

1 non-compliant result on:

a) group B1:

- trimethoprim

- sulfamonomethoxine

b) group B2b:

lasalocid

One target sample (A 33318) taken (13/05/2013) at

farm confirmed non-compliant for:

1. trimethoprim (MDK = presence; CCα = 2,8 µg/kg)

= 118,8 µg/kg

2. sulfamonomethoxine (MDK = presence; CCα =

6,7 µg/kg) = 239,9 µg/kg

3. lasalocid (MDK = 150 µg/kg only if used as VMP;

CCα = 166,5 µg/kg) = 663,2 µg/kg

The non-compliant result was received 1 month after

the sample was taken on 10/06/2013. Full on-farm

investigation included examination of the farm,

records on use of medical products and feed. This is

small private farm with only 20 hens and 15 broilers.

Broilers where feed with feed that contained lasalocid,

and leftovers of this feed was eaten by hens. Farmer

didn’t know that feed containing lasalocid should not

be given to laying hens. In the meantime the broilers

where killed for their own consumption. Hens where

sick one month earlier to the sampling and where

given veterinary medicinal product “Trisulfon” that

contains trimethoprim & sulfamonomethoxine. Farmer

was not aware that he should respect withdrawal

period when using “Trisulfon” for laying hens. Eggs

were taken to the local market. Inspectors had taken

administrative measures against this farmer including

banning him of selling eggs on the market before he

can prove that they comply with food safety

legislation.

Group B2b – Anticoccidials:

Chicken eggs

1 non-compliant result on: lasalocid

One target sample (A 35814) taken (07/11/2013) at

farm confirmed non-compliant for lasalocid (MDK =

150 µg/kg only if used as VMP; CCα = 166,5 µg/kg) =

260,99 µg/kg

The non-compliant result was received 1 month after

the sample was taken on 03/12/2013.

The sample of eggs taken from this farm for NRCP in

2012 was also non-compliant on the group B2c

[salinomycin sodium (MC = 3 µg/kg; CCα = 3,29

µg/kg) = 3,81 µg/kg (16/08/2012)].

Full on-farm investigation included examination of the

farm, records on use of medical products and feed.

This is small private farm with only 20 laying hens,

broilers and fattening pigs. Animals are fed with feed

109

for laying hens, other feed for broilers and another

feed for fattening pigs. Feed for broilers on its

declaration had lasalocid. Inspector had taken

administrative measures against this farmer including

banning of selling eggs on the market before he can

prove that they comply with food safety legislation and

feeding laying hens with other feed that is not

exclusively produce for them.

Hen eggs: Due to 8 non-compliant results in 2012, the number of samples in 2013 has been

increased for:

1. Group B1 = 237 samples (207 in 2012);

2. Group B2b = 237 samples (227 in 2012).

Wild game



Lead (Pb)

Muscle

One sample was non-compliant on lead (Pb)

(LOQ = 0,01 mg/kg; MC = 0,25 mg/kg):

1. A 33277 = 6,9 mg/kg (Zagreb 29/04/2013). The

sampling of wild game in this area is intensified.

Honey

Group B1 – Antibacterial substances

– Sulfonamides:

2 non-compliant results on

sulfamonomethoxine

Two target samples of honey where non-compliant on

sulfamonomethoxine (MDK = presence; CCα =

2,9 µg/kg).

1st sample A 35403 (Varaždin) was taken 08/07/2013

at farm level and was non-compliant = 8,11 µg/kg.

The non-compliant result was received almost three

months after the sample was taken on 23/09/2013. Full

on-farm investigation included examination of the

farm, records on use of medical products and records

of issued veterinary medicinal product for that farm at

the veterinary ambulance.

Except bees on the farm there are bovines and laying

hens.

Records on use of medical products are not kept

properly and there is no record of using veterinary

medicinal products “Trisulfon” although farmer admits

using it on the bee hives last autumn. Honey that was

sampled was sold from door on the farm (600 kg). At

the time of inspection only 60 kg of honey could be

found. Inspector issued ban on selling this honey and

took one suspect sample B 1167 (27/08/2013) that was

also non-compliant on sulfamonomethoxine = 10,94

µg/kg. When result was received inspector ordered this

honey to be safely disposed.

2nd

sample A 35402 (Varaždin) was taken 30/07/2013

in processing plant and was non-compliant =

18,64 µg/kg.

Investigation in the processing plant reviled that

sample was taken from the farm that is not in register

of honey producers, that is against the law. Also from

110

the same farm processing plant bought two type of

honey.

Type I (100kg) was already processed and mixed up

with other honey: now was 12.900 kg of such honey.

That honey was analysed on antibacterial substances

by the buyer laboratory (Germany) and was compliant.

Type II (584 kg) honey from where sample A 35402

was taken, was still in original drums. Suspect sample

B 7903 was taken (12/09/2014) from this honey and

was non-compliant again for sulfamonomethoxine =

12,47 µg/kg.

Before selling honey the farmer had analysed this

honey in the laboratory that doesn’t have official

method for analysing antibacterial substances in

honey. Results were compliant and they were shown to

the owner of the processing plant before sail.

The inspector ordered following in the processing

plant:

1. For the honey Type II to be destroyed;

2. That processing plant should not buy honey from

producers that are not in register;

3. Before buying honey from producer the producer

had to show them analytical report from official

laboratory that honey is compliant.

Investigation on the farm of origin found :

1. honey Type I, from it was taken one suspect

sample B 7901 (04/09/2014) and was compliant;

2. honey mixed Type II and Type III, from it was

taken one suspect sample B 7904 (09/09/2014)

and was compliant;

3. honey Type II, from it was taken one suspect

sample B 7904 (09/09/2014) and was not

compliant again for sulfamonomethoxine =

7,43 µg/kg.

The inspector on the farm ordered following:

1. For the honey Type II to be destroyed;

2. To pay for extra sampling and analyses

3. Administrative measures were taken against this

farmer.

Group B2c – Carbamates &

pyrethroids: allethrin & permethrin

One target sample A 35701 was taken 31/07/2013 in

processing plant (Zagreb) and was non-compliant on :

1. allethrin (MC = Presence; LOQ = 0,005 mg/kg ) =

0,103 µg/kg; and

2. permethrin (MC = Presence; LOQ = 0,002 mg/kg) =

0,043 µg/kg;

Investigation in the processing plant reviled that

sample was taken from empty drum that was lying

open in the processing plant 6 months. All honey from

111

this drum was already mixed with other honey and

sold. It was taken suspect sample B 7551 (03/09/2014)

of already processed honey Type I that was in bottles

and mixed up with other honey. The sample B 7551

was non-compliant again on permethrin = 0,034 µg/kg.

Allethrin is only registered as insecticide. It was found

in honey because sample was taken from drum that

was lying open in the processing plant for several

months. Therefore inspectors ordered corrective

measures to the person who took sample A35701.

The inspector ordered following in the processing

plant:

1. For this honey to be withdrawn from the market;

2. that they should buy honey only from producers that

are in the register;

3. to improve measures of withdrawing products when

need be.

Investigation on the farm of origin of honey (in

Bjelovar) found:

a) that farmer is not in register of honey producers;

b) that has honey Type I and from it suspect sample B

5387 was taken (16/09/2013.) and was non-compliant

on permethrin = 0,038 µg/kg;

c) also from three other type of honey suspect sample

were taken (B 5392, 5395 & 5398) and all of them

were compliant.

The inspector on the farm ordered following:

1. for the honey Type I to be destroyed;

2. to pay for extra sampling and analyses

3. to registered as honey producer.

Salt water catch


Muscle & skin

2 non-compliant results: 1 x lead

(Pb) & 1 x mercury (Hg)

Two target sample of muscle & skin from salt water

catch confirmed non-compliant for heavy metals:

1. A 32916 (Split, 17/06/2013) = lead (Pb) (ML =

0,3 mg/kg; LOQ = 0,015 mg/kg) – 1,23 mg/kg it was

sample of ray;

2. A 32921 (Split, 27/08/2013) = Mercury (Hg) (ML =

1,0 mg/kg; LOQ = 0,002 mg/kg) – 2,21 mg/kg it was

sample of mullet.

Salt water catch: Due to one non-compliant result in 2012 number of samples in 2013 has

been increased to 30 samples (24 in 2012).

Ovine & caprine – Equine – Rabbit –

Aquaculture – Farmed game

None None

112



Member State CYPRUS

Sampling should take place over the entire year (January to December);

The tender of Veterinary Services of Cyprus for the interest of accredited laboratories

to carry out the laboratory examinations of substances of animal tissues and food of

animal origin that are included in the National Residues Plan concerning the year

2015 must be published in the European gazette early in July 2014;

Horsemeat. There is not slaughterhouse for horses. Horsemeat is not used for human

consumption in Cyprus. Horses exported from Cyprus accompanied by a Passport

(Commission Decision 2000/68/EC, Commission Regulation 504/2008/EC)) is

implemented on the basis of “Genetic improvement of Animals” Laws of 2001 and

2004, Κ.Δ.Π. 224/2009, Αρ. 4361, 29.05.2009 in which mentioned all the drugs used

for this horse and the withdrawal period;

A number of samples analysis included in the Cyprus Residue Plan were not possible

to be analysed by the State General Laboratory. The Veterinary Services in order to

cover this need published during 2013 a Tender, after tender evaluation chosen two

laboratories for the implementation of sample analyses;

WE CONFIRM that all methods used by the foreign laboratories to carry out analysis

were validated and accredited. This is a basic term included in the Tender. During the

evaluation of laboratories responded to the Tender, the evaluation committee checked

first if the method used by the laboratory is validated and accredited and for which

matrix and if this method is included in the list of the accreditation body;

We have minor changes in number of samples and substances

Group A substances


None

NON-COMPLIANT RESULTS




None None

Group B substances


None

NON-COMPLIANT RESULTS


Porcine

B1. Antibiotics / Chemotherapeutics

One porcine farm/ fattening pigs

Lincomycin – meat 254 μg/kg

1. Nicosia

Investigation in the farm of origin √

Verification of records √

Additional sampling √

113

Animals held in the farm (8.000 fattening pigs /

1.100 sows)

Intensified checks on the animals and products

from the farm / establishment in the event of

repeated infringements √

Carcasses and products declare unfit for human

consumption (NONE)

Administrative measures (NONE)



2. Nicosia




Animals held in the farm (10.420 fattening pigs

/ 750 sows)





consumption (NONE)




3. Nicosia




Animals held in the farm (11.580 Fattening

pigs / 1.538 sows)





consumption (NONE)




4. Larnaca




Animals held in the farm (2.200 Fattening pigs

/ 320 sows)





consumption (NONE)


114

Milk

B1.Antibiotics / Chemotherapeutics

Antibiotics – Inhibitors (Delvo SP

test) – cows – Dairy (1 case)

1. Nicosia

• Investigation in the farm of origin √

• Verification of records √

• Additional sampling √

• Animals held in the farm (NONE)

• Intensified checks on the animals and products

from the farm / establishment in the event of repeated

infringements √

• Carcasses and products declare unfit for human

consumption (6.268 liter of milk confiscated and

destroyed)

• Administrative measures √


test) – sheep and goat – Dairy (1

case)

2. Limassol




Animals held in the farm (NONE)



infringements √


consumption (310 liter of milk confiscated and

destroyed)

Administrative measures √


test) – sheep and goat farm (1 case)

3. Paphos




Animals held in the farm (23 sheep and 129

goats)



infringements √


consumption (130 liter of milk confiscated and

destroyed)



test) – sheep and Goat – Raw milk

collecting track

4. Paphos




Animals held in the farm (NONE)



infringements √

115


consumption (1.888,4 liter of milk confiscated and

destroyed)


Antibiotics – sheep and goat farm –

ampicillin (1 case) – ampicillin

19,3 μg/kg

5. Paphos




Animals held in the farm (364 sheep and goats)



infringements √


consumption (NONE)


Eggs

B1.Antibiotics / Chemotherapeutics

Laying hens – sulphadiazine – eggs

– 7,15 μg/kg

1.Larnaca




Animals held in the farm (3.745 hens)



infringements √


consumption (NONE)


B2b. Coccidiostats

Laying hens – lasalocid – eggs –

199 μg/kg

2. Paphos




Animals held in the farm (11.400 hens)



infringements √


consumption (NONE)


Bovine – Ovine & caprine – Equine – Poultry – Aquaculture –

Rabbit – Wild game – Farmed game – Honey

None None

116

Import third countries


Poultry

B2b Coccidiostats – Frozen whole

chicken from Brazil – clopidol –

chicken meat – 5,92 μg/kg

Border inspection post (BIP Limassol)

Rejected at BIP, re-export to country of origin.

Intensified checks

Aquaculture

B3c Heavy metal

Fish (Dentex dentex)from Egypt

Mercury – fish – 0,91 μg/kg

Border inspection post (BIP Larnaca)

Intensified checks

Bovine – Ovine & caprine – Porcine – Equine – Milk –

Eggs – Rabbit – Wild game – Farmed game – Honey

None None

117



Member State CZECH REPUBLIC

Group A substances

Modification of national residue plan 2014

The numbers of samples were increased. The farms are under stricter control.


Bovine

1x CAP: calf muscle (2,4 ppb) Investigation and further sampling together with

checks on the medicines records and storage were

conducted on the farm. Results of follow-up samples

were compliant (milk from dairy tank, milk for calf

feeding, 5 samples of calf blood (serum), 3 samples of

urine of calves, two samples of calf muscle and two

samples of cows muscle, liver and kidney).

Extraordinary veterinary measures were imposed -

prohibition of movement of animals until satisfactory

results. No evidence of the use of CAP on the farm.

The investigation was unable to establish the exact

cause of these residues. Individual responsibility was

not proved. The farm is under stricter control for one

year.

Porcine

17-ß-19-nortestostosteron: (14 ppb)

fattening pig urine

On farm investigation and further sampling together

with checks on the medicines records and storage were

conducted. Results of follow-up samples were

compliant (3x pig urine). Illegal use of hormonal

substances has not been found.

1x dimetridazole, ipronidazole:

fattening pig serum (2,4 ppb, 13,1

ppb)

Investigation and further sampling together with



were compliant (5x serum). Extraordinary veterinary

measures were imposed - prohibition of movement of

animals until satisfactory results. No evidence of the

use of dimetridazole on farm. The investigation was

unable to establish the exact cause of these residues.

Individual responsibility was not proved. The farm is

under stricter control for one year.

Poultry

1x CAP: chicken broiler muscle

(2,1 ppb)



conducted on the farm. Extraordinary veterinary

measures were imposed. Other results of follow-up

samples (water to animals, compound feed and 10

118

samples of chicken from other halls) were compliant.

Total was destroyed – 9.262 kg of chicken meat. The

investigation was unable to establish the exact cause of

these residues. Individual responsibility was not

proved. The farm is under stricter control for one year.

1x metronidazole: goose muscle

(10,1 ppb)




were compliant (water, 3x complete feed, 5 samples of

blood/serum). Illegal use of prohibited drug has not

been proven.

1x metronidazole: chicken broiler

muscle (18,1 ppb)




were compliant (1x complete feed, 1x water, 5 samples

of meat) and the samples of litter and droppings were

negative. Illegal use of prohibited drug has not been

proven. Total of 317 kg of meat has been withdrawn

and destroyed.

Farmed game

1x CAP: farm deer muscle (1,4 ppb) Investigation and further sampling together with


conducted on farm. Other results of follow-up samples

(water to animals, feed, feeding salt and four samples

of meat from other deer) were compliant.

Extraordinary veterinary measures were imposed. The


these residues. Individual responsibility was not

proved. The farm is under stricter control for one year.

Ovine & caprine – Equine – Aquaculture –

Milk – Eggs – Rabbit – Honey

None None

Group B substances


The main problems are the residues of MG / LMG in freshwater fish, residues of

antimicrobials for individually treated animals (pigs, cows) and a high content of mercury in

the kidneys of pigs and cattle – this could be a problem correctly specified ML. On these

issues, we will focus in 2014.


Bovine

1x dihydrostreptomycine: cow

kidney (1.456 ppb)

Investigation and check on the medicines records and

storage were conducted on the farm. Records of

treatment were correctly. The dairy cow was treated

with Tetra-delta and Peracef.

Withdrawal period have been observed.

Contents of residues of dihydrostreptomycine in

119

muscle and liver were compliant. Additional samples

will be taken. The case is under investigation by the

pharmacovigilance.

1x neomycin: cow liver (578 ppb) Investigation and check on the medicines records and

storage were conducted on the farm. Records of

treatment were correct. The dairy cow was treated with

Synolux LC, Gynobiotic and Amoxicilin. Withdrawal

period have been observed. Contents of residues of

neomycin in muscle and kidney were compliant.

Additional samples were compliant

(pharmacovigilance).

1x NDL-PCBs: bull – muscle

(126,598 ng/g fat) and WHO-

PCDD/F-PCB-TEQ (44,2 pg/g fat)

On farm investigation. The source of PCBs-

contamination was found in old paints, which were

used for painting of metal barriers in the stable.

Extraordinary veterinary measures were imposed - all

old paints had to be removed; - all slaughtered animals

were tested for PCBs content; movement of animals

was kept under veterinary control.

1x WHO-PCCD/F-PCB-TEQ: bull

muscle (11,6 pg/g fat)

On farm investigation. The source of PCBs-

contamination was found in old paints, which were

used for painting of metal barriers in the stable.

Extraordinary veterinary measures were imposed - all

old paints had to be removed;- all slaughtered animals

were tested for PCBs content; movement of animals

was kept under veterinary control.

2x cadmium: cow – kidney

(1,82 ppm; 2,109 ppm)

Follow-up investigations were conducted at the

slaughterhouses and on the farms. Additional samples

of cow´s kidneys on one farm (13 samples of kidney –

8x non-compliant, 5x compliant). The feed were

compliant. All kidneys from cows older than six years

are confiscated. On the other farm investigation is still

ongoing.

1x mercury: cow – kidney

(0,025 ppm)

Follow-up investigations were conducted at the

slaughterhouse and on the farm. Analyses of the feed

were compliant. Other two samples of kidneys were

compliant. The investigation was unable to establish

the exact cause of these residues. We have a slight

suspicion that the source of mercury could be previous

vaccination Kolibin RC Neo (contain Thiomersal –

ethyl-mercury). Relationship between mercury content

in the kidneys and in the vaccines is not completely

clear or ML for mercury).

120

Ovine & caprine

1x WHO-PCDD/F-PCB-TEQ: sheep

liver (20,8 pg/g fat)

WHO-PCDD/F-PCB-TEQ – other

targeted testing in breeding – sheep

liver: (34,8 pg/g fat, 1,2 pg/g fat)

Investigation was conducted on the farm. Sheep (1

year old) was in the pasture during summer. The


these residues (environmental contaminant).

1x WHO-PCDD/F-TEQ + WHO-

PCDD/F-PCB-TEQ: lamb liver

(21,3 pg/g fat + 38,9 pg/g fat)

Investigation was conducted on the farm. Source of

contamination has not been found. The investigation is

still ongoing.

1x cadmium: sheep kidney

(1,29 ppm)

Investigation was conducted on the farm. Source of

contamination has not been found. Examinations of

other sheep kidneys were compliant. The sheep was

more than 7 years old.

Porcine

1x enrofloxacin + ciprofloxacin):

sow muscle (528 ppb, liver 1.804

ppb, kidney 1.563 ppb).

Failure to comply the withdrawal period. Fine was

imposed. Breeding is under stricter supervision.

3x dihydrostreptomycine: sow liver

and kidney (1.340 ppb, 1.413 ppb,

2.429 ppb, 1.561 ppb, 2.586 ppb,

2.079 ppb)

Three different farms. Investigations and check on the

medicines records and storage were conducted on the

farms. Records of treatment were correct. The sows

were treated by Norostrep. The withdrawal period was

observed. The cases are still under investigation (there

were administered overdose of Norostrep). Fines were

imposed.

3x dihydrostreptomycine: sow liver

(1.039 ppb, 813 ppb, 819 ppb)

Two different farms. In these cases were administered

overdose of Norostrep. Fines were imposed.

4x mercury: sow kidney

(0,0268 ppm, 0,0558 ppm,

0,0254 ppm and 0,0436 ppm)

Investigations were conducted on the farms. Other two

samples of kidneys were compliant. The investigations

were unable to establish the exact cause of these

residues but – vaccination by ROCOVAC NEO,

Colistin TP, Circovac, Suivak Parvoery-in – contain

Thiomersal – ethyl-mercury? Extraordinary veterinary

measures were imposed.

4x mercury: fattening pigs kidney

(0,0332 ppm, 0,032 ppm,

0,0210 ppm and 0,0272 ppm)

Investigations were conducted on the farms. The

investigations were unable to establish the exact cause

of these residues (vaccination by ERYSTIN SINGLE

SHOT, Erisin, Biosuis M, Biosuis APP, Pleurogal,

imunocastration by Improvac – contain Thiomersal –

ethyl-mercury). The investigation is still ongoing.

Extraordinary veterinary measures were imposed.

1x cadmium: sow kidney (1,75 ppm) Investigations were conducted on the farm. The

investigations were unable to establish the exact cause

of the source of high cadmium content.

121

1x NDL-PCB: fattening pig muscle

(144,3693 ng/g fat)

NDL-PCB – other targeted testing in

breeding: fattening pigs muscle:

(142,2878 ng/g fat, 142,4545 ng/g

fat, 234,6745 ng/g fat,

155,3683 ng/g fat, 146,4275 ng/g

fat)

On farm investigation. Pigs were kept in an old stable,

where paints contained PCBs (755,05 ppm) and were

used in the past . Examination of samples from an

additional 5 pigs proved that all pigs kept in the stable

had been contaminated with PCBs in quantities above

40 ng/g of fat. All contaminated pigs were destroyed

and disposed as a category I material. Other young

pigs and piglets were moved to other stables. The fine

was imposed.

Equine

1x cadmium: muscle (0,274 ppm)

and liver (30,2 ppm) and kidney

(82,1 ppm) and mercury in kidney

(0,023 ppm)

Results of examination of fodder for cadmium and

mercury were compliant. There was no follow-up

investigation (the horse was 12 years old).

Poultry

1x decoquinate: chicken broiler liver

(25,2 ppb)

Follow-up investigations were conducted on the farm

and at the slaughterhouse. Additional samples (liver)

from the subsequent batch were compliant. The fine

was imposed.

Aquaculture

3x malachite green MG/LMG: trout

muscle (24,28 ppb, 4,63 ppb and

6,66 ppb)

On farm investigations. All batches of trout with

concentration of sum MG/LMG above 2 ppb were

condemned. Subsequent investigation will be

conducted in these farms. Fines were imposed.

1x malachite green MG/LMG: carp

muscle (2,57 ppb)

(MG/LMG: trout muscle 1,39 ppb,

0,31 ppb, 0,47 ppb and 0,62 ppb)

The investigations were unable to establish the exact

cause of these residues. Probably, illegally treated fry

were imported in some cases.

Eggs

1x enrofloxacine: eggs (155,6 ppb) Investigation was conducted on the farm. The

contaminated eggs were destroyed (45.255 pieces).

Examinations of samples from the other batches were

satisfactory. Examinations of muscle samples were

compliant.

Rabbit

1x salinomycin: rabbit liver: (3,8

ppb)

Investigation was conducted on the farm.

Examinations of samples from the other batches were

satisfactory.

122

Wild game

3x NDL-PCB: wild boar muscle

(82,8926 ng/g fat; 137,0418 ng/g fat;

266,2493 ng/g fat)

1x sum DDT: mallard muscle

(0,56346 ppm)

2x lead: wild boar muscle

(0,41 ppm, 3.650,0 ppm)

1x lead: fallow-deer muscle

(0,565 ppm)

4x lead: pheasant-muscle

(0,585 ppm, 0,826 ppm, 0,259 ppm,

4,73 ppm)

3x lead: wild duck muscle

(0,404 ppm, 3,2 ppm, 0,14 ppm)

1x mercury: wild duck muscle

(0,0644 mg/kg)

On three different localities exceeded the action level –

40 ng/g fat. Examination of other pieces of wild boar

has been compliant.

Examination of another piece of mallard was

satisfactory.

There were no follow-up investigations as the residues

were likely to have been the results of the boars (deer)

and other animals being shot. FBOs of wild game

plants were warned and informed about the problem of

lead contamination from the shots and about the

necessity for the removal of meat from the site of shot

wound.

Farmed game

1x NDL-PCB: ostrich muscle

(7,2772 ng/g fat)

On farm investigations. Ostriches are bred in the

former stables for cattle, where previously there were

problems with PCBs in paints. Breeding is under strict

veterinary supervision.

Milk – Honey

None None

123



Member State DENMARK

Group A substances


None




No non-compliant results found in

2013

None

Group B substances


None


Porcine

1 penicillin G – kidney Investigations in the farm of origin and verification of

records. Carcass and products declared unfit for human

consumption. No administrative fines.

1 trimethoprim Investigations in the farm of origin and verification of

records. No administrative fines.

Equine

WHO-PCDD/F-PCB-TEQ

WHO-PCDD/F-TEQ

After investigations it was concluded that this finding

was related to background pollution. It is not unusual

for a horse that has been grazing for seven years.

Aquaculture

1 crystal violet Investigations in the fish farm of origin and

verification of records. There were no sign of use of

crystal violet on the fish farm. Follow-up samples

from fish and feed did not show residues of crystal

violet.

Bovine – Ovine & caprine – Poultry – Milk – Eggs –


None None

124



Member State ESTONIA

Group A substances


We did not increase the number of samples for testing of antithyroid agents (A2) because most

probably the residues of thiouracil are a result of having feeding diets rich in cruciferous

plants (natural origin).


Porcine

Thiouracil – 8,87 μg/kg – urine – pig The farm of origin was investigated immediately.

There was no indication of an illegal use of thiouracil.

The presence of thiouracil at such low level could be

linked as a result of the natural presence of crucifera

plants in feed.



None None

Group B substances


New: Fish will be tested for B3d substances in 2014.

New: Animal feed (fish) will be tested for aflatoxins B1 in 2014.

All 2013 year non-compliant results (except wild game) have been taken into account in

composing the 2014 year plan and the numbers of samples have been increased

accordingly.

The number of samples planned to be taken from the wild game will stay at the same

level as in 2013.


Porcine

Dihydrostreptomycin – 2.740 µg/kg

– kidney

The farm of origin was investigated.

The use of medical feedingstuffs, feed and the use of

veterinary medicines and records of the use of

medicinal products were checked. Also the presence of

animal diseases outbreaks within last three months was

checked.

Additional 3 kidney samples were taken (from pigs

originated from this farm) and analyzed with negative

results.

At the time of inspection the pigs under treatment were

marked correctly.

Probable cause of dihydrostreptomycin presence: the

pig was treated with Pen-strep, but the withdrawal

125

period was not followed or due to physiological

individuality the residues have not disappeared from

animal body during time that is foreseen for that.

Dihydrostreptomycin – 3.700 µg/kg

– kidney

The farm of origin was investigated.

The use of medical feedingstuffs, feed and the use of

veterinary medicines and records of the use of

medicinal products were checked. Also the presence of

animal diseases outbreaks within last three months was

checked.

Additional 1 kidney sample was taken (from pig

originated from this farm) and analyzed with negative

result.

Probable cause of dihydrostreptomycin presence: the

pig was treated with Shotapen, but the withdrawal

period was not followed or due to physiological

individuality the residues have not disappeared from

animal body during time that is foreseen for that.

Wild game

1 muscle sample from elks was

positive for lead 0,30 ± 0,09 mg/kg

No investigation. Heavy metals are present in the

environment as a result of a long-time absorption and

may accumulate in animal tissues.



None None

126



Member State FINLAND

Group A substances


Modifications 2013 2014

A3: Bovine, pigs: New substances: melengestrol acetate, megestrol acetate,

chlormadinone acetate (kidney fat, LC-MSMS, LC-MSMS)

Some changes are made due to changes in production numbers

Some changes or new information on CC-alfa and/or CC-beta-values are added to the

plans.


Bovine – Ovine & caprine – Porcine – Equine – Poultry – Aquaculture –


There were no non-compliant

samples for group A substances.

None

Additional information: Pigs: one urine sample of pig (male) contained 2-thiouracil (10.3

µg/kg) more than the limit of action. Due to the result official control actions have been

carried out. On the spot control was made by the official veterinarian. Three additional

samples (“suspect samples”) were taken and all these samples were compliant. No violation of

medication was detected. It was assumed that the reason for the finding was the quality of

feed. Bovine: three samples of bovine serum contained very small amounts of beta-

testosterone (< 25.7 µg/kg) Due to the results official control actions have been carried out on

the farm in one case. On the spot control was made by the official veterinarian. No violation

of medication was detected.

Group B substances


B2b: Poultry, eggs: new substances: halofuginone (muscle, LC-MSMS, LC-MSMS)

B2d: Bovine, sheep, horses: new method: xylazine (kidney, LC-MSMS, LC-MSMS)

Bovine, sheep, horses: new substances: azaperol, acepromazine, azaperone.

propionylpromazine, haloperidol (kidney, LC-MSMS, LC-MSMS)

B2e: Milk: new substances: flunixin, diclofen (milk, LC-MSMS, LC-MSMS)

Some changes are made due to changes in production numbers

Some changes or new information on CC-alfa and CC-beta-values are added to the plans

The number of farmed game samples will be at the same level as 2013 (even when there

were non-compliant reindeer liver and kidney)

The number of wild game samples will be at the same level as 2013 (even when there

were non-compliant elks liver and kidney)

127


Bovine

Suspect sample – Carprofen

780 µg/kg

One muscle sample of bovine was NC for carprofen

(780 µg/kg). The sample was taken in the

slaughterhouse as “suspect sample” due to visible

injection sites. No information of medication in the

last three months could be found in the food chain

information. Due to the results official control actions

have been carried out on the farm.

The animal had got a carprofen-injection but this

information was missing in the medical records and

the owner has sent the animal to the slaughter by

mistake.

Porcine

Zearalenol-alfa ( 1,6 – 9,4 µg/kg) Seven urine sample of slaughtered pigs contained

zearalenol-alfa (1,6 – 9,4 µg/kg) more than the limit of

action. Due to the results official control actions have

been carried out. At the slaughterhouse 14 additional

urine samples (“suspect samples”) of pigs from the

same producers were taken and these samples except

for three were compliant. The concentrations were 5,8

– 8,6 µg/kg. It was assumed that the reason for the

finding was contaminated feed.

Milk

Aflatoxin-M1 (0,065µg/kg) One milk sample from farm contained residue of

aflatoxin-M1 (0,065 µg/kg). Due to the result official

control actions have been carried out and. One new

sample (“suspect sample”) from the farm was taken

and it was compliant. It was assumed that the reason

for the findings was contaminated feed.

Eight official milk samples (“suspect samples”) were

taken due to positive results in antimicrobial residue

tests in dairies. All samples were compliant for beta-

lactams. On the spot controls were made by the official

veterinarian. No violation of medication was detected.

Wild game

4/9 liver samples and 8/10 kidney

samples in elks were non-compliant

for cadmium.

4/9 liver samples and 8/10 kidney samples in elks were

non-compliant for cadmium. According to Finnish

legislation livers and kidneys of over one year old elks

are not accepted for human consumption.

Farmed game

5/11 liver samples and 8/12 kidney

samples in reindeer were non-

compliant for cadmium

5/11 liver and 8/12 kidney samples in reindeer were

non-compliant for cadmium. Kidneys from reindeer

are not commercially used and livers are used very

seldom.

Ovine & caprine – Equine – Poultry –

Aquaculture – Eggs – Rabbit – Honey

None None

128



Member State FRANCE

Group A substances


All the farms and establishments with non-compliant results during the 2013 monitoring plans

are targeted for 2014.


Bovine

1 X Cis DES + Trans DES (bovine

hair) – identified

A judicial investigation is under way

1 X Cis DES + Trans DES (bovine

urine) – identified

Porcine

1 X Salbutamol (pig lung) –

identified

The BNEVP (National Brigade for Veterinary and

Phytosanitary Investigation) has been informed and an

investigation is under way

1 X Metronidazole (pig muscle)

1.69 ppb

The BNEVP has been informed and an investigation is

under way


Milk – Eggs – Rabbit – Farmed game –Honey

None None

Group B substances


All the farms and establishments with non-compliant results during the 2013 monitoring plans

are targeted for 2014.

Non-compliant results

(in µg/kg)

Follow-up actions

Bovine

1 X oxytetracycline (bovine muscle)

– 786

With regard to the positive results for veterinary

medicinal products and in particular antibiotics, the

selection criteria for carcasses are globally relevant:

- arthritis, peritonitis, pneumonia, congestion,

myositis, pleurisy;

- oedematous meat;

- average general condition of the carcass;

- infiltration/abnormal colouring of the neck;

- traces of injection;

- details in the food chain information document

(ICA).

Following the non-compliances detected, inspections


– 245

1 X dihydrostreptomycin (bovine

muscle) – 2.265

1 X neomycin (bovine muscle) –

1.485

1 X enrofloxacin and ciprofloxacin

(bovine muscle) – 700

1 X sulfadimethoxine (bovine

muscle) – 466

129

1 X penicillin G +

dihydrostreptomycin (bovine

muscle) – 1.819 and 999

were carried out on the majority of farms from which

the animals found to be non-compliant originated.

While failure to fulfil the withdrawal period is the

most frequent cause of non-compliance, the

inspections on farms have highlighted other non-

compliances, such as:

- no farm register or incomplete farm register;

- poorly kept farm medical supplies;

- non-compliance with the veterinary prescription

(dose error, error in the animals treated, etc.);

- administration of a medicinal product without a

prescription;

The inspection records are submitted to the interested

parties with at least a reminder of the applicable

legislation.

Where traceability allowed, non-compliant animals

were seized, either totally (carcass and offal) or

partially.

1 X sulfadimerazine + penicillin G

(bovine muscle) – 4.360 and 76

1 X tulathromycin (bovine muscle) –

485

1 X sulfadimerazine (bovine muscle)

– 853

1 X marbofloxacin + penicillin G +

dihydrostreptomycin (bovine

muscle) – 585 and 70 and 800

1 X marbofloxacin + oxytetracycline

(bovine muscle) – 382 and 128

1 X chlortetracycline and

epichlortetracycline (bovine muscle)

– 229

1 X sulfamethoxypyridazine (bovine

muscle) – 595


– 507


muscle) – 50.550


– 394


muscle) – 10.395


– 565


– 399


– 298


– 258


– 414


– 129


– 387


– 330

1 X doramectin (bovine muscle) –

172

1 X meloxicam (bovine muscle) – 75

130

1 X meloxicam (bovine muscle) – 41

1 X prednisolone (bovine muscle) –

12

1 X prednisolone (bovine muscle) –

10

1 x cadmium

The substance level in the muscle of cull cows was

0.118 mg/kg. The downstream traceability was

performed in order to make a withdrawal. The farm

was placed under sequestration and subjected to an

epidemiological investigation: the analysis results

obtained led to the conclusion that the rest of the flock

was compliant. Only the cow skin in question remains

under sequestration and must undergo a release

analysis at the time of slaughter. No sources of

contamination were found.

Ovine & caprine

1 X dihydrostreptomycin (ovine

muscle) – 1.150

The targeting criteria chosen in the case of non-

compliances were:

- details of the food chain information document (ICA)

- random

As follow-up to the non-compliances detected,

inspections were conducted on the majority of farms

from which animals found to be non-compliant

originated.

The inspection reports were sent to the interested

parties with at least a reminder of the applicable

legislation.



partially.

1 X spiramycin and neospiramycin

(ovine muscle) – 2.394

1 X oxytetracycline (ovine muscle) –

245

1 X monensin (ovine muscle) – 6.4

Porcine

1 X enrofloxacin and ciprofloxacin

(porcine muscle) – 599

With regard to the positive results for antibiotics, the

targeting criteria selected were as follows:

- abscess

- details from the food chain information document

(ICA): sick animal on the farm

- random

Following the non-compliances detected, inspections

were conducted on most farms from which animals

found to be non-compliant originated.

While failure to observe the withdrawal period was the

most frequent cause of non-compliance, the on-farm

inspections highlighted other non-compliances such as

the administration of a medicinal product without

prescription. The inspection records have been sent to

the interested parties with at least a reminder of the

applicable legislation (two warnings and a letter of

formal notice were sent).

1 X sulfadimethoxine (porcine

muscle) – 479

1 X sulfadiazine (porcine muscle) –

672

1 X sulfadiazine (porcine muscle) –

735

1 X sulfadimethoxine (porcine

muscle) – 181

131



partially.

Equine

1 X cadmium The animal in question was a 27-year-old horse from

the Netherlands. The cadmium level in the muscle was

0.52 mg/kg. Its entire carcass had been seized at the

slaughterhouse (reason: cachexia). Information was

also provided to the authorities in the Netherlands.

Poultry

1 X lasalocid (broiler chicken

muscle) – 138

An inspection was conducted on the farm from which

the poultry found to be non-compliant originated. The

assumption that feed not supplemented by medicated

feed had been contaminated appears to be probable.

Eggs

1 X sulfadiazine (quail eggs) – 62 An inspection was conducted on the farm from which

the batch of quail egg found to be non-compliant

originated. The assumption that feed not supplemented

by medicated feed had been contaminated was

validated by an investigation on the premises of the

feed supplier, who received a warning.

Rabbit

1 X sulfadimethoxine (rabbit

muscle) – 1.143

Inspections were conducted on the farms from which

the batches of rabbits found to be non-compliant

originated. The hypothesis that feed not supplemented

by medicated feed had been contaminated appears to

be probable. The inspection reports were sent to the

interested parties with a reminder of applicable

legislation.

1 X sulfadimethoxine +

sulfaquinoxaline (rabbit muscle) –

1.020 et 410

1 X sulfadimethoxine (rabbit muscle)

– 110


sulfaquinoxaline (rabbit muscle) – 79

+ 44


sulfaquinoxaline (rabbit muscle) – 99

+ 28


– 200


– 960

Farmed game

1 X lasalocid (muscle) – 306 An inspection was conducted on the farm from which

the batch of farmed game found to be non-compliant

originated. The hypothesis of cross-contamination of

feed not supplemented by medicated feed appears to

be probable.

Milk – Aquaculture – Wild game – Honey

None None

132



Member State GERMANY

Group A substances


No changes.


Bovine

1 testosterone 17-beta-testosterone;

cattle for fattening; plasma; 48 µg/kg

The bull concerned probably suffered from a

development disorder or malformation. According to

the keeper of the animal, it was retarded and

disproportioned. The bull was therefore not used for

breeding but killed. On-site investigation at the farm of

origin; examination of the records. The keeper

abandoned breeding by 1 October 2013. Investigations

at the farm’s dispensary and the veterinary practitioner

did not produce signs of drug abuse either.

1 taleranol (beta-zearalanol); cattle

for fattening; urine; 2,4 µg/kg

The findings of taleranol, alpha-zearalenol, beta-

zearalenol and zearalenone (mycotoxin F) are very

likely attributable to mycotoxin contamination,

possibly of the feed.



The findings of taleranol, beta-zearalenol and

zearalenone (mycotoxin F) are very likely attributable

to mycotoxin contamination, possibly of the feed.













1 chloramphenicol; cattle for

fattening; urine; 0,54 µg/kg

None

Porcine

1 hexestrol,

dihydrodiethylstilbestrol; fattening

pigs; urine; 21,2 µg/kg

Source could not be clarified. Follow-up sampling not

possible because pig farming was abandoned. At the

beginning of the fattening period, the piglet herd was

treated with belacol and flubenol on 29 December

2012, and single animals were treated with vetrimoxin

on 30 December 2012 and 01 January 2013. There

were no further treatments in the stock.

1 chloramphenicol; fattening pigs; Contamination by the sampling veterinarian or with

133

muscle; 17,4 µg/kg dust from around the stable; source could not be finally

clarified. On-site investigation at the farm of origin;

examination of the records; 11 x additional sampling;

ban on transport and delivery of livestock; increased

controls in the establishment of origin; criminal

proceedings. Withdrawal of the possibility of receiving

or requesting EU-subsidies.

1 chloramphenicol; fattening pigs;

muscle; 0,27 µg/kg.

Information to competent authority.

1 metronidazol; fattening pigs;

plasma; 1,82 µg/kg

None


plasma; 1,8 µg/kg

Additional sampling; stock closed; withdrawal of the

possibility of receiving or requesting EU-subsidies.


plasma; 0,29 µg/kg

On-site investigation at the farm of origin; examination

of the records; criminal proceedings.

Equine

1 epinandrolon, 17-alpha-19-

nortestosteron, alpha-19-

nortestosteron; other horses; urine;

25,3 µg/kg

None; examination of the records; information to

competent authority.

1 17-beta-19-nortestosteron beta-19-

nortestosteron 17-beta-


36,5 µg/kg

Animal originating from Belgium.

1 17-beta-19-nortestosteron beta-19-

nortestosteron 17-beta-


3,9 µg/kg

Horse was collected "a few days before slaughter". It

underwent last treatment for laminitis (analgesics,

acupuncture) as indicated in the documents. On-site

investigation at the farm of origin; examination of the

records

1 epinandrolon, 17-alpha-19-

nortestosteron, alpha-19-


7,1 µg/kg

None

Poultry

1 chloramphenicol; fattening

broilers; plasma; 0,33 µg/kg

Laboratory finding, contamination cannot be excluded.

No indication of use by the farmer, no drugs on store.


of the records; additional sampling. No use of

veterinary drugs in the stock were the finding

occurred, and no use of drugs in the current stock. 8

follow-up samples: 7 samples of muscle and 1 sample

of animal drinking water: no finding. Ban on transport

and delivery of livestock; feed checks; testing of the

sampling containers.


broilers; muscle; 0,6 µg/kg.

None


broilers; plasma; 0,22 µg/kg

Source not clarified, possible contamination of the

sampling material by the veterinarian, as he did not

134

wear gloves while sampling. On-site investigation at

the farm of origin; examination of the records; 16 x

additional sampling: 7 x blood and 7 x muscle, 1

drinking water and 1 feed. Ban on transport and

delivery of livestock; preliminary closure of broiler

fattening.

Milk

1 trichloromethane chloroform;

cows; milk; 0,01 mg/kg

Was not subject to complaint, because 0,1 mg/kg was

considered the permitted maximum level.

1 trichloromethane chloroform;

cows; milk; 0,02 mg/kg

Was not subject to complaint, because 0,1 mg/kg was

considered the permitted maximum level.

Ovine & caprine – Aquaculture – Eggs –

Rabbit – Farmed game – Honey

None None

Group B substances


B 1 Substances with anti-bacterial effect, including sulfonamides and quinolone

Thiamphenicol and florfenicol (multi-method) are included in the 2014 NRCP for

aquacultures, in order to check whether Maximum Residue Levels are complied with.

Sulfonamides in honey: The laboratories stay below the current RC of 50 µg/kg. The EURL

also considers this RC too high. The RC will therefore be adjusted. On the national level, the

2014 NRCP will set the minimum performance limit at 20 µg/kg. Still, state laboratories are

encouraged to validate their findings and, accordingly, raise complaints at the lowest level

possible, although this will result in different procedures taken by the Laender.

Tilmicosin and Tulathromycin had again one positive finding both in 2013. The increased

sample numbers of 2013 will therefore remain in 2014.

Marbofloxacin in poultry is newly included in the 2014 NRCP, because it can be covered by

the widely-used multi-method. The aim is to check compliance with the ban on use.

B 2 b) Coccidiostatics, including Nitroimidazoles

Laidlomycin is cancelled from the NRCP, because the NRL can currently not deliver a

standard. The substance will be re-included when a standard is available.

B 2 f) Other substances with pharmacological action

The increased number of samples in laying hens (18 birds) for tests for nicotine and cotinine

will remain in 2014.

Synthetic corticosteroids: Increased sample numbers of the 2013 NRCP (dexamethasone in

cows) will remain in the 2014 NRCP.

B 3 b) Phosphorus-organic compounds

The increased number of samples in laying hens (40 birds) for tests for phosmet and phoxim

will remain in the 2014 NRCP.

B 3 e) Dyes

The number of samples in aquacultures had significantly decreased since the European

Aquaculture Statistics Regulation (EC) No. 762/2008 took effect. As there were findings in

previous years, however, the total number of samples for dyes has now been increased by

25 % again. In addition, all samples drawn from aquaculture must also be tested for dyes.

135


Bovine

1 gentamicin, total of gentamicin C1,

gentamicin C1a, gentamicin C2 and

C2a; calves for fattening; kidney;

1.550 µg/kg


of the records; ban on transport and delivery of

livestock; criminal proceedings; withdrawal of the

possibility of receiving or requesting EU-subsidies;

review of veterinary documentation

1 sulfadoxine; cattle for fattening;

muscles; 388 µg/kg


of the records; 88 ban on transport and delivery of

livestock; animals and products classified as not

suitable for human consumption; remaining meat

disposed of; criminal proceedings; Withdrawal of the

possibility of receiving or requesting EU-subsidies

1 phenylbutazon; cattle for fattening;

plasma; 2,18 µg/kg

The herd showed no indications of the possible causes

of the residue. It is possible that the cause of the residue

reading is linked to a previous owner; On-site


records; additional sampling; 4; sample results all

negative; ban on transport and delivery of livestock;

upon completion of the investigation, the order was

lifted.

1 meloxicam; cows; kidneys;

690 µg/kg

Due to personal circumstances, the farmer failed

through inadvertence and negligence to ask the

veterinarian administering the treatment about the type

and manner of treatment and the medicinal product

used. Consequently, the withdrawal period was not

observed and the animal was released for slaughter.

The on-site search gave rise to no suspicion of

intentional manipulation. The public prosecutor's office

terminated the proceedings. On-site investigation at the

farm of origin; examination of the records; criminal

proceedings.

1 flunixin; cows; muscles; 421 µg/kg Use of TAM without documentation; on-site


records; more samples taken at the slaughterhouse;

criminal proceedings; withdrawal of the possibility of

receiving or requesting EU-subsidies, if the livestock

owner is proven to be responsible; submission to the

competent authority for a check of the in-house

veterinary medical supplies

1 4-methylamino-antipyrine 4-

methylaminophenazone; cows;

muscles; 8.700 µg/kg

No information.

1 dexamethasone; cows; muscles;

18 µg/kg


1 dexamethasone; cows; liver;

18,7 µg/kg


136


6,1 µg/kg

Presumed missing information on withdrawal periods

from the veterinarian performing the treatment; on-site


records; criminal proceedings; withdrawal of the


review of veterinary documentation


5,6 µg/kg


of the records; criminal proceedings; review of

veterinary documentation


31 µg/kg

The veterinary treatment of the cattle with 12 ml

dexatat (IM) (outside the withdrawal period) is

recorded. No documentation on earlier or later use of

dexamethasone. On-site investigation at the farm of

origin; examination of the records; ban on transport and

delivery of livestock; animals and products classified as

not suitable for human consumption. Remaining

quantity destroyed; herd confined (99 animals);

criminal proceedings; check of the prescription

documents with the farm veterinarian.


9,2 µg/kg

The last cause could not be identified, no prescription

documents for the animal in question, the livestock

breeder cannot recall the animal in question being

treated with medication, medication documentation on

the farm in order, well run farm with very low use of

medicinal products; on-site investigation at the farm of

origin; examination of the records; issue relating to an

individual animal; letter of instruction; withdrawal of

the possibility of receiving or requesting EU-subsidies;

CC-crosscheck performed.

1 dexamethasone; cattle for fattening;

muscles; 15 µg/kg

Delivery for slaughter within the withdrawal period;

due to missing documents, the withdrawal period was

not observed; on-site investigation at the farm of origin;

examination of the records; initiation of an

administrative infringement procedure (Tierhalter-

Arzneimittel-NachweisVO, Ordinance on livestock

breeders' veterinary medicinal records); penalty


5 µg/kg

The cow in question was treated with the medicinal

product Ketoprosol® (active substance: ketoprofen -

NSAID); the withdrawal period was observed; causes

of the increased level of dexamethasone could not be

established; on-site investigation at the farm of origin;

examination of the records; animals and products

classified as not suitable for human consumption; 1;

rapid alert for affected carcasses; withdrawal of the


CC-Cross-Check;

1 dexamethasone; cattle for fattening;

muscles; 7,53 µg/kg


137


453 µg/kg

No information.

1 lead Pb; cows; kidney; 0,82 mg/kg Young animals are generally not reared on the dairy

farm, pregnant heifers are purchased from a range of

other farms. There is no explanation for the high lead

level. There are no longer any electricity pylons in the

fields, lead pipes removed; 02.05.2013 test for Pb in

kidneys in the next two cows for slaughter following

prior notification of the veterinary office; testing of a

drinking water sample;

1 lead Pb; cattle for fattening; liver;

0,718 mg/kg and kidney; 1,14 mg/kg


1 cadmium Cd; other cattle; kidney;

1,68 mg/kg

The cause could not be established; on-site


records; additional sampling; 4; urine, Plasma, grass +

maize silage;

1 cadmium Cd; cows; liver;

0,598 mg/kg

No information.

1 cadmium Cd; cows; muscles;

0,339 mg/kg

No information.

2 cadmium Cd; cows; kidney; 1,56

and 1,89 mg/kg

1 No information. 1 on-site check on the farm of origin

and check of the records did not provide any insights

into the causes of the residue levels; at the time of

sampling, the animal was > 7.5 years old; On-site


records;

4 cadmium Cd; cattle for fattening;

kidney; 1,08 – 2,025 mg/kg

3 No information. 1 For the cadmium level detected,

environmental pollution was assumed, given the age of

the animal (4.5 years); on-site investigation at the farm

of origin; examination of the records; Withdrawal of

the possibility of receiving or requesting EU-subsidies;

no CC-infringement could be established;

1 copper Cu; piglet; liver; 51 mg/kg No information.

52 copper Cu; cows; liver; 100 –

259 mg/kg

32 No information. 1 Information to competent

authority. 19 In the 2012 EFSA report on the re-

evaluation of copper (EFSA Journal 2012;

10(12):2969), a new maximum residue limit of

140 mg/kg was proposed for copper in the liver of

cattle. In view of this pending legislative amendment,

the sample was not contested.

13 copper Cu; calves for fattening;

liver; 100 – 365 mg/kg

10 no information.; 5 on-site investigations at the farm

of origin; 3 examinations of the records; additional

sampling; 2 Information to competent authority.

138

31 copper Cu; cattle for fattening;


1 In the 2012 EFSA report on the re-evaluation of

copper (EFSA Journal 2012; 10(12):2969), a new

maximum residue limit of 140 mg/kg (currently 30

mg/kg pursuant to Regulation (EC) No VO 396/2005)

is proposed for copper in the liver of cattle. In view of

this pending legislative amendment, the sample was not

contested, since the established copper level was below

the future MRL. 1 Comment on Cu: Cu is naturally

present in higher concentrations in livers than the

authorised limit value of 30 mg/kg. Cu is also an

ingredient in feed. Therefore no complaint was filed. 5

Information to competent authority. 24 No information.

7 mercury Hg; cows; kidney; 0,011 –

0,043 mg/kg

3 On-site investigation at the farm of origin;

examination of the records; Withdrawal of the

possibility of receiving or requesting EU-subsidies; no

CC infringement could be established; 2 age of the

animals, 2 No information.

12 mercury Hg; cattle for fattening;

liver; 0,019 mg/kg

1 The heavy metal contamination detected is due to

normal environmental pollution and the age of the

animal; 1 presumably, mercury was passed from

cyanised roof beams of the shed into substances (such

as insulation material) which were consumed by the

cattle; On-site investigation on the farm of origin;

additional sampling; 11; of 1 bull: muscles, liver and

kidneys, feed, drinking water, insulation material; 66

ban on transport and delivery of livestock; lifting of the

ban after causes were established and presentation of

the results of the additional samples; 1 animals

confiscated at the slaughterhouse; animals and products

classified as not suitable for human consumption; 2 age

of the animals; 9 No information.

Ovine & caprine

1 cadmium Cd; sheep and lamps for

fattening; liver; 0,716 mg/kg

No information.

2 cadmium Cd; sheep and lambs for

fattening; kidney; 1,74 and

4,621 mg/kg

1 No information; 1 not indicated; On-site investigation

at the farm of origin; examination of the records;

additional sampling; 1; inventory control on the use of

feed; ban on transport and delivery of livestock; order

to slaughter sheep; order to take samples at the next

time of slaughter;

3 copper Cu; sheep and lambs for

fattening; liver; 48 – 68 mg/kg

1 Information to competent authority. 2 No

information.

2 mercury Hg; sheep and lambs for

fattening; liver; 0,017 – 0,03 mg/kg

1 No information. 1 Vaccination of the lamb with

Heptavac P Plus (contains 0.26mg thiomersal and

0.129mg Hg per vaccination dose); Vaccination of

dams in 2008, 2009 und 2013 with Coxevac (contains

thiomersal); On-site investigation at the farm of origin;

examination of the records;

139

4 mercury Hg; sheep and lamb for

fattening; kidney; 0,02 – 0,11 mg/kg

4 No information.

Porcine

1 combination of enrofloxacin and

ciprofloxacin; pigs for fattening;


Pig evidently delivered before the end of the

withdrawal period because the label was no longer

visible; on-site investigation at the farm of origin;

examination of the records; increased controls in the

establishment of origin; higher risk classification;


receiving or requesting EU-subsidies; after completion

of the penalty proceedings;

1 trimethoprim; pigs for fattening;

kidney; 68,3 µg/kg

none; on-site investigation at the farm of origin;

examination of the records; ban on transport and

delivery of livestock; criminal proceedings; Withdrawal

of the possibility of receiving or requesting EU-

subsidies


kidney; 91,5 µg/kg

The farm in the Netherlands was abandoned. It has not

yet been possible to identify the veterinary practice

which provided treatment; criminal proceedings


muscles; 149 µg/kg

No information on the use of antibiotic active medicinal

products or on health problems on the farm and in the

veterinarian's practice could be found. On-site


records; Withdrawal of the possibility of receiving or

requesting EU-subsidies; check of the veterinarian

providing treatment


kidney; 202,3 µg/kg

No information.

1 sulfadiazine sulfapyridine; pigs for

fattening; kidney; 115 µg/kg

Cause cannot be ascertained; on-site investigation at the

farm of origin; examination of the records; criminal

proceedings; event-driven inspection of the in-house

veterinary medical supplies


fattening; kidney; 127,9 µg/kg



fattening; kidney; 108 µg/kg

Mistake on the part of the mixing unit for feed; on-site


records; ban on transport and delivery of livestock; tel.

announcement of slaughter to the official veterinarian;


receiving or requesting EU-subsidies

1 sulfadimidine sulfamethazine; pigs

for fattening; muscles; 558 µg/kg

No information.

1 sulfadimethoxine; pigs for

fattening; kidney; 120,9 µg/kg

No information.

1 sulfadiazine; pigs for fattening;

kidney; 114,2 µg/kg

Withdrawal of the possibility of receiving or requesting

EU-subsidies; submission to the public prosecutor

140

1 Tetracycline, sum of the parent drug

and its 4-epimer; pigs for fattening;

muscles; 171 µg/kg

No information.

1 tetracycline; pigs for fattening;

muscles; 171 µg/kg

No information.

1 xylazine; pigs for fattening;



1 xylazine; pigs for fattening; kidney;

0,17 µg/kg

Active substance was not found in the producer

establishment and, according to the documentation

found, was also not used there; on-site investigation at

the farm of origin; examination of the records;

additional sampling.

1 4-methylamino-antipyrine 4-

methylaminophenazone; pigs for

fattening; liver; 121,96 µg/kg

An on-site check on the farm of origin and a check of

the records did not reveal causes of the residue; On-site


records; physically separate breeding and fattening

holdings; complete records available; in the period

before the causal sample a finished medicinal product

containing a tracing substance was used in the area of

the breeding holding; at the time of the on-site check of

the farm of origin, there was no indication of negligent

or intentional transfer or use of the medicinal product in

the area of the fattening holding.

3 Lead Pb; breeding pigs; liver;

0,574 mg/kg and kidney; 0,548 mg/kg

and 0,787 mg/kg.

No information.

1 Cadmium Cd; pigs for fattening;

kidney; 1,39 mg/kg.

No information.

7 Cadmium Cd; breeding

pigs; kidney; 1,018 – 1,44 mg/kg

4 Information to competent authority. 1 Animal older

than two years; On-site investigation at the farm of

origin; examination of the records; no fault on the part

of the livestock owner was found. 2 No information.

39 Copper Cu; pigs for fattening;


37 No information. 2 No causes for the copper residue

(pig's liver) in the herd of origin could be established;


of the records; Withdrawal of the possibility of

receiving or requesting EU-subsidies.

18 Copper Cu; breeding pigs; liver;

33 – 187 mg/kg

8 Information to competent authority. 10 No

information.

2 Mercury Hg; Other pigs; kidney;

0,035 and 0,044 mg/kg

2 Information to competent authority.

65 Mercury Hg; pigs for fattening; 63

kidney; 0,011 – 0,543 mg/kg; 16 liver

0,011 – 0,063 mg/kg


authority.

141

30 Mercury Hg; 2 breeding pigs;

liver; 0,013 – 0,0246 mg/kg; 30

kidney; 0,012 – 0,0673 mg/kg

9 The heavy metal pollution found is caused by normal

environmental pollution and/or the age of the animals;

15 Information to competent authority; 5 No

information. 1 On-site investigation at the farm of

origin; examination of the records.

Equine

8 Cadmium Cd; other horses; liver;

0,798 – 11,5 mg/kg; kidney; 18,5 –

63,4 mg/kg; muscles; 0,287 mg/kg


authority.

1 Mercury Hg; other horses; liver;

0,021 mg/kg

1 Mercury Hg; Other horses; liver; 0,021 mg/kg

3 Mercury Hg; other horses; kidney;

0,0209 – 0,183 mg/kg

3 Mercury Hg; Other horses; kidney; 0,0209 –

0,183 mg/kg

Poultry

1 Sum of enrofloxacin and

ciprofloxacin; turkeys; muscles;

272 µg/kg


1 Trimethoprim; broilers; muscles;

88,5 µg/kg

Outlier value in a series of 10 chickens, of which one

chicken showed 88 ppb trimethoprim, 3 chickens 2, 5

and 9 ppb trimethoprim and 6 chickens no

trimethoprim;

1 Doxycycline; turkeys; muscles;

118,2 µg/kg

No information.

1 Doxycycline; turkeys; muscles;

118,2 µg/kg

Withdrawal of the possibility of receiving or requesting

EU-subsidies

1 Lasalocid; lasalocid A; laying hens

(soup chickens); eggs; 390 µg/kg

Contaminated feed; On-site investigation at the farm of

origin; examination of the records; 2 additional

sampling; no anomalies; ban on transport and delivery

of livestock; ban on the sale of eggs and poultry;

animals were not brought to a slaughterhouse; animals

and products classified as not suitable for human

consumption; eggs and poultry meat; criminal

proceedings; Withdrawal of the possibility of receiving

or requesting EU-subsidies

1 Toltrazuril sulfone; turkeys;

muscles; 160 µg/kg

No information.

142

1 nicotine; broilers; muscles;

0,0017 mg/kg

The herdbook was kept according to the rules and, as

far as can be seen, had been properly completed. The

delivery and use of medicinal products and vaccines

were recorded in accordance with the rules. At the time

of control, no information could be found regarding the

use of prohibited substances. No medicinal products

were available on the farm. Two empty brown screw-

top bottles with handwritten labels were found which

had contained a homeopathic preparation produced by

the responsible veterinary practice for all fattening

cycles. The case was forwarded for further examination

to the veterinary office of the herd veterinarian. A

secondary contamination of the meat sample with

nicotine (smokers involved in the sampling procedure)

was suspected; On-site investigation at the farm of

origin; examination of the records; no livestock on the

farm at the time of testing, no infringement could be

found; the authority responsible for the herd

veterinarian in question was informed of the result of

the medicinal product check.

1 copper Cu; ducks; liver; 62 mg/kg No information.

Aquaculture

1 Prosulfocarb; trout; fish muscles;

0,34 mg/kg

Assumption: entry of pesticides from surrounding fields

during a period of heavy rain; On-site investigation at

the farm of origin; examination of the records; 4

additional sampling: 2 pond water samples, 2 fish

samples; the result is not yet available; instruction;

1 cis-heptachlor epoxide; other fish;

fish muscles; 0,0152 mg/kg

No information.

1 hexachlorbenzene HCB; other fish;

fish muscles; 0,3181 mg/kg

No information.

1 pp-DDE; other fish; fish muscles;

0,5637 mg/kg

No information.

1 pp-DDD; other fish; fish muscles;

0,8612 mg/kg

No information.

1 DDT, sum of DDT, DDE, DDD,

calculated as DDT; other fish; fish

muscles; 1,972 mg/kg

No information.

2 Leucocrystal violet; trout; fish

muscles; 0,00204 and 0,00354 mg/kg

None. Creation of a working group.

Removal of surface water and drinking water; On-site


records; 12 additional sampling; 1 follow-up samples;

ban on transport and delivery of livestock; blocking

order/marketing ban; operating restrictions; criminal

proceedings

143

Milk

1 benzylpenicillin, penicillin G; cows;

milk; 17 µg/kg

It was considered possible that a cow treated for

mastitis might have been milked by mistake, or that

reflux occurred; on-site investigation at the farm of

origin; examination of the records; criminal

proceedings; Withdrawal of the possibility of receiving

or requesting EU-subsidies

Eggs

1 sum dioxin and dl-PCBs; laying

hens (soup chickens); eggs;

0,0000458 mg/kg

Soil analyses showed that the soil in the runs had the

same pollutant distribution as the contaminated eggs.;

on-site investigation at the farm of origin; examination

of the records; 38 additional sampling: 30 eggs, 7

chickens, 1l raw milk; 254 ban on transport and

delivery of livestock; 1.086 animals and products

classified as not suitable for human consumption; all

chickens and all eggs still available, in addition to all

eggs still to be laid until further notice; all 254 chickens

and all available eggs (832) as well as all eggs still to

be laid immediately seized, consultation on the need to

inform the public, monitoring of the unreported recall;

advice to the operator regarding the existing legal

situation and the related restrictions on the killing of

animals with positive residue readings.

1 dl-PCBs; laying hens (soup

chickens); eggs; 0,0000437 mg/kg

No information.

1 WHO-PCDD/F/dl-PCB-TEQ/g fat;

laying hens (soup chickens); eggs;

0,0000088 mg/kg

Entry about soil pollution in the outdoor stable

suspected; at the time of the test result, there were no

more animals, feed or eggs in stock

1 WHO-PCDD/F/dl-PCB-TEQ/g fat;

laying hens (soup chickens); eggs;

0,0000031 mg/kg


Wild game

1 DDT, sum of DDT, DDE, DDD,

calculated as DDT; wild boar; fat;

1,21 mg/kg

No information.

1 copper Cu; wild boar; muscles;

6,1 mg/kg

No information.

1 DDT (sum of DDT, DDE, DDD,

calculated as DDT); wild boar;

muscles; 0,307 mg/kg

It not was to possible to identify the cause of the

residue contamination.

1 beta-HCH; wild boar; fat;

0,123 mg/kg


1 copper Cu; deer; liver; 44 mg/kg No information.

144

1 copper Cu; red deer; liver;

33,9 mg/kg

Lead bullets; the responsible person was informed of

the report by telephone: the part of the carcass

containing lead (head and neck) was completely

discarded. The remaining carcass was consumed by

employees of the wildlife park. No sale outside the

wildlife park; in future, non-lead bullets must be used.

35 mercury Hg; wild boar; 26 liver;

0,018 – 0,126 mg/kg; 1 muscles;

0,017 mg/kg; 23 kidney; 0,052 –

0,28 mg/kg


authority. 1 soil contamination with heavy metals;

animals and products classified as not suitable for

human consumption; 5 environmental contamination

Rabbit – Farmed Game – Honey

None None

145



Member State GREECE

Group A substances


Due to non-compliant results in 2013, extra samples have been added in the NRCP 2014 in the

group substances and the species/products where non-compliant results were found. The

number of wild game samples remains the same as in 2013 regardless the fact of non-

compliant results.


Poultry

1 target – AMOZ

Suspect – 2 AOZ (3-amino-2-

oxazolidone) – muscle 4 AMOZ

Target: The farm was investigated and placed under

surveillance. The animals were killed (animal by-

products Reg. 1069/2009). Additional official samples

were taken with positive results.

Water sampling with negative results. Feed sampling

with negative results

Bovine – Ovine & caprine – Porcine – Equine – Aquaculture –


None None

Group B substances


None


Ovine & caprine

1 oxytetracycline – sheep – muscle

1 cadmium – goat – liver

Investigation in the farm of origin and controls on the

farm records. The farm was placed under surveillance.

Additional sampling was carried out.

Porcine

1 sulfadimidine – muscle

ochratoxin A – kidney

12 – target

6 – suspect

Investigation in the farm of origin and control on the

farm records. The farm was placed under surveillance.

Additional sampling was carried out.

Investigation in the farms. Checks were carried out on

the feed storage at the farms. Feed sampling.

Additional samples have been taken and the official

controls have been intensified

Aquaculture

Import: 1 lead (Pb) – fish

Others: 1 lead (Pb) – fish

1 cadmium (Cd) & lead (Pb) – fish

Border rejection

Investigation of contamination source

146

Milk

2 aflatoxin M1 – sheep Investigation in the farm. Checks were carried out on

the feed storage at the farm. Additional samples have

been taken and the official controls have been

intensified.

Wild game

4 lead (Pb) – muscle Free range animals. The local hunting club was

informed.

Contamination due to the bullet used for killing.

Honey

1 oxytetracycline & tetracycline –

honey – target

1 oxytetracycline – honey – suspect

3 cadmium (Cd) – honey

5 lead (Pb) – honey

Investigation in the farm of origin. Additional

sampling was carried out. Administrative measures

were undertaken.

Bovine – Equine – Poultry – Eggs – Rabbit – Farmed game

None None

147



Member State HUNGARY

Group A substances


None




None None

Group B substances


None.


Bovine

Bovine kidney: cadmium (Cd) 1 pc - additional sampling

- administrative measures,

- modifications of the NRCP of 2014:

Intensified control of Cadmium contamination of

bovines and simultaneous change of matrix from

kidney to liver, because kidney consumption in

Hungary is negligible.

Ovine & caprine

Sheep kidney: cadmium (Cd) 2 pcs - additional sampling


- result of investigation: the sheep were grazed on a

contaminated field,

- the further use of the field is forbidden,

- the official vet controls regularly if the owner follows

the instructions


increased sample numbers:

B3c: from 3 to 4

Equine

Horse liver: cadmium (Cd) 8 pcs

Horse kidney: cadmium (Cd) 8 pcs


- the kidneys and livers have been destroyed,



B3c: from 2 to 10

Horse offal declared as not fit for human consumption.

148

Milk

Bovine milk:

aflatoxin M1 : 2 pcs


- the lots of the contaminated milk have been

destroyed



B3d: from 20 to 23

Suspected samples:

Aflatoxin M1: 10 pcs


- the lots of the contaminated milk have been

destroyed

Wild game

Wild boar muscle: mercury (Hg): 1

pc, lead (Pb): 1 pc




B3c: from 110 to 125

Porcine – Poultry – Aquaculture – Eggs –

Rabbit – Farmed game – Honey

None None

149



Member State IRELAND

Group A substances


An LCMSMS method has been validated and accredited to confirm stilbenes in poultry liver

An LCMSMS method has been validated and accredited to confirm trenbolone in poultry liver


Bovine

Thyrostats – thiouracil – Urine: 18


17 target samples confirmed non-compliant for

thiouracil at the following levels:

(1) 15,3 µg/kg (2) 8,5 µg/kg (3) 7,8 µg/kg

(4) 21,6 µg/kg (5) 12,6 µg/kg (6) 24,7 µg/kg

(7) 16,8 µg/kg (8) 15,7 µg/kg (9) 8,3 µg/kg

(10) 8,8 µg/kg (11) 9,7 µg/kg (12) 10,5 µg/kg

(13) 8,5 µg/kg (14) 10,9 µg/kg (15) 8,4 µg/kg

(16) 22,3 µg/kg (17) 10,5 µg/kg

1 target sample confirmed non-compliant for thiouracil

& methylthiouracil 23,8 µg/kg & 10,2 µg/kg.


all cases and no evidence of illegal use was identified.

In line with scientific evidence, the Competent

Authority has concluded that the residues resulted

from dietary factors.

Nitrofurans – nitrofurazone as SEM

– plasma: 2 non-compliant results

2 target sample confirmed non-compliant for

nitrofurazone as SEM at the following levels: (1)

0,258 µg/kg (2) 0,23 µg/kg. A follow-up investigation

was initiated at the farms of origin and no evidence of

illegal use was identified. In line with scientific

evidence, the Competent Authority has concluded that

the residues may have resulted from accidental

exposure to environment or dietary factors.

Ovine & caprine

Nitrofurans – nitrofurazone as SEM

– muscle: 1 non-compliant result


nitrofurazone as SEM at the following levels:

0,323 µg/kg. A follow-up investigation was initiated at

farm level and no evidence of illegal use was

identified. In line with scientific evidence, the

Competent Authority has concluded that the residues

may have resulted from accidental exposure to

environment or dietary factors.

Porcine – Equine – Poultry – Aquaculture – Milk –


None None

150

Group B substances


Method for NSAID’s in kidney and plasma extended to include oxyphenbutazone and

flufenamic acid


Bovine

Antimicrobials – muscle: 8 non-

compliant results*

8 suspect samples confirmed non-compliant for

antibiotics:

(1) oxytetracyline > 400 µg/kg

(2) oxytetracycline 226 µg/kg

(3) benzylpenicillin (Pen G) 74,8 µg/kg

(4) oxytetracycline 166,5 µg/kg

(5) enrofloxacin & ciprofloxacin > 200 µg/kg

(6) marbofloxacin > 300 µg/kg

(7) Marbofloxacin > 300 µg/kg

(8) Oxytetracycline 116,9 μg/kg

All suspect carcasses declared unfit for human

consumption and destroyed. Full on-farm

investigations including examination of medicines on

farm and animal remedies record were carried out in

each case. As appropriate, advice is given to the farmer

and follow-up visits take place.

Ovine & caprine

NSAID’s – kidney: 2 non-compliant

results*

2 target samples confirmed non-compliant for 4-MAA

(1) 2,5 µg/kg (2) 4,6 µg/kg

An investigation revealed that the most likely source

was cross-contamination by the veterinarian that took

the sample.

Anthelmintics – liver: 3 non-

compliant results

1 target sample confirmed non-compliant for closantel

4.861 µg/kg


fenbendazole (1) 546 µg/kg (2) 810 µg/kg

Full on-farm investigations including examination of

medicines on farm and animal remedies record were

carried out in each case. As appropriate, advice is

given to the farmer and follow-up visits take place.

Porcine

Antimicrobials – muscle: 2 non-

compliant results*


oxytetracycline > 400 µg/kg

1 suspect sample confirmed non-compliant for

chlortetracycline 229,4 µg/kg

Suspect carcass declared unfit for human consumption

and destroyed. Full on-farm investigations including

examination of medicines on farm and animal

remedies record were carried out in each case. As

appropriate, advice is given to the farmer and follow-

up visits take place.

151

Poultry

Anticoccidials – muscle: 2 non-

compliant results


toltrazuril sulphone at the following level 162 µg/kg

1 target sample confirmed non-compliant for narasin at

the following level 270 μg/kg

In both cases, full on-farm investigations including

examination of feed records were carried out. As

appropriate, advice is given to the farmer and follow-

up visits take place.

Milk

Antimicrobials – milk: 1 non-

compliant result

Anthelmintics – milk: 1 non-

compliant result


cloxacillin (1) 42,5 µg/kg


rafoxanide (1) 2,1 µg/kg

Full on-farm investigations including examination of

medicines on farm and animal remedies records were

carried out in each case. As appropriate, advice is

given to the farmer and follow-up visits take place.

Wild game

Chemical elements – wild game: 4


2 target samples confirmed non-compliant for lead

(Pb) > 100 µg/kg

1 target samples confirmed non-compliant for lead

(Pb) at levels – 68,058 µg, 161,241 µg/kg,

593,428 µg/kg

1 target sample confirmed non-compliant for lead (Pb)

> 200 μg/kg

Honey

Chemical elements – honey: 2 non-

compliant results

2 suspect samples confirmed non-compliant as

follows:

(1) 64,7 µg/kg

(2) > 200 µg/kg

The suspect samples were taken as part of the follow-

up to the 2 cases of elevated lead in honey identified in

2012. While one case is now fully closed out

investigations are on-going in the other case.

Equine – Aquaculture – Eggs – Rabbit – Farmed game

None None

* Non-compliant results as appropriate have been reported to the relevant Services of the competent authority for the purposes of

implementation of Commission Regulation (EC) No 796/2004.

152



Member State ITALY


New researches

The following new researches have been inserted:

cephalosporins in milk matrix. The analytical work will be completed in the second half of

the year / last quarter of 2014;

dyes for the sector Aquaculture: the number of molecules to search belonging to the group

of dyes was extended. The analytical work will be completed in the second half of 2014.

Updating of pre-existing researches

zeranol and metabolites: the confirmation method used for analytical research of

substances belonging to the group A4 - Resorcylic acid lactones (including zeranol) - in

urine matrix, must be able to detect the following molecules : α-zearalanol (zeranol), β -

zearalanol (taleranol), zearalanone, α-zearalenol , β-zearalenol and zearalenone;

non dioxin-like PCBs: the single research of such compounds was eliminated and included

in the group "organochlorine compounds including PCBs" which includes, therefore, non-

dioxin -like PCBs, dioxins and dioxin-like PCBs;

non dioxin-like PCBs in honey matrix: in 2012 this research was eliminated in

consideration of the non-importance of the honey matrix for the purpose of seeking such

fat-soluble contaminants. Such reasoning is also supported by the EFSA report "Update of

the monitoring of levels of dioxins and PCBs in food and feed" [ EFSA Journal 2012; 10

(7): 2832 ];

porcine sector: the research was divided into the animal category “lattonzoli”, which

covers both the “lattonzoli” and “magroncelli”, pigs that includes "magroni", "grassi" and

little sows, and the categories sows, with sows and boars;

eggs sector: the sampling activity is expected both in the farm or in packing centers, in

application of Decision 97/747/EC, according to which “at least 30 % of the samples must

be collected from packing centers which have the most significant proportion of eggs

intended for human consumption”;

aquaculture sector: sampling is carried out exclusively in registered sites of production.

Since 2014, the Regions and Autonomous Provinces may include sampling for the

detection of substances in category B also in processing plants or wholesale level, on fresh

fish in a position to go back to the original farm, provided that the community requirement

of "a minimum of 10% of registered sites of production" is respected;

Update of program based on non-compliance find out on the previous year

On the basis of previous not compliances, number of samples has been proportionally

increased for the following combination:

Bovines: steroids, resorcycil acid lactones including zeranol, β--agonists, compounds

included in Table II of Annex to Council Regulation (EU) No 37/2010, antibacterial

substances including sulfonamides and quinolones, other pharmacologically active

substances, chemical elements and mycotoxins ;

Pigs: antibacterial substances including sulfonamides and quinolones, and chemical

elements;

Sheep-Goats: chemical elements;

153

Poultry: compounds included in Table II of Annex to Council Regulation (EU) No

37/2010, antibacterial substances including sulfonamides and quinolones, anticoccidials

Aquaculture: dyes;

Milk: antibacterial substances including sulphonamides and quinolones, organochlorine

compounds including PCBs, mycotoxins;

Eggs: antibacterial substances including sulfonamides and quinolones, anticoccidials and

organochlorine compounds including PCBs;

Honey: antibacterial substances including sulphonamides and quinolones.

Group A substances


Bovine

3 clenbuterol – urine – veal calves

0,63 ng/ml

0,84 ng/ml

0,79 ng/ml

Target samples. Investigations in the farm. Additional

samples have been taken (20), intensified checks in the

farm. The source has not been established.

1 taleranol – urine – cow – 0,78 µg/l Target sample. The source was related to

contamination from mycotoxins.

Porcine

1 chloramphenicol – muscle – pig –

5,4 µg/kg

Target sample. Investigations in the farm, records

check. Additional samples have been taken (19),

intensified checks in the farm. The source has not been

established. 89 animals have been put under seizure.

93,6 kg of product declared unfit for human

consumption.

Rabbit

1 AMOZ – muscle – rabbit –

1,75 µg/kg

Target sample. Investigations in the farm. Additional

samples have been taken (21), intensified checks in the

farm. The source has not been established. 12.000

animals in the farm have been put under seizure.

Investigation in progress.


Milk – Eggs – Farmed game – Honey

None None

Group B substances


Bovine

1 dexamethasone – young bovines –

liver

Target sample. Investigation in the farm: record

checks. 9 additional samples have been taken.

Intensified checks. The source has not been

established. 9 animals have been put under seizure, 1

carcass has been declared unfit for the human

consumption. Intensified checks in 3 farms.

154


liver


checks. Intensified checks. The source has been

established: probably not registered treatment.

Administrative measures and criminal penalties.

1 sulfametazine – veal calves –

muscle


checks. Intensified checks. The source has not been

established. 12,30 kg of products have been declared

unfit for the human consumption. Investigations in

progress.

1 dexamethasone – cows – liver Target sample. Investigation in the farm: record

checks. Intensified checks. The source was related to a

treatment. Administrative measures and criminal

penalties.

1 sulfapyridine – cows – muscle Target sample. Investigation in the farm: record

checks. The source has not been established.

Administrative measures and criminal penalties. 1

animal has been put under seizure.

1 dexamethasone – veal calves –

liver



Intensified checks. The source was related to a

treatment. Administrative measures and criminal

penalties. 279 animals have been put under seizure.



checks. Investigation in progress.



Intensified checks in the farm. The source has not been

established (probably illegal treatment). 406 animals

have been put under seizure.


liver




established. Administrative measures and criminal

penalties. Investigation in progress.


liver





penalties.


urine





penalties. 2 animals have been put under seizure.

155


urine

Other sample. Investigation in the farm: record checks.

14 additional samples have been taken. Intensified

checks in the farm. The source has not been


penalties. 1 animal has been put under seizure.


1 sulfametazine – cows – muscle Other sample. Investigation in the farm: record checks.

Intensified checks. The source has not been



1 dexamethasone – cows – liver Other sample. Investigation in the farm: record checks.





liver

Other sample. Investigation in the farm: record checks.

Intensified checks in the farm. 1 animal has been put

under seizure and declared unfit for human

consumption.

1 dexamethasone – cows – liver Suspect sample. Investigation in the farm: record



established. 406 animals have been put under seizure.


liver

Suspect sample. 1 carcass put under seizure, 522 kg

declared unfit for human consumption. Investigation in

progress.

1 dexamethasone – cows – muscle Suspect sample. 1 carcass put under seizure.


1 ciprofloxacin, enrofloxacin – cows

– muscle

Suspect sample. Investigation in the farm: record

checks. The source was related to treatment. 1 animal

has been put under seizure and declared unfit for the

human consumption.

1 marbofloxacin – cows – muscle Suspect sample.

1 ampicillin – young bovines –

muscle


checks. Intensified checks in the farm. The source has

not been established. 1 animal has been put under

seizure and declared unfit for the human consumption.

Administrative measures. Investigation in progress.

1 dexamethasone – veal calves –

liver


checks. Intensified checks in the farm. 1 animal has

been put under seizure and declared unfit for the

human consumption. Administrative measures.


1 oxytetracycline – cows – muscle Suspect sample. 1 animal has been put under seizure

and declared unfit for the human consumption.


1 sulfametazine – cows – muscle Suspect sample. 1 animal has been put under seizure

and declared unfit for the human consumption.

156

1 marbofloxacin – young bovines –

muscle



not been established. 1 animal has been put under

seizure and declared unfit for the human consumption.

Porcine

1 sulfadimethoxine – muscle Target sample. Investigation in the farm, record check.

Intensified checks in farm. The source has been

established: not registered treatment. Administrative

measures. Investigations are still in progress.



established: no respect of withdrawal periods.

Administrative measures.



established: not registered treatment. Administrative

measures and criminal penalties. 1 carcass put under

temporary seizure in the slaughterhouse and declared

unfit for the human consumption.


Intensified checks in farm. The source was related to a

probable exchange with the medicated food.


1 oxytetracycline – muscle Target sample. 1 carcass put under temporary seizure

in the slaughterhouse and declared unfit for the human

consumption. Investigation in progress.

1 lead (Pb) – muscle Target sample. Investigation in the farm, record check.

1 additional sample. Intensified checks in farm. The

source has not been established. Investigation in

progress.


Intensified checks in farm. The source has not been

established. Administrative measures. 1 carcass put

under temporary seizure in the slaughterhouse and

declared unfit for the human consumption.


1 sulfadimethoxine – muscle Target sample. Administrative measures. Investigation

in progress.

1 aflatoxin B1 – feed Target sample. Investigation in the farm.Record check.

Additional samples. Intensified checks in farm. The

source has not been established. Investigation in

progress.

1 sulfadimidine – muscle Target sample. Investigation in the farm, record check.

The source was related to absence of records and

veterinary requirements. Administrative measures.

157


Additional samples. Intensified checks. The source has

not been established (probably drinking water

contaminated by residues of drugs used in previous

treatment). Administrative measures and criminal

penalties.

1 sulfadimethoxine – muscle Other sample. Investigation in the farm, record check.

2 additional samples. Intensified checks. The source

has not been established.

1 enrofloxacin – muscle Other sample. Investigation in the farm, record check.

1 carcass put under temporary seizure in the

slaughterhouse and declared unfit for the human

consumption. The source was related to possible

treatment.

1 doxycycline – muscle Other samples. Investigation in the farm: record

checks. Intensified checks in the farm. The source was

related to treatment. Administrative measures and

criminal penalties. 100 kg of sausages put under

temporary seizure in the farm.

1 doxycycline – muscle Other samples. Investigation in the farm: record

checks. 1 additional sample. Intensified checks in the

farm. The source was related to withdrawal period not

respected. Administrative measures.

1 sulfadimethoxine – muscle Other sample. Investigation in the farm, record check.

Intensified checks. The source was related to

medicated feed (human error). Administrative

measures and criminal penalties.

1 aflatoxin B1 – feed Suspect sample. Investigation in the farm. Record

check. 1 additional sample. Intensified checks in farm.

The source was related to maize contaminated.

Equine

1 cadmium (Cd) – muscle Target sample. Investigation in the farm, record

checks. 1 additional sample has been taken. The source

has not been established. Investigation in progress.

1 cadmium (Cd) – muscle Target sample. Intensified checks in the farm. The

source has not been established.

1 cadmium (Cd) – muscle Target sample. No news of activity from local

authority, as Cd is environmental contaminant.

Poultry

1 enrofloxacin – muscle turkey Target samples. Investigation in progress.

2 colistin, erythormycin – water –

hen

Other samples. Investigation in the farm: record


not been established. Investigation in progress.

Milk

1 aflatoxin M1 – bovine Target sample. 1 additional sample has been taken,

intensified checks in the farm. Investigation in

progress.

158

1 aflatoxin M1 – bovine Target sample. 2.200 kg of milk were declared unfit

for the human consumption.

1 aflatoxin M1 – bovine Target sample. 1 additional sample has been taken.

Intensified checks in the farm. Criminal penalties.

1 aflatoxin M1 – bovine Target sample. Investigation in the farm, record

checks. 1 additional sample has been taken. Intensified

checks in the farm. The source of contamination was

related to contamination of corn flour produced in the

farm 7.980 litres of milk were declared unfit for the

human consumption.

1 PCB-DL – sheep and goat Target sample. 9 additional samples have been taken.


established. 7.980 litres of milk were declared unfit for

the human consumption.

1 PCB-DL – sheep and goat Target sample. 9 additional samples have been taken.


established. Investigation in progress.

1 tetracycline – sheep and goat Suspect sample. Investigation in the farm, record

checks. Intensified checks in the farm. The source was

related to treatment. Criminal penalties. 260 animals

put under temporary seizure in the farm Investigation

in progress.

1 aflatoxin M1 – bovine Suspect sample. Investigation in the farm, record


checks in the farm. 18 animals put under temporary

seizure in the farm. 320 litres of milk were declared



checks. 3 additional samples of feed have been taken.


established. Investigation in progress.

1 aflatoxin M1 – buffalo Target sample. Investigation in the farm, record

checks. 5 additional samples (4 feed, 1 milk) have

been taken. Intensified checks in the farm. The source

has not been established. 450 litres of milk were




checks in the farm. Criminal penalties. The source has

not been established.



checks in the farm. The source was related to

contaminated maize. Administrative measures.



not been established. Administrative measures.


159




established. Administrative measures.

1 aflatoxin M1 – bovine Other sample. Investigation in the farm, record checks.



contaminated maize. 11.000 kg of milk put under

seizure in the farm.


1 additional sample has been taken. Intensified checks

in the farm. The source has not been established.

Notification.


11 additional samples have been taken. The source has


1 aflatoxin M1 – bovine Other sample. 1 additional sample has been taken.

Intensified checks in the farm. The source was related

to contaminated feed. Administrative measures. 500

liters of milk put under seizure in the farm.



in the farm. The source was related to contaminated

feed.




feed. 1.000 kg of milk put under seizure in the farm.




feed. 20.200 liters of milk put under seizure in the

farm.



in the farm.




feed. 26.000 kg of milk and 272 forms of Parmigiano

Reggiano put under seizure in the farm.




contaminated feed. 39.300 kg of milk put under


160


Intensified checks in the farm. Administrative

measures.



in the farm. The source was related to contamination.

51.680 kg of milk not put on the market, 9.300 liter of

milk put under seizure in the farm.


Intensified checks in the farm. The source was related

to contamination of feed.



in the farm. The source was related to contamination

of feed. 500 kg of milk put under seizure in the farm.




of feed. 15.000 kg of milk put under seizure in the

farm.




of feed. 32 forms of cheese (1.600 kg) put under





of feed. 700 kg of milk put under seizure in the farm.


Intensified checks in the farm.

1 aflatoxin M1 – sheep and goat Other sample. Investigation in the farm, record checks.



in the farm. The source has not been established. 16

forms of cheese (800 kg) put under seizure in the farm.


1 additional sample has been taken. The source was

related to contamination of feed. 21 forms of

Parmigiano reggiano put under seizure in the farm.




of feed (alert object).

1 penicillin B – bovine Other sample. Investigation in the farm, record checks,

1 additional sample. Administrative measures and

criminal penalties.

161



checks in the farm. Administrative measures and

criminal penalties.




contamination of cereals. Administrative measures and

criminal penalties. Investigation in progress.




contamination of feed (but within the limits).

Administrative measures. 600 liters of milk were



1 aflatoxin M1 – sheep and goat Other sample. Investigation in the farm, record checks.



of feed. Administrative measures. 21 forms of cheese

(each of 1 kg) were declared unfit for the human

consumption.



in the farm. The source has not been established.



checks in the farm. The source has not been

established.



in the farm. The source of contamination was related

to contaminated flour maize used for feed. 360 kg of

Branzi cheese (36 forms) were declared unfit for the

human consumption.




related to contaminated feed.

1 aflatoxin M1 – bovine Other sample. Investigation in the farm, records check.

1 additional sample. Intensified checks in the farm.

The source of contamination was related to

contaminated maize used for feed. Administrative

measures.

1 aflatoxin M1 – sheep and goat Other sample. Investigation in the farm, records check.



contaminated feed. Administrative measures.

162


2 additional samples. Intensified checks in the farm.

The source of contamination has not been established.

Administrative measures. 1.600 kg of milk were





Administrative measures. 1.500 kg of milk was





contaminated maize.


Additional samples. Intensified checks in the farm.

Administrative measures. 50 kg of cheese were












contaminated maize.




1 aflatoxin M1 – bovine Other sample. 1 additional sample.. The source of

contamination was related to contaminated maize.


1 additional sample. The source of contamination has



1 additional sample. The source of contamination was

related to contaminated maize.


1 additional sample. The source of contamination was

related to contaminated maize. Administrative

measures.

2 aflatoxin M1 – bovine Other sample. 2 additional samples. Intensified checks

in the farm.

163




contaminated maize.


2 additional samples of feed. Intensified checks in the

farm. The source of contamination has not been

established.


1 additional sample of milk. Intensified checks in the

farm. The source of contamination was related to

contaminated feed. Investigation in progress.








contaminated feed. 30 liters of milk were declared


1 beta-HCH – bovine Other sample. Investigation in the farm, record checks,

additional samples have been taken. Intensified checks

in the farm. The source of contamination was not

found. Investigations are still in progress.

1 beta-HCH – buffalo Other sample. Investigation in the farm, record checks,


in the farm. 53 animals put under seizure. 600 liters of

milk declared unfit for the human consumption.

Investigations in progress.


2 additional samples have been taken. The source of

contamination was not found. Investigations in

progress.




related to contaminated feed.




to contaminated feed. 9620 kg of milk put temporally

under seizure.




to contaminated feed. Investigation in progress.

164




to contaminated feed.



in the farm. The source of contamination was not

found.

1 aflatoxin M1 – bovine Suspect sample. Investigation in the farm, records

check. 3 additional samples have been taken.

Intensified checks in the farm. 12.500 liters of milk



check. 2 additional samples have been taken.

Intensified checks in the farm. 2.000 kg of milk



check. Intensified checks in the farm. The source of

contamination was related to contaminated feed.

38.300 kg of milk declared unfit for the human

consumption.

1 aflatoxin M1 – bovine Suspect sample. 1 additional sample has been taken.

Intensified checks in the farm. The source of

contamination was related to contaminated feed. 7.967

liters of milk declared unfit for the human

consumption.

1 aflatoxin M1 – bovine Suspect sample. Intensified checks in the farm. 1

additional sample has been taken. The source of


kg of milk declared unfit for the human consumption.

1 aflatoxin M1 – bovine Suspect sample. Intensified checks in the farm. 2

additional samples have been taken. The source of




check. Intensified checks in the farm. 1 additional

sample has been taken. The source of contamination

has not been established. 7.500 kg of milk declared






check. Intensified checks in the farm. 3 additional

samples have been taken. The source of contamination

was related to contaminated feed. 2.400 kg of milk



165












consumption.



contamination was related to contaminated feed. 820


consumption.





1 Aflatoxin M1 – bovine Suspect sample. 1 additional sample has been taken.






contaminated feed. 11.294 liters of milk declared unfit



check. 1 additional sample has been taken. Intensified


related to contaminated feed. 484 kg of milk declared












contaminated feed. 1.100 kg of milk declared unfit for

the human consumption.

166





consumption.


check. 1 additional sample has been taken. The source

of contamination was not found. 1.100 liters of milk



970 kg of milk declared unfit for the human

consumption.


1.600 liters of milk declared unfit for the human

consumption.



contaminated feed. 7.000 liters of milk declared unfit



check. 1 additional sample has been taken. Intensified


not found. 4.000 kg of milk declared unfit for the

human consumption.

Eggs

2 dioxin and dl-PCBl – hen Other sample. 2 additional samples. Intensified checks


to contamination by coating the chicken coop in the

presence of polystyrene and lubricants on ground.

1 ndl-PCB – hen Other sample. 2 additional samples. Intensified checks


to contamination by coating the chicken coop in the

presence of polystyrene and lubricants on ground.

1 ndl-PCB – hen Other sample. Investigation in the farm: record checks.

Wild game

1 lead (Pb) – boar – muscle Other sample.

Honey

1 tetracycline Target sample. Investigation in the farm, records

check. 7 additional samples. Intensified checks in the

farm. The source of contamination has not been

established. Administrative measures. 33 hives and

150 kg of honey put under temporary seizure.


167

1 tetracycline Target and suspect sample. Investigation in the farm,

records check. 7 additional samples. Intensified checks

in the farm. The source of contamination has not been

established. Administrative measures. 33 hives and

150 kg of honey put under temporary seizure.


1 oxytetracycline Target and suspect sample. Administrative measures.

30 hives put under temporary seizure. Investigation in

progress.

Ovine & caprine – Aquaculture – Rabbit – Farmed game

None None

168



Member State LATVIA

Group A substances


None


Milk

Chloramphenicol in cow milk –

0,23 µg/kg

1 farm (7 cows held in the farm) was investigated and

the origin of CAP was not identified. Additional

sampling – 1 milk sample. The result was compliant.


Aquaculture – Eggs – Rabbit – Farmed game – Honey

None None

Group B substances


None


Bovine

Cadmium (Cd) – 2,32 ± 0,23 mg/kg

– bovine kidney

Extraordinary inspection was carried out in the farm

and the following was found – the pasture was located

near motorway.


– bovine kidney

Extraordinary inspection was carried out in the farm.

The source of contamination was not clarified.


– bovine kidney

Extraordinary inspection was carried out in the farm.

The source of contamination was not clarified.

Eggs

Salinomycin – 8,3 ± 2,7 µg/kg 1 farm (120 birds held in the farm) was investigated.

Additional sampling – 1 feed sample.

Wild game

Cadmium (Cd) – 24 offal samples

(0,207 to 70,6 mg/kg); 33 muscle

samples (0,115 to 6,2 mg/kg).

Lead (Pb) – 7 offal samples (0,787

to 3,37 mg/kg); 25 muscle samples

(0,126 to 6,3 mg/kg).

None.

Ovine & caprine – Porcine – Equine – Poultry – Aquaculture –

Milk – Rabbit – Farmed game – Honey

None None

169



Member State LITHUANIA

Group A substances


Number of samples is calculated on the basis of the production data from 2013.

Official laboratories involved in analyses of residues of veterinary medicinal products are

accredited in accordance with EN ISO/IEC 17025 on ‘General requirements for the

competence of testing and calibration laboratories’ standard and they use validated methods

according to Commission Decision 2002/657/EC.

According to CRL recommendations testing of nitroimidazoles in bovine, aquaculture, milk

and honey samples is introduced into the RMP for 2014.


Bovine

4 x 2-thiouracil – urine In all 4 cases, investigations were carried-out, farms of

origin and animals were identified. Inspections of the

farms were conducted. No infringements were

detected. The causes of the origin were not identified

(the probable causes of the detection of 2-thiouracil in

urine were considered as the use of cruciferous plants

for animal feeding).

Porcine

2 x 2-thiouracil – urine Investigations were carried out, the farms of origin and

the animals were identified. Inspections of the pig

farms were conducted, suspect samples were taken (all

with negative results). No infringements were

detected. The causes for the origin were not identified

(the probable causes of the detection of 2-thiouracil in

urine were considered as the use of cruciferous plants

for animal feeding).

1 x 2-thiouracil and 6-methyl-2-

thiouracil – urine

An investigation was carried-out, the farm of origin

and the animal were identified. An inspection of the

pig farm was conducted. No infringements were

detected. The cause of the origin was not identified

(the probable cause of the detection of 2-thiouracil in

urine was considered as the use of cruciferous plants

for animal feeding – rape cakes were used for pig

feeding).

Rabbit

1 x 2-thiouracil – urine An investigation was carried-out, the farm of origin

and the animal were identified. An inspection of the

farm was conducted. No infringements were detected.

The cause of the origin was not identified.

170


Milk – Eggs – Farmed game – Honey

None None

Group B substances


Number of bovine samples for testing of dexamethasone is increased considering RASFF

data and the results of residue monitoring in EU.

Considering the results of residue monitoring in EU, testing of florfenicol in bovine

samples is introduced into the RMP.

Considering data on the use of veterinary medicinal products in Lithuania, testing of

colistin in bovine, pig and poultry samples is introduced into the RMP.

Considering the results of residue monitoring in Lithuania, testing of antimicrobial

substances in honey samples is increased.

According to CRL recommendations, testing of closantel, rafoxanide and nitroxinil is

introduced into the RMP for bovines, pigs, sheep/goats, rabbits, poultry.

According to CRL recommendations, testing of flubendazole and mebendazole is

introduced into the RMP for eggs. Scope of benzimidazoles is also increased in other

samples (bovine, pigs, sheep/goats, rabbits, poultry).

According to RASFF data, testing of clopidol is introduced into the monitoring plan for

poultry.

According to CRL recommendations, testing of metamizole in milk is introduced into the

RMP.


Bovine

1 enrofloxacin and ciprofloxacin,

benzylpenicillin – muscle

An investigation was carried-out, the farm of origin

and the animal were identified. Infringements of

requirements for use of veterinary medicines, for

treatment data recording and for withdrawal periods

were detected. Administrative sanctions for the farm

and veterinarian were applied.

1 prednisolone – urine An investigation was carried-out, the farm of origin

and the animal were identified. Inspections of the farm

and veterinarian attending that farm were conducted.

No infringements were detected. The cause of the

origin was not identified.

Porcine

1 levamisole – liver An investigation was carried-out, the farm of origin

and the animal were identified. As a result of the

investigation it was established that a therapy of the

animals was applied. Infringements of requirements

for withdrawal periods of medicines and of

requirements for accompanying documents were

detected. Administrative sanctions for the farm were

applied.

171

5 diclofenac – muscle Investigations were carried out, the farms of origin and

the animals were identified. Inspections of the pig

farms were conducted; suspect samples were taken

(negative results). Inspections of the feed producer and

veterinarian were also conducted. No infringements

were detected. The causes of the origin were not

identified. The farms were reclassified in the higher

risk group.

Eggs

3 lasalocid An inspection of the poultry farm was conducted.

Infringements regarding the use of feed additives –

coccidiostats were detected. Suspect samples were

taken (negative results). Eggs were recalled from the

market and disposed of. Control on the farm was

strengthened; the farm was reclassified in the higher

risk group.

Honey

1 sulfamonomethoxine and

trimethoprim

An inspection of the apiary was conducted. During

investigation no antibacterial substances were found.

Release of the remaining honey was prohibited. A

suspect sample was taken with no positive results. A

repeated inspection of the apiary was conducted,

decision on an unsafe product was issued and honey

was disposed of.

1 sulfathiazole An inspection of the apiary was conducted. During

investigation no antibacterial substances were found,

all honey was already consumed. A suspect sample

from other (fresh) honey was taken with positive

results. A decision on an unsafe product was issued

and release of the remaining honey was prohibited.


Milk – Rabbit – Wild game – Farmed game

None None

172



Member State LUXEMBURG

Group A substances


None




None None

Group B substances


None


Wild game

Cadmium (Cd): 8 samples – liver –

wild boar / roe – 0,811 mg/kg,

0,497 mg/kg, 0,618 mg/kg,

0,534 mg/kg, 0,628 mg/kg,

0,695 mg/kg, 0,511 mg/kg and

1,605 mg/kg

Lead (Pb): 9 samples – liver – wild

boar / roe – 0,635 mg/kg,

0,579 mg/kg, 1,69 mg/kg, 0,538

mg/kg, 1,2 mg/kg, 0,958 mg/kg,

1,467 mg/kg, 2,44 mg/kg and

1,127 mg/kg

The number of positive results seems increasing, for

2014. Cadmium is considered as a national priority

together with the surveillance of plants.



None None

173



Member State MALTA

Group A substances


None




None None

Group B substances


None


Poultry

R1300238; 1 liver sample non-

compliant for Salinomycin;

> 6 µg/kg (Suspect) (Sampled in

March 2013)

The operator was a repeated offender in 2012. A

warning letter had been sent. Poultry liver samples

were taken again from every batch slaughtered during

2013. 27 samples were taken; 22 samples were

negative, 1 confirmed positive for salinomycin and 4

samples still pending results.

In 2014, a different lab was awarded for the analysis of

ionophores since the results were not reported in a

timely manner. During 2014, 13 liver samples were

taken from every batch slaughtered from the same

operator. 12 samples were found to be compliant for

ionophores and the last sample is still pending.


Milk – Eggs – Rabbit – Wild game – Farmed game – Honey

None None

174



Member State THE NETHERLANDS

Group A substances

Modification of national residue plan None


Bovine

3 non-compliant results for

conjugated alfa-boldenone bovine in

calves

In 3 cases investigation was carried out. Additional

sampling was carried out which did not reveal further

indications of the abuse of beta-boldenone. A probable

cause was not observed. No penalties applied.

Investigations are closed.

1 non-compliant result for

testosterone-17-beta in calves

No investigation was carried out because a mistake

was made in the administration.


thiouracil in bovine (7 calves and 3

older bovine).

In one case of an older bovine the animal originated

from Germany. German veterinary authorities were

informed.

In the case of 6 calves and 2 older bovine additional

sampling was carried out. In 6 cases the results of all

the tests were < 30 µg/l. A probable cause was not

observed. Investigation closed. In 1 case of a calf the

result of the tests is pending.

In one case of a calf no investigation was carried.


chloramphenicol in bovine (bull)

Investigation was carried out. Additional sampling of

bovines on the farm was carried out. All the bovines of

which the result of the test of the sample > 0,3 µg/ml

was, are culled. On inspection it appeared that the hay

and straw on the farm contained chloramphenicol.

Penalty applied and investigation was closed.

Ovine & caprine

3 non-compliant results for alfa-

testosterone in sheep

Investigation was carried out. In all the cases the

administration records were inspected and in 2 cases

additional sampling was carried out which did not

reveal further indications of the abuse of testosterone.

In 2 cases the records of VMP use were improperly

kept. Therefore penalties were applied. In one case the

sheep were kept by a hobby-farmer.

Investigations are closed.

Porcine


nortestosterone in pigs (9x 17-beta

nortestosterone and 2x 17-alpha

nortestosterone)

In 9 cases the investigation in slaughterhouse or on

holding produced the evidence that male pigs were

misidentified as male pigs. So, the found residue beta-

nortestosterone was endogenous.

175

In 2 cases investigation on farm was carried out. In all

the cases the administration records were inspected

and additional sampling was carried out which did not

reveal further indications of the abuse of beta-

nortestosterone. Investigations are closed.

1 non-compliant result for thiouracil

in a pig

Additional sampling was carried out. The results of the

test are still unknown.



None None

Group B substances


None


Bovine


dexamethasone in bovine (older

bovine)

Investigation was carried out. The legal application of

dexamethasone was confirmed, but not mentioned by

the food chain information. The record of VMP use

was properly kept and the withdrawal period was

respected. Official warning was given for the incorrect

food chain information. Investigation closed.


neomycin in bovine (2 older bovine

and 2 calves)

Investigation was carried out. In 1 case the withdrawal

period was not respected. Penalties applied.

In 2 cases the records of VMP use were properly kept

and the withdrawal period was respected. Penalties

applied for exceeding of the MRL at the moment of

the slaughtering. Investigations are closed.

In one case no records of the use of neomycin were

found. Investigation was closed.


gentamycin in bovine (3 calves)

Investigation was carried out. In the 3 cases no records

of the use of gentamycin were found. Penalties applied

for exceeding of the MRL at the moment of the

slaughtering. Investigation was closed.

Ovine & caprine


neomycin in sheep

Investigation was carried out. The records of

veterinary medicinal product use were improperly

kept. Veterinary medicinal product use was not

mentioned by the food chain information. Penalties

applied.

1 non-compliant result for cadmium

(Cd) in sheep

No investigation was carried out.

Porcine

1 non-compliant result for neomycin

in pig

Investigation was carried out. The application of

neomycin was not mentioned by the food chain

information. An official warning was given.

176


dihydrostreptomycin in pig

In 2 cases investigation was carried out. In one case

the records of VMP use were properly kept, but not

mentioned by the food chain information. Penalty


the slaughtering. In the other case the records of VMP

use were properly kept and the withdrawal period was

respected. Investigation was closed.


doxycyclin in pig

Investigation was carried out. Possible the tap of the

wrong feed silo was opened, so that the pigs got the

wrong food with veterinary medicines instead of feed

without veterinary medicines. Penalty applied for

exceeding of the MRL at the moment of slaughtering.

Investigation was closed.


enrofloxacin in pig

Investigation was carried out. No records of the use of

enrofloxacin were found and in fact there was no

enrofloxacin at the farm. Investigation was closed.


oxytetracycline in pigs

Investigation was carried out. In one case the records

of VMP use were improperly kept. Penalties applied.

In the other case the records of the VMP use were

properly kept and the withdrawal period was

respected. Penalty applied for exceeding of the MRL at

the moment of the slaughtering.


sulfadiazine in a pig

Investigation was carried out. The records of VMP use

were improperly kept. Penalty applied.


tulathromycin in a pig

Investigation was carried out. Perhaps the withdrawal

period was no respected. Penalty applied for exceeding

of the MRL at the moment of the slaughtering.


levamisole in pigs

Investigation was carried out. In one case levamisole

was used via the feed. Penalty applied for exceeding of

the MRL. In the other case levamisole was used, but in

the beginning of the fattening of the pigs. Penalty


the slaughtering.

1 non-compliant result for mercury

(Hg) in a pig

Investigation was carried out. A probable cause was

not observed. Perhaps the feed? Investigation by the

feed factory will be carried out. The result of this

investigation is unknown.

Poultry


doxycycline in broiler chicken

Investigation was carried out. In one case the broilers

originated from Germany. German veterinary

authorities were informed. In 4 cases the application of

doxycycline was confirmed. Records of the VMP use

were kept properly and the withdrawal period was

respected, but in 2 cases the dose was probably wrong.

Penalties applied for exceeding of the MRL at the

moment of the slaughtering.

177

Aquaculture

2 non-compliant results for leuco-

malachite green in fish

Investigation was carried out. The fish was a trout

coming from a put and take pond. Probably the

application of malachite green was at that fish farm.

All the fishes in the ponds of the farm were culled.

Penalties applied. Investigation is closed.

Wild game

5 non-compliant results for lead in

wild game (1 roe, 1 follow deer, 3

rabbits)

Free range animals. No investigation was carried out.

Equine – Milk – Eggs – Rabbit – Farmed game – Honey

None None



Poultry

1 non-compliant for doxycyclin in

chicken meat

The chicken meat came from Brazil. The procedure in

accordance with article 30 of Directive 96/23/EG is

started.



None None

178



Member State POLAND

Group A substances


Taking into account the production data and non-compliant results increased the number of

samples of bovines, pigs, poulty (chicken), rabbit, honey and reduced the number of samples

of horses and poultry (turkey) for many substances from group A.

For bovines species in the group of A5 substances the lungs matrix was added. In the group of

A6 substances the muscle samples taken from poultry slaughterhouse towards nitroimidazoles

have been replced by the plasma samples.

Updating of action levels (MRLs, MLs, national levels) and validation data (CCα and CC).


Bovine

A2 – thiouracil (target)

Bovines – urine – 40,4 ppb

Investigation in the establishment and on the farm of

origin; meat and meat product thereof was already

eaten; additional sampling (urine, water) – animals

held till the results – all compliant; origin of thiouracil

was not identified.

A6 – chloramphenicol (target)

Bovines – urine

1. – 12,6 ppb

2. – 9,1 ppb

Bovines – muscle – 0,6 ppb

Bovine urine:

1. Investigation on the farm of origin; verification of

records – sampled animal was not treated; during

control, open bag of oxytetracycline was found; no

documentation for purchase of this VMP. Owner used

it by his own; case refer to Prosecutor's Office;

additional sampling (feed and urine) – compliant

results; reason for presence of chloramphenicol was

not established. Farm subjected to intensified checks.

2. Investigation on the farm of origin; verification of

records – animal was not treated; additional sampling

(milk, urine, feed) – all results compliant; no proof of

use of chloramphenicol was established.

Bovine muscle:

Investigation in the establishment – meat was on the

market – Sanitary Inspection was informed;

Investigation on the farm of origin – animals in good

condition, no proof of use of chloramphenicol was

established; additional sampling (feed and urine) –

compliant results; order put on owner – to inform

competent authority about sending animals to

slaughterhouse → sampling.

179

Porcine

A2 – thiouracil (target)

Pigs – urine

1. – 23,7 ppb

2. – 15,9 ppb

1. Investigation on the farm; verification of records –

kept correct; additional sampling (urine, water) –

animals held till the results – all compliant; reason for

presence of thiouracil was not established; farm

subjected to intensified checks.

2. Investigation in the establishment and on the farm of

origin; meat was already eaten; 2 pigs in the farm

during control; additional sampling (water) –

compliant result; no proof of illegal use of thiouracil

was established; farm subjected to sampling next year.

A3 – nandrolone (target)

Pigs – urine

1. – 345,5 ppb

2. – 227,5 ppb

3. – 33,5 ppb

4. – 29,5 ppb

1. Investigation in the establishment – meat wasn’t

already on the market; investigation on the farm of

origin, additional sampling (3x urine) – animals held

till the results – all compliant; reason for presence of

nandrolone was not established. 1 administrative

measure.

2. Sample was taken for trenbolone – from male; it’s

possible, that nandrolone and boldenone occur

endogenous in male – statement of NRL; However 2

additional sampling of urine was taken – results

compliant.


origin; verification of records – medical treatment

documentation kept correct; additional sampling

(urine, water) – animals held till the results – all

compliant; no proof of illegal use of nandrolone was

established.


origin; verification of records – kept correct; reason for

presence of nandrolone was not established.

A3 – boldenone (target)

Pigs – urine – 5,9 ppb

Same sample as in case above no 2 (nandrolone and

trenbolone was detected in one sample).


Pigs – muscle – 9,6 ppb

Investigation in the establishment – meat was already

eaten; Investigation on the farm of origin – small one,

8 pigs only; no traces of injection nor illegal treatment

was found – medical treatment documentation kept

correct; farm subjected to intensified checks; order to

inform competent authority about sending animals to

slaughterhouse.

Equine

A3 – nandrolone (target)

Horses – urine – 4,3 ppb (17alpha)

and 3,7 ppb (17beta)

Investigation in the slaughterhouse and on the farm of

origine; contact with practitioner, who was on charge

of the stable; no proof of illegal use of nandrolone was

established.

180

Poultry


Poultry (chickens) – muscle

1. – 1,1 ppb

2. – 0,3 ppb

1. Investigation in the establishment – meat wasn’t on

the market anymore; Investigation on the farm of

origin; verification of medical treatment

documentation – kept correct; additional sampling

(water, feed) – compliant results;during control owner

admitted that he used feed from unknown source

(purchased on the local market) – unfortunately it

wasn’t on farm anymore; case referred to Prosecutor's

Office.


origin; meat was already eaten; verification of records

– according to documentation enrofloxacine and

doxycycline were used, witdhdrawal period was kept;

additional sampling (feed, water, muscles taken in the

slaughterhouse from the animals from the same farm )

– compliant results; reason for presence of

chloramphenicol was not established.

Honey

A6 – metronidazole (1 target +

1 suspect)

1. 9,5 ppb (target)

2. 5,1 ppb (suspect)

Investigation in the apiary; “Apiwarol” – veterinary

medicinal product with amitraz was found – legally

purchased; additonal sampling (3 samples of honey) –

product held until obtaining results – one non-

compliant result; 60 kg of honey was rendered. Origin

of metronidazole was not identified. Farm subjected to

intensified checks.

Ovine & caprine – Aquaculture – Milk –

Eggs – Rabbit – Farmed game

None None

Group B substances


Taking into account the production data and non-compliant results increased the number of

samples of pigs, poultry (chicken), rabbit, honey and reduced the number of samples of

bovines and milk for many substances from group B.

Testing of muscle samples of sheep/goats, horses, poultry (turkey, ducks, other poultry), fish,

rabbits and wild farmed animals for sulfonamides and testing of honey samples for

streptomycin and tetracycline have been replaced by testing of these matrices for Antibiotics

and chemioterapeutics by multi LC-MS/MS method.

Updating of action levels (MRLs, MLs, national levels), validation data (CCα and CC) and

methods.

181


Bovine

B1 – 3 oxytetracycline – muscle /

kidney (target)

3 investigations in the establishments and on the farms

of origin; in one case lack of medical treatment

documentation established; owner admitted that he

used medicines by his own; fine was imposed; in two

other cases reason for presence of residues wasn’t

established – on one farm according to documentation

oxytetracycline was used, but withdrawal period was

kept; farms subjected to intensified checks.

B1 – 2 dihydrostreptomycin

B1 – 3 neomycin


of origin; verification of records; in one case

withdrawal period wasn’t kept, case refer to

Prosecutor's Office; order to inform competent

authority about sending animals to slaughterhouse;

additional sampling (milk) – compliant results; in

other cases lack of documentation – fines were

imposed.

B1 – enrofloxacin

B1 – ciprofloxacin – kidney (target)

Investigation in the establishment and on the farm;

origin of antibiotics was not identified.

Porcine

B1 – 6 doxycycline – muscle (target)

B1 – 3 doxycycline – kidney (target)


of origin; additional sampling (feed, water) –

compliant results; in one case RASFF procedure

initiated and meat recalled from the market, 900 kg of

meat was rendered; in two cases withdrawal period

wasn’t kept; farms subjected to intensified checks;

order to inform competent authority about sending

animals to slaughterhouse.

B1 – chlortetracyclin – muscle /

kidney (target)

B1 – amoxycillin – kidney (target)

B1 – dihydrostreptomycin

B1 – penicillin G – muscle (target)

B1 – amoxycillin, ciprofloxacin,

enrofloxacin (muscle);

dihydrostreptomycin, amoxycillin,

enrofloxacin (kidney) – (suspect)


of origin; suspect sample was taken due to emaciation

of the carcass; in one case frozen meat in the stock of

establishment – rendered;additional sampling from the

same farms in the slaughterhouse – compliant results;

records on the farm kept correct; in one case reason for

presence of antibiotic could be residues of medical

feed with chlortetracyclin in feeders; fine of 300 PLN

was imposed;in other cases origin of residues was not

established;farms subjected to intensified checks.

B2b – Lasalocid – liver (target) Investigation on the farm;verification of records – kept

correct; additional sampling (3x feed) – compliant

results; origin of lasalocid was not identified; farm

subjected to intensified checks.

B3c – mercury (Hg) – muscle

(import)

Investigation in establishment (swine from another EU

Member State); raw meat wasn’t distributed – carcass

was processed into products available in the

establishment; additional sampling of products – all

results compliant.

182

Equine

B3c – cadmium (Cd) – muscle

(target)

Investigation in the slaughterhouse; problems with

finding whereabouts of the owner; no reason was

found.

Poultry

B1 – 2 Doxycycline – muscle

(target)

B1 – Doxycycline – liver (target)


of origin; additional sampling (feed, water), animals

held till the results – compliant results; verification of

records – withdrawal period kept; reason for residues

of antibiotics was not established in any case

B2b – 2 Salinomycin – liver (target) 2 investigations in the establishments – 103 kg of offal

was rendered; 2 investigations on the farms; in one

case neglect in cleaning of silo could be the reason of

non-compliance → the fine was imposed; in both

cases order to inform competent authority about

sending animals to slaughterhouse.

Aquaculture

B3e – 3 malachite green – muscle –

fish (target)

3 investigations on the farm of origin (2 carps, 1 trout);

additional sampling; fish held on the farm until

compliant results received; farms subjected to

intensified checks.

B3e – 1 leuco malachite green –

muscle – fish (suspect)

1 suspect sample concerning non-compliance in 2012;

2 samples were taken – with 1 NC result; after one

month 6 samples taken – all results compliant.

B3c – arsenic (As) – muscle – fish

(import)

B3c – mercury (Hg) – muscle – fish

(import)

1 investigation in the processing farm – raw meat was

held till the results of additional sampling – results

compliant.

Milk

B1 – amoxycillin – (target)

B1 – penicilin G – (target)

2 investigations in the farm; additional sampling; in

one case, use of beta-lactams was proved – withdrawal

period wasn’t kept – fine of 15.000 PLN was imposed;

case refer to Prosecutor's Office; in other case, origin

of antibiotics wasn’t established (additional sampling

– compliant result). Farm subjected to intensified

checks.

Eggs

B2b – salinomycin (target)

Investigation on the farm; according to documentation

neither feed additives nor medicines were applied;

additional sampling – eggs held till the results – all

compliant. No reason was found.

Wild game

B3c – 10 lead (Pb) – muscle (target)

B3c – 2 cadmium (Cd) – liver

(target)

B3c – 4 mercury (Hg) – liver (target)

12 investigations in processing plants performed (6

does, 8 boars); carcasses or/and offal declared unfit for

human consumption (65 kg of meat rendered)

183

Honey

B1 – 14 sulfonamides (5 target +

9 suspect)

5 investigations on the farms; additional sampling

(product held until obtaining results); in one case

usage of sulfonamides was proved – fine impose; 72

kg of honey was rendered in total.

B3c – lead (suspect) Suspect samples – concerning non-compliance in

2012. 580 kg of honey was rendered.

Ovine & caprine – Rabbit – Farmed game

None None

184



Member State PORTUGAL

Group A substances


Balance allocation, especially for A2 and A5 in Bovines, due to positive results in RMP 2013


Bovine

Thyreostats

Propylthiouracil (PTU) – 1 positive

result in bovine urine

(> 0,45 < 5,0 µg/l)

Investigation in the farm origin. Inquiry of possible

reasons for the presence of the substance. Whenever

the non-compliant animal was still in the farm, was

slaughtered, rejected and destroyed as a by-product

category 1. Additional sampling of urine. All animals

held in the farm until results were available. All results

were negative. Sanctions will be applied accordingly

with the results of the investigation.



(> 0,45 < 5,0 µg/l)











(> 0,45 < 5,0 µg/l)









Methylthiouracil(MTU) – 1 positive

result in bovine thyroid

(> 0,03 < 5,0 µg/l)


reasons for the presence of the substance. Additional

sampling of urine. All animals held in the farm until

results were available. All results were negative.

Sanctions will be applied accordingly with the results

of the investigation

185

β-agonists

Ractopamine – 1 positive result in

bovine liver (0,2 µg/kg)



sampling of urine, feed and water. All animals held in

the farm until results were available. One positive feed

sample. Five positive urines sample. These animals

were slaughtered, rejected and destroyed as a by-

product category 1. Additional urine, feed and water

samples. All animals stayed held in the farm until



of the investigation.


bovine liver (> 0,03 < 0,5 µg/kg)




the farm until results were available. Five positive

urines sample. These animals were slaughtered,

rejected and destroyed as a by-product category 1.

Additional urine, feed and water samples. All animals

stayed held in the farm until results were available. All

results were negative. Sanctions will be applied

accordingly with the results of the investigation.


bovine liver (> 0,03 < 0,5 µg/kg)

Investigation in the farms origin. Inquiry of possible



the farms origin and related holdings, until results were

available. All results were negative. Sanctions will be

applied accordingly with the results of the

investigation.

Clenbuterol – 1 positive result in

bovine urine (> 4 µg/l)





category 1. Additional sampling of urine, feed and

water. All animals held in the farm until results were

available. Three positive urines samples. These

animals were slaughtered, rejected and destroyed as a

by-product category 1. Additional urine, feed and

water samples. All animals stayed held in the farm

until results were available. All results were negative.



186


bovine liver (> 6 µg/kg)




the farm until results were available. Two positive

urines samples. These animals were slaughtered,







bovine urine (0,14 µg/l).





category 1Additional sampling of urine, feed and


available. These animals were rejected and destroyed

as a by-product category 1. Additional urine, feed and

water samples. All animals stayed held in the farm

until results were available. All results were negative.




bovine urine (> 14 µg/l).







available. Two positive urines samples. These animals








bovine urine (> 0,01 < 0,1 µg/l).














187


bovine urine (0,22 µg/l).






water. All animals held in the farms origin and related

holdings, until results were available. All results were

negative. Sanctions will be applied accordingly with

the results of the investigation.


bovine urine (> 0,4 µg/l).















bovine liver (> 0,4 < 0,5 µg/kg).







investigation.


water for bovines




the farm until results were available. One water

positive result. Additional urine, feed and water

representative samples. All animals stayed held in the

farm until results were available. Urine results were.

Investigation ongoing. Sanctions will be applied


188

Porcine

Thiouracil (TU) – 1 positive result in

pig urine (17,6 µg/l)

Accordingly with the Spanish Competent Authorities:

Farm under official control. Additional sampling and

animals held until results were available. Verification

of records of animal movements, veterinary treatments

and feed. Additional samples in slaughterhouse feed

and water. All results negative. Farm free of official

control but had to communicate when animals go to

the slaughterhouse for additional samples. Animals

held in slaughterhouse until results were available. All

results negative. The animals feed included rapeseed.


pig liver (0,9 µg/kg)




the farm until results were available. Seven positive

urines samples. These animals were slaughtered,







pig liver > 2 µg/kg)




the farm until results were available. Twenty nine

positive urines samples and two positive feed. The

animals were slaughtered, rejected and destroyed as a

by-product category 1. Fifty selected pigs from the

official authorities were sent to the slaughterhouse and

all were analysed for beta-agonists in liver. Animals

stayed held in slaughterhouse until results were



investigation.

Poultry

Nitrofurans: AMOZ – 1 positive

result in broiler – 4 µg/kg





available. All results were compliant. Sanctions will be


investigation.

Ovine & caprine – Equine – Aquaculture – Milk –


None None

189

Group B substances


Balance allocation for B2e in horses like in RMP 2013.


Ovine & caprine

Lead – 1 non-compliant result in

ovine liver – 1 mg/kg

Investigations in the farm of origin: inquiry of possible

reasons for the presence of the substance.


ovine liver – 0,74 mg/kg




ovine liver – 6,1 mg/kg



Porcine

Antimicrobials

Amoxicillin – 1 non-compliant result

in pig kidney – 107 µg/kg


reasons for the presence of the substance. Verification

of records. Sanctions will be applied accordingly with


Doxicilin – 1 non-compliant result in

pig kidney – 150 µg/kg





Heavy Metals

Lead – 1 non-compliant result in pig

liver – 10,5 mg/kg

Accordingly with the Spanish Competent Authorities:

Investigations in the farm of origin. Additional

sampling of feed and water. Verification of records of

animal movements, feed and raw material, water

supply control. Additional samples in slaughterhouse.

No positive results. There will be additional controls

during 2014 at the farm, and at the slaughterhouse.

Poultry

Coccidiostatics

Salinomicin – 1 non-compliant result

in Broiler liver – > 15 µg/kg





Monensin – 1 non-compliant result

in Broiler liver – > 24 µg/kg





Heavy metals


broiler liver – 1,4 mg/kg



Milk

Heavy metals


ovine milk – 0,020 mg/kg



Mycotoxins

Aflatoxin M1 – 1 non-compliant

result in bovine milk – 0,089 mg/kg

Detection of non-compliant results in feed.

273 milk samples were collected, 144 non-compliant

due to the contaminated feed. The feed was put under

190

official control and the milk was withdrawal of the

market. In 2014 there is ongoing a special program for

mycotoxins control in milk. Until now, there are 172

results available, all compliant.

Rabbit

Antimicrobials

Sulfadimetoxin – 1 non-compliant

result in rabbit muscle – 320 µg/kg

Inquiry of possible reasons for the presence of the

substance. Verification of records. Sanctions will be


investigation.

Wild game

Heavy metals


wild boar – 1,3 mg/kg; 0,8 mg/kg;

1,0 mg/kg

Inquiry of possible reasons for the presence of the

substance.

Honey

Organophosphorus compounds

Chlorfenvinphos – 1 non-compliant

result in honey – 0,024 µg/kg

(± 0,006)


reasons for the presence of the substance. Sanctions

will be applied accordingly with the results of the

investigation.

Chlorfenvinphos – 1 non-compliant

result in honey – 0,019 µg/kg

(± 0,005)


reasons for the presence of the substance. Sanctions

will be applied accordingly with the results of the

investigation.

Bovine – Equine – Aquaculture – Eggs – Farmed game

None None

191



Member State ROMANIA

Group A substances


A.1. No changes.

A.2. No changes.

A.3. Were added stanozolol and 16-beta-hydroxy stanozolol for pig and poultry. Matrix

analysed is liver.

A.4. No changes.

A. 5. Was added Clenbuterol from bovine liver.

A.6. No changes.




None None

Group B substances


B.1. Matrix liver was excluded.

B.2.a Were added Ivermectine and Doramectine for aqvaculture and Levamisol,

Ketotriclabendazole, Triclabendazol, Thiabendazole, hydroxi-thiabendazole, Mebendazole,

amino-mebendazole, hidroxy-mebendazole for milk.

B.2. b. Diclazuril was excluded for pig.

B.2. c. Were excluded lambda cyhalothrin and flucitrinat.

B.2.d. No changes.

B.2.e. Was included Metamizole. Matrix analysed are muscle from bovine.

B.2.f. Were added Prednison, flumethasone, beclomethazone, isoflupredone, triamcinolone.

Matrix analysed are urine, muscle and milk.

B.3.a. Tecnazene and Quintozene were excluded.

B.3. b. Phoxim, Fenthion, Phorate, Azinphos ethyl were excluded.

B.3. c. No changes.

B.3. d. Ochratoxin A and aflatoxin B1 (no MRL) are excluded, in the previous years was no

positive samples. Aflatoxin B1 and Ochratoxin A are monitored on separate control

programme on feed materials. Zearalenone and metabolites are included for all species based

on positive findings.

B.3.e Was added Brilliant green.

192


Bovine

B.3.d – Four (4) samples reported as

non-compliant for presence of

lactones of resorcilic acid:

1 sample from slaughterhouse

(bovine urine) reported non-

compliant for zearalenone (0,555

µg/kg), beta zearalenol (1,399

µg/kg), beta zearalanol

(0,465 µg/kg) – BA

26579/16.01.2013

Animal ID (RO 507000925460). There was found no

evidence of illegal treatment in the investigation

performed on site. The result of investigation (Control

Note nr. 75/21.01.2013) was established as source the

feeds contaminated with moulds. Follow the

investigation was established supplementary sampling

of feeds for mycotoxins levels on 2014.

1 sample from farm (bovine urine)

reported non-compliant for

zearalenone (1,61 µg/kg), beta

zearalenol (2,07 µg/kg) – BA

21487/27.03.2013



performed on farm. The result of investigation

(Control Note nr. 50/29.03.2013) was established as

source the feeds contaminated with moulds. Follow the


of feeds for mycotoxins levels on 2013 and also

samples of milk were tested for mycotoxins level. The

incriminated feed material was removed from feeding.

1 sample from slaughterhouse

(young bovine urine) reported non-

compliant for zearalenone

(2.65 µg/kg), beta zearalenol

(12.45 µg/kg), alfa zearalenol

(1.13 µg/kg), alfa and beta

zearalanol (0.65 – 0.57 µg/kg) – BA

21212/27.03.2013




Note nr. 4072/01.04.2013) was established as source

the feeds contaminated with moulds. Follow the



1 sample from farm (bovine urine)

reported non-compliant for

zearalenone (5.23 µg/kg), beta

zearalenol (19.88 µg/kg), alfa

zearalenol (1.96 µg/kg), alfa and

beta zearalanol (1.66 – 1.61 µg/kg) –

BA 21208/27.03.2013




Note 29.03.2013) was established as source the feeds

contaminated with moulds. Follow the investigation

was established supplementary sampling of feeds for

mycotoxins levels on 2014.

Porcine

B.1 – One (1) sample reported as

non-compliant for residues of

sulphonamides above MRL:

1 sample from slaughterhouse (pig

muscle) reported non-compliant for

sulfadimidine (174.63 µg/kg) – BA

31145/04.09.2013

Lot ID (IF003/ 130). The result of investigation

(Control Note nr. 153/09.09.2013 and follow-up note

127/22.10.2013) established that there was no

evidence of non-declared treatment on farm and the

source of substances was the compound feeding stuffs.

193

Equine

B.3.d – One (1) sample reported as

non-compliant for presence of

lactones of resorcilic acid:

1 sample from slaughterhouse (horse

urine) reported non-compliant for

zearalenone (2.62 µg/kg), beta



zearalanol (0.65 µg/kg) – BA

20471/13.03.2013

Animal ID (RO 968000003081755). There was found

no evidence of illegal treatment in the investigation


Note nr. 1234/19.03.2013) was established as source

the feeds contaminated with moulds. Follow the



Milk

B.3.d – One (1) sample reported as

non-compliant for residues of

aflatoxin M1 above MRL:

1 sample of milk from bovine farm

reported non-compliant for aflatoxin

M1 (0.226 µg/L) – BA

23178/21.06.2013

Farm ID (RO 1024829001). The result of investigation

(Control Note nr. 6390/21.06.2013) was established as

source the feeds contaminated with aflatoxin B1.

Follow the investigations supplementary samples of

milk from new batch of milk on the same farm were

tested until 03/07/2014.

Ovine & caprine – Poultry – Aquaculture – Eggs –


None None

194



Member State SLOVAK REPUBLIC

Group A substances


None


Milk

A6 – chloramphenicol – sheep milk;

10,9 ppb.

In the said non-compliant finding the presence of

chloramphenicol was detected in the sample of raw

sheep milk taken on a farm. Following detection of a

positive finding the inspectors performed additional

official control on a farm with the aim to find out the

reasons of residue occurrence and took the suspect

official sample which was evaluated as compliant.

Upon the investigation on a farm the inspectors did not

detect the presence of veterinary preparations which

could leave the residues of inhibitory substances and

also they did not detect the veterinary preparations

with the effective substance chloramphenicol. Upon

the additional official control the inspectors ordered

without any delay to the farm operator the measure of

the ban to place on the market raw sheep milk and also

processed products thereof. Subsequently, the

inspectors performed the veterinary control also in

establishment processing sheep milk from this farm.

Based on the result of examination and findings from

the veterinary control the following measures were

ordered in the establishment: ban of taking raw sheep

milk from the supplier – the farm in question and ban

of the placing on the market of lump sheep´s cheese

produced from milk in which the presence of

chloramphenicol was detected. The DVFA ordered the

liquidation of 500 litres of positive sheep milk and 445

kg of cheeses produced from the milk in which the

presence of residues of chloramphenicol was detected.

The farm in question is under the tightened veterinary

supervision and further suspect sheep milk samples

will be taken.



None None

195

Group B substances


None


Aquaculture

Leucomalachite green – trout –

muscle – 9,0 ppb

Suspect samples:

1. Leucomalachite green –trout –

muscle – 1,1 ppb

2. Leucomalachite green –trout –

muscle – 4,3 ppb Crystal violet

– trout – muscle – 0,4 ppb

In the first case, in the fish breeder the fish sample –

rainbow trout – was taken within the NRCP in which

the value of leucomalachite green above the

established MRPL was detected. Subsequently, the

respective DVFA performed the official control in the

fish breeder. The inspectors took two suspect fish

samples that were subject to examination for the

presence of dyes. Both suspect samples were

evaluated as non-compliant. In one of these samples

repeatedly the presence of leucomalachite green was

confirmed and the second sample was positive for

leucomalachite green and crystal violet. The respective

DVFA ordered the ban of distribution, movement,

placing on the market, trade and export of fish bred in

the breeding area. Based on these results and imposed

measures the administrative procedure was

commenced towards natural person - entrepreneur,

who was informed in writing on the commencement of

the administrative procedure. At present, the

administrative procedure is still under way.

Leucomalachite green – trout –

muscle – 1,3 ppb

Also in further case, in compliance with the sampling

plan for the NRPC, the fish sample was taken in which

the presence of leucomalachite green was detected,

however, the measured value of residues did not

exceed the legislatively established MRPL value.

Upon the additional veterinary control the veterinary

inspector found out that at the time of taking the

sample also the delivery of live fish from the Czech

Republic was placed in the relying area and the

sampling was performed just from this delivery. Thus,

the examined sample did not represent the product

from the own breeding. With regard to this fact, the

further fish sample was taken, which after the analysis

in the accredited laboratory was evaluated as

compliant. Upon the official control in the breeder

neither the law violation nor the use of leucomalachite

green was detected and for this reason the measures

were not imposed to him.

Bovine – Ovine & caprine – Porcine – Equine – Poultry – Milk –


None None

196



Member State SLOVENIA

Group A substances


Salmeterol CAS 89365-50-4

Zilpaterol CAS117827-79-9

Clencyclohexerol

Clenhexerol CAS 78982-88-4

Clenpenterol CAS 38339-21-8

Clenproperol CAS 28339-11-6


Milk

1x chloramphenicol – Matrix: milk –

Animal: cow – Results: 2,5 µg/kg

- inquiry on the farms of origin including official

sampling of the milk

- prohibition of placing milk on the market till the

results of analyses showed compliance with the

relevant legislation

- official controls in respective agricultural cooperative

were conducted

- official controls in respective dairy were conducted



None None

Group B substances


Prednisolone CAS 50-24-8

Carazolol CAS 57775-29-8


Bovine

1x cadmium (Cd) – Matrix: kidney –

Animal: cow – Results: > 1,5 mg/kg

- both of the kidneys were sampled;

- data on heavy metals are collected separately and

they will be processed with specialised web

application (GIS – geographical information system),

which will provide us with an exact geographical

overview of the situation regarding contamination with

heavy metals in our country.

Milk

1x cloxacillin – Matrix: milk –

Animal: cow – Results: 157 µg/kg

- inquiry on the farms of origin

- the withdrawal period was not respected

4x cadmium (Cd) – Matrix: kidney –

Animal: horse - Results:

> 1,5 mg/kg, > 1,5 mg/kg,

- both of the kidneys were sampled;

- data on heavy metals are collected separately and

they will be processed with specialised web

197

> 1,5 mg/kg, > 1,5 mg/kg application (GIS – geographical information system),

which will provide us with an exact geographical

overview of the situation regarding contamination with

heavy metals in our country.

Eggs

2x narasin – Matrix: eggs – Animal:

hen – Results: 4,4 µg/kg, 4,1 µg/kg

- inquiry on the farms of origin including official

sampling of the eggs

- prohibition of placing eggs on the market till the

results of analyses showed compliance with the

relevant legislation

- official samples of feed on respective farms were

taken and official controls in respective feed mills

were conducted

Ovine & caprine – Porcine – Equine – Poultry – Aquaculture –


None None



Aquaculture

1x mercury (Hg) – Matrix: fish –

Animal: fish – Results: 2,69 mg/kg

Next 10 batches from the same source were not

impounded and checked on presence of mercury (Hg)

due to the fact that there was no more consignment of

fish.

Bovine – Ovine & caprine – Porcine – Equine – Poultry – Milk –


None None

198



Member State SPAIN

Group A substances


Inclusion of the following compounds, within group A3, for the bovine, porcine and ovine

species and for poultry and rabbits: chlormadinon acetate, megestrol acetate and

medroxyprogesterone acetate.

Inclusion of the following compounds, within group A5, for the bovine, porcine, ovine and

equine species and for poultry and rabbits: bambuterol and clenhexerol.


Bovine

1 Thiouracil in bovine thyroid cells.

Targeted check. More than

32,4 µg/kg.

Measures by the Department of Health:

Communication in SCIRI (coordinated rapid

information exchange system).

Communication to the competent authority of origin

concerning livestock production.

Review and verification during the official control of

own checks run in the slaughterhouse to guarantee the

safety of the carcasses which it processes.

Measures in the Autonomous Community of origin:

Communication to the Servicio de Seguridad

Agroalimentaria (Food and Agriculture Safety

Service)

Form to determine the reasons for the presence of

residues; two samples taken of feed for two lots of

animals, separated according to age; preventive action

for 80 fattening animals on the farm.

Negative results

Counter-analysis: more than 100 µg/kg.

Rapeseed oilcakes are included in the feed given to the

animals.

Act lifting the seizure of the animals as a preventive

measure and the restriction on movements, and

establishment of monitoring for 12 months.

Porcine

1 17 β-boldenone in the urine of pigs

for fattening. Targeted check. More

than 0,25 µg/kg.

Measures by the Directorate-General for Public Health

and Consumer Affairs:


information exchange system)

Communication to the livestock service

Official surveillance from the farm to the

slaughterhouse. 32 urine samples were taken. 17 β-

boldenone was detected in three of them (2 in

199

uncastrated males).

After consulting the relevant literature and following

conversations with technical experts from the National

Reference Laboratory, the slaughterhouse veterinarian

was asked to provide a report on the condition of the

animal (uncastrated or castrated) in which 17 β-

boldenone was detected during the official surveillance

from the farm to the slaughterhouse. The response was

that confirmation of whether or not the animal had

been castrated could not be provided.

In view of the above, and since it was not possible to

prove that the presence of the substance 17 β-

boldenone was due to an illegal treatment, the

procedure unit dismissed the case.

Withdrawal from the SCIRI

Measures by the Livestock Service:

Inspection of the two farms owned by the prosecuted

party, on which no irregularities were detected,

marking of the 350 animals on the farm.



None None

Group B substances


Inclusion in group B1 of florfenicol and thiamphenicol in milk.

Inclusion of the following compounds in group B2a, in the bovine, porcine, ovine, caprine and

equine species and in poultry, aquaculture and rabbits: emamectin B1a and eprinomectin B1a.


Bovine

1 Dihydrostreptomycin in bovine

kidney. Targeted check.

2.675 µg/kg.

Measures by the Ministry of Health. After positive

anti-bacterial screening, dihydrostreptomycin 2.675

ppb) levels exceeding the MRLs were confirmed.

Female bovine animal, 131 months old. Origin:

Asturias

Infringement procedure launched. The SCIRI

(coordinated rapid information exchange system) has

been notified.

Instructions to slaughterhouses of the Autonomous

Community to withhold and take samples from

animals from the same farm over a three-month period,

as shown in the document on action to take in the

event of non-compliant results under the National

Residue Control Plan. No animals were presented for

slaughter within this time.

All the information was submitted to the Ministry of

Livestock Farming and Regional Natural Resources.

200

Measures by the Ministry of Livestock Farming and

Regional Natural Resources: during the investigation

on the animals' farm of origin performed by the

official veterinary services of the Department for

Animal Health and Production, and having checked

the documentation on treatments administered to the

animals, it emerged that:

The animal had been treated with a medicine whose

ingredients included: Procaine benzylpenicillin and

dihydrostreptomycin sulfate.

The prescription for the treatment has been kept and a

correct record of it has been entered in the herdbook.

The compulsory 30-day waiting period for meat

indicated on the prescription and in the product

specifications was observed, since the period during

which the positive animal was treated was from 25

May 2013 to 28 May 2013, followed by slaughter on

30 July 2013

Measures taken (for a 3-month period): removal of the

farm transfer documents with the aim of ensuring

animals are transported to the slaughterhouse in line

with the relevant permit, which indicates that the farm

is subject to checks for antibiotic residues, indicating

the date from which the farm is subject to checks and

specifying the type of substance. Our department must

give its explicit authorisation to allow the transfer of

farm animals to the slaughterhouse, following a

request from the farm owner with sufficient advance

notice.

A report on the above has been submitted to the

Ministry of Health.

3 Enrofloxacin and ciprofloxacin

(more than 600 µg/kg.) Doxycycline

(more than 1 700 µg/kg.) and

oxytetracycline (more than

1 800 µg/kg.) in bovine kidney.

Control on suspect case.

Measures by the Ministry of Health. After positive

anti-bacterial screening, levels of enrofloxacin

(enrofloxacin+ciprofloxacin > 600 ppb),

oxytetracycline (oxytetracycline + epioxytetracycline

> 1 800 ppb) and doxycycline (> 1 700 ppb) exceeding

the MRLs were confirmed in three animals. All male

bovines < 12 months.

Origin: arrival on the farm in the month prior to

sampling.

All three animals were declared unfit for human

consumption.

The infringement procedure was launched. The owner

of the animals admitted to making a mistake. Penalty

of EUR 5 001.

The SCIRI (coordinated rapid information exchange

system) has been notified.

Instructions to slaughterhouses in the Autonomous

201

Community to confine and take samples from animals

present on the same farm over a three-month period, as

set out in the document on action to be taken in the

event of non-compliant results in the National Residue

Control Plan. Five animals presented for slaughter

within this period were confined and samples were

taken from them. The results were satisfactory.

All the information was submitted to the Ministry of

Livestock Farming and Regional Natural Resources.


Regional Natural Resources: during the investigation

on the animals' farm of origin by the official veterinary

services of the Department for Animal Production and

Health, the following aspects were revealed:

All the positive animals stayed on the farm of origin

for 15 days or longer prior to departure for the

slaughterhouse.

According to the documentation on the treatments

administered to animals, the 28-day mandatory waiting

period for meat, indicated in Royal Decree

No 109/1995 on veterinary medicinal products, was

not completed for the medicinal treatments

administered.

Measures taken:

Movement restriction on the departure of animals from

the farm.

Withdrawal of the farm's movement documents so that

animals are transferred to the slaughterhouse in line

with the corresponding permit, which states that the

farm tested positive for residues. All departures of

animals must be notified and authorised in advance by

our Department.

A report on the above has been submitted to the

Ministry of Health.

1 Benzylpenicillin in bovine kidney.

Control of suspect case. 150 µg/kg.

Notification in SCIRI (coordinated rapid information

exchange system).

Carcass declared unfit for human consumption and

destroyed.

In accordance with Royal Decree No 1749/1998:

official control of the use of veterinary medicinal

products on the farm. Confiscation of the notes from

the own permits (autoguías) on movements to

slaughterhouses. Precautionary measures on the farm:

ban on the entry of animals and restriction on

movements for life (60 days' restriction for the

transferred animals) and for human consumption

(requirement to notify the Directorate-General for

Livestock with a view to coordinating monitoring of

202

the animal(s) in the slaughterhouse).

Administrative penalty proceedings against the farm

owner.

In view of the claims and sworn statement of the farm

veterinarian who treated the positive animal, freeing

the livestock breeder from the responsibility of

complying with the withdrawal period due to lack of

knowledge, the penalty proceedings against the

livestock breeder have been suspended, the

precautionary measures lifted and the case removed

from the SCIRI.

Penalty proceedings have been initiated against the

farm veterinarian for failing to write a veterinary

prescription and not entering the antibiotic in the

record of medicinal treatments.

1 Benzylpenicillin in the kidney of a

fighting bull. Targeted check.

84 µg/kg.

Measures by the Ministry of Health.



Penalty proceedings in the final phase for an amount of

EUR 3 005.7.


for livestock production.

Measures by the Autonomous Community of Origin:

The holding was placed under restriction, and a farm

inspection was carried out, revealing the incorrect use

of an authorised veterinary medicinal product and

failure to observe the 30-day elimination period. The

restriction on movement is lifted after this period has

passed. Monitoring and control of the farm for three

months.

1 Doxycycline in bovine muscle.

Targeted check. 148 μg/kg.

Measures by the Ministry of Health:

Communication in SCIRI, (coordinated rapid



slaughterhouse.

Communication to the responsible authorities

concerning the control of the farm of origin.

Penalty proceedings against the farm of origin. The

proceedings initiated due to a serious infringement

resulted in a penalty of EUR 3 001.

Measures by the Ministry of Agriculture and

Livestock: Visit to the farm and document review. The

existing livestock and correct identification was

checked. The medical kit and waste container was

checked to identify the origin of the positive results.

The prescriptions were checked. No documentary

infringements were found. Notification of the actions

taken to the Department of Health.

203

1 Dexamethasone in bovine liver.

Targeted check. 11,9 µg/kg.





Measures in the Autonomous Community of Origin:

The Department of Agriculture has sent reports on the

result of the investigation on the farm and related

documents. It was not possible to determine the reason

for the presence of residues, since there were no

treatment records for the 30 days prior to the animal

being slaughtered, although two other animals had

previously received treatment involving the active

substance dexamethasone. At the time of the

inspection, these two animals were still on the farm.

Non-compliance documentation submitted to the

Sanctions and Remedies Service with a view to

initiating penalty proceedings if necessary.

1 PCB138 (16 ng/gr) and PCB153

(21 ng/gr) and PCB180 (25 ng/gr) in

bovine fat. Targeted check.



The intermediate ceiling amount is 69 +/- 7 ng/gr of

non-coplanar PCBs, exceeding the maximum content

of 40 ng/gr of bovine fat pursuant to Regulation (EC)

No 1881/2006.

The counter-analysis confirmed the presence of PCBs:

PCB138 (18 ng/kg), PCB153 (24 ng/kg), PCB180

(24 ng/kg).

The official slaughterhouse service performed the

inspection of the self-check programme for chemical

risks, with favourable results. 14 carcasses were placed

under restriction and samples were taken to test for

PCBs, with compliant results.



After the period of precautionary measures, the farm is

excluded from the SCIRI.


The official veterinary service of the District

Agricultural Office carried out an inspection of the

farm which involved the relevant investigations

regarding the treatment record book, storage of

treatments, veterinary prescriptions for medicinal

products and medicated feed, and documentary checks

on incoming and outgoing animals, and feed and water

intended for animal feed. No irregularities were

detected.

These investigations revealed that the supplier

company is located in the Autonomous Community

which reported the non-compliance. This was notified

204

to the technical experts for animal feed of that

Autonomous Community, which provided information

on self-checks for dioxins and PCBs in feed and raw

materials carried out by the company in question over

the last year as part of its self-check programme, with

compliant results. The company took samples of the

feed being consumed on the farm and of the supply

water to test for PCBs. Both PCB tests showed

compliant results.

From 2009, the farm has been subjected to a regular

control programme by the feed supplier. The sample

results were requested, and the livestock producer

provided them with the rest of the requested

documentation.

The technical experts of the District Agricultural

Office have performed investigations into the

existence of possible sources of the environmental

contamination in the production area of the straw used

for the animals' bedding, such as rendering plants,

paint or fuel factories. It was not possible to identify a

source of contamination.

1 Dexamethasone in the liver of a

fighting bull. Targeted check.

3 µg/kg.



During the surveillance period, no samples were taken

since there was no intake of animals in the

slaughterhouse.

A penalty of EUR 3 005.07 was proposed.



After the period of precautionary measures, the farm

was taken out of the SCIRI.

Actions on the livestock holding by the Autonomous

Community of origin

During the visit of the official control services to the

farm, the animals were counted and the records of

incoming and outgoing animals and of feed were

checked. Records were taken and the presence of a

medicinal product was found (in a 20 ml bottle) which

contained dexamethasone. However, according to the

owner, this is a suitable medication for turkeys. It may

have been given to bovine animals by mistake.

Movements in and out of the farm were restricted, and

it was indicated in the record that if animals were

moved to the slaughterhouse, protocol measures would

be taken in accordance with the procedure to be

followed in the event of non-compliant results

(Santiago agreements), for a three-month period. To

date, there have been no movements on the farm.

205

2 Cadmium in bovine kidney.

Targeted check 1,62 +/- 0,28 mg/kg

and 1,65 +/- 0,29 mg/kg.

Communication to the Department of Agriculture,

Livestock, Fisheries, Food and the Environment.

Communication to the Directorate-General for the

Environment and Diversity of the Department of

Agriculture.

Ovine & caprine

1 Chlortetracycline (1723 µg/kg) and

sulfadiazine (more than 200 µg/kg)

in kidney of sheep for fattening.

Targeted check.








slaughterhouse. 32 kidney samples were taken from

the carcasses. All test results were satisfactory.

Finally, the farm was removed from the SCIRI.


An inspection was carried out by the Livestock

Service, with the following findings:

Medicated feed A containing sulfadiazine and

trimethoprim is normally used with a waiting period of

four days, accompanied by the corresponding

veterinary prescriptions.

At one point, another medicated feed B was purchased,

containing sulfadiazine, trimethoprim and

chlortetracycline, with a waiting period of ten days.

According to the treatment book, this is the only

consignment of feed B: the consignments before and

after are feed A.

All the medicated feed is accompanied by the

appropriate veterinary prescription.

According to the declaration by the livestock producer,

product B was used in a batch of lambs over a 20-day

period. Also according to the declaration by the

livestock producer, it is possible that since the usual

withdrawal period was four days, no one realised that

feed B had a withdrawal period of ten days.

In conclusion, it can be established that, among the

substances detected, chlortetracycline is present in feed

B, but not in feed A; the date on which the non-

compliance was detected coincides with the date of use

of feed B, and it is therefore probable that animals

which had consumed a feed with a ten-day waiting

period were sent to the slaughterhouse after just the

customary four-day waiting period.

Measures taken: withdrawal of the livestock producer's

right to draw up his own permits for the

slaughterhouse through the internet application. Until

206

the farm is removed from the SCIRI, all permits will

bear the observation that the farm is subject to control

for the presence of residues.

1 Sulfadiazine in the kidney of a

sheep for fattening. Targeted check.

159 µg/kg.








A visit was paid to the sheep farm. The livestock and

identification of the animals was checked. The

medication kit and waste container was examined, and

the appropriate medication was noted to be missing in

both cases. The farm herd-book and the medication

and medicated feed forms as well as the sulfadiazine

prescriptions were checked. Failure to indicate the date

and identification of the animals was noted and the

legal services were informed with a view to opening

infringement proceedings.

1 Chlortetracycline (179,2 µg/kg)

and sulfadiazine (more than

150 µg/kg) in the muscle of sheep

for fattening. Targeted check.



Establishment of precautionary measures involving the

restriction of 1 580 animals (lambs for fattening), one

water sample and one feed sample with negative test

results. Investigation on the sheep farm, verification of

the farm records, especially concerning veterinary

treatments, source and consumption of feed, and

medicated feed prescriptions. Deficiencies were found

in the record of veterinary treatments.

Slaughter under health supervision was performed

following the analytical sampling of a batch of 21

animals in the slaughterhouse, all with negative results

for the detection of both substances.

Initiation of penalty proceedings qualified as serious

for a sum of EUR 5 500, currently in the phase of

pleadings on notification of the start of proceedings.

1 Chlortetracycline in sheep muscle.







This farm is in the phase of precautionary measures

and the completion of precautionary measures.

The official control services paid an official visit to the

farm and took the following actions: census, check of

the entry and exit records and investigation. In all this

time, there had been no entries or exits. Sampling

207

continued for animals arriving at the slaughterhouse.

No information regarding the performance of the

counter-analysis was received from the livestock

producer, located in another Autonomous Community.

Therefore, after the time period had passed, this right

was considered to have been renounced.

1 Chlortetracycline (179,2 µg/kg)

and sulfadiazine (more than

150 µg/kg) in sheep muscle.

Targeted check.






Opening of proceedings against the livestock producer.

Once the established time period expires, the party

concerned is no longer entitled to a counter-analysis.


farm and took the following measures:

230 females and 14 lambs were counted at this time,

correctly identified using ear tags and ruminal boluses.

Although there was a journal for veterinary treatments

on the farm, it was found not to be up-to-date, nor

were the details entered in the journal in line with

Article 8 of Royal Decree No 1749/98. Furthermore, it

was not possible to check compliance with the

withdrawal periods, or whether prescriptions were

being kept for a five-year period. A negative opinion

was therefore given, and proceedings were opened for

non-compliance with the Animal Health Law.

During the period of precautionary measures, no

animals for fattening were sold for transfer to the

slaughterhouse.


removed from the SCIRI.

The procedure is ongoing, with a penalty proposal.

1 Chlortetracycline (more than

900 µg/kg) and sulfadiazine (more

than 150 µg/kg) in sheep muscle.

Targeted check.



The livestock farm, of zootechnical orientation for

milk production, was inspected by the Area Livestock

Services, which imposed precautionary restrictions,

counted the animals, and investigated the feed and the

treatment journals for the last two months.

Examination of the records of treatment and veterinary

prescriptions. An investigation was also carried out of

tests on milk to detect antibiotics, and it was found

that, in the 25 tests performed over the previous and

subsequent period, no antibiotic residues were

detected. There was no evidence of administration to

animals of any medication or feed containing

sulfadiazine and chlortetracycline.

208

Representative samples were taken from six of the 161

animals on the farm. Since the results were compliant,

the animals were sent to the slaughterhouse, samples

were taken and they were placed under restriction.


removed from the SCIRI.

1 Sulfadiazine in sheep muscle.


200 µg/kg.



Ruling on the penalty proceedings as a serious

infringement.

Communication to the Ministry of Agriculture,

Fisheries, Food and Water.

The Ministry submitted a report on its investigation

indicating that the farm had regularly used medicated

feed containing sulfadiazine.

The journal of treatments does not indicate the number

of animals treated or their identification. There is

therefore no documentary evidence of compliance with

the waiting periods.

The medicated feed prescriptions do not identify the

animals to be treated.

In conclusion, the residue detected in the

slaughterhouse must be due to an error in the

management of the animals treated on the farm,

resulting in non-compliance with the waiting period, to

which the similarity of the labels for standard feed and

for medicated feed contributed, as pointed out by the

veterinarian and the livestock producer in their claims.

1 Doxycycline (288 µg/kg) and

penicillin V (more than 50 µg/kg) in

sheep kidney. Targeted check.



Ruling on the penalty proceedings as a serious

infringement.



The Ministry submitted a report on its investigation,

indicating that no animal treatment records had been

found on the farm and that, given its management

approach, any treatment was improbable, since the

animals were sent quickly to the slaughterhouse.

The feed on the farm contains antibiotic residues,

probably due to cross-contamination, which differ

from the residues detected at the slaughterhouse,

although logically the feed tested is not the same as

that consumed by the animals slaughtered in August.

In conclusion, the reason for the occurrence of residue

cannot be determined with absolute certainty.

1 Oxytetracycline in sheep muscle.




209

200 µg/kg. Measures on the farm:

The official veterinary services of the District

Agricultural Office paid an inspection visit to the farm

in question, and performed the relevant investigations

into the treatment journal, showing the last notes on

treatments with oxytetracycline, records of veterinary

prescriptions for medication, and documentary checks

on incoming and outgoing animals, feed and raw

material used in animal feed. No irregularities were

detected.

Following the investigations on the farm, it can be

deduced that the reason for the non-compliance could

be failure to complete the waiting periods indicated by

the producer of the medicinal product, probably due to

a management error on the farm, although there is no

documentary proof.

After the inspection, the livestock producer was

informed that, over the first three months, monitoring

would be performed in the slaughterhouse with

sampling and action on carcasses.

Furthermore, over the first six months following this

date, the documents accompanying animals to the

slaughterhouse will mention that the farm in question

is under surveillance due to the detection of

oxytetracycline in one of the animals from that farm,

as part of measures under the National Residue

Control Plan, with a view to taking the measures set

out in Article 22 of Royal Decree No 1749/1998.

Measures at the slaughterhouse:

No samples were taken during the surveillance period

since there were no entries of animals to the

slaughterhouse.

Administrative measures:

Penalty with a fine of EUR 3 005.07.

1 Sulfadiazine in sheep kidney.


200 µg/kg.



Communications to the competent authority of origin



The farm was inspected and placed under restriction.

Its records of animal movements, treatments and feed

were checked. On the day before the positive animal

was slaughtered, a batch of animals with the same

identification number arrived. At the time of

inspection there were no animals from the same batch.

NO records of treatments in 2013 were kept for the

consignment under suspicion.

The restrictions were lifted after the waiting period for

210

the medical product, and the farm was removed from

the SCIRI.



150 µg/kg.






Revision and check by the official control services of

the self-checks at the slaughterhouse to guarantee the

safety of the carcasses being processed.


Investigation on the sheep farm, verification of the

farm records, especially those veterinary treatments,

origin, consumption of feed and prescriptions of

medicated feed containing sulfadiazine. Establishment

of precautionary restriction measures for 1 390 animals

(lambs for fattening), with one water sample showing

negative test results and another feed sample with a

result of 3.14 ppm sulfadiazine.

Further samples of unmedicated feed were taken, again

testing positive for sulfadiazine, 12 mg/kg,

trimethoprim, 6.28 mg/kg and chlortetracycline

12 mg/kg.

An inspection was carried out of the feed production

facility, checking for cross-contamination in the

production process.

The animals were slaughtered under health control

after analytical sampling from a batch of 21 animals at

the slaughterhouse, all testing negative for

sulfadiazine. Initiation of penalty proceedings

classified as serious for a quantity of EUR 5 500. The

ruling is currently pending.






Proceedings initiated and suspended after submission

to the public prosecutor's office. Communication to the

Department of Agriculture and to the Unit of

Consumer Affairs of "Mossos d'Esquadra".

Revision and verification by the official control

services of the self-checks at the slaughterhouse to

guarantee the safety of the carcasses being processed.

Measures by the Department of Agriculture:

Inspection and investigation of the reason for the non-

compliant result on the farm.

Investigation into the reason for the residue detected in

the slaughterhouse:

During the investigations on the livestock farm,

211

treatment containing sulfadiazine was detected in feed.

The documentation was checked (prescription, record

of veterinary treatments and records of departure for

the slaughterhouse) and compliance with the waiting

period was established.

Measures on the farm:

Intervention on the farm over three months with at

least one targeted sample at the slaughterhouse during

these three months.

Control of possession and use of veterinary medicinal

products:

On-farm checks of medical storage, documentation

(prescriptions and record of veterinary treatments),

medicinal products containing restricted substances

and self-checks for compliance with the waiting

periods.

The results of all checks were compliant.

1 Enrofloxacin and ciprofloxacin in

sheep muscle. Targeted check. More

than 150 µg/kg.




Proceedings initiated and suspended after submission


Department of Agriculture and the Unit for Consumer

Affairs of "Mossos d'Esquadra".


services of the self-checks at the slaughterhouse to



Inspection and investigation of the reason for the

positive result on the livestock farm.

Investigation of the reason for the residue detected at

the slaughterhouse:

The investigations on the livestock farm led to the

conclusion that the animal in which residues were

detected had not been receiving any treatment on the

farm and that it had come from a batch of lambs which

arrived one week earlier from another farm in another

Autonomous Community.

This finding was communicated to the authorities of

the other Autonomous Community.


Intervention on the farm over three months with at

least one targeted sample at the slaughterhouse during

these three months.


products:


products:

212





periods.


1 p,p'-DDE (0,155 +/- 0,078 mg/kg)

and DDT (initial: 0,173 +/- 0,086

mg/kg) in sheep fat. Targeted check.



1 p-p’ DDD+o-p’ DDT (0,053 +/-

0,027 mg/kg) and p-p’ DDE (0,254

+/- 0,127 mg/kg) and p-p’ DDT

(0,278 mg/kg) in sheep fat. Targeted

check.


Livestock, Fisheries, Food and the Environment

1 p-p’ DDE (initial: 0,023 +/-

0,012 mg/kg) and DDT (initial:

0,026 +/- 0,013 mg/kg) in bovine fat.

Targeted check.



1 Enrofloxacine and oxytetracycline

in goat muscle. Targeted check.

Both with more than 300 µg/kg.




Fisheries and Rural Development and the

corresponding provincial delegation.

The owner rejects his entitlement to a counter-analysis.

Although he picked a specimen for counter-analysis, it

was not tested within the prescribed period.

On the farm, the official control services counted 395

breeding females, and 100 animals for fattening.

No prescriptions or notes in the veterinary treatment

journal were found, suggesting that the withdrawal

periods had not been respected after giving the animals

medicated feed. No medicinal products were found on

the farm at the time. The livestock producer was

informed that the farm was subject to restrictions and

that samples had to be taken, with control of the

carcasses pending results. There were no movements

over the three months.

The proceedings are at the decision stage, with a

proposed penalty of EUR 3 005.

After the period of precautionary measures has been

satisfactorily completed, the farm is excluded from

SCIRI.

1 Sulfadiazine in goat muscle.

Targeted check.

Data entry error.


Targeted check. 170 µg/kg.




Fisheries and Rural Development and corresponding

213

provincial delegation.

Control services paid an official visit during which it

was found that the census on the farm matched that in

the database. At the time of inspection, there were 52

animals for fattening. The treatment journal indicated

the administration of a product containing the active

substance sulfadiazine. Therefore, although the

livestock producer denies it, everything points to

failure to comply with the withdrawal periods prior to

slaughtering the animals.

No animals arrived at or left the farm during the period

of precautionary measures.

The livestock producer exercised his right to a counter-

analysis, sending the sample to a laboratory which is

not accredited for the matrix substance in question.

The result is therefore considered to be invalid and the

initial result has been maintained.

Once the period of precautionary measures is

satisfactorily completed, the farm is removed from

SCIRI.

The Provincial Proceedings Department is continuing

with the food industry procedure with a proposed

penalty of EUR 3 005.

1 Lead in sheep liver. Targeted

check. More than 0,5 mg/kg.

The file has been transferred to the appropriate

Livestock Service, which carried out an inspection and

took samples of water (from stalls, pastures and a

spring), freshly cut grass, feed and soil (from six plots

on which the livestock was grazing). The analysis

results are within the accepted ranges, and do not help

to identify the origin of the contamination.

1 Lead in sheep liver. Targeted

check. 0,14 mg/kg.

Samples were taken under the Suspect Feed Plan, with

favourable results.

The inspection report indicates that the livestock

grazed and drank from one marsh area bordering the

farm, and the animals graze in small game hunting

areas.

The treatment journal was inspected, and no

discrepancies or anomalies were found. The last

recorded treatment was for parasites.

It was concluded that the levels of PB found in the

sheep muscle were not due to fraudulent

administration, and therefore no proceedings or

livestock intervention was initiated.



200 μg/kg and 192 µg/kg

respectively.






214

Since this was a repeat infringement, the period of

precautionary measures was extended to six months

instead of three months.

After the visit by the official control services, in

addition to taking a census of the animals and placing

them under restriction, treatments with a medication

containing sulfadiazine were detected.

Chlortetracycline and oxytetracycline may also have

been supplied, and therefore controls for these three

substances will be intensified. It was found that

malpractice had occurred repeatedly on the farm.

During the period of precautionary measures in two of

the samples collected, the results were non-compliant

(more than 200 μg/kg) and the carcasses were declared

unfit for human consumption and destroyed.

A penalty was proposed by both the Ministry of

Equality, Health and Social Policies and the Ministry

of Agriculture, Fisheries and Rural Development for

non-compliance with the Animal Health Law.


Control of suspect case. More than

200 μg/kg.

Sample taken as a consequence of the non-compliant

result referred to in the previous paragraph, and the

carcasses were declared unfit for human consumption

and destroyed.

2 Sulfadiazine in sheep kidney.

Control of suspect case. 121 μg/kg

and 219 μg/kg respectively.

The farm in question is the same as that referred to in

the last two paragraphs.

The party involved decided against conducting

counter-analyses. Communication to the competent

authority of origin for livestock production.

One slaughterhouse did not accept a consignment of

sheep from this farm and returned them to their place

of origin, indicating to the competent authority of

origin for livestock production the number of seals on

the vehicle transporting the animals.







slaughterhouse.

Statement to the authorities responsible for the control

on the farm of origin.

Penalty proceedings on the farm of origin. Proceedings

initiated for serious infringement in the statement of

objections phase.


Livestock: visit to the farm and documentary check.

The presence and correct identification of animals on

the holding were checked. The medical supply kit and

the waste container were checked to identify the origin

215

of the non-compliance. No physical or documentary

cause was found for the positive results, nor were any

indications of undeclared treatments detected.

Notification of the measures taken to the Department

of Health.






A counter-analysis was performed with a result of

135 μg/kg.


slaughterhouse.

Statement to the authorities responsible for the control

on the farm of origin.

Penalty proceedings against the farm of origin. File

opened for a serious infringement in the draft

resolution phase.


Livestock:

Visit to the farm and documentary check. The presence

and correct identification of animals on the holding

were checked. The medical supply kit and the waste

container were checked to identify the origin of the

non-compliance. Two consignments of medicated feed

containing the detected substance were found, and one

consignment which had not completed the withdrawal

period indicated in the prescription. Notification of the

measures taken to the Department of Health.

Porcine

2 Sulfadiazine (more than

200 µg/kg) and ampicillin (more

than 120 µg/kg) in pig kidney.

Targeted check.

Measures by the Ministry of Health



Penalty proceedings in the final phase for a sum of

EUR 3 005.70.




A visit was paid to the pig farm. The presence and

correct identification of animals on the holding were

checked. The medical kit and residue container were

checked. The holding register and the forms for

medication and medicated feed as well as the

sulfadiazine and amoxicillin prescriptions are being

checked. The farm veterinarian pointed out that the

waiting periods for the medication administered had

been completed, and that the origin of the non-

compliance was unknown. A regulatory sample was

taken to determine the group B1 substances found

216

(amoxicillin and sulfadiazine). The animals were

confined until negative test results were obtained from

sampling. The result was negative and the restrictions

were lifted.

Notification of the measures taken to the Department

of Health.

2 Flumethasone (3,7 µg/kg and

1,3 µg/kg) in pig liver. Targeted

check.



Two farms were affected (one for fattening and the

other closed loop).

Establishment of precautionary measures confining

489 and 2 216 animals (for fattening) on each of the

farms, taking one feed sample from each farm, with

negative test results. Investigation on the farms,

verification of farm registers, especially of veterinary

treatments, origin and feed consumption and

medicated feed prescriptions. No evidence of illegal

treatment was found.

The competent authority was asked to test the samples

from the batch consumed by the animals when the

substance was detected. The results were negative for

the presence of corticoids.

Slaughter under health control was performed

following analytical sampling of a batch of 19 animals

and 21 animals respectively in the slaughterhouse, all

with negative results for the detection of flumethasone.

Given the unusual nature of this finding (no authorised

veterinary products contain flumethasone), the records

of non-compliant results in all Member States from

which data had been submitted were searched, and not

one single case of non-compliant results involving this

substance was found. An anti-inflammatory vial on

one of the farms (containing dexamethasone) was also

tested to rule out the possibility of any contamination

in the laboratory production process, and no

flumethasone residues were detected. There is also the

fact that the two positive samples were taken on the

same day in the same slaughterhouse and according to

the same protocol: an investigation was therefore also

carried out in the slaughterhouse to rule out the

possibility of contamination of the samples by one of

the staff handling the livers from which samples were

taken (operators on the slaughter chain, veterinarians,

etc.), through a hand cream (this substance is one of

the normal ingredients in this type of treatment in

human medicine), but the results were not conclusive.

Since no data or suspicion pointing to illegal treatment

was obtained, it was decided not to initiate penalty

217

proceedings.

1 Doxycycline in the kidney of pig

for fattening. Targeted check.

1.890 µg/kg.




Communication to the court of first instance.

Monitoring in the slaughterhouse for three months.

Opening of penalty proceedings.

The counter-analysis showed a concentration of

2.180 µg/kg.



Once the period of precautionary measures was over,

the farm was removed from SCIRI.


A visit to the pig farm resulted in the detection of

medicated feed containing doxycycline, but intended

for piglets in transition, not for fattening. Doxycycline

was also found in powder to be added to drinking

water.

The appropriate penalty proceedings were initiated.

1 Enrofloxacin in pig muscle.


150 µg/kg.






Review and verification as part of the official control

of the self-checks in the slaughterhouse to guarantee

the safety of the carcasses being processed.


Communication with the Agri-Food Safety Service.

Form to determine the reasons for the presence of

residues: investigation of food and veterinary

treatments: although the incorrect use of a medicinal

product could be suspected, there is no proof that the

withdrawal period was not observed.

Opening of penalty proceedings by the Department of

Health, Social Welfare and Family.

1 Sulfadiazine in pig muscle.







Investigation on the pig farm, verification of the farm

registers, particularly of veterinary treatments, origin

and consumption of feed and prescriptions for

medicated feed, containing SULFADIAZINE.

Precautionary measures taken to place under

restriction 2 811 animals for fattening, taking one

218

water simple with negative test results and two feed

samples also with negative results.

Slaughter under health control following analytical

sampling from one batch of 21 animals at the

slaughterhouse, all with negative results for the

detection of SULFADIAZINE. Opening of penalty

proceedings which were finally dismissed.



150 µg/kg.




Counter-analysis 110 µg/kg.

Proceedings instituted and suspended upon submission


Department of Agriculture and the Consumer Affairs

Unit of "Mossos d'Esquadra".

Review and verification by official control of the self-

checks at the slaughterhouse to guarantee the safety of

the carcasses being processed.

Measures by the Department of Agriculture

Inspection and investigations on the livestock farm

which gave the positive result without any samples

taken.

Investigation of the cause of the residue detected in the

slaughterhouse.

The investigations on the livestock farm revealed an

injectable enroflaxacin treatment several days prior to

the transfer of the animals to the slaughterhouse. The

documentation was checked (prescription, record of

veterinary treatments and records of departures to the

slaughterhouse), and compliance with the withdrawal

period was established.

The reason for the presence of the residue in the

slaughterhouse is unknown.


products





periods.







Fisheries and the Environment, and corresponding


The producer has decided against a counter-analysis.

After the inspection of the farm, it was placed under

219

restriction for a 28-day period. In the journal for

treatments, it was observed that treatment containing

enrofloxacin had been administered. The records

therefore state that the farm would be subject to

residue controls, which would be indicated in the

origin and animal health permits, where these exist. On

the day of the inspection, there were no animals on the

farm. Notes of treatments containing enroflaxacin were

found, with a withdrawal period of nine days. It is

possible that this period may not have been completed

for some animals.

Since there were no movements on the farm, and once

the period of precautionary measures had expired, the

farm was removed from SCIRI.

A penalty of EUR 3 005 was proposed for the

slaughterhouse. Proceedings were opened and they are

at the decision stage.

1 Sulfadiazine in pig muscle.


200 µg/kg.




Fisheries and Rural Development, and corresponding


The interested party has decided against a counter-

analysis.

During a visit to the farm by the official control

services, it was found that one sick animal, which had

therefore received medication, had been sent to the

slaughterhouse by mistake. The withdrawal period for

the medicinal product therefore had not been observed.

Malpractice was established, due to failure to comply

with the waiting period, specified as 28 days in the

prescription.

Samples were taken from animals for fattening ready

to be sent to the slaughterhouse. The consignment was

perfectly marked and the results were all negative.

After the period of precautionary measures, and since

there were no more animal movements on the farm,



slaughterhouse.

4 Cadmium in pig kidney. (1,57 +/-

0,28 mg/kg, 1,26 +/- 0,22 mg/kg,

1,39 +/- 0,25 mg/kg and 1,73 +/-

0,30 mg/kg). Targeted check.


Livestock, Fisheries, Food and the Environment



Agriculture.

1 Diazinon in pig fat. Targeted

check. 0,18 mg/kg.




220

Fisheries and Rural Development, and corresponding


The producer decided against a counter-analysis.

On the farm, the official control services counted the

livestock present at the time, namely suckler cows and

pigs for fattening, feeding off the acorns on the

owner's farm under operating lease.

No medication or feed containing this product were

found. The farm is soon to be emptied and there will

be no arrivals of animals until the 'Montanheira'

period, when the pigs feed off acorns.


slaughterhouse.

Lastly, after the precautionary measures, the farm was

removed from SCIRI.

Poultry

1 Enrofloxacin in chicken muscle for

meat. Targeted check. 166 µg/kg.






The farm was placed under restriction and started the

period of precautionary measures. During this time,

there were no movements on the farm because the

existing consignments had been dispatched and the

farm was empty.


farm, checking and reviewing the treatment journals,

in which no anomalies were found. The producer

stated that the consignment of hens had not been

treated with any products containing enrofloxacin.

There was only a prescription for a booster vaccination

against Gumboro disease, and it can therefore be

assumed that no medicated feed treatments have been

recorded.

After the appropriate deadline, the party in question

decided against the counter-analysis, and the initial

result was therefore maintained.

In the three months of precautionary measures, there

were no arrivals or departures from the farm.

After the period of precautionary measures had passed,



slaughterhouse.

1 Enrofloxacin in broiler chicken

muscle. Targeted check. More than

150 µg/kg.




Final analysis 163,6 µg/kg.

221

Proceedings instituted and suspended upon submission




Review and verification as part of the official control

of the self-checks at the slaughterhouse to guarantee

the safety of the carcasses being processed.


Inspection and investigation of the cause of the

positive result on the livestock farm, with sampling:

one feed sample, one farm water sample and five

muscle samples at the slaughterhouse.

Investigation of the cause of the residue detected at the

slaughterhouse.

The investigations on the livestock farm resulted in the

detection of an enrofloxacin treatment in drinking

water a few days before the animals were transferred

to the slaughterhouse. The documentation was checked

(prescription, record of veterinary treatments and

records of departures to the slaughterhouse), and

compliance with the withdrawal period was

established.

According to the technical information sheet for the

product administered containing enrofloxacin,

depending on drinking water composition,

enrofloxacin precipitation may occur in the dosing

devices. The owner therefore attributes the non-

compliant result to this.


None of the animals on the farm was from the same

batch as the animal with the non-compliant result.

However, the batch present had also undergone the

same enrofloxacin treatment. Although the withdrawal

period had already passed, it was decided to take a

sample of water, feed and animals at the

slaughterhouse. All results were compliant


products





periods.


1 Enrofloxacin in chicken muscle.




Ruling of serious infringement in the penalty

proceedings.

222



The Ministry submitted a report on its farm inspection.

Its records therefore show the last enrofloxacin

treatment before the batch in question was slaughtered.

Compliance with the specified withdrawal period

could therefore be confirmed, and it can be assumed

that residual contamination of the drinking water

cistern and pipes had occurred. Therefore, no signs of

intent regarding the use of this substance were found.

1 Enrofloxacin in turkey muscle.







Investigation on the livestock farm, with the animals

placed under restriction (3 400 turkeys), verification of

the farm records, especially those concerning

veterinary treatments, origin and the consumption of

feed and prescriptions for medicated feed.

The start of an enrofloxacin treatment under

prescription was noted for a different batch of animals

to that in which the substance was detected. The

animals were slaughtered under health control after

analytical sampling from a batch of 21 animals in the

slaughterhouse, all showing negative results for the

detection of enrofloxacin. Start of penalty proceedings

qualified as serious for a sum of EUR 5 500, currently

still pending.

1 Enrofloxacin in poultry muscle.






The farm was removed from SCIRI because the

animals are in short-cycle production.


Visit to the farm. It was empty. A three-month

monitoring period was established.

Penalty proceedings dismissed.

1 Enrofloxacin in poultry muscle.






The farm was removed from SCIRI.


Inspection and investigation of the cause of the non-

compliant result on the livestock holding.

Investigation of the cause of the residue detected at the

223

slaughterhouse.

The investigations on the livestock holding revealed an

enrofloxacin treatment in drinking water a number of

days before the animals were transferred to the

slaughterhouse. The documentation was checked

(prescription, record of veterinary treatments and

records of departures to the slaughterhouse) and the

withdrawal period was found to have been observed.


The farm was empty at the time of inspection.


products





periods.


1 Doxycycline in poultry muscle.


100 µg/kg.



Veterinary inspectors paid an official visit to the farm

where:

The company was notified that the farm animals would

be placed under restriction as a precautionary measure

until the investigation was completed.

The “farm record book” was checked, and the

livestock batches were identified.

The farm record book of medical treatments and/or

medicated feed was checked, as were the prescriptions,

and it was found that there were no entries in the

record book on poultry from the batch from which the

sample had been taken indicating that the chickens had

received medical treatment, nor were there any copies

of prescriptions intended for the poultry on the farm.

The book of farm inspections was checked, and it was

found to have been completed. All the visits by the

ADS veterinarian coincide with the previous farm

inspections for issue of the certificate after inspection

for permits to transfer the animals to the

slaughterhouse.

The documentation and feed labels were checked.

Various types of feed, none of them medicated, were

purchased.

It was found that the self-check system of the

Salmonella Programme was in use.

Conclusions:

After the investigation, it was concluded that there was

no veterinary prescription or entry in the treatment

224

record book indicating that the poultry in the batch in

question had been treated with doxycycline.

The penalty proceedings are under way with the

Procedure Unit.

Aquaculture

1 Mercury in tuna muscle from a

fish farm. Targeted check. 1,9 +/-

0,5 mg/kg.

Investigation in the factory to establish origin (FAO

zone) and traceability, review of the HACCP

programme, where it was found that an investigative

analysis of the heavy metals had been carried out in all

consignments. The results for the consignment in

question were compliant. There was no remaining

stock of this consignment, since it had been sold in its

entirety. Penalty proceedings were not initiated since

the contamination was of environmental origin.

1 Mercury in tuna muscle from a

fish farm. Targeted check. 1,2 +/-

0,3 mg/kg.

Investigation in the factory to establish origin (FAO

zone) and traceability, review of the HACCP

programme, where it was found that an investigative

analysis of heavy metal residues had been carried out

in all consignments. The results for the consignment in

question were compliant. There was no remaining

stock of the consignment in question, since it had been

sold in its entirety. Penalty proceedings were not

initiated since the contamination was of environmental

origin.

1 Arsenic in piece of fish. Targeted

check.

1,08 +/- 0,25 mg/kg.

Measures by the Department of Agriculture, Food and

Rural Action.



Agriculture.

1 Mercury in piece of fish. Targeted

check.

0,115 +/- 0,018 mg/kg.

Data entry mistake. Results are compliant because the

limit set out in the legislation was not exceeded.

1 Arsenic in piece of fish. Targeted

check.

0,29 +/- 0,07mg/kg.


Rural Action.



Agriculture.

1 Brilliant Green in piece of fish

(rainbow trout). Targeted check.

0,5 µg/kg.


Regional Natural Resources: since this substance is not

authorised as a medicinal product but has a possible

use as a bactericide, investigation measures and

sampling was carried out on the farm, with the

following results:

Correctly archived prescriptions and treatment records.

No indications of the presence on the fish farm of

chemical substances were detected (cleaning products,

D+D+D, other biocides, etc.), or of any other suspect

substance.

225

No other possible sources of contamination were

detected in water upstream from the fish farm

(factories, laboratories, etc.).

All the samples collected (animals from the different

lots, incoming water, outgoing water and each of the

tanks), are sending out negative results.

As regards the measures taken, and given the

compliant results for all the samples taken, the

following monitoring actions should to be taken over

the following 12 months:

Representative samples in triplicate, once every two

months, from batches intended for consumption.

Investigation into veterinary medicinal products.

Investigation of the presence of chemical substances

(cleaning products, D+D+D, other biocides, etc.) on

the fish farm, and of any other suspect substance.

To date, all the samples taken during monitoring tested

negative.

Penalty proceedings have been initiated.

Milk

1 Aflatoxin M1 in cow's milk.



Penalty proceedings initiated in the statement of

objections phase.

Communication to the authorities responsible for

monitoring on the farm of origin.


Livestock:

Visit of the farm to find the origin of the

contamination in feed and primary materials. No damp

or fungal growth was found. Samples were taken of

maize, cotton seed and milk with negative results.

These measures were reported to the Health Service.

1 Doxycycline in sheep's milk.

Targeted check.

Data entry error.

2 Doxycycline in cow's milk.

Targeted check. 9,8 and 1,7 µg/kg.


Rural Action.

Verification of the self-checks on livestock farms

which gave rise to non-compliant results.

Instructions were given to the local veterinary services

to investigate the reason for the non-compliant results,

paying attention to the exceptional prescription.

1 Aflatoxin M1 in cow's milk.

Control of suspect case. 0,120µg/kg.


Livestock:

Given the communication of non-compliant results

from a dairy farm, a visit was paid to the farm of

origin. Identification and documentary checks were

run. Fodder and primary material were checked.

Samples were taken of raw milk with non-compliant

226

results of 0.12 μg aflatoxin M1/kg, the milk was

destroyed and a new sample was taken with negative

results. Samples of primary materials were taken:

rescue grass, vetch hay, cotton seed, straw, dried

alfalfa and compound feed, all with negative results.

These measures were reported to the Health Service.

Eggs

1 Enrofloxacin (more than

37,5 µg/kg) and ciprofloxacin (more

than 37,5 µg/kg). Targeted check.






Counter-analysis of more than 37,5 µg/kg for both

substances.

Proceedings initiated and suspended when sent to the

public prosecutor's office. Communication to the




services of the self-checks on the establishment to



Instructions were given to the local veterinary services

to investigate the reason for the non-compliant result,

focussing on the exceptional prescription.

Results of the investigations are pending.


10 µg/kg). Targeted check.






An inspection of the farm was carried out, the eggs to

be dispatched to the packaging centre were withheld

and the traceability of these eggs which may have been

on the market was ensured.

Samples were taken from the eggs on the farm and the

test results were positive (more than µg/kg).

After this result, all animals on the farm were placed

under restriction without a deadline.

Once all the eggs on the market were located, they

were destroyed in accordance with Regulation (EC)

No 1069/2009.

The traceability of all the eggs on the market was

checked and, once located, they were destroyed as

category 1 in line with Royal Decree No 1069/2009.

The hens were sent to the slaughterhouse in line with

the guidelines in the procedure for action in the case of

non-compliant results in the national residue

227

investigation plan.

Further samples were taken on the farm, with

favourable results.

The period of precautionary measures followed,

although the restriction on the hens was lifted, with an

indication in the record that when the animals in

question were to be transferred, a representative

sample would be sent for testing.

Further sampling was carried out in the packaging

centre, and all results were favourable.

After the period of precautionary measures had passed,


A penalty of EUR 3 005 was proposed to the egg

packaging centre.


10 µg/kg). Control of suspect case.

Sampling as a consequence of the non-compliant result

mentioned in the previous paragraph.

Once all the eggs on the market had been located, they

were destroyed in accordance with Regulation (EC)

No 1069/2009.

The traceability of all the eggs placed on the market

was checked and, after being located, they were

destroyed as category 1 eggs in line with Royal Decree

No 1069/2009.

Rabbit

1 Doxycycline in rabbit muscle.





The official veterinary services of the District

Agricultural Office carried out an inspection of the

farm, with the consequent relevant investigations,

relating to the treatment records, prescriptions for

veterinary medicinal products and the documentary

checks on incoming and outgoing animals, feed and

primary material intended for animal feed, without any

irregularities being detected.

During the investigation, it was found that the owner

had given various types of medicated feed to the

animals in the fattening phase, some containing

doxycycline as a medicated premix. These were

supplied under veterinary prescription.

The withdrawal period indicated on the veterinary

prescription is 28 days, although the responsible

veterinarian in the feed factory who issued the

veterinary prescription reported that the withdrawal

period observed on the farm prior to dispatch to the

slaughterhouse was 7 to 8 days, since it was

considered sufficient following in-house tests to check

that no residue remained in the meat.

228

Since these are short-cycle animals, departure of

animals to the slaughterhouse was limited until a

favourable result was obtained following

representative sampling of the animals in the fattening

phase. After the compliant result for these samples, the

rest of the batch was sent out.

Information was requested from the veterinarian

concerning the prescription for medicated feed. The

veterinarian claimed that the residue came from

treatment to prevent Pasteurella multocida, since the

farm in question was experiencing problems with this

and the choice of doxycycline follows on from the

antimicrobial susceptibility tests performed on various

farms with the same problem.

Both the livestock farmer and the responsible

veterinarian of the feed factory were informed that this

feed should have been prescribed by way of exception,

according to the provisions in Article 4 of Royal

Decree No 1904/2009 on medicated feed and Articles

80 and 82 of Royal Decree No 109/95 on veterinary

medicinal products, completing the required waiting

time of 28 days.

The livestock farmer was informed that the farm

would remain under alert for 12 months and that,

during those months, it would be subject to sampling.

Since the feed factory is located in another

Autonomous Community, this incident was reported to

the competent authorities for animal feed for their due

action.

Measures in the slaughterhouse:

During the surveillance period, 21 samples were taken,

all of them showing compliant results.

Administrative measures:

The proceedings initiated by the legal services have

expired. Since the infringement committed has not yet

expired, the proceedings will be initiated again on the

same grounds.

Honey

1 Sulfathiazole. Targeted check.

1,4 µg/kg.


Rural Action.

Investigation into the reason for the non-compliant

result on the farm, with sampling.

This is a subsistence farm. The veterinary treatments

record has been revised and no trace of any treatments

with sulphonamides were found. Nor was the presence

of this medication found on the farm.

Sampling with satisfactory results.

The owner attributes the results to the proximity of a

229

water-treatment plant and of farms on which animals

are treated with antibiotics.

Equine – Wild game – Farmed game

None None

230



Member State SWEDEN

Group A substances


None




None None

Group B substances


None




None None

231



Member State UNITED KINGDOM

Group A substances


None


Bovine

Fourteen cases of zeranol found in

cattle urine samples at 0,96 µg/l,

1 µg/l, 1,78 µg/l, 2,32 µg/l, 2,6 µg/l,

2,74 µg/l, 3 µg/l, 3,4 µg/l, 3,7 µg/l,

4,1 µg/l, 4,8 µg/l, 15,6 µg/l,

19,3 µg/l and 23,8 µg/l.

No investigations were required for these as research

has shown that low levels of zeranol and fungal

metabolites may be present in the urine of animals that

have ingested feedingstuffs contaminated with the

fusarium fungus.

Eleven cases of thiouracil found in

cattle urine samples at 10 µg/l,

11 µg/l, 13 µg/l, 16 µg/l, 16 µg/l,

17 µg/l, 5 µg/l, 25 µg/l, 26 µg/l,

29 µg/l and 47 µg/l.

For each of these samples the source of non-

compliance is considered to be most likely due to

animals being fed on a diet rich in brassica.

One case of chloramphenicol found

in a cattle urine sample at 0,5 µg/l.

According to the medicine records this animal had not

received any treatments, only routine medicinal use

that is expected in dairy herds. There was no evidence

of any chloramphenicol-containing drugs on the farm

and follow-up samples, which included a sample from

the original animal, were all compliant.

Ovine & caprine

One case of thiouracil found in a

sheep urine sample at 14 µg/l.

The source of non-compliance is considered to be most

likely due to animals being fed on a diet rich in

brassica.

Porcine

One case of thiouracil found in a pig

urine sample at 16 µg/l.

The source of non-compliance is considered to be most

likely due to animals being fed on a diet rich in

brassica.



None None

232

Group B substances


None


Bovine

One dihydrostreptomycin in calf

kidney at 3.200 µg/kg.

The medicine records of this farm had no recording of

this calf being treated, however, the farmer conceded

that it was possible that a member of staff could have

used it for something like a navel infection but failed

to record it. This unrecorded treatment and subsequent

slaughter within the withdrawal period is considered to

be the most likely cause of this residue. The farmer has

been given written advice about the requirements for

accurate record keeping and this case has been referred

to the Rural Payments Agency.

Two doxycycline in calves kidneys

at 30.000 and 56.000 µg/kg.

For the case concerning the concentration of

30.000 µg/kg, the cause is mostly likely due to the calf

being erroneously fed with medicated feed. The

treatments of Karidox had not been recorded in the

medicine records as the current software package was

unable to record batches of treated cattle. The farmer

was given written advice regarding the requirement for

keeping accurate records and how to avoid such

residues in future and this case has been referred to the

Rural Payments Agency.

For the 56.000 µg/kg case, the farmer’s vet confirmed

that doxycycline had been prescribed for use on this

farm; however there was no record of this treatment in

the medicine records. The cause of this residue is from

an unrecorded treatment and subsequent erroneous

slaughter within the withdrawal period. The farmer has

been given written advice on how to avoid such

residues in future and this case has been referred to the

Rural Payments Agency.

One gamithromycin in calf kidney at

210 µg/kg.

This calf was treated with Zactran which has a 64 day

withdrawal period. Although medicine records are kept

for calves on this farm, they were not checked prior to

sending this animal to slaughter, five weeks before the

end of the withdrawal period. The farmer has been

given written advice on how to avoid such residues in

future and this case has been referred to the Rural

Payments Agency for consideration.

233

One sulfadiazine in calf kidney at

180 µg/kg.

The farmer had not recorded a treatment of Strinacin

20 which has a withdrawal period of 15 days.

Although the exact treatment date is unknown it is

assumed that this animal was sent to slaughter whilst

still within the withdrawal period. The farmer has been

given written advice on how to avoid such residues in

future and this case has been referred to the Rural

Payments Agency.

One tulathromycin in calf kidney at

4.400 µg/kg.

This residue originated from a bull calf which came

from a dairy farm under TB restriction. The cause of

this residue is because this animal was sent to

slaughter within the withdrawal period following

administration of Draxxin. This case will be referred to

the Rural Payments Agency.

One closantel in cattle liver at

2.180 µg/kg.

This animal was from a beef breeding herd and upon

inspection of the medicine records it was revealed that

there was a discrepancy in the dates of a closantel

treatment between the farm notebook and the official

record. The cause of this residue is because this

mistake led to the slaughter of this animal within a

withdrawal period. The farmer received a penalty and

the herd will be targeted at a later date.

One halofuginone in calf liver at

110 µg/kg.

On this dairy farm, only medicine treatments to the

milking cows were recorded in the medicine records.

All other treatments were not recorded for any other

animal on farm. The farmer had treated this calf with

Halocur prior to slaughter and claimed to be unaware

of any withdrawal period for this product, despite his

vet confirming that he had told the farmer where to

find withdrawal information on the product literature.

This farmer has been given written advice on the

requirements for keeping full and accurate medicine

records and this case has been referred to the Rural

Payments Agency for consideration.

One phenylbutazone in cattle liver at

9,1 µg/kg and oxyphenbutazone at

1,31 µg/kg.

This animal was from a small beef finisher herd and

the farmer could not explain how this residue had

occurred. He had two mares and foals at the premises

but stated that phenylbutazone was not used in them

and no evidence of the use of this substance was

found. Therefore, it was not possible to adequately

establish the cause of this residue, however, the farmer

received a penalty and the herd will be targeted at a

later date.

234

Seven cadmium in cattle kidneys at

1.010 µg/kg, 1.100 µg/kg,

1.100 µg/kg, 1.200 µg/kg,

1.274 µg/kg, 1.600 µg/kg and

2.000 µg/kg.

The investigations in the cases of 1.010 and 1.100

concluded that the causes of these residues were due to

environmental contaminants.

The investigations in to the cases of 1.100, 1.200,

1.274, 1.600 and 2.000 concluded that as there was no

obvious source of cadmium on the farms, and as these

were older animals the most likely cause of these

residues was due to accumulation in the kidney over

time.

One cadmium and lead in cattle

kidney at 2.900 and 1.100 µg/kg,

respectively.

This residue came from a 9 year old cow which was

born on the farm where it lived its entire life. Some

fields were leased to another farm in the past where

maize was grown in an adjacent field to the grazing

land. It is possible that strong fertilizers used on the

maize contaminated the grazing land which has

contributed to this accumulation over time.

One lead in cattle kidney at

550 µg/kg.

This non-compliant residue originated from an eight

year old cow. There was no obvious source of lead on

the farm therefore, the cause of this residue is most

likely due to an accumulation over time from

environmental contamination.

Ovine & caprine

One fenbendazole in sheep liver at

640 µg/kg.

This farmer applied the wrong withdrawal period and

the animal was sent to slaughter too early. The farmer

has been given written advice on how to avoid such

residues in the future and this case has been referred to

the Rural Payments Agency.

Two cadmium in sheep kidneys at

1.300 and 1.700 µg/kg.

It was not possible to trace the origin of the animal

from which the concentration of 1.300 µg/kg came

from therefore no investigation could take place.

For the residue of 1.700 µg/kg there was no obvious

source of possible cadmium contamination, therefore,

it was not possible to adequately determine the cause

of this residue.

One lead in sheep kidney at

1.200 µg/kg.

This farm is made up of 30 acres of grazing land which

is known to have been mined for lead in the 1950’s

and there has been some history of lead poisoning in

cattle some years ago. The farmer has been given

advice on how to manage exposed areas to avoid these

residues in future.

One ibuprofen in sheep kidney at

13 µg/kg.

Initial enquires showed that the sampling officer was

taking ibuprofen at the time of sampling and this result

is likely to be the cause of cross-contamination.

Porcine

One chlortetracycline in pig kidney

at 1.700 µg/kg.

The most likely cause of this residue was from cross

contamination of medicated feed on farm and the

farmer has been given written advice on how to avoid

such residues in the future.

235

One albendazole in pig liver at

33 µg/kg.

This animal originated from a farm which breeds their

own pigs for slaughter. The herd keeper stated that

albendazole has never been bought, used or prescribed

on the farm and he believed that the animal in question

must have eaten something elsewhere to have been

exposed to albendazole. Five follow-up samples were

collected, two were compliant but three contained

albendazole at 0.5, 1.2 and 1.2 µg/kg. Three further

batches of samples were collected on farm and all were

compliant. A feed sample was collected from the farm

which was also compliant for albendazole but low

levels of sulphadiazine and trimethoprim were

detected in it. The farmer received an SMR11 penalty

and was given written advice on how to avoid such

residues in future.

One ibuprofen in pig kidney at

6,9 µg/kg.

Pigs usually arrive at this farm at 12 weeks of age and

are fattened for approximately 10 to 12 weeks. On

arrival, pigs are fed medicated feed for one week then

usually no other medication is required. No ibuprofen

had been administered to any of the pigs nor had it

been used by the staff. The sampling officer had been

taking ibuprofen in tablet form but the likelihood of

contamination is considered minimal. Therefore it was

not possible to determine the cause of this residue.

Equine

One cadmium in horse kidney at

8.400 µg/kg.

Unable to trace the origin of this horse, therefore, it

was not possible to carry out an investigation into the

cause of this residue.

Poultry

One amoxicillin in broiler muscle at

290 µg/kg.

The investigation established that the most likely cause

of this residue is due to accidental cross contamination

on the farm in the water delivery system. Octacillin

had been used on a different batch a few months prior

to this slaughter date and there may have been some

medicated water left in the system. The farmer has

been given written advice on how to prevent such

residues occurring in the future.

236

Two chlortetracycline in broiler

muscle at 110 and 240 µg/kg.

For the residue of 110 µg/kg, the birds were given an

Aurofac feed treatment which ended 5 days prior to

slaughter, which complies with the withdrawal period,

however, it is likely that as the pipeline for medicated

and non-medicated feed is shared there was residual

contamination resulting in this non-compliant residue.

The farmer has been given advice on how to avoid

such residues in the future.

For the residue of 240 µg/kg, the cause is due to cross

contamination of medicated feed carried over with

non-medicated feed in the belts or spillage from joints.

The farm is currently changing to digital timers which

will reduce likelihood of feed getting crushed or

becoming dust and so carry-over will be reduced.

One chlortetracycline in turkey

muscle at 130 µg/kg.

The investigation at the feed mill which supplied this

farm could not identify any opportunity for

contamination and retained samples of the feed batches

were analysed and found to be compliant. The farm’s

vet confirmed that chlortetracycline had not been

prescribed for this site since 5 months prior to

slaughter and could not offer any possible reason for

this residue. The Food Standards Agency (FSA)

withheld this consignment of turkeys from the food

chain. In accordance with legislation, the food business

operator opted to challenge the result and further

testing of the original sample has since provided a

compliant result. The FSA has been informed. The

farm will be targeted at a later date.

One lasalocid and salinomycin in

broiler liver at 270 and 57 µg/kg,

respectively

The investigation into this residue established that it

was caused by the feed manufacturer supplying the

farmer with medicated feed in error. The mill has been

given written advice on the practises they need to

adopt to avoid such errors in the future.

Aquaculture

One leucomalachite green in trout

skin & muscle at 7,1 µg/kg.

Movement restrictions were placed on the fish while

further target samples were taken. These confirmed as

compliant and the movement restrictions were lifted

with no further action taken.

Milk

One amoxicillin in cattle milk at

4,9 µg/l.

It is likely that cross contamination occurred by the

person who administered the product to another

animal, then handled the sample pot when the sample

was taken.

237

Two penicillin g in cattle milk at 5,4

and 17 µg/l.

The cause of the 5,4 µg/l residue is due to the cow

calving earlier than expected and the farmer milking

this animal whilst within the withdrawal period. The

farmer has received written advice on the requirements

for keeping accurate medicine records to avoid such

residues in future.

The investigation established that the cause of the

17 µg/l residue was due to a sampling error. The

farmer directed the sampling officer to a waste tank

subsequently detecting this residue.

One flubendazole in cattle milk at

1 µg/l.

This sample of milk had been collected from a 109

animal dairy and beef rearing farm. The investigating

officer noted that the medicine records were not kept

in accordance with legislation. A follow-up sample

was collected which was compliant. It was suggested

the residue was due to some of these cows being

treated on the farm of origin, however, a SMR10

penalty was applied and the farmer received written

advice on how to avoid such residues in the future.

One ivermectin in cattle milk at

2,9 µg/l.

The farmer administered Premadex Pour On to cows at

drying off which is contra-indicated in the product data

sheet, however, the medicine records were incomplete.

The farmer has been given written advice on the use of

veterinary medicines and the requirement for adequate

record keeping and has also been referred to the Rural

Payments Agency for further action.

One nitroxynil in cattle milk at

51 µg/l.

The medicine records were accurate and recorded a

treatment of Trodax and the discarding of the milk.

However, the farmer admitted that he may not have

discarded the milk on the day of sampling. The farmer

was unaware that Trodax is no longer permitted in

dairy cows and was given verbal advice on consulting

with his veterinary surgeon to avoid such residues in

the future. The vet was contacted and agreed to send

advisory leaflets to all their clients with regard to the

changes in flukicide use. A follow up visit will be

carried out by the AHVLA Officer.

One triclabendazole in cattle milk at

37 µg/l.

The most likely cause of this residue is due to a cow

which calved before the expected due date after being

given Triclacert 10% Fluke Drench and therefore the

lactating cow would have still been in the withdrawal

period. The farmer has been given written advice on

how to avoid such residues in the future.

Eggs

Two oxytetracycline in free range

hen eggs at 240 and 270 µg/kg.

The investigation in to the concentration of 240 µg/kg

showed that it was clear that the withdrawal period

was observed; however, the cause of this residue could

not be established.

238

For the case of 270 µg/kg, oxytetracycline had not

been used on this farm however, a ‘sister’ farm located

nearby had used this substance. The medicine records

were incomplete, but there was evidence of the use of

Franvet (an imported veterinary medicine from France

containing oxytetracycline) at a date prior to the arrival

of this flock. Also, feed intended for one farm may

have been erroneously delivered to the other. The

farms now use different suppliers to prevent this from

happening again. It is possible that cross

contamination has occurred.

One sulphadiazine in a free range

hen egg at 135 µg/kg.

The most likely cause of this residue is due to

contamination at the mill.

Five lasalocid in free range eggs at

190 µg/kg, 220 µg/kg, 230 µg/kg,

880 µg/kg and 1.100 µg/kg.

190 µg/kg: The investigation into this residue

concluded that the most likely cause was due to slides

not shutting completely on the conveyor which feeds

the finished products bin at the manufacturing mill.

220 µg/kg: This egg originated from a shed which

housed 19 week old hens which were fed layer pellets

for the previous 5 weeks. The feed was purchased

bagged but the mill had not retained samples of bagged

feed (as is practice not to) therefore it was not possible

to adequately determine the cause of this residue. The

mill has been advised to retain samples of feed for

both bulk and bagged consignments in the future.

230 µg/kg; The manufacture of the last 2 batches of

feed delivered did not follow any medicated feed

therefore it was not possible to adequately determine

the cause of this residue. The mill has, however, taken

steps to ensure that cross-contamination is unlikely to

occur.

880 µg/kg; This farm purchases plain layers pellets, of

which a retained sample contained a residue of

lasalocid at a concentration of 5400 µg/kg. The

investigation at the feed mill could not find any

evidence that contamination occurred as a result of

production scheduling; therefore, it was not possible to

adequately determine the cause of this residue. The

mill will undergo a routine inspection early in 2014.

1.100 µg/kg; This egg originated from a farm with 700

laying hens at any one time which are housed in

traditional wooden houses. Every three months 100

pullets are brought in and these are fed rearer pellets

and anti-coccidiol supplements. Some of these pullets

formed part of the laying flock which resulted in this

residue. The farmer has immediately ceased this

practice using layers meal in future and he was given

written advice on how to avoid such residues in future.

239

Farmed game

One lasalocid in quail muscle at

46 µg/kg.

On this farm, in the first 5 days of life the quails are

fed a medicated starter feed and then on to a quail

grower for the next 30 days until slaughter. The feed

management practice is good using a separate feed bin

for medicated feed. The investigation into the mill

found no obvious source of contamination and further

sample analysis was compliant. It could be speculated

that there may have been a spill on farm but there is no

evidence to support that, therefore, it was not possible

to adequately determine the cause of this residue.

Rabbit – Wild game – Honey

None None

report on the implementation of national residue ... · 2 regulation (ec) no 396/20055 or the...

Documents